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 1
Summary 
 
The Sertoli cell tight junction (TJ) of the seminiferous epithelium is the major component of 
the blood-testis barrier (BTB), and is important for the developmental process of spermatogenesis as it 
separates germ cells in the seminiferous tubules from components of the general circulation in the 
testicular interstitium. Absence of the TJ leads to spermatogenic arrest and infertility. TJs form at 
puberty as circulating gonadotrophins luteinising hormone (LH) and follicle stimulating hormone 
(FSH) increase, with LH causing elevated serum and testicular testosterone (T). Several studies have 
demonstrated hormonal regulation of the two major TJ proteins, claudin-11 and occludin, and also of 
TJ function in vitro and in vivo. Men with low levels of circulating gonadotrophins exhibit an 
immature and dysfunctional TJ phenotype, which is reversed upon the exogenous application of 
gonadotrophins.  
This thesis hypothesises that claudin-11 and occludin are the major contributors to TJ 
function, and that gonadotrophins regulate TJ function and structure via these two proteins in several 
species including humans. 
This PhD was divided into four separate studies to address these hypotheses. The first study 
assessed the relative contribution of claudin-11 and occludin to TJ function in vitro using small 
interfering RNA (siRNA)-mediated gene silencing in cultured immature rat Sertoli cells.  As a result 
of silencing both proteins, separately or in combination, TJ function was significantly (p < 0.01) 
reduced as measured by transepithelial electrical resistance (TER). This was associated with marked 
reductions in the localisation of the siRNA targeted protein to the TJ in vitro as shown by 
immunocytochemistry, with minimal effects on other nearby proteins or cell junctions. A significant 
(p < 0.01) reduction in claudin-11 mRNA expression was also observed following claudin-11 siRNA 
treatment as assessed by real-time RT-PCR analysis. It was concluded in this study that both claudin-
11 and occludin contribute significantly to TJ function in vitro. 
The second study then aimed to determine the effect of gonadotrophin suppression and short-
term hormone replacement on TJ structure and function in a gonadotrophin releasing hormone 
(GnRH) antagonist-treated rat model in vivo. Weekly injections of the GnRH antagonist, acyline, 
significantly suppressed testis weights, serum LH, FSH, and androgens as well as germ cell numbers. 
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This was coincident with undetectable occludin staining, and the relocalisation of claudin-11 from the 
Sertoli cell TJ to the cytoplasm as assessed by immunohistochemistry in vivo. Western blot analysis 
also revealed decreases in the protein expression of both proteins. Disruption to TJ structure 
was associated with a disruption in TJ function as shown by the penetration of small 
molecular weight tracer biotin into the seminiferous tubules, which had been excluded to the 
testicular interstitium in control rats.  
Short-term hormone replacement (daily, one week) with human recombinant FSH, 
human chorionic gonadotrophin (hCG) (to stimulate testicular production of testosterone and 
FSH), and hCG + FSH antibody (to stimulate testicular production of testosterone alone) 
partially reversed the acyline-induced effects as shown by significant recoveries in testis 
weights, serum hormones and germ cell numbers. The reinitiation of spermatogenic activity 
was associated with some occludin and claudin-11 relocalisation to the TJ, although limited 
biotin tracer permeation remained . It was therefore concluded that gonadotrophins regulate 
TJ structure and function in vivo, and that re-initiation of spermatogenesis does not require a 
fully functional TJ.  
The third study aimed to analyse the role of gonadotrophin regulation in TJ formation. 
This aim used the hypogonadal (hpg) mouse model, which is a naturally occurring model of 
hormone deficiency, with basal levels of LH/T, undetectable FSH, arrested spermatogenesis 
and incomplete TJs. Immunohistochemical analysis revealed extensive claudin-11 staining at 
the TJ in wildtype testes, whereas claudin-11 localised to the cytoplasm of Sertoli cells in hpg 
testes. Wildtype TJs were fully functional as shown with biotin tracer, whereas hpg testes 
exhibited extensive biotin penetration throughout the tubules indicating dysfunctional TJs.. 
The presence of transgenic FSH (tgFSH) in hpg mice stimulated a redistribution of claudin-11 
to the Sertoli cell TJ, which varied from being dysfunctional to functional. Administration of 
the potent androgen dihydrotestosterone (DHT) to hpg mice stimulated claudin-11 
redistribution toward the TJ after 2 days, with extensive claudin-11 at a functional TJ by 10 
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days. The proportion of functional tubules in the hpg + tgFSH mice also appeared to 
qualitatively increase following DHT treatment. 
Claudin-3 is a recently-described androgen-regulated protein present at mouse Sertoli 
cell TJs. It is transiently expressed as germ cells cross the BTB, hence this third study 
additionally aimed to analyse claudin-3 recruitment to the TJ following DHT treatment and 
the initiation of spermatogenesis. Claudin-3 staining at TJs was extensive in wildtype mice, 
but absent in hpg mice and predominantly absent in hpg + tgFSH mice. Claudin-3 staining 
was not detectable in hpg mice until 10 days of DHT treatment, but was detectable after 2 
days of DHT treatment in hpg + tgFSH mice. These results indicated a priming role for FSH 
in the localisation of androgen-dependent claudin-3 to the TJ. It was concluded that 
gonadotrophins regulate the formation of a structurally and functionally competent TJ in the 
mouse, which is associated with the recruitment of claudin-3 to the TJ. 
The final study of this thesis aimed to examine TJ structure and mRNA expression in 
men given male hormonal contraception (MHC) for 8 weeks to suppress circulating FSH, LH, 
and hence testicular spermatogenesis. Claudin-11 staining was extensive at the TJ in control men 
but generally became punctate following hormone suppression. The extent of claudin-11 disruption 
was usually associated with the extent of adluminal germ cell suppression which had been quantified 
previously. TJ mRNA expression levels of claudin-11 did not change following gonadotrophin 
suppression. It was concluded that gonadotrophins also appear to regulate the structure of the Sertoli 
cell TJ in men. 
In summary, it is concluded that the Sertoli cell TJ is hormonally regulated, and that the major 
contributors to TJ function in vivo and in vitro are claudin-11 and occludin. It is hypothesised that the 
reduction of claudin-11 localisation to the TJ in men may also result in a loss of human Sertoli cell TJ 
function, suggesting that the TJ may be a potential target of hormonal contraception in men. 
 
 
 
 
 
 
 
 
 
Chapter One: Literature Review 
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1.1 Introduction 
Spermatogenesis is the process of germ cell development in the testis, and involves complex 
interactions between testicular components of the interstitium and seminiferous tubules with each 
other and the germ cells. In particular, the Sertoli cell of the seminiferous epithelium is the key 
provider of nutrients and structural support and the key mediator of hormone and other signals 
essential to the germ cell during spermatogenesis (Aravindan et al. 1997, Griswold, 1998, Cheng and 
Mruk, 2002). 
The Sertoli cells also provide the inter-cellular junctions between themselves and the germ 
cells. These junctions include the gap junctions which specialise in cell-cell communication and the 
adhesive type junctions such as the desmosomes, ectoplasmic specialisations and the adherens 
junctions which serve to i) adhere the Sertoli cells to the basement membrane of the seminiferous 
epithelium or ii) adhere the Sertoli cells to other Sertoli cells or iii) adhere Sertoli cells to germ cells 
(Russell and Peterson, 1985, Pelletier and Byers, 1992, Mulholland et al. 2001, Lui et al. 2003a, Lui et 
al. 2003b).  
The blood-testis barrier (BTB) which utilises these adhesive junction complexes to regulate 
germ cell migration into the seminiferous tubules is another provision of the Sertoli cells. The major 
component of the blood-testis barrier is another junctional type called the Sertoli cell tight junction 
(TJ) (Setchell, 2004). These TJs provide germ cells with a specialised microenvironment in the 
seminiferous tubules in which to develop into mature sperm. TJs achieve this by sealing the 
membranes of adjacent Sertoli cells together and thereby separating the germ cells from the general 
circulation (Cheng and Mruk, 2002). 
In general, TJs form the paracellular pathway between cells, and are size-selective in which 
solutes or molecules can cross the barrier (Moroi et al. 1998). In the testis, the absence of the Sertoli 
cell TJ means that the germ cells are exposed to components of the blood stream, and spermatogenesis 
stops, resulting in infertility Chung and Cheng, 2001, Chung et al. 2001). TJs are therefore an essential 
component of the seminiferous epithelium, which form at puberty when hormone levels increase and 
spermatogenesis starts (Vitale et al. 1973, Setchell et al. 1981, Russell and Peterson, 1985, Setchell et 
al. 1998).  
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TJs are not unique to the seminiferous epithelium, in fact they are ubiquitous in all epithelia 
and form barriers between body cavities or blood vessels and bodily organs. The loss of the TJ from 
the blood-brain barrier results in excessive fluid accumulation in the brain and can be potentially fatal 
(Hirase et al. 1997). Its absence from the skin results in the death of mice at birth due to massive 
transepidermal water loss (Furuse et al. 2002) and when the intestinal epithelium lacks a TJ, water loss 
occurs and diarrhoea results (Mitic et al. 2000). Over the past several decades, researchers applied in 
vivo and in vitro techniques to analyse the changes in TJ function in response to various stimuli and 
this has enhanced the general understanding of the role of the TJ, but also raised further questions 
about which components of the TJ are most important for its function, and to what extent a TJ can be 
disrupted before function is lost (Pelletier, 1986, Pelletier, 1988, Hirase et al. 1997, Mitic et al. 2000, 
Tao et al. 2000, Furuse et al. 2002, Myers et al. 2005, Kaitu’u et al. 2007, Tarulli et al. 2008). 
In the testis, the gonadotrophins luteinising hormone/testosterone (LH/T) and follicle 
stimulating hormone (FSH) regulate spermatogenesis (Griswold, 1998). Evidence shows that 
gonadotrophins also regulate the Sertoli cell TJ, which forms at puberty as gonadotrophin levels 
increase as already mentioned. At the molecular level, men exhibiting low levels of circulating 
gonadotrophins displayed an immature TJ phenotype which was reverted to a mature phenotype upon 
the exogenous application of gonadotrophins (de Kretser and Burger, 1972). More recent in vitro and 
in vivo studies have shown that LH/T and FSH ablation disrupts Sertoli cell TJ structure and function, 
although this is model dependent (Pelletier, 1988, Florin et al. 2005, Meng et al. 2005, Myers et al. 
2005, Tarulli et al. 2006, Kaitu’u et al. 2007, Tarulli et al. 2008). In the Sertoli cell specific androgen 
receptor knockout mouse, TJs are absent or marginal (Meng et al. 2005), and when FSH is given to 
seasonally regressed testes of the Djungarian hamster which display dysfunctional Sertoli cell TJs, TJ 
function is restored (Tarulli et al. 2008). Disruptions in the function of the Sertoli cell TJs are 
associated with disruptions to spermatogenesis, suggesting that TJs are pivotal to successful 
spermatogenesis and that their function is conferred by hormonal regulation. 
 The scope of this literature review will be to outline the entire process of spermatogenesis, the 
role of the Sertoli cell, the structural components of the TJ, and studies which have analysed changes 
in TJ function and size-selectivity in response to various stimuli including gene knockouts and 
wounding.  
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1.2 Overview of spermatogenesis 
 
1.2.1 The mammalian testis 
The testis is encased in a tough fibrous skin termed the tunica albuginea and is composed of 
two functional units- i) the interstitium, which contains Leydig cells, peritubular myoid cells, 
lymphocytes and macrophages and ii) the seminiferous tubules (Ross, 1995), which are highly 
convoluted structures taking up most of the testis and where germ cell development, or 
spermatogenesis occurs (Figure 1.1). The seminiferous tubule is composed of the seminiferous 
epithelium, which comprises germ cells and the somatic Sertoli cells.  
Sertoli cells are attached to the basement membrane of the tubule and extend toward the tubule 
lumen. Throughout spermatogenesis, germs cells occupy niches formed by the Sertoli cells with which 
they are always in contact via complex cell junction formations (Meachem et al. 2001, Sofikitis et al. 
2008). In later stages of spermatogenesis, germ cells occupy a cavity formed by the invagination of the 
Sertoli cell (Russell and Clermont, 1976, de Kretser and Kerr, 1988, Russell et al. 1990). Because of 
their close association, it can be assumed that both germ cells and Sertoli cells interact and 
communicate with each other. Over the past several decades, studies have shown that Sertoli cells 
provide nutritional and structural support to developing germ cells (Aravindan et al. 1997, Griswold, 
1998, Cheng and Mruk, 2002). As spermatogenesis progresses, early germ cells move from the 
basement membrane, across the blood-testis barrier and Sertoli cell TJ which are located close to the 
basement membrane, toward the tubule lumen until they are released as mature spermatids. These 
spermatids collect in the rete-testis before exiting the testis through the efferent ducts into the 
epididymides. The presence of the Sertoli cell TJ therefore produces two compartments of distinct 
composition within the seminiferous epithelium, these being the basal compartment which contains 
the earliest germ cell types, and the adluminal compartment which contains the later maturing germ 
cell types (Cheng and Mruk, 2002).  
In the interstitium, Leydig cells are the predominant cell type present, and these synthesise and secrete 
androgens (Saez, 1994, Setchell, 2004) which play a key regulatory role in spermatogenesis. 
Macrophages and lymphocytes are present in the interstitium also and appear to play key roles in 
  
 
 
 
 
 
 
Figure 1.1 Organisation of the mammalian testis. 
 The testis is enclosed within the tunica albuginea (panel A) and is composed of two functional 
units, the highly convoluted seminiferous tubules and the interstitium in between them (Panel B). The 
interstitium contains Leydig cells (LC) and peritubular myoid (PTM) cells, as well as blood vessels. 
Lining the seminiferous tubules are the Sertoli cells which help nurture developing germ cells through 
spermatogenesis (Panel C) by providing nutrients, hormone signals and the tight junction. The tight  
junction forms between adjacent Sertoli cells and is located toward the basal aspect of the 
seminiferous tubules, just above the pre-leptotene spermatocytes. Modified from Cooke and Saunders, 
(2002). 
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regulating both the Leydig cell and spermatogenesis (Hedger, 2002, Hussein et al. 2005, Ballow et al. 
2006). 
 
1.2.2 Spermatogenesis 
 Spermatogenesis is the dynamic process of germ cell development, where undifferentiated 
diploid spermatogonial stem cells become highly differentiated haploid spermatozoa (Ballow et al. 
2006). Only the earliest types of germ cells, the mitotic types A and B spermatogonia, and 
preleptotene spermatocytes, develop on the basal side of the Sertoli cell TJ, and the latter cells must 
cross the TJ into the adluminal compartment to continue spermatogenesis (Cheng and Mruk, 2002). 
The meiotic and haploid spermatocytes on the adluminal side of the Sertoli cell TJ produce antigens 
which need to be sequestered from the immune system in the interstitium, and the provision of this 
sequestered space in which to develop is a key function of the Sertoli cell TJ, as in its absence, the 
latter germ cells are lost, and spermatogenesis stops Chung and Cheng, 2001, Chung et al. 2001). 
 Spermatogenesis can be separated into three separate phases according to germ cell 
development, these being mitosis, meiosis and spermiogenesis. Diploid spermatogonia are the earliest 
germ cell types, and are found located basally to the TJ along the basement membrane of the 
seminiferous tubule (Figure 1.2). Spermatogonia initiate the spermatogenic process and are major 
players in determining the final sperm output of the testis (for reviews see de Rooij and Russell 
(2000), Sofikitis et al. (2008)). A single spermatogonium can undergo mitotic divisions up to 8 or 9 
times before becoming a spermatocyte (Lok and de Rooij, 1983). Spermatogonia are divided into three 
subgroups, and in order of most primitive to most differentiated, these are type A, intermediate and 
type B spermatogonia. These are distinguishable by the amount of heterochromatin contained in their 
nuclei. The most differentiated cell has most heterochromatin (Leblond and Clermont, 1952a, de Rooij 
and Russell, 2000). Type B spermatogonia divide into the preleptotene spermatocytes, and from this 
point, spermatogenesis enters the meiotic phase. 
 Preleptotene spermatocytes are similar in appearance to the type B spermatogonia but smaller 
(Leblond and Clermont, 1952a). The appearance of a network of thin chromosomic filaments in the 
nuclei are characteristic of leptotene spermatocyte formation, the first germ cells to appear adluminally 
  
 
 
 
 
 
 
Figure 1.2 Spermatogenesis in the testis. 
 Spermatogenesis occurs in the seminiferous tubules of the testis and is supported by the 
Sertoli cells (SC). In the centre of this photo is a seminiferous tubule with interstitial spaces either 
side. The interstitium contains Leydig cells (LC) and blood vessels (BV). The outer edge of the 
seminiferous tubules is referred to as the basement membrane (BM) and the closest germ cells to it are 
the spermatogonia (Sg) and preleptotene spermatocytes (Pl). These early germ cell types reside basally 
to the Sertoli cell tight junction and among the first germ cells to appear adluminally to the TJ are the 
pachytene spermatocytes (P). When the pachytene spermatocytes complete meiotic division, they 
become haploid round spermatids (RS). Spermiogenesis is then commenced and involves the 
transformation of the round spermatids into elongated spermatids (ES). This photo shows the 
elongated spermatids with their tails suspended in the lumens of the seminiferous tubules ready for 
release or spermiation. Those of which have already been released leave behind their cytoplasm which 
are termed residual bodies (RB). 
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to the TJ (Cheng and Mruk, 2002). When these chromosomic filaments pair together, the germ cells 
are termed zygotene spermatocytes (Leblond and Clermont, 1952a).  
The transformation of the zygotene spermatocytes into pachytene spermatocytes involves 
genetic recombination and is a long process lasting several weeks (Leblond and Clermont, 1952a). 
Following this phase, the pachytenes undergo rapid division into diplotene and then secondary 
spermatocytes, before becoming round spermatids, signalling the start of spermiogenesis (Leblond and 
Clermont, 1952a). 
 Spermiogenesis is the morphological differentiation of the round spermatids into elongated 
spermatids, at which point they will be released into the tubule lumen as mature sperm in a process 
termed spermiation. Spermiogenesis is divided into several phases each consisting of multiple stages 
(Leblond and Clermont, 1952a). The end result of these phases is the elongation of the round 
spermatid and its nucleus and the development of an acrosome (head) and filament (tail). For more 
details see Leblond and Clermont, (1952). Once these phases are complete, the fully mature sperm is 
ready for release. 
 The process of germ cell development from spermatogonia to elongated spermatid, is called 
the spermatogenic wave. The lengths and types of spermatogenic waves vary across species from 40 
days in the mouse to 59 days in the rat (Roosen-Runge, 1952, França et al. 1998), and given that the 
scope of this thesis covers TJs and spermatogenesis in the rat, mouse and human, the cycles for these 
species will be briefly covered below. 
 
1.2.3 Cycles of spermatogenesis 
 In mammals, different consecutive cell associations and compositions can be observed along 
the seminiferous tubule (Steinberger and Steinberger, 1975, Cusan et al. 1981, França et al. 1998) 
(Figure 1.3). Each of these associations and the period of time for which they exist, are termed 
‘stages,’ and these are classified according to the morphology of the developing germ cells which are 
interacting with the Sertoli cells (Leblond and Clermont, 1952a). Subsequent generations of germ cells 
are produced before the previous generation has completed its progression, thus spermatogenesis is a 
continual process, and cross-sections through multiple tubules can reveal any given stage of 
spermatogenesis (Leblond and Clermont, 1952a). In the rat and mouse, the spermatogenic wave is 
  
 
 
 
 
 
 
Figure 1.3 The spermatogenic wave and spermatogenic cycle. 
 Spermatogenesis in the rat (panel A) and mouse (panel B) occurs in 14 and 12 stages 
respectively. Each vertical column in the schematics represents each stage of spermatogenesis as 
indicated by the roman numerals below each column. Germ cell maturation occurs horizontally across 
the columns. Each wave consists of 4.6 cycles, and each cycle lasts 12.9 days in the rat and 8.6 days in 
the mouse. This is equivalent to one wave of spermatogenesis taking 59 days to complete in the rat, 
and 40 days to complete in the mouse. Germ cells which reside in the basal compartment of the 
seminiferous tubule are indicated by the hashed box. The point where the preleptotene spermatocytes 
cross the TJ into the adluminal compartment and give rise to all other adluminal germ cell types is 
indicated by the arrow. Cross-sections through seminiferous tubules of rats or mice can reveal any 
given stage of spermatogenesis, and these tables are useful for assigning a stage to a cross-section as it 
shows which germ cell types appear in which stage, and at which morphology. Modified from França 
et al. (1998). 
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‘cyclical,’ and germ cell development follows an orderly progression through the stages along the 
seminiferous tubule (França et al. 1998, Chiarini-Garcia et al. 2001). The characterisation of the rat 
spermatogenic wave was conducted using the periodic acid-Schiff staining technique (Hotchkiss, 
1948, Leblond and Clermont, 1952b, Russell et al. 1990) after this stain was found to specifically stain 
carbohydrates (Clermont and Harvey, 1965). With respect to the germ cell, this stain highlighted 
acrosome and tail development particularly well (Leblond and Clermont, 1952b). The periodic acid-
Schiff stain is still used today extensively, to determine stages in testis tissue cross-sections and to 
identify germ cell types. The number of stages varies across species, with 14 in the rat, 12 in mice and 
6 observed in humans (Roosen-Runge, 1952, Clermont, 1963, França et al. 1998). Waves are divided 
into cycles and in the Sprague Dawley rat, one spermatogenic cycle takes 12.9 days to complete and 
the development of an immature spermatogonium into a mature elongated spermatid requires 4.6 
cycles. One spermatogenic wave therefore takes 59 days to complete (Clermont and Harvey, 1965, 
França et al. 1998). In the mouse, one spermatogenic cycle occurs in 8.6 days, which means one 
spermatogenic wave in the mouse, is completed in approximately 40 days (Figure 1.3) (Clermont and 
Trott, 1969, França et al. 1998). 
 The type of spermatogenic wave which occurs in the human is different to that which occurs 
in rats and mice. In 1902, it was observed that the maturing sperm in the human testis, were less 
regularly organised in the seminiferous tubules than in other mammals (Clermont, 1963). Later on it 
was seen that there was no correlation between clumps of differing stages of spermatogenesis within 
any given area of a tubule, and that unlike in rats, there was no synchronicity of germ cell 
development (Roosen-Runge and Barlow, 1953). However, Clermont (1963) identified 6 consistent 
cellular associations across serial sections from adult human testes, and that like in other mammals, 
these ‘stages,’ would follow each other in time. Clermont (1963) noted that each stage would appear in 
several areas across the tubule and that the borders between stages were ill-defined, leading to the 
apparent ‘disorganisation’ of spermatogenesis noted in the past. Schulze (1982) noticed that these 
stages were actually arranged helically along the length of the seminiferous tubule, which led to the 
helical classification of spermatogenesis in the human and other primates, as opposed to the cyclical 
classification of rat, mouse and other mammalian spermatogenesis (Figure 1.4) (França et al. 1998, 
Chiarini-Garcia et al. 2001).  
  
 
 
 
 
 
 
 
Figure 1.4 The spermatogenic cycle in the human. 
 Spermatogenesis in the human is divided into 6 consecutive stages of germ cell maturation as 
indicated by the roman numerals. Unlike rat or mouse seminiferous tubules, cross sections through 
human tubules reveal multiple spermatogenic stages which initially made it difficult to stage the 
spermatogenic cycle and led to the helical term for human spermatogenesis. Lettering in this 
schematic are: ser, Sertoli cell nuclei; Ad and Ap are types of type A spermatogonia; B, type B 
Spermatogonia; R, resting primary spermatocytes; L, leptotene spermatocytes; Z, zygotene 
spermatocytes; P, pachytene spermatocytes; Di, diplotene spermatocytes; Sptc-Im, spermatocytes in 
division; Sptc-II, secondary spermatocytes in interphase; Sa, Sb, Sc, Sd, spermatids at various 
spermiogenic stages and RB, residual bodies. Modified from Clermont, (1963). 
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The helical arrangement of spermatogenesis in the human has led to the term ‘multi-stage,’ 
that is, several stages of spermatogenesis can be seen in a single cross-section of a seminiferous 
tubule, as opposed to the ‘single-stage’ seen in other mammalian species (Wistuba et al. 2003). At first 
it was suspected that the multi-stage arrangement would decrease the efficiency of spermatogenesis 
(Sharpe, 1994, Johnson, 1995), however the use of the optical dissector technique for quantifying 
different germ cell types has shown that the spermatogenic efficiency of the human may have been 
better than first suggested (Wreford, 1995). As reported in Wistuba et al. (2003), the finding of highly 
efficient spermatogenesis in the marmoset despite the presence of multi-stage spermatogenesis has 
suggested that the topographical arrangement of spermatogenesis in the seminiferous tubules is not 
related to spermatogenic efficiency (Zhengwei et al. 1998, Weinbauer et al. 2001, McLachlan et al. 
2002a, McLachlan et al. 2002b). More recently, it was shown that the spermatogenic efficiency was 
similar across several different species of primates, including in an ancestral primate belonging to the 
Strepsirrhini sub-order (which includes lemurs) that displayed single-stage spermatogenesis (Wistuba 
et al. 2003). The authors concluded that the presence of a multi/single stage spermatogenesis may 
simply reflect the germ cell clonal size (Wistuba et al. 2003). 
 In all species, the continuing waves of spermatogenesis allows the testis to continually 
produce sperm, and this process requires the continual regulatory contributions and complex cell-cell 
interactions provided by the Sertoli cells. 
 
1.2.4: The Sertoli cell 
 Sertoli cells are the somatic cells of the seminiferous epithelium and are essential for 
spermatogenesis (for reviews, see Griswold, (1995), Griswold, (1998), Sofikitis et al. (2008)). They 
are large, highly branched cells, extending from the basement membrane to the tubule lumen, and they 
are in direct contact with germ cells throughout spermatogenesis (Griswold, 1995, Griswold, 1998, 
Sofikitis et al. 2008). Sertoli cells have several key functions. Firstly, the number of Sertoli cells 
dictates the spermatogenic output of mature spermatozoa. A rat model which showed a 54% decrease 
in Sertoli cell number, also displayed a 55% decrease in round spermatid number (Orth et al. 1984), 
yet the ratio of round spermatids to Sertoli cells was the same in the control rats compared to the 
Sertoli cell-deplete rats. Treatment of neonatal mice for the first 2 weeks of life with the 
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gonadotrophin follicle stimulating hormone (FSH),stimulated an increase in Sertoli cell number and 
sperm output by the testis (Singh and Handelsman, 1996). A similar study treated prepubertal mice 
with FSH which resulted in larger than normal testes and higher numbers of germ cells (Meachem et 
al. 1996). The findings of these studies showed that the production of normal germ cell numbers 
depends on the size of the Sertoli cell population and that FSH is critical for determining the final 
Sertoli cell number.   
Secondly, Sertoli cells secrete a number of glycoproteins and nutrients that form the basis of 
Sertoli-germ cell interactions (Griswold, 1993, Setchell, 1993, Griswold, 1995, Griswold, 1998). 
Griswold (1998), reviewed several pieces of evidence which showed that Sertoli cells secrete various 
factors such as an abundance of transport or bioprotective proteins, and proteases and protease 
inhibitors which are essential for tissue remodelling such as required through spermiation and the 
passage of preleptotene spermatocytes across the blood-testis barrier. Sertoli cells also provide the 
basement membrane between Sertoli and peritubular myoid cells and secrete growth factors or 
paracrine factors such as Müllerian inhibiting substance, c-kit ligand and inhibin in low amounts and 
also the provision of energy metabolites such as lactate and pyruvate (Jutte et al. 1983, Griswold, 
1998).  
Sertoli cells are also the key mediator of the main hormone signals essential for 
spermatogenesis, FSH and the androgen testosterone, the receptors for which are found on Sertoli 
cells, but not on germ cells (Lyon et al. 1975, Bremner et al. 1994, Rannikki et al. 1995, Tapanainen 
et al. 1997, Sofikitis et al. 2008). As discussed previously, FSH has been shown to be pivotal in 
determining final Sertoli cell number. In prepubertal rats, FSH increases intracellular cAMP, protein 
synthesis and estradiol production (Fritz and Rath, 1978). In adult animals, the role of FSH is more 
controversial and according to Griswold (1998), may vary from species to species and in many cases 
testosterone may assume the biochemical role of FSH. Either way, there is a change in FSH activity 
after puberty and this is coincident with the cessation of Sertoli cell proliferation (Zirkin et al. 1994, 
Walker, 2003). On its own, FSH can maintain spermatogenesis through to the round spermatid stage, 
but after that, spermatogenesis ceases (Singh et al. 1995, McLachlan et al. 1995). Testosterone also 
plays key roles in spermatogenesis and the maturation of germ cells. In the absence of FSH in a 
hypogonadal mouse model, low levels of testosterone were sufficient to drive spermatogenesis (Singh 
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et al. 1995). This has also been seen in FSHβ subunit gene knockout (Kumar et al. 1997) and hormone 
suppressed rat models under the influence of testosterone alone (Awoniyi et al. 1989), albeit at a 
reduced spermatogenic capacity compared to controls (Kumar et al. 1997, Meachem et al. 1998). 
Results from studies which specifically ablated or inhibited the Sertoli cell androgen receptor showed 
that androgens are essential for germ cell meiosis, the transition from round to elongate spermatids and 
the final stages of spermiogenesis (O’Donnell et al. 1999, Chang et al. 2004, de Gendt et al. 2004, 
Holdcraft and Braun, 2004). For a review on the role of testosterone in primate and human 
spermatogenesis, see McLachlan et al. (2002a). 
Within the Sertoli cell, the androgen receptor is maximally expressed when TJs form and 
when germ cells migrate across the blood testis barrier (Russell, 1977, Bremner et al. 1994, Zhou et al. 
2002). Furthermore, testosterone was shown to regulate the localisation and/or mRNA expression of 
some pivotal Sertoli cell TJ proteins (Kaitu’u et al. 2007).  
 
1.2.5 Cell-cell interactions 
Cell-cell interactions are ubiquitous in all epithelia and are also another key feature of the 
Sertoli-germ cell relationship. There are three main types of cell-cell junctions which are 
morphologically and functionally distinct from each other. Broadly these are the anchoring junctions, 
gap junctions and TJs (Mruk and Cheng, 2004). In the seminiferous epithelium, these three junctional 
types contribute to the formation of the blood-testis barrier (Pointis et al. 2005). Each are briefly 
described below and are presented in Figure 1.5. 
 
a. Anchoring junctions  
The anchoring junctions connect the cytoskeletons of adjacent cells and can be sub-divided 
into four smaller groups of junctional types, and these are adherens junctions, cell focal contacts, 
desmosomes and hemidesmosomes (for reviews see Cheng and Mruk, (2002); Mruk and Cheng, 
(2004)). Each of these subgroups are present in the testis except for the cell focal contacts, which have 
as yet not been localised to the testis but are involved in anchoring other epithelial cells to 
extracellular matrices (Cheng and Mruk, 2002, Xia et al. 2005). 
  
 
 
 
 
 
 
Figure 1.5 The junctional complex. 
 This figure displays diagrammatic representation of junctions between adjacent epithelial cells 
generally (panel A) and also between adjacent Sertoli cells in the testis (panel B). Panel A shows 
junctional complexes at the lateral sides of the membranes with electron micrograph representation 
also. In most epithelia, the tight junctions are the apical junction. Also apparent in panel A are gap 
junctions, which provide communication channels between adjacent cells, and the desmosomes, which 
are a type of anchoring junction. In the Sertoli cell figure in panel B, TJs (yellow) are part of a 
junctional complex composed of adherens junctions (green) and ectoplasmic specialisation (red) and 
together form the blood-testis barrier. Note that in the Sertoli cells, the TJs are the most basally located 
junction. Panel A is taken from Oroi and Perrelet, (1975) and panel B is modified from Sluka et al. 
(2006).  
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Adherens junctions link neighbouring cells via cytoskeletal actin filaments. In the testis, they are 
involved with connecting adjacent Sertoli cells to each other and to germ cells (Pointis et al. 2005, Cyr 
et al. 2007). A specialised type of adherens junction found only in the testis is the ectoplasmic 
specialisation (Vogl et al. 2000, Mulholland et al. 2002, Toyama et al. 2003, Pointis et al. 2005, Xia et 
al. 2005, Yan et al. 2007). These junctions are found basally between Sertoli cells where they stabilise 
and maintain the blood-testis barrier, and adluminally, where they anchor elongating/elgonated 
spermatids to the Sertoli cells (Siu et al. 2005, Xia et al. 2005, Beardsley et al. 2006).  
Desmosomes are similar to the adherens junction in that they adhere adjacent cells together as 
well. They have most extensively been studied in the epidermis where they play an important role in 
maintaining tissue integrity (Cheng and Mruk, 2004). In the testis, they are present at contact points 
between Sertoli cells and other Sertoli cells, and between Sertoli cells and germ cells. The mechanism 
of adherence mediated by the desmosomes differs to that mediated by the adherens junction in that the 
desmosomes are linked to the intermediate filaments of the cytoskeleton rather than the actin filaments 
(Connell, 1977, Vogl et al. 2000, Cheng and Mruk, 2004). Hemidesmosomes in the seminiferous 
epithelium are restricted to Sertoli cell basal regions, where they anchor the cells to the basement 
membranes of the seminiferous tubules (Wrobel et al. 1979, Vogl, 1988, Cheng and Mruk, 2004). 
So that the anchoring junctions can collectively facilitate the movement of germ cells through 
spermatogenesis, the continual redistribution of the Sertoli cell cytoskeleton is required to ensure that 
the Sertoli cell is morphologically suitable to each germ cell maturation stage (Russell and Clermont, 
1976, Connell, 1977, Parvinen, 1993, Zhu et al. 1997, Siu and Cheng, 2004). The regulatory 
mechanisms behind this process are not well known, but the germ cells themselves may play a role. 
When rat spermatogonia were transplanted into mouse testes and were interacting with mouse Sertoli 
cells, they differentiated with cell cycle timing characteristic of rat spermatogenesis and also generated 
the spermatogenic structural pattern of the rat (França et al. 1998). In the same animals, mouse 
spermatogonia initiated spermatogenic cycles indicative of mouse spermatogenesis. This indicated that 
germ cells do have roles in regulating their own maturation and more specifically, the cell 
differentiation process is regulated by the germ cells alone (França et al. 1998). 
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b. Gap junctions 
The second type of cell-cell junction, is the gap junction. These form communicative channels 
between adjacent cells in nearly all epithelia. A channel between two cells is formed by the 
contribution of a hemichannel called a connexon from each cell (Brehm et al. 2007), which in turn are 
made up of proteins called connexins (For a review, see Sridharan et al. (2008)). In the seminiferous 
epithelium, gap junctions provide the route through which ions and small molecules are exchanged 
between Sertoli cells and spermatogonia and between Sertoli cells and primary spermatocytes (Brehm 
et al. 2007). Kumar and Gilula (1996), reported that gap junctions in the seminiferous epithelium are 
pivotal to germ cell growth, differentiation, homeostasis and neoplastic transformation. Upon the 
Sertoli cell specific knock out of connexin-43, testis weights and spermatogonia were markedly 
reduced and most of the seminiferous tubules did not show normal spermatogenesis (Brehm et al. 
2007), thereby indicating the important role that gap junctions also have in maintaining successful 
spermatogenesis. 
 
c. Tight junctions  
 The third junction is the TJ. The TJ, as stated previously, is the major component of the blood-
testis-barrier and its provision is a separate, key function of the Sertoli cell. In early studies, the rete 
testis was cannulated and testicular fluid collected (Setchell, 1967, Waites and Setchell, 1969, Dym 
and Fawcett, 1970). This fluid was found to contain significantly lower amounts of protein, amino 
acids and ions that are in abundance in the blood plasma and testis lymph (Setchell, 1967, Waites and 
Setchell, 1969, Dym and Fawcett, 1970). It was concluded that there must be a blood-testis-barrier in 
the seminiferous epithelium, capable of excluding blood plasma and testis lymph proteins, amino acids 
and ions from the tubule lumens. Later, a variety of different electron opaque tracers of varying sizes 
were administered to the testes of guinea pigs and chinchillas. The larger molecules were excluded 
from the tubules completely, and were restricted to the interstitial side of the myoid cells which 
surround the seminiferous tubules (Fawcett et al. 1970). The smaller tracers, penetrated into the 
seminiferous tubules and surrounded the spermatogonia, but penetrated no further towards the tubule 
lumens than that (Fawcett et al. 1970). When the tracer lanthanum nitrate was administered to adult rat 
testes, it was also seen to enter the tubules only as far as the spermatogonia (Dym and Fawcett, 1970). 
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Electron microscopy revealed that TJs sealed adjacent Sertoli cells just above the spermatogonia and 
were blocking the progression of the tracer into the adluminal compartment (Dym and Fawcett, 1970). 
This was the first piece of evidence of the compartmentalisation function of the Sertoli cell TJ.  
 The function of Sertoli cell TJs has also been tested in in vitro culture systems, with Sertoli 
cells cultured onto bicameral units which are placed into culture wells. Bicameral units have a thin, 
porous membrane separating the inside of the unit from the outside. In a number of studies it has been 
shown that Sertoli cells had formed an impermeable barrier between the inside and outside of the 
bicameral unit as shown by decreased passage of [3H]inulin and electrical currents across the cells, and 
that most de novo synthesised proteins had been secreted into the inside of the bicameral unit (Onoda 
et al. 1990). Subsequent studies have looked at the function of the Sertoli cell TJ and other TJs in 
different bodily systems, and the remainder of this literature review will focus on the TJ and the 
regulation of Sertoli cell TJs as revealed by hormone-suppression models. 
 
1.3 The tight junction 
 
1.3.1 Tight junction ultrastructure 
TJs were first identified as types of intercellular junctions by ultrathin-section electron 
microscopy (Farquhar and Palade, 1963) where they appeared as a series of contact points or “kissing 
points” involving the plasma membranes of adjacent cells (Tsukita and Furuse, 1999). Since the 
advent of freeze-fracture electron microscopy it has become possible to examine TJs in greater detail 
(Cereijido and Anderson, 2001). This form of microscopy reveals the membrane components of the 
TJ, which appear as a mesh like network of continuous, anastomosing strands that wrap around the 
periphery of epithelial cells (Gonzalez-Mariscal et al. 2003). TJ strands on adjacent membranes 
interact with each other, effectively forming a seal between membranes and eliminating the 
extracellular space at that point (Figure 1.6) (Furuse et al. 1999). This seal is selectively permeable in 
that it does not allow solutes or water free passage between cells, which is known as the paracellular 
pathway (Mitic and Anderson, 1998) (discussed later). Hence the seal can form compartments of very 
different solute and fluid composition between adjacent tissues (Cereijido and Anderson, 2001) as 
earlier described for in the seminiferous epithelium.  
  
 
 
 
 
 
 
Figure 1.6 Protein interactions within the tight junction. 
 In this schematic of the testicular Sertoli cell TJs, the extracellular domains of the occludin, 
claudin-11 and junctional adhesion molecule can be seen interacting with their counterparts on the 
adjacent cell. The C-termini of each protein binds to the cytoplasmic plaques within the cell, which 
consist of a complex of large proteins including the zonulae occludens (ZO-1 and ZO-2). This 
complex links the transmembrane proteins to the cytoskeleton which is depicted here as F-actin in 
yellow. Taken from Mruk and Cheng, (2004). 
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The composition of the TJ strands has been hotly debated over the past 20 years (Lapierre, 2000). 
Hypothesised models for TJ composition varied from strands being formed by the polymerisation of 
integral membrane proteins within plasma membranes (Tsukita and Furuse, 1999), to TJ strands being 
predominantly lipid in nature, formed by inverted, cylindrical lipid micelles (Mitic and Anderson, 
1998). The latter model survived until observations by electron microscopy showed TJ strands were 
stable in detergent (Stevenson and Goodenough, 1984), suggesting that they were not entirely lipid in 
nature. Recent work, although not discounting the possible presence of lipids (Lapierre, 2000), has 
identified at least two pivotal protein components of TJ strands and these are occludin and the 
claudins, with the latter comprising a large superfamily of more than 20 members (Gonzalez-Mariscal 
et al. 2003).  
 
1.3.2 Molecular composition and architecture of the tight junction 
The TJ consists of transmembrane proteins which seal adjacent epithelial cells together 
through interactions between their extracellular domains. These proteins are linked to the cytoplasmic 
plaque just inside the cell, which in turn is linked to the cytoskeleton. The next part of this review will 
look at the transmembrane proteins and the zonnulae occludens of the cytoplasmic plaque. 
 
a. Membrane components  
The first transmembrane protein component of the TJ strand was identified in 1993 (Furuse et 
al. 1993). Occludin was isolated from chicken liver as an antigen for monoclonal antibodies raised 
against a junctional fraction, and was so called after the Latin word ‘occludere’ which means to 
occlude (Gonzalez-Mariscal et al. 2003). After sequencing and cloning occludin from the rat, chicken, 
human, dog and mouse, Ando-Akatsuka et al. (1996) found that the size of occludin is relatively 
conserved between species at about 65kDa. However, interspecies variation in the sequence of 
occludin was observed, with greater dissimilarity between chickens and placental mammals, than 
between placental mammals themselves (Mitic and Anderson, 1998). Occludin spans the membrane 
four times and has two extracellular loops and one intracellular turn which keeps the N- and C-termini 
on the cytosolic side of the plasma membrane (Tsukita and Furuse, 1999, Tsukita et al. 2001) (Figure 
1.7). The first extracellular loop of occludin is characteristically rich in tyrosine and glycine residues 
  
 
 
 
 
 
 
Figure 1.7 Transmembrane components of the tight junction. 
 Diagrammatic representation of the key transmembrane components of the tight junction; 
occludin (panel A), claudin (panel B) and junctional adhesion molecule (panel C). Occludin and the 
claudins are structurally similar as they span the membrane four times, and keep their N- and C- 
termini within the cell. They are however dissimilar in size and sequence. Junctional adhesion 
molecule is structurally different to occludin and the claudins. It dimerises with an adjacent junctional 
adhesion molecule, forming a U-shaped domain in the extracellular space. Taken from Tsukita et al. 
(2001). 
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(60%) and this feature is conserved highly among species. Several lines of evidence suggest that 
occludin has an important role in defining the TJ barrier (Mitic et al. 2000). The addition of a synthetic 
peptide to cultured Xenopus epithelial cells and rat Sertoli cells which corresponded to the sequence of 
one of the extracellular loops of occludin, decreased TJ function as shown by transepithelial electrical 
resistance (TER) in vitro (Wong and Gumbiner, 1997, Chung et al. 2001). Furthermore, the 
transfection of occludin into fibroblasts lacking occludin and TJs, resulted in the gain of adhesive 
function between cells (van Itallie and Anderson, 1997). Despite this data supporting the importance 
of occludin in TJs, occludin knockout mice displayed well developed TJs strands and with respect to 
the Sertoli cell TJ, these mice were fertile until late adulthood (Saitou et al. 2000). Furthermore, 
epithelial cell morphology was unaltered after the addition of the antagonist peptide mentioned above 
(Saitou et al. 1998). These findings suggested the presence of another protein in these strands.  
In 1998, Claudin-1 and Claudin-2 were discovered as 22kDa bands isolated from the same liver 
fraction used to isolate occludin (Furuse et al. 1998) and were named after the Latin word ‘claudere’ 
meaning, ‘to close.’ Currently, 24 members of the claudin superfamily have been identified as proteins 
of masses between 20-27kDa (see Table 1.1). They are structurally similar to occludin, spanning the 
membrane four times, having two extracellular loops (one of which is much larger than the other) and 
a short tail on the inside of the cell membrane. Despite this structural similarity with occludin (Figure 
1.7), there is no similarity in sequence between the claudins and occludin. There is also sequence 
dissimilarity between members of the claudin superfamily, and these differences lie in the third and 
fourth membrane spanning domains (Lapierre, 2000). Furthermore, the claudins are distributed 
differently among different types of tissue (Lapierre, 2000). For example, claudin- 5 is ubiquitously 
expressed whereas claudin-11 is isolated to the Sertoli cells and central nervous system. All claudin 
sequences contain a C-terminal PDZ-binding motif, which is a common 80-100 amino acid domain 
that reside on molecules that target the C-terminal of intracellular and cell-surface proteins (Sidhu et 
al. 2003). The interaction between the PDZ domains and PDZ binding motifs, results in large 
multiprotein complexes at specific subcellular sites (Craven and Bredt, 1998, Fanning and Anderson, 
1999, Sidhu et al. 2003). Through their PDZ domains, the claudins bind to the zonulae occluden 
family of the cytoplasmic plaque beneath the membrane (described in section 1.3.1b) (Itoh et al. 
1999).  
Table 1.1 Localisation and characterisation of members of the claudin superfamily. 
 To date, 24 members of the claudin superfamily have been identified and characterisation of 
their localisation and expression is ongoing. Tight junctions consist of one or more claudin 
components, each apparently with different functional roles. Generally most of the claudins have been 
well characterised (panel A, taken from Gonzalez-Mariscal et al. (2003), with claudin-9, 10, 12, 13, 17 
and 19-24 the exceptions and subjects of more recent studies (panel B). There are 7 claudins localised 
to the testis, with claudin-11 being specific for the Sertoli cell tight junction.  
 
 
 
 
Claudin Distinctive Characteristics 
9 Present in hepatocytes. Potential receptor for HIV virus (Nunes et al. 2006; Meertens et al. 2008) 
10 Absent in vascular epithelia. Present in kidney and jejunum (Inai et al. 2005) 
12 Present in the blood-brain barrier (Nitta et al. 2003) 
13 Immunolocalised to the colon in mice (Fujita et al. 2006) 
17 Immunolocalised to the plasma membrane of cultured human embryonic kidney cells (Hu et al. 2006) 
19 Immunolocalised to the kidney in mice, rats and humans. Decreased expression in humans with renal 
disease (Lee et al. 2006) 
20 mRNA expression detected in duodenum of rats (Charoenphandu et al. 2007) 
21 Limited data available, although expression detected in human gastric epithelia (Katoh and Katoh, 2003). 
No rodent data available 
22 High mRNA expression in rat duodenum and brain (Charoenphandu et al. 2007; Newrzella et al. 2007). 
Implicated in regulation of paracellular pathway in rat duodenum (Charoenphandu et al. 2007) 
23 mRNA expression detected in duodenum of rats (Charoenphandu et al. 2007) 
24 Limited data available, although expression detected in human gastric epithelia (Katoh and Katoh, 2003). 
No rodent data available 
A 
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Junctional adhesion molecule (JAM) is a third family of proteins consisting of three members 
(JAM-A, JAM-B, JAM-C) that has been localised to epithelial and endothelial TJs as well as effect on 
well developed TJs, suggesting that JAM molecules assist in TJ sealing, and once this seal is formed, 
they are inaccessible (Liu et al. 2000, Gonzalez-Mariscal et al. 2003).  
A good model for studying TJ formation between cells is the mouse trophectoderm, which 
forms a layer around blastocysts and generates the blastocoel cavity by polarised water and ion 
transport (Thomas et al. 2004). It also initiates attachment and invasion of the uterine endometrium 
(Thomas et al. 2004). Early in the differentiation process of the trophectoderm, JAM-A was seen to 
localise at cell-cell contact points and co-localise with nectin-2, an adhesion complex protein 
important for enhancing E-cadherin adhesion for adherens junction formation (Tachibana et al. 2000, 
Honda et al. 2003, Takai et al. 2003, Thomas et al. 2004). E-cadherin has been implicated in 
providing normal spatial and temporal control of TJ protein assembly and stability (Fleming et al. 
1989, Javed et al. 1993, Sheth et al. 2000a, Sheth et al. 2000b, Thomas et al. 2004), and the 
localisation of occludin and the claudins does not occur until after the recruitment of E-cadherin to the 
adherens junction (Fleming et al. 1989, Fleming et al. 2001, Thomas et al. 2004). The early 
localisation of JAM-A to cell-cell contact points in that study, demonstrated a clear role for JAM-A in 
TJ assembly mediated through its possible role in also stimulating adherens junction assembly 
(Thomas et al. 2004). This was also seen in Caco-2 cultured cells, where after calcium addition, JAM-
A was rapidly recruited to cell-cell contact points to initiate cellular differentiation, prior to the 
recruitment of occludin and the claudins (Martinez-Estrada et al. 2001) and the recruitment of the TJ 
cytoplasmic plaque protein, ZO-1 (Bazzoni et al. 2000) (see below). Thomas et al. (2004) also 
demonstrated that JAM-A migrated to the apical poles of the epithelial cells and co-localised with 
actin at the microvillus poles after cell-cell contacts had been established, and so it may have a role in 
epithelial cell polarisation also.  
All three members of the JAM family have been localised to the testis, with JAM-A and JAM-
B at the Sertoli cell TJ and JAM-C important for the conversion of round spermatids into elongated 
spermatids (Gliki et al. 2004, Mirza et al. 2007). The contribution of JAM-A and JAM-B to the Sertoli 
cell TJ is not well known but recently, JAM-A was also localised in germ cells (Tarulli et al. 2008), 
suggesting that like its role with leukocyte migration across epithelial TJs, JAM-A may also have a 
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role in mediating germ cell migration across the Sertoli cell TJ (Tarulli et al. 2008). Interestingly, 
while E-cadherin has been localised to the testis in one week old rats (Wu et al. 1993), it is not present 
in Sertoli cells (Byers et al. 1994) and therefore does has not appear to be important for blood-testis 
barrier formation, suggesting that JAM-A may interact with other cadherins or proteins at the time of 
adherens junction and subsequent TJ formation. This is an area which requires further research. 
 
b. The cytoplasmic plaque  
The cytoplasmic plaque is a complex of proteins that interact with each other to link the 
cytoskeleton to the membrane components of the TJ (Fanning et al. 1998) (see Figure 1.6). Zonula 
occluden-1 (ZO-1) was the first TJ-related protein discovered (Stevenson et al. 1986) and has since 
been shown to be a pivotal component of the cytoplasmic plaque through its interactions with the C-
terminal of occludin, the claudins and JAM (Furuse et al. 1994, Mitic et al. 1999). Since the discovery 
of ZO-1, ZO-2 and ZO-3 have also been localised to the cytoplasmic plaque. Citi, (2000), also showed 
that the cytoplasmic plaque acts as targets and effectors of signalling pathways involved in regulating 
the function of the TJ.  
 
1.4 The function of the tight junction 
As has been discussed, the role of the TJ is essential in all epithelia, to form a protective 
barrier between bodily organs and cavities or blood vessels, and to allow the passage of select solutes 
across via the paracellular pathway, in a function known as the TJ ‘fence’ function (Gonzalez-
Mariscal et al. 2008). Over the past several decades, qualitative and quantitative techniques have been 
employed by researchers to assess the loss or gain of TJ function in response to various stimuli. This 
section of the review will focus on qualitative and quantitative methods of analysing TJ function, the 
size-selective nature of the TJ and then move into the apparent roles that occludin and the claudins 
have in TJ function. 
 
1.4.1 Qualitative assessment of tight junction function  
 In general, qualitative TJ function analysis has largely involved the use of tracer 
administration to target tissue in vivo, and subsequent visualisation of its localisation with respect to 
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the TJ by some form of microscopy. Electron microscopy-opaque tracers such as horse-radish 
peroxidase (HRP) (44kDa) and lanthanum nitrate (433kDa) were originally the more popular tracers 
for analysis and have been used since the 1970s and 1980s. When administered to the testes of adult 
minks via arterial perfusion, HRP entered the seminiferous tubules only as far as the Sertoli cell TJ, 
indicating that the TJ was functioning to exclude the tracer from the adluminal compartment of the 
seminiferous epithelium. During seasonal testicular regression which coincides with the cessation of 
spermatogenic activity, the HRP tracer was seen to enter the adluminal compartment of the 
seminiferous epithelium indicating that the TJs were no longer functioning normally and had become 
permeable to the tracer (Pelletier, 1986, Pelletier, 1988, Pelletier, 1994). Pelletier, (1994), cast doubt 
on the validity of lanthanum nitrate as a marker of TJ function, after it was seen on the ‘protected’ or 
adluminal side of the epididymal TJ, despite HRP being blocked. It was concluded that lanthanum had 
affinities for membrane components on the epithelial cells, and was being taken up by the cell, and 
displayed on the opposite side of the TJ (Pelletier, 1994). A similar result was obtained for the TJ 
tracer, tannic acid in the liver (Pelletier, 1994). Despite these findings, lanthanum has continued to be 
used more recently as a marker for Sertoli cell TJ function in the dog (Mann et al. 2003).  
 In the past few years, the use of tracers which can be visualised by immunohistochemistry 
using fluorescent or light microscopy to analyse TJ function has increased. A biotin (~600Da) tracer 
containing a long spacer arm which enables it to cross-link primary amines and not cross cell 
membranes has been used recently as a TJ function marker which can be probed with streptavidin 
(Furuse et al. 2002, Bratt et al. 2005, Meng et al. 2005). In a superficial keratectomy rat model, biotin 
readily permeated through wounded corneas, until the epithelium had healed and restored TJ function 
approximately 72 hours after wounding, at which point, biotin was once more restricted to the outside 
of the TJ (Hutcheon et al. 2007). In a claudin-5 knockout mouse model, biotin was restricted from 
entering the brain parenchyma by the blood-brain barrier in wildtype mice, yet readily permeated 
through the TJ and into the brain parenchyma in the knockout, indicating that due to the absence of 
claudin-5, TJ function had been compromised (Nitta et al. 2003). In the testis, biotin was restricted to 
the interstitium in wildtype mice, but in a Sertoli cell specific androgen receptor knockout mouse 
model, biotin readily permeated across TJs and spread throughout the seminiferous tubules (Figure 
1.8) (Meng et al. 2005). This indicated compromised and altered TJ function in the knockout mice 
  
 
 
 
 
 
 
Figure 1.8 Biotin penetration into the seminiferous epithelium. 
 Fluorescence microscopy was used to demonstrate that biotin tracer (red, arrow) was able to 
penetrate throughout the seminiferous epithelium of pre-pubertal mice, consistent with the absence of 
a tight junction which forms at puberty (panel A). In the adult mouse where mature tight junctions 
have formed, biotin staining was absent from the seminiferous tubules and restricted to the interstitium 
(panel B). In the adult Sertoli cell-specific androgen receptor knockout mouse, biotin tracer readily 
permeated throughout the seminiferous tubules as per the pre-pubertal mouse, indicating a non-
functional tight junction. Modified from Meng et al. (2005). Bar = 50μm. 
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(Meng et al. 2005). The localisation of biotin in the control testis, was comparable to the localisation 
of HRP, with both tracers only entering the tubules as far as the TJ (Pelletier, 1986, Meng et al. 2005). 
More recent studies probe for TJ protein components at the same time as TJ function tracers, which 
means that the degree of TJ disruption can be visualised at the same time as its function (Figure 1.9) 
(Meng et al. 2005, Xia et al. 2007, Tarulli et al. 2008). Studies have revealed however, that despite 
tracer permeation, TJs sometimes appear intact by immunohistochemistry and this has displayed the 
need to study specific TJ components in more detail (discussed below) and their role in regulating both 
the quantitative function and size-selective discrimination properties of the TJ (Nitta et al. 2003, Bratt 
et al. 2005).  
 
1.4.2 Quantitative assessment of tight junction function  
 Medical resonance imaging (MRI) has been applied to quantify changes in the function of the 
TJ of the blood-brain barrier in the claudin-5 knockout mouse model analysed in the Nitta et al. (2003) 
study above. Wildtype and claudin-5 mice were injected with a low molecular weight tracer (Gd-
DTPA: 742Da) into the heart. In wildtype mice, every organ except for the central nervous system 
(CNS) displayed positive signalling for the tracer (Nitta et al. 2003). In the claudin-5 knockout mice, 
the CNS stained positively for the tracer in a dose dependent manner. The change in TJ function was 
quantified by comparing the change in tracer-accessible space/unit volume in the brains of the 
wildtype mice to the knockout mice. This showed that TJ function was disrupted by approximately 
15% due to the claudin-5 knockout (Nitta et al. 2003). Thus this study was able to demonstrate both a 
qualitative decrease in TJ function, and a quantitative decrease. 
However, like qualitative TJ functional analysis, quantitative analysis of TJ function in vivo 
largely uses tracers, which are most commonly radio-labelled. Testicular efferent duct ligation leads to 
fluid retention in the testis, increased testicular turgidity and eventually degeneration of the 
seminiferous epithelium and the cessation of spermatogenesis (Setchell, 1970, Kumar and Gilula, 
1996, Tao et al. 2000). The function of the Sertoli cell TJ has been assessed in this efferent duct 
ligation model in the rat, by the vasculature administration of small molecular weight tracer [51Cr]-
EDTA (341 Da), which was monitored by a gamma-counter (Setchell et al. 1996, Tao et al. 2000). 
  
 
 
 
 
 
Figure 1.9 Co-localisation of tight junction components with biotin tracer. 
 Experiments analysing changes in tight junction structure can be conducted at the same time 
as analysing changes in tight junction function. These are fluorescent immunomicrographs of biotin 
tracer (green) and Sertoli cell tight junction protein claudin-11 (blue) localisation in the photoregulated 
Djungarian hamster. Sertoli cell nuclei are highlighted with GATA-4 (red). In the seasonally regressed 
testis of the short-day hamster (panel A), biotin permeates throughout the seminiferous tubules and 
claudin-11 is localised within the cytoplasm of the Sertoli cells and not at the TJ, indicating 
functionally and structurally incompetent TJs. After 2 days of FSH treatment to these hamsters (panel 
B), claudin-11 is still cytoplasmic and TJs are still dysfunctional as shown by the continued presence 
of biotin within the tubules. After 10 days of treatment, claudin-11 has largely redistributed to the TJ, 
and the permeation of biotin in the tubules gets no further than claudin-11, indicating some restoration 
in TJ structure and function. Taken from Tarulli et al. (2006). Circle indicates junction between biotin 
and claudin-11 staining. Bar = 50μm. 
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The TJ was effective for the first 24 hours of fluid accumulation in the testis, with the concentration of 
the tracer remaining higher in the interstitium than in the tubules. However after 40-48 hours of duct 
ligation, the tracer permeated through the tubules and concentrations exceeded that seen in the 
interstitium, indicating the breakdown of the Sertoli cell TJ (Tao et al. 2000). In a similar study, 
Sertoli cell TJ function was disrupted by the intratesticular injection of glycerol (Eng et al. 1994, 
Igdoura and Wiebe, 1994, Setchell et al. 1996). This was shown after seminiferous tubules were 
collected from control and glycerol-treated testes and incubated in [3H]methoxy-inulin tracer (Eng et 
al. 1994). The accumulation of the tracer inside the seminiferous tubules was ten-fold greater in the 
glycerol-treated testes than the controls as shown by scintillation spectrometry, indicating that the 
function of the Sertoli cell TJs had been disrupted (Eng et al. 1994). A follow up study showed that 
the intratesticular injection of glycerol disrupted and disorganised the actin based cytoskeleton and 
occludin localisation to the Sertoli cell TJ (Wiebe et al. 2000). While the seminiferous tubules from 
the Wiebe et al. (2000) study were not incubated in the [3H]methoxy-inulin tracer, there appears to be 
a connection with the removal of occludin from the Sertoli cell TJ and a loss of function as induced by 
glycerol (Eng et al. 1994, Wiebe et al. 2000). However, given that the actin based cytoskeleton was 
disrupted, it is reasonable to assume that the adherens junction which connects to actin at the blood-
testis barrier (Cheng and Mruk, 2004) was also disrupted, meaning that the loss of barrier function in 
the Eng et al. (1994) study could not necessarily be directly attributed to the loss of TJ function, but 
rather the loss of the blood-testis barrier function as a whole.  
 Tracers can also be used in in vitro culture models for quantitative TJ functional analysis. 
When rat brain cells were cultured in bicameral units (see section 1.2.5) and incubated in [14C]-inulin, 
the cells were unable to prevent the passage of the tracer across the filter to the outside of the 
bicameral unit (Ohtsuki et al. 2007). However, when TJ protein claudin-5 was transfected into these 
cells, the permeability of [14C]-inulin was markedly decreased, indicating that the cells had formed 
impermeable TJs (Ohtsuki et al. 2007). There are not many recent reviews readily available in the 
literature, but for further details about other methods for measuring TJ function quantitatively in vivo, 
see Vedula et al. (2005). 
 Transepithelial electrical resistance (TER) is another method for in vitro quantification of TJ 
function, and uses the same bicameral unit as above. A current is applied across the cell monolayer, 
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and the increasing resistance that occurs as TJs form is measured. TER actually measures the 
permeability of a cell monolayer to Na+ and Cl- salts which most culture media contain in an 
electrically applied field (for reviews see Fanning et al. (1999), Matter and Balda, (2003), Gonzalez-
Mariscal and Nava, (2005), Vedula et al. (2005)). Permeability of cell monolayers to electrical 
currents varies greatly across bodily epithelia, and this is due to differences in the ‘tightness’ of 
different epithelial TJs (Fanning et al. 1999). As reviewed in Fanning et al. (1999), the leaky 
mammalian proximal renal tubules recorded TER values of 6-7Ω/cm2 whereas the very tight bladder 
epithelium records TER values of 6,000-300,000Ω/cm2. Results obtained by TER and the application 
of tracers such as inulin (Dym and Fawcett, 1970) in vitro are not comparable. While the TJ 
permeability measured by TER varies widely across different epithelia, the size selectivity of TJs 
(detailed in section 1.4.3) from different cultured epithelial cells to any given tracer does not vary to 
the same extent (Fanning et al. 1999). Furthermore, tracers themselves vary in size and so any results 
obtained for TJ function would reflect the changes in permeability to the particular tracer applied 
alone. Therefore, TER provides a more global measure of changes in TJ function and while a 
decreasing trend in TER would correlate to an increasing trend in tracer permeability, final numbers 
would not be the same. TER is sensitive to changes in media temperature and media volume and so 
should be measured at a constant temperature of 37oC and in an environment containing the same 
amount of media on the outside of the bicameral unit as what is inside the unit (Janecki et al. 1991, 
Matter and Balda, 2003).  
As mentioned previously in this review, TER was used to show decreases in TJ function in 
response to the addition of a peptide corresponding to one of the extracellular loops of occludin in 
cultured Xenopus epithelial cells and rat Sertoli cells (Wong and Gumbiner, 1997, Chung et al. 2001). 
TER also showed an increase in TJ function in cultured Madin-Darby canine kidney (MDCK) cells 
following the over-expression of occludin (McCarthy et al. 1996). In cultured Sertoli cells, increases 
in TER were seen with FSH and testosterone treatment (Janecki et al. 1991, Kaitu’u et al. 2007) 
whereas decreases in TER were seen following cytokine TNF-α and TGF-β and phosphatase inhibitor 
treatment to cultured Sertoli cells (Li et al. 2001, Lui et al. 2001, Siu et al. 2003, Cheng and Mruk, 
2004). These data indicate that TER is a versatile means of measuring TJ function in a variety of 
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cultured epithelial cells, but in order to determine changes in size-selectivity, it would be useful to use 
tracers of varying molecular weight in the same culture experiments. 
Interestingly, TER has also been successfully applied to the insect TJ analogue, septate 
junctions in vivo to measure the effect of a peptide known to regulate the paracellular pathway in the 
malphigian tubules of the mosquito (Clark et al. 1998, Carlson et al. 2000). Tubules were incubated in 
the peptide and then the resistance across the epithelial lining of the individual tubules were recorded. 
The TER across tubules treated with the peptide was significantly lower than in controls, indicating an 
alternative means to the use of tracers for analysing TJ function in vivo (Clark et al. 1998, Carlson et 
al. 2000). 
 
1.4.3 The size-selective nature of the tight junction 
 Several studies have suggested the existence of size-selective pores in TJs. The blood-brain 
barrier protects the brain from harmful chemicals in the blood (Nitta et al. 2003). It was found in 1885, 
that when dyes were injected into veins, all organs stained except for the brain (Nitta et al. 2003). A 
major component of the blood-brain barrier is the TJ protein claudin-5 (Nitta et al. 2003). When a low 
molecular weight biotin tracer (443D) was administered to the brains of claudin-5 knockout mice in 
vivo, it readily crossed the TJ into the brain parenchyma, whereas it was restricted to the blood vessels 
in the control (Nitta et al. 2003). When a larger microperoxidase tracer (1.9kDa) was applied to this 
model, the tracer did not cross the TJ. This data indicated that the claudin-5 knockout reduced TJ 
function in a size-selective manner. This was further demonstrated by applying a 10kDa dextran-
conjugated molecule to the brain mixed with a small nuclear dye. Both stains were observed in the 
blood vessels, but only the small nuclear dye penetrated through the TJ into the brain parenchyma 
(Nitta et al. 2003). Interestingly, despite the apparent loss of TJ function to low molecular weight 
molecules, the mice were healthy, there was no morphological difference in the blood-brain barrier 
compared to controls, and no bleeding or edema was apparent (Nitta et al. 2003). This raises the 
question about how functional and size-selective a TJ needs to be to maintain barrier integrity. Nitta et 
al. (2003) reasoned that the probable cause of loss of blood-brain barrier size-selectivity against low 
molecular weight tracers and not large molecular weight tracers in the claudin-5 knockout mice, was 
due to the continued presence of another TJ protein, claudin-12. That is, the loss of claudin-5 reduces 
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the blood-brain TJ to selectively inhibit small molecular weight molecules passage across the barrier, 
but the presence of claudin-12 in the absence of claudin-5, maintains the ability of the TJ to 
discriminate against larger molecular weight molecules and therefore maintain its integrity (Nitta et al. 
2003).  
This phenomenon has also been observed at the Sertoli cell TJ in the rat. Sertoli cell TJs form 
at puberty, which is coincident with a rise in circulating gonadotrophins and the commencement of 
spermatogenesis (Russell et al. 1989). In the rat, this is at 15 days of age. However, the small 
molecular weight tracer [51Cr]-EDTA was still able to cross the Sertoli cell TJ after 15 days, and 
indicated that the barrier function of the TJ is not fully competent until 44 days of age, at a time well 
into spermatogenesis (Setchell et al. 1981, Setchell et al. 1988). Such data indicates the further need to 
study the importance of TJ function and size-selectiveness and the threshold at which TJ interference 
will result in a non-functional and non-size-selective barrier. 
Several studies have analysed size-selectivity in TJs more closely. The permeability of 24 
polyethylene glycols (PEG) ranging in molecular radii from 3.5Å-7.4Å was tested in two intestinal-
derived model cell lines, Caco-2 and T84 (Watson et al. 2001). The molecular radius of PEGs can be 
converted to molecular weights by the equation: r (Å) = 0.29 M0.454 (Ruddy and Hadzija, 1992, 
Watson et al. 2001). Therefore the range of PEGs used was in the molecular weight range of 252Da-
1255Da. Watson et al. (2001) showed that the permeability of the TJs was inversely proportional to 
molecular size, and there was a cut-off of molecules penetrating the TJ at a molecular radii of greater 
than 4.68Å (458Da). The authors of the paper presented other literature which suggested that size-
selective pores exist in the TJs and that these are formed by claudins. The larger molecules did 
eventually cross the TJ and the authors postulated that this was due to possible dilatation of the 
existing pores, or an increase in pore size and/or number, which may be another separate function of 
the TJ (Watson et al. 2001).  
 Another study looking at the size-selective nature of the TJ in vitro, used mannitol to induce 
permeation in cultured brain cells (Deli et al. 1995). Three radio-labelled tracers of varying molecular 
weights, [14C]-sucrose (342Da), [3H]-inulin (5kDa) and Evans Blue dye (EBA, 67kDa) were used. A 
significant increase in permeation to sucrose was observed, as was observed for inulin, although at a 3-
fold lower concentration to sucrose which may have been directly due to inulin being a larger 
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molecule. Evans Blue dye did not cross the TJ in this treatment (Deli et al. 1995). This study therefore 
provided further evidence of the size-selective nature of the blood-brain barrier, where the smallest 
tracer was able to penetrate the disrupted TJ, as was a slightly larger tracer albeit at a reduced capacity 
and the largest tracer was completely excluded. Similar data was seen for various radioactive tracers of 
varying sizes used to analyse TJ function in the alveoli of the lung epithelium in sheep in vivo as well 
(Egan et al. 1976). 
Therefore, TJs are size-selective across several different types of epithelia and it appears that 
this property is directly proportional to the functionality of the TJ barrier.  
 The next question that arises is which of the TJ proteins contribute to the functional and size-
selective properties of the TJ. This review will now look at the role occludin and the claudins play in 
mediating these properties. 
 
1.4.4 The role of occludin and the claudins in tight junction function 
 
a. Occludin 
Occludin is localised at membrane fusion points in intact TJs, as shown by 
immunofluorescence and immunoelectron microscopy (Furuse et al. 1993, Clarke et al. 2000). In 
disrupted TJs induced by Ca2+ depletion, wound healing, pro-inflammatory cytokines or in the case of 
the Sertoli cell TJ low circulating gonadotrophins, occludin is localised in intercellular pools within 
the cytoplasm of the epithelial cells (Ando-Akatsuka et al. 1999, Lu et al. 2001, Bruewer et al. 2003, 
Bruewer et al. 2005, Ivanov et al. 2004, Morimoto et al. 2005, Tarulli et al. 2008). How occludin is 
distributed to the TJ is the subject of much debate.  
As mentioned previously, occludin consists of intracellular C- and N- terminal domains, two 
extracellular domains and four transmembrane domains (Tsukita and Furuse, 1999) (see Figure 1.7). 
The C-terminal of occludin while being thought to be important for the localisation of occludin to the 
TJ, was also seen to mediate the binding of occludin to ZO-1 of the cytoplasmic plaque (Martinez-
Estrada et al. 2001). Transfected connexin (a gap junction component) chimeras containing the C-
terminal of occludin were localised to cell-contact points (Matter and Balda, 1998) but were not 
integrated into TJ fibrils as seen with different chimeras also containing the occludin C-terminal 
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(Matter and Balda, 1998). Conversely, chicken occludin lacking the entire C-terminal was also 
localised to the TJ in MDCK cells and integrated into the TJ fibrils as shown by an increase in TER 
(Balda et al. 1996). A similar phenomenon was also observed in Xenopus embryos (Chen et al. 1997). 
These findings suggested that another component of occludin is responsible for it localisation to, and 
integration into TJ fibrils such as its transmembrane and/or extracellular domains. The removal of the 
second extracellular loop of occludin resulted in its absence from the TJ (Medina et al. 2000), 
demonstrating that this domain may therefore be important for its integration into the TJ. Furthermore, 
the extracellular and transmembrane domains of occludin may interact with claudins to form an anchor 
that binds to the underlying scaffolding complex (cytoplasmic plaque) containing ZO-1, ZO-2 and 
ZO-3 (Chen et al. 1997). As mentioned above, the C-terminal may be important for the interaction 
with the cytoplasmic plaque, as occludin minus its C-terminal formed discontinuous TJ fibrils and an 
increase in paracellular flux, suggesting a disruption in the barrier between cells and a loss in TJ 
function (Chen et al. 1997, Hirase et al. 1997, Bamforth et al. 1999). Interestingly, Occludin is more 
prevalent in ‘tighter’ TJs such as in the blood-brain barrier, than in leakier junctions such as those in 
non-neural tissues (Claude, 1978, Hirase et al. 1997), suggesting that occludin may have a regulatory 
role, rather than a functional role in the TJ (Nusrat et al. 2000, Ban et al. 2003). 
 
b. Claudins 
The claudins have come under close scrutiny since the idea arose that occludin may not be 
pivotal to the function of the TJ (Nusrat et al. 2000, Ban et al. 2003). The relative contribution of 
claudin-1 and claudin-2 to the TJ has been studied (Furuse et al. 1998). These two claudins were 
tagged and transfected into mouse L fibroblasts that were void of TJs to observe the ability of the 
transfected cells to form TJ strands (Furuse et al. 1998). The results showed that fibroblasts 
transfected with occludin alone, produced TJ strands that were short in length and low in number. 
However, when the fibroblasts were transfected with the claudins alone, or the claudins in conjunction 
with occludin, complete TJ fibrils were formed (Furuse et al. 1998).  
To further demonstrate the importance of claudins to TJs, claudin-1 knockout mice, a type of 
claudin prevalent in the epidermal layer, died within one day of birth (Furuse et al. 2002). These mice 
displayed a wrinkled phenotype and had died of dehydration due to severe transepidermal water loss 
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(Furuse et al. 2002), indicating that the paracellular regulatory mechanism of the TJ had been 
compromised. Under the microscope, the layered organisation of the keratinocytes in the dead mice 
appeared normal and the continuous fibrils of the TJs were visually comparable to those observed in 
the surviving wildtype mice (Furuse et al. 2002). Occludin and claudin-4 were still present in the TJ 
fibrils. To show, though, that the fibrils were different in the mutant mice, a low molecular weight 
biotin tracer (~600Da) tracer was injected subcutaneously into both the wildtype and claudin-1 
knockout mice. The tracer could not cross the epithelial layer in the wildtype mice, but could in the 
mutant (Furuse et al. 2002), suggesting that the loss of claudin-1 from the TJ fibrils, had disrupted that 
function of the TJ and altered its size-selectivity properties. In an MDCK cell-line, Clostridium 
perfringens enterotoxin selectively removed claudin-3 and -4 from TJ complexes in an intestinal cell 
line, resulting in a decrease in TJ function as shown by TER and a large size-selective increase in 
paracellular flux to 4kDa and 10kDa FITC-Dextran, but not to 40kDa FITC-Dextran (Sonoda et al. 
1999). In the claudin-5 knockout mouse model mentioned previously with respect to the blood brain 
barrier, TJ function was compromised in a size-selective manner but was still functional and size-
selective enough to prevent bleeding or edema, and the TJ strands looked morphologically normal 
(Nitta et al. 2003). This may have been due to the presence of claudin-12 at the blood-brain barrier, 
the localisation of which is not effected by the claudin-5 knockout (Nitta et al. 2003, Ohtsuki et al. 
2007). Despite findings that claudin-5 mRNA is expressed 751 fold greater than claudin-12 in cultured 
rat brain cells (Ohtsuki et al. 2007), it may have been possible that claudin-12 was providing the 
function and enough size-selectivity needed to prevent bleeding in the claudin-5 knockout mice. In 
wildtype mice, claudin-3 localised to the testicular Sertoli cell TJ at the time of TJ formation, whereas 
in the Sertoli cell-specific androgen receptor knockout mouse model, claudin-3 staining was absent 
(Meng et al. 2005). When claudin-11 was probed in these androgen receptor knockout mouse testes, 
the TJs still appeared morphologically normal, however biotin penetration into the seminiferous 
tubules in these animals showed that TJ function had been compromised and discrimination against 
low molecular weight tracers had been disrupted (Meng et al. 2005). However, evidence also suggests 
that claudin-11 is essential for TJ function, in that its knockout leads to infertility in the mouse (Gow 
et al. 1999).  
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In the corneal wounding experiment mentioned previously, low molecular weight biotin 
permeated through the epithelium until barrier function was restored 72 hours later (Hutcheon et al. 
2007). The tracer did not penetrate the corneal epithelium anywhere else, including at the regions 
flanking the wound (Hutcheon et al. 2007). Interestingly, the localisation of occludin and ZO-1 
remained constant at the TJ even before the wound had healed and barrier function had been restored 
(Hutcheon et al. 2007). The authors did not stain for any of the claudin proteins that may have been 
involved in the corneal epithelium, but the constant staining pattern of the other TJ proteins in this 
epithelial layer, and results obtained for the claudins in other epithelia, suggests that the claudins may 
have been involved with the restoration of barrier function and size-selectivity against biotin in the 
corneal epithelium also. 
 Several in vitro studies have also demonstrated the importance of the claudins to TJ function. 
The over-expression of claudin-2 in a MDCK cell-line appeared to decrease TJ function as measured 
by TER (Amasheh et al. 2002). When testing for changes in paracellular flux in the same model, the 
TJ continued to exclude low molecular weight mannitol (182Da) and higher molecular weight dextran 
(4kDa) as per the control cells (Amasheh et al. 2002). These results reinforce the point made earlier 
that results obtained from TER are not comparable with results obtained from measuring paracellular 
flux with tracers. Nonetheless, the negative impact that claudin-2 has on TER is unusual among 
claudins. For example, the over-expression of claudin-4 in MDCK cells and the localisation of 
claudin-11 to Sertoli cell TJs, increased TER (van Itallie et al. 2001, Kaitu’u et al. 2007). As 
mentioned previously, the extracellular domains of the claudins pair up with their counterparts on 
adjacent cells and several claudin pairs have been identified. Each ‘pairing’ has a different effect on 
the paracellular flux (Mitic et al. 2000). 
 
1.5 The role of phosphorylation in tight junction assembly 
Phosphorylation and dephosphorylation of some TJ proteins were first seen to be pivotal in 
regulating their assembly and disassembly in 1991 (Balda et al. 1991, Nigam et al. 1991, for a review 
see Gonzalez-Mariscal et al. (2008)). The protein kinases and phosphatases involved in regulating the 
phosphorylation state of TJ proteins are activated in the presence of calcium (Ca2+), which binds to 
and activates E-cadherin on the extracellular side of the membrane (Yap et al. 1997). E-cadherin 
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activation leads to a cascade of events involving phosphokinases, phospholipases and calmodulin 
(Farquhar and Palade, 1963) which eventually leads to the phosphorylation of occludin, the claudins 
and ZO-1, and their subsequent recruitment to the TJ (Gonzalez-Mariscal et al. 1985, Sim and Scott, 
1999, Matter and Balda, 2003, Gonzalez-Mariscal et al. 2008). Cells plated in vitro in medium 
containing low Ca2+ concentrations, do not form TJs (Gonzalez-Mariscal et al. 1985). However, upon 
restoration of ‘normal’ Ca2+ levels, TJs formed rapidly (Gonzalez-Mariscal et al. 1985). This turning 
on and off of Ca2+, is termed the calcium switch. This calcium switch has been exploited by many 
research groups studying the phosphorylation pathways that TJ proteins follow (Citi, 1992, Farshori 
and Kachar, 1999, Lawrence et al. 2002). 
 Occludin is phosphorylated at TJs in MDCK cells, with non phosphorylated occludin located 
at the basolateral membrane and not contributing to the TJ (Sakakibara et al. 1997, Farshori and 
Kachar, 1999). By SDS-PAGE gels, occludin bands appear at apparent molecular weights ranging 
from 62-82kDa (Sakakibara et al. 1997), with the heavier bands being those which are more 
phosphorylated. The removal of phosphate groups by alkaline phosphatase treatment, converged these 
bands (Sakakibara et al. 1997). Less or non-phosphorylated occludin was found to be soluble in 1% 
NP-40 detergent, and most of the occludin pool was found in this detergent fraction when media 
concentrations of Ca2+ were low. Most occludin however, appeared in an NP-40 insoluble extract upon 
restoration of Ca2+ levels, suggesting it had been phosphorylated (Sakakibara et al. 1997). Different 
detergents also exhibited the same differential solubilisation of occludin (Wong, 1997). The amino 
acid residues that are phosphorylated on occludin are serine and threonine (Sakakibara et al. 1997), 
but whether their phosphorylation and dephosphorylation is random or sequential is unknown 
(Sakakibara et al. 1997). 
Claudins are also targets of phosphorylation by a variety of kinases (Gonzalez-Mariscal et al. 
2008). The blood-brain barrier and claudin-5 has already been mentioned extensively in this literature 
review with respect to TJ function and size-selectivity. What has not been mentioned thus far with 
respect to claudin-5, is that cAMP induces an increase in its mRNA expression, regulates its 
localisation to the TJ and promotes a switch within the protein from serine phosphorylation to 
threonine phosphorylation via protein kinase A (PKA) (Ishizaki et al. 2003). These events are 
associated with an increase in TJ function and therefore size-selectivity (Ishizaki et al. 2003). When 
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lung endothelial cells expressed claudin-5 which had a point mutation of a PKA phosphorylation site, 
the TJ excluded the passage of low molecular weight tracer mannitol (182Da) and large molecular 
weight tracer inulin (5kDa), whereas in the wildtype the TJ was permeable to mannitol (Gonzalez-
Mariscal et al. 2008). This data thereby demonstrated the importance of TJ protein phosphorylation 
and directly implicated the role of phosphorylation in regulating TJ size-selectivity. Serine 
phosphorylation also appears to be important for claudin localisation to TJs. Serine phosphorylation of 
claudin-16 as mediated by PKA at residue Ser217, is essential for its localisation to kidney TJs where 
it acts as a paracellular pore for Mg2+ (Simon et al. 1999, Mitic et al. 2000, Gonzalez-Mariscal et al. 
2008). Mg2+ and Ca2+ wastage as seen in some human renal diseases is coincident with claudin-16 not 
localising to the TJ and displaying mutations in domains of the protein important for phosphorylation, 
including the C-terminal where Ser217 resides (Simon et al. 1999, Kausalya et al. 2006, Muller et al. 
2006, Gonzalez-Mariscal et al. 2008). Tyrosine phosphorylation has also been seen to be important for 
the interaction of claudin-4 with ZO-1 of the cytoplasmic plaque. Phosphorylation of residue Tyr208 
which resides on the PDZ binding motif of claudin-4, attenuates its interaction with ZO-1 and actually 
enhances TJ permeability (Tanaka et al. 2005). These results indicate that the phosphorylation of 
different residues on the claudins has differential effects on TJ function across different epithelia. For 
a more comprehensive review of claudin phosphorylation see Gonzalez-Mariscal et al. (2008). 
The zonulae occludens of the cytoplasmic plaque are also phosphorylated proteins, with 
phosphoamino acid analysis from purified ZO-1 and ZO-2 revealing strong phosphoserine signals 
(Anderson et al. 1988, Balda and Anderson, 1993, Avila-Flores et al. 2001, Gonzalez-Mariscal et al. 
2008). Serine residues of ZO-2 in TJ deficient cells induced by low Ca2+ concentrations are 
significantly more phosphorylated than in monolayers displaying established TJs (Gonzalez-Mariscal 
et al. 2008). According to Gonzalez-Mariscal et al. (2008), much of the literature suggests that 
extensive serine phosphorylation on ZO-1 and ZO-2 results in decreased TJ function in vitro. 
Interestingly, zonulae occluden tyrosine phosphorylation has differential effects on TJ function with 
increases and decreases in TJ function observed after phosphorylation in different models (for a 
review see Gonzalez-Mariscal et al. (2008)). This is probably due to different amino acid residues 
being phosphorylated on the target proteins to achieve the desired TJ effect. 
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 Considering that phosphorylation of TJ proteins is important for the maintenance of TJ 
function, one would expect that dephosphorylation of TJ proteins would also be important. 
Serine/threonine phosphatase PP2A, was the first TJ-related phosphatase found (Nunbhakdi-Craig et 
al. 2002). Occludin, ZO-1 and claudin-1 were dephosphorylated in its presence in MDCK cells, 
correlating with a loss of the TJ (Nunbhakdi-Craig et al. 2002). PP2A binds to and inhibits protein 
kinase C which subsequently blocks the phosphorylation of the aforementioned proteins. In the 
presence of okadaic acid however, this inhibition of PKC was overridden and tight junctions reformed 
(Nunbhakdi-Craig et al. 2002). It is widely agreed that phosphorylation of serine and threonine 
residues on occludin and ZO-1 results in the formation of the TJ (Chen et al. 1997). More recent 
studies have also implicated a role for claudin phosphorylation as outlined above. 
The role of tyrosine phosphorylation in TJ function is controversial, in that it appears to have 
effects both on TJ assembly and disassembly. ATP depletion stimulates anoxia and the aggregation of 
occludin, ZO-1 and ZO-2 into large macromolecular aggregates, thereby destroying the TJ barrier 
(Tsukamoto and Nigam, 1999). After ATP replenishment and the addition of tyrosine kinases, the 
aggregated macromolecules broke up and regained their original conformation (Tsukamoto and 
Nigam, 1999). Upon the addition of a tyrosine kinase inhibitor, this recovery of the TJ conformation 
was blocked. However, Kale et al. (2003), showed that tyrosine phosphorylation actually resulted in 
the disassembly of the TJ in MDCK cells, showing that tyrosine phosphorylation of the C-terminal of 
occludin, inhibited its interaction with cytoplasmic plaque proteins ZO-1, ZO-2 and ZO-3 (Kale et al. 
2003). Furthermore, oxidative stress in MDCK and Caco-2 cell monolayers, resulted in the 
phosphorylation of tyrosine residues on TJ proteins, which were associated with TJ disassembly 
(Atkinson and Rao, 2001, Kale et al. 2003). The addition of tyrosine kinase inhibitors to the Caco-2 
cell monolayers prevented oxidative stress and acetaldehyde-induced TJ disruption (Atkinson and 
Rao, 2001). Due to the apparent biphasic effect of tyrosine phosphorylation on TJ proteins, further 
research is needed to uncover the exact mechanism of not only this kinase, but also serine and 
threonine kinases and phosphatases to improve the understanding of TJ regulation by phosphorylation. 
This topic has been recently reviewed by Gonzalez-Mariscal et al. (2008). 
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1.6 The inter-Sertoli cell tight junction 
 
1.6.1 The structure of the Sertoli cell tight junction 
Sertoli cell TJs resemble TJs from other epithelial tissues and are composed of the same 
types/families of proteins as other TJs, but differ to other TJs in terms of associations with other 
junctional complexes and also by localisation with respect to the epithelial cell. Sertoli cell TJs are 
part of a complex made up of several different types of junctions and this complex does not exist in 
other epithelia. These junctions; TJ, adherens junction, ectoplasmic specialisation, desmosomes, and 
gap junction, are all packed closely together and are localised at the basal aspect of the Sertoli cell and 
provide the blood-testis barrier (Russell and Peterson, 1985, Pelletier and Byers, 1992, Mulholland et 
al. 2001, Lui et al. 2003a, Lui et al. 2003b). TJs in all other epithelial types are located at the apical 
aspect of their applicable epithelial cell (Morita et al. 1999). 
The main TJ proteins comprising the Sertoli cell TJ, are occludin and claudin-11, just one of 
the seven claudins localised to the testis (Morita et al. 1999). In more recent years, claudin-3 has been 
localised to newly formed Sertoli cell TJs in the mouse and hamster (Meng et al. 2005, Tarulli et al. 
2008), but mRNA expression in rat Sertoli cells was undetected and the only part of the rat testis in 
which claudin-3 protein was detected, was in blood vessels (Kaitu’u et al. 2007) . 
 The importance of occludin in the testis is controversial. When a peptide corresponding to the 
second extracellular loop of occludin was added to cultured Xenopus epithelial cells and rat Sertoli 
cells, there was a disruption of TJ formation in vitro (Wong and Gumbiner, 1997, Chung et al. 2001). 
These results suggest that in part, occludin may be important in the function of the TJ. Furthermore, 
testosterone and dihydrotestosterone (DHT) regulated the localisation of occludin to cultured rat 
Sertoli cells in vitro, but did not regulate its mRNA expression (Kaitu’u et al. 2007). In a hamster 
model, FSH was seen to also regulate occludin localisation to the Sertoli cell TJ in vivo and in the 
absence of circulating gonadotrophins, occludin mRNA expression increased (Tarulli et al. 2008). As 
has been mentioned previously in this review, there is strong evidence that claudin-11 is pivotal for the 
working Sertoli cell TJ, as claudin-11 knockout mice were infertile and suffered from massive germ 
cell loss (Gow et al. 1999). 
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Another protein which may have important roles in the Sertoli cell TJ, is one which has thus 
far not been mentioned in this literature review.   
 The Coxsackie virus and adenovirus receptor (CAR) is expressed at most epithelial TJs 
(Raschperger et al. 2006, Mirza et al. 2007), where it forms a complex with Junctional Adhesion 
Molecule-Like (JAM-L) protein to regulate the passage of leukocytes across epithelia (Mirza et al. 
2007). Studies have shown that CAR has important roles in the heart and muscle and its protein 
expression is controlled by signals that regulate proliferation, differentiation and inflammatory 
responses (Carson et al. 1999, Nalbantoglu et al. 1999,  Hutchin et al. 2000, Ito et al. 2000, Rebel et 
al. 2000, Tallone et al. 2001, Vincent et al. 2004, Asher et al. 2005, Dorner et al. 2005, Chen et al. 
2006, Shaw et al. 2006, Mirza et al. 2007).  
In the adult seminiferous epithelium, CAR is expressed in germ cells when they are migrating 
across the Sertoli cell TJ (Mirza et al. 2007). Wang et al. (2007), showed that CAR is also expressed 
in rat Sertoli cells at the time of TJ formation at Sertoli cell-Sertoli cell contacts in vitro. These results 
suggested that CAR expression in both Sertoli cells and germ cells is important for spermatogenesis, 
in particular the migration of germ cells across the blood-testis barrier. Interestingly, CAR was shown 
to be involved in a complex containing JAM-L at the Sertoli cell TJ at the time of germ cell migration 
(Mirza et al. 2007), suggesting that the regulatory processes which allow leukocyte transmigration 
across epithelia, are very similar to the processes which allow germ cell migration across the blood-
testis barrier (Mirza et al. 2007). The three subtypes of Junctional Adhesion Molecule (A, B and C) 
are all found in the testis but their roles are not certain (Gliki et al. 2004, Mirza et al. 2007). JAM-A 
and JAM-B partially co-localised with CAR at the Sertoli cell TJ by immunofluorescence (Mirza et al. 
2007). However, JAM-A and JAM-B were expressed at all stages of the spermatogenic cycle, and no 
complex association with CAR could be ascertained (Mirza et al. 2007) suggesting that there may be 
no interaction between JAM-A/B and CAR at the Sertoli cell TJ and any common roles in mediating 
germ cell passage across the blood-testis barrier may involve separate pathways and interactions. 
However the authors noted that more work in this respect may be required before the role of these 
proteins in testicular TJ function is fully elucidated (Mirza et al. 2007). Recent in vitro work in 
cultured rat Sertoli cells showed that the protein expression of JAM-A and CAR increased as TJs 
formed. Furthermore, JAM-A protein was seen localised around spermatogonia and preleptotene and 
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leptotene spermatocytes in a hamster model (Tarulli et al. 2008). These results suggest that JAM-A is 
expressed by both Sertoli cells and germ cells in a similar manner to CAR and therefore JAM-A may 
also play a role in regulating Sertoli cell TJ assembly and transmigration of germ cell across the blood-
testis barrier (Wang et al. 2007, Tarulli et al. 2008). Interestingly, CAR co-localised with claudin-3 in 
mouse testes which surrounded migratory germ cells, suggesting both proteins may be involved in TJ 
remodelling as germ cell crossed (Meng et al. 2005, Mirza et al. 2007). The Mirza et al. (2007) study 
provided evidence by immunofluorescence that as the CAR positive germ cells traversed the blood-
testis barrier, TJ strands formed beneath them, before the adluminal strands broke down (Figure 1.10). 
This demonstrated nicely the pivotal function of the Sertoli cell TJ to maintain successful 
spermatogenesis. In order for the TJ to open and close correctly and maintain its own integrity and that 
of the seminiferous epithelium, tight regulatory controls are necessary.  
 
1.6.2 Regulation of tight junction proteins within the Sertoli cell  
 
a. Protein phosphorylation  
Occludin in most epithelia appears to be phosphorylated when the protein is localised at the TJ. When 
phosphatase inhibitors were added to cultured Sertoli cells in vitro, there was a disruption at the TJ 
level as shown by a decrease in TER, and a rise in permeability (Li et al. 2001). It is noteworthy at this 
point that such inhibitors would alter various phosphorylation dependent pathways and proteins, and 
not just the TJ. The result obtained for occludin by Li et al. (2001), was unexpected as the phosphatase 
inhibitors were expected to prevent dephosphorylation of occludin and should have maintained TJ 
integrity. A possible explanation for this dilemma is that the pool of dephosphorylated occludins as 
mentioned previously residing at the basolateral membrane may be there in case the TJ needs to 
expand suddenly and rapidly (Li et al. 2001). Indeed, TER soared quickly after the addition of trypsin 
to MDCK cells (Lynch et al. 1995), showing that mammalian cells have a mechanism which can 
quickly assemble TJs. The interaction between preleptotene/leptotene germ cells with TJ membrane 
proteins just before and after they traverse the barrier could occur within a specialised 
microenvironment. Data has shown that as preleptotene spermatocytes cross the TJ, new TJ strands 
form beneath the germ cell before TJ strands above the germ cell break down, thereby maintaining 
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Sertoli cell TJ integrity and the exclusion of the adluminal compartment of the seminiferous 
epithelium from the basal compartment (Setchell, 1967, Zhou et al. 2002) (Figure 1.10). In order to 
achieve this the germ cell may contain the stimulus required to quickly alter the phosphorylation state 
of occludin in the TJ (Li et al. 2001). Therefore, phosphorylation appears to be an important process 
for establishing TJ function in Sertoli cells, however it may well not be the key regulatory mechanism 
concerned with TJs. Chen et al. (2000) observed claudin-1 forming fibrils with claudins in apposing 
membranes of MDCK cells were largely unphosphorylated, suggesting that the opening and closing of 
Sertoli cell TJs may be regulated by many pathways. Furthermore, the addition of phosphatase 
inhibitors did not completely abolish TJ assembly (Li et al. 2001). The contribution of 
phosphorylation to TJ regulation still needs to be fully elucidated.  
 
b. The role of the extracellular matrix  
The extracellular matrix that constitutes the basement membrane of Sertoli cells, is composed of 
collagen types I and IV (Hadley et al. 1985, Siu et al. 2003, Cheng and Mruk, 2004) and is regulated 
by metalloproteases and metalloprotease inhibitors (Siu et al. 2003). Due to the unusual position of 
Sertoli cell TJs at the basal aspect of these cells, the extracellular matrix is within close proximity, 
hence it may be possible that the constituent proteins of the extracellular matrix contribute to or 
regulate the opening and closing of the TJ. Previous data has shown that Sertoli cells secrete collagen I 
into the extracellular matrix (Hadley et al. 1985, Lee et al. 2007), and germ cells secrete collagen IV 
(Siu et al. 2003). The rising concentration of collagen correlates with TJ formation (Siu et al. 2003). 
Upon the addition of a collagen antibody to cultured rat Sertoli cells, TJ disassembly was observed by 
a decrease in TER in vitro (Siu et al. 2003). Collagen may have a biphasic effect on the Sertoli cell TJ 
proteins however, in that upon exogenous addition of cytokine TNFα, collagen levels rose, but TJs 
were disassembled (Siu et al. 2003). This cytokine enhances TJ disassembly and as would be 
expected, endogenous levels of TNFα are low in Sertoli cells at the time of TJ formation (Siu et al. 
2003). This shows that other pathways are possibly involved in Sertoli cell TJ regulation, and the 
evidence provided above for TNFα indicates that regulation by local cytokines may be another 
regulatory pathway. 
  
 
 
 
 
 
 
Figure 1.10 Migration of germ cells across the Sertoli cell tight junction. 
 In this immunomicrograph representation of preleptotene spermatocytes (blue, asterisk) 
migrating from the basal compartment of the seminiferous tubule into the adluminal compartment, the 
formation of tight junction strands containing the protein occludin (red, arrow) basally to the germ cell 
can be seen occurring before the breakdown of the tight junction adluminally to the germ cell, thereby 
demonstrating the ability of the tight junction to maintain the integrity of the specialised 
microenvironment in the adluminal compartment during germ cell migration. Taken from Mirza et al. 
(2007). 
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c. The role of local paracrine factors  
Until recently, the role of local cytokine regulation of the Sertoli cell TJ was largely unknown 
(Xia et al. 2007) and only now is becoming clearer. While many cytokines have been implicated in the 
regulation of other epithelial TJs (see Mruk and Cheng, (2004)), most of the work conducted in the 
testis has involved looking at the roles of tumour necrosis factor-α (TNF-α) and transforming growth 
factor-β3 (TGF-β3) (Hellani et al. 2000, Siu et al. 2003, Cheng and Mruk, 2004, Wong et al. 2004, 
Xia and Cheng, 2005, Lui and Lee, 2006). TNF-α is secreted by Sertoli cells, pachytene spermatocytes 
and round spermatids, but is minimally expressed as germ cells cross the Sertoli cell TJ (Siu et al. 
2003, Lui and Lee, 2006). Its administration to rats, results in the loss of germ cells in vivo, as well as 
reductions in occludin and claudin-11 mRNA and protein expression and reduced occludin localisation 
to the Sertoli cell TJ, indicating that this cytokine can disrupt the structure of the Sertoli cell TJ. 
Increased permeability of the TJ to a fluorescent dye after TNF-α treatment in the Lui and Lee (2006) 
study indicated that TJ function had also been disrupted thereby indicating an additional aspect of 
cytokine regulation. 
TGF-β3 appears to have similar regulatory roles to TNF-α, in that at the time of Sertoli cell TJ 
formation in vitro, TGF-β3 levels decrease (Lui et al. 2001, Lui et al. 2003a). Treatment of these 
cultured Sertoli cells with TGF-β3 perturbed the TJ and prevented the localisation of occludin, 
claudin-11 and ZO-1 to the TJ in vitro (Lui et al. 2001). In vivo studies have shown that blood-testis 
barrier disruption induced by CdCl2 treatment is associated with an increase in TGF-β3 levels and a 
loss of occludin and ZO-1 from the Sertoli cell TJ (Lui et al. 2003b, Wong et al. 2004). These studies 
therefore provide further evidence of local cytokine regulation of the Sertoli cell TJ. 
A recent study also implicated the role at the Sertoli cell TJ of a peptide called C-natriuretic 
peptide (CNP) which belongs to a family of 2 other peptides which regulate blood pressure and 
volume, fat metabolism and steroidogenesis in the testis (Lucas et al. 2000, Potter et al. 2006, Xia et 
al. 2007). Sertoli cells and germ cells both secrete CNP although the receptors for CNP have only 
been localised to the Sertoli cells and not the germ cells (Xia et al. 2007). Furthermore, CNP is 
secreted at stage VIII of the spermatogenic cycle in rats, which is when germ cells cross the BTB 
barrier (Xia et al. 2007). When administered to cultured rat Sertoli cells, CNP-22 synthetic peptide 
disrupted the localisation of JAM-A and occludin to the TJ in vitro and induced a transient increase of 
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CNP in the cells (Xia et al. 2007). When CNP was administered to rat testes via an intratesticular 
injection in vivo, the blood-testis barrier became permeable to low molecular weight protein FITC 
(389Da) (Xia et al. 2007) demonstrating that CNP regulates TJ function in vivo. Given that CNP is 
expressed maximally at the time of germ cell migration into the adluminal compartment of the 
seminiferous epithelium and that it has since been shown to regulate TJ protein localisation and 
function, there appears to be an important role for this peptide in regulating spermatogenesis. 
The effects of other cytokines on the Sertoli cell TJ are largely unknown, but in the normal 
testis, anti-inflammatory cytokines such as macrophage migrating inhibitory factor, interferon-γ and 
pro-inflammatory cytokines such as TNF-α and interleukin-1 (IL-1)-α/β circulate (Gerprasert et al. 
2002, Hedger, 2002, Hedger et al. 2005, O’Bryan et al. 2005). Bacterial lipopolysaccharide (LPS) 
treatment to the testis induces a pro-inflammatory response (Hedger et al. 2005) and recently it was 
shown that LPS disrupted the maturation of leptotene/zygotene spermatocytes which are the first germ 
cells adluminal to the blood-testis barrier (Liew et al. 2007). These germ cells and the more mature 
round spermatids were released prematurely from the testis within 6 days of LPS treatment which was 
associated with an increase in germ cell apoptosis (Liew et al. 2007). While the Liew et al. (2007) 
study did not analyse the effects of LPS on the Sertoli cell TJ or the blood-testis barrier, the results 
obtained for the adluminal germ cells suggest that they may have been exposed to the pro-
inflammatory cytokines, which may have been mediated by changes in the TJ. The role of the pro-
inflammatory cytokine TNF-α has already been discussed with respect to the Sertoli cell TJ in this 
section of the review, but interestingly, pro-inflammatory cytokines IL-1α and IL-6 have been shown 
to disrupt TJ function in thyrocytes and umbilical vein endothelial cells in other studies, suggesting 
that these cytokines might also effect the Sertoli cell TJ (Nilsson et al. 1998, Desai et al. 2002, Cheng 
and Mruk, 2004). Furthermore, anti-inflammatory cytokine interferon-γ has also been implicated in 
regulating TJs in cultured intestinal T84 cells, suggesting that it too may play a role in regulating the 
Sertoli cell TJ (Madara and Stafford, 1989, Youakim and Ahdieh, 1999, Cheng and Mruk, 2004).  
This section of the literature review has revealed some of the important and necessary 
regulatory mechanisms of local paracrine factors in the testis on the Sertoli cell TJ. For a more global 
picture of cytokine regulation of the Sertoli cell TJ, much more work needs to be conducted on the 
extensive array of cytokines yet to be analysed in the testis, but which have shown propensities to 
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regulate TJs in other tissues. There appears to be co-operation between all of the TJ regulatory 
pathways so far reviewed from protein phosphorylation, to components of the extracellular matrix and 
now the paracrine system in maintaining Sertoli cell TJ dynamics. The fourth regulatory process 
which may also work in co-operation with these other pathways is the gonadotrophin-based endocrine 
system.  
 
d. The endocrine system  
Several lines of evidence suggest that gonadotrophins are involved in Sertoli cell TJ formation 
and regulation. The formation of inter-Sertoli cell TJs is delayed until the onset of puberty, during 
which time there is a rise in the levels of the gonadotrophins or hormones- luteinising hormone (LH) 
and FSH (Russell and Peterson, 1985). In the absence of these hormones, TJ formation is delayed or 
prevented (Bressler, 1976). In addition, inter-Sertoli cell TJs in hypogonadotrophic hypogonadal men 
display a prepubertal phenotype. These men have low levels of circulating gonadotrophins, and when 
these are given exogenously, the TJs change to display a mature phenotype both in morphological and 
functional terms (de Kretser and Burger, 1972). Gonadotrophin effects on TJ formation can also be 
observed in animals. The season in which animals breed may depend on the photoperiod length during 
that season (Bergmann, 1987). The Djungarian hamster is such an animal and during short 
photoperiods, circulating gonadotrophin levels are low, the testes are regressed, and seminiferous 
tubule lumens disappear. As a result of all this, spermatogenesis ceases and inter-Sertoli cell TJ 
proteins are redistributed into the Sertoli cell cytoplasm, rather than at the cell-cell contact points 
(Bergmann, 1987, Tarulli et al. 2006, Tarulli et al. 2008). The restoration of gonadotrophin levels 
during longer photoperiods correlates with the relocalisation of Sertoli cell TJ proteins to the TJ and 
reappearance of testicular lumens, restoration of the testicular function and spermatogenesis begins 
again (Tarulli et al. 2006, Tarulli et al. 2008,  for a review, see Bergmann, (1987)).  
As mentioned briefly in the above paragraph, fluctuations in circulating gonadotrophins also 
effects the state of seminiferous tubule lumens, the presence of which is indicative of a functional 
Sertoli cell TJ and the absence of which is indicative of a non-functional TJ (Pelletier, 1990). 
Interestingly in other seasonal breeders such as the duck, testicular regression includes only a partial 
closure of the tubule lumens, which becomes occupied by a lipid plug, and the TJ is still functional 
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(Pelletier, 1990). When disruption of the basement membrane was induced in guinea pigs by an 
antibody against laminin, a non-collagenous extracellular matrix component, spermatogenesis was 
disrupted, testes were regressed and the tubule lumens had closed partially over a lipid plug as seen in 
the duck (Lustig et al. 2000). The Sertoli cell TJ however was still functional, as shown by its 
continued ability to exclude HRP tracer (Figure 1.11) (Lustig et al. 2000). These studies suggest that 
the loss of TJ function, is associated only with a complete loss of tubule lumens. 
Several in vivo and in vitro studies have demonstrated the regulatory role of androgens and 
FSH at the molecular level of Sertoli cell TJs. Testosterone and to a lesser extent, FSH, stimulated TJ 
formation as shown by an increase in TER in vitro (Janecki et al. 1991, Kaitu’u et al. 2007). 
Furthermore, the mRNA expression of claudin-11 and the localisation of claudin-11 and occludin to 
the TJ was seen to be regulated by testosterone as well (Kaitu’u et al. 2007). In cultured mouse Sertoli 
cells, FSH was actually seen to decrease claudin-11 mRNA expression (Hellani et al. 2000). In two 
separate in vivo studies, androgen antagonist flutamide was administered to rats and caused significant 
decreases in the mRNA expression of occludin and claudin-11 (Gye and Ohsako, 2003, Florin et al. 
2005). Interestingly, the presence of androgen receptors on Sertoli cells is maximal at the stage of 
spermatogenesis when germ cells need to cross the Sertoli cell TJ (Russell, 1977, Bremner et al. 1994, 
Holdcraft and Braun, 2004, Meng et al. 2005), and therefore the results of the flutamide studies 
provide a direct link of androgen regulation of the Sertoli cell TJ. The role of androgens at the Sertoli 
cell TJ level was further demonstrated in the Sertoli cell specific androgen receptor knockout mouse 
model (Meng et al. 2005). This model showed a small decrease in claudin-11 mRNA expression (Tan 
et al. 2005) but a much larger decrease in claudin-3 mRNA expression, which was associated with a 
disruption of TJ function as shown by biotin penetration into the seminiferous epithelium (Meng et al. 
2005). These results showed that androgens do not only regulate the expression and localisation of TJ 
proteins to the TJ, but also the function of the Sertoli cell TJ (Meng et al. 2005). In the seasonally 
regressed testes of the hamster mentioned above, circulating gonadotrophins are absent and the 
localisation of Sertoli cell TJ proteins claudin-11, claudin-3, occludin and JAM-A are disrupted in vivo 
(Tarulli et al. 2006, Tarulli et al. 2008). Furthermore, in control hamsters TJs were seen to be 
functional by their ability to exclude low molecular weight tracer biotin from entering the 
seminiferous epithelium, yet in the absence of circulating gonadotrophins, biotin readily permeated 
  
 
 
 
 
 
 
Figure 1.11 Horse-radish peroxidase tracer penetration into the seminiferous 
epithelium. 
 Electron micrograph representation of TJ function following HRP perfusion into the 
testes of adult guinea pigs. HRP (dark line) readily permeated through the seminiferous tubule 
and surrounded the preleptotene spermatocyte (Pl). The tight junction was able to prevent the 
passage of HRP into the adluminal compartment (arrow head) as was seen by the lack of 
staining around the pachytene spermatocyte (P). Taken from Lustig et al. (2000) 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
                         
 
 
 
 
Basal
Adluminal
 41
throughout the tubules indicating the disruption of TJ function in vivo (Tarulli et al. 2008). FSH 
replacement was seen to redistribute the TJ proteins back to the TJ and restore function as shown by 
biotin exclusion (Tarulli et al. 2008). It appears therefore, that both androgens and FSH regulate the 
Sertoli cell TJ according to the literature, and FSH has also been implicated in regulating CAR mRNA 
expression (Mirza et al. 2007). The hamster model is valuable at providing another perspective of 
gonadotrophin regulation of Sertoli cell TJs in vivo. The fact that TJ function and structure is disrupted 
following the loss of circulating gonadotrophins in this model, shows that gonadotrophins have an 
important role in the maintenance of the Sertoli cell TJ. When structure and function of the TJ is 
restored upon gonadotrophin replacement in these animals, results show that gonadotrophins also play 
a role in Sertoli cell TJ formation. 
Therefore, gonadotrophins are essential for the structure and function of the Sertoli cell TJ 
both from a maintenance point of view, and a formation point of view. The variety of gonadotrophin 
suppression models used to study the Sertoli cell TJ provides an invaluable means of determining the 
importance of the Sertoli cell TJ to spermatogenesis and how it fits in with the global gonadotrophin 
regulation of spermatogenesis. 
 
1.7 Gonadotrophin suppression models and their effects on spermatogenesis  
 Various animal models exist to study the effect of suppression of testosterone and/or FSH on 
spermatogenesis and potentially TJs in vivo. FSH and LH are released by the pituitary, with the latter 
gonadotrophin stimulating the release of testosterone from the testicular Leydig cells (Meachem et al. 
1998). The release of FSH and LH are dependent upon stimulation by the decapeptide gonadotrophin 
releasing hormone (GnRH), which binds to its receptor on the pituitary after release from the 
hypothalamus (Herbst, 2003). Hormone suppression models which manipulate circulating hormones 
use methods such as hypophysectomy (Bartlett et al. 1989a, Bartlett et al. 1989b, Takase et al. 1990a, 
Takase et al. 1990b, Dombrowicz et al. 1992), GnRH signal inhibition with immunogens (Mclachlan 
et al. 1994b, Meachem et al. 1998, Pratis et al. 2003, Sluka et al. 2006, Ruwanpura et al. 2008) or 
antagonists (Hikim and Swerdloff, 1995, Jiang et al. 2001, Broqua et al. 2002, Herbst et al. 2002, Hild 
et al. 2004, Matthiesson et al. 2005b, Porter et al. 2006) and steroidal/hormonal negative feedback 
(Awoniyi et al. 1989, Mclachlan et al. 1994a, O’Donnell et al. 1994, O’Donnell et al. 1996a, 
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O’Donnell et al. 1996b, Meachem et al. 1998, Pratis et al. 2003). Alternatively, some models such as 
the hypogonadal (hpg) mouse (Charlton et al. 1983, Handelsman et al. 1999, Allan et al. 2001, 
Walker, 2003, Allan et al. 2004, Bruewer et al. 2005b, Myers et al. 2005), photoregulated Djungarian 
hamster (Tarulli et al. 2006, Tarulli et al. 2008) and other seasonal breeders (Pelletier, 1986, Pelletier, 
1988, Pelletier, 1994) are naturally occurring hormone deficient models. 
Each of these models can be grouped into the information they provide about hormonal 
regulation of spermatogenesis and therefore potentially the Sertoli cell TJ as well. In gonadotrophin 
suppression models (by hypophysectomy, GnRH immunisation/antagonism or steroidal negative 
feedback), normal circulating gonadotrophins exist in the animals prior to suppression (Bartlett et al. 
1989a, Bartlett et al. 1989b, Hikim and Swerdloff, 1995, Meachem et al. 1998, Jiang et al. 2001). 
Therefore, these models are used for analysing the role of hormonal maintenance on spermatogenesis. 
In the hpg mouse, a naturally occurring deletion in the GnRH gene (see section 1.7.4) deprives the 
animal of circulating gonadotrophins and no spermatogenic activity (Ando et al. 1990, Singh et al. 
1995, Ebling et al. 2000, Myers et al. 2005). Gonadotrophin treatment to these animals therefore 
allows the study of spermatogenesis from an initiation point of view, which may include the initiation 
of TJ formation. The seasonal breeders offer models which analyse spermatogenesis from both a 
maintenance and initiation point of view due to naturally occurring hormone suppression and 
restoration (Pelletier, 1986, Pelletier, 1988, Tarulli et al. 2006, Tarulli et al. 2008). This section of the 
review will focus on some of these models. 
 
1.7.1 Hormone suppression by GnRH immunisation 
 Up until the early 1990s, there was a lack of suitable hormone suppression models, which 
could suppress testosterone and/or FSH, without affecting other hormonal systems (Mclachlan et al. 
1994b). Hypophysectomy, which involves the surgical removal of the pituitary, not only suppresses 
testosterone and FSH, but also other pituitary hormones such as prolactin (Bartlett et al. 1989a, 
Bartlett et al. 1989b, Takase et al. 1990a, Takase et al. 1990b, Dombrowicz et al. 1992) and thyroid 
stimulating hormone (Ebling et al. 2000), both of which are also important for Sertoli cell function 
(Takase and Tsutsui, 1997). Hypophysectomised rats tend to be less healthy and underweight as well 
compared to intact rats (Awoniyi et al. 1992a, Awoniyi et al. 1992b). Hypophysectomy in rats, results 
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in significantly reduced numbers of pachytene spermatocytes and round and elongated spermatids 
(Bartlett et al. 1989a, Bartlett et al. 1989b). The subsequent administration of testosterone to these 
rats, showed that it could only maintain a reduced level of spermatogenesis compared to intact rats 
(Huang et al. 1987, Awoniyi et al. 1992a, Awoniyi et al. 1992b). Under the regulation of FSH alone, 
spermatogenesis stopped at the round spermatid level (Bartlett et al. 1989a, Bartlett et al. 1989b). The 
reasons for these spermatogenic defects however, were not necessarily due to the absence of the 
‘other’ hormone in these experiments, but possibly due to the absence of other pituitary factors as well 
(Huang et al. 1987, Awoniyi et al. 1992a, Awoniyi et al. 1992b).  This necessitated the advent of a 
model which would specifically suppress both testosterone and FSH, such that any observations made 
with respect to spermatogenesis, could be directly attributed to these hormones or their derivatives 
(Awoniyi et al. 1992a, Awoniyi et al. 1992b).  
 To suppress both LH and FSH, GnRH immunisation has been employed in the rat. This 
method works by stimulating the recipient animal to produce antibodies against its own GnRH 
(Mclachlan et al. 1994b). When administered every 4 weeks for 12 weeks to healthy male rats, a 
significant reduction in testis weights occurred with severe spermatogenic regression at all stages, with 
serum FSH, LH and testosterone reduced below assay sensitivity (Meachem et al. 1998, Pratis et al. 
2003). It is possible to replace FSH alone in this model and study its effects on spermatogenic 
restoration in the short term (1-7 days) (Awoniyi et al. 1989), but when replacing testosterone alone, 
FSH levels return to near-normal levels via a GnRH independent mechanism (Mclachlan et al. 1994b). 
As a result, it is necessary to add an FSH antibody to suppress endogenous FSH production after the 
exogenous application of testosterone (Meachem et al. 1998, Pratis et al. 2003). Such FSH antibodies 
neutralise at least 90% of serum FSH without effecting serum testosterone (Meachem et al. 1998). The 
disadvantage of this model, is that to date, only recombinant human FSH (rhFSH) has been available 
for FSH replacement, and this stimulates rat antibodies against the rhFSH within 2 weeks (Meachem 
et al. 1998), thereby restricting FSH replacement times to short-term experiments of approximately 1 
week (Meachem et al. 1998, Pratis et al. 2003). The same problem is applicable for the FSH antibody 
used to suppress endogenous FSH production in testosterone-alone replacement experiments 
(Meachem et al. 1998).  
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One recent study, did administer recombinant rat FSH (rrFSH) to GnRH immunised rats in the 
long-term (Ruwanpura et al. 2008). Decreases in testis weights in the Ruwanpura et al. (2008) study 
following GnRH immunisation were comparable to those recorded previously with the same treatment 
(Mclachlan et al. 1994b, Meachem et al. 1998, Pratis et al. 2003). There were no significant recoveries 
in testis weights or serum FSH following long-term rrFSH treatment, but significant recoveries in the 
early germ cell types through to the pachytene spermatocytes were obtained (Ruwanpura et al. 2008). 
While it was expected that long-term FSH treatment would lead to significant recoveries in testis 
weights and serum FSH, the failure to obtain such results could have been due to a suboptimal dose of 
the rrFSH (Ruwanpura et al. 2008). 
There have not been many studies which have applied either this GnRH immunised model, or 
the similar GnRH-antagonised model (see section 1.7.2 below), to studying Sertoli cell TJs in vivo. 
However, a recent study looked at the effects of FSH and testosterone on the re-organisation of the 
adherens junction and ectoplasmic specialisation following GnRH immunisation (Sluka et al. 2006) by 
electron and confocal microscopy. In control animals, pan-cadherin stained extensively at the adherens 
junction and actin and espin both co-localised extensively at the ectoplasmic specialisation. Both 
junctions formed characteristic ‘scalloped’ appearances at cell contacts between Sertoli cells. 
Following GnRH immunisation, pan-cadherin re-localised to the Sertoli cell cytoplasm and was 
perpendicular to the basement membranes of the seminiferous tubules (Sluka et al. 2006). Actin and 
espin no longer co-localised at the ectoplasmic specialisation but were detected in the Sertoli cell 
cytoplasm also, with espin being perpendicular to the basement membranes of the seminiferous 
tubules like pan-cadherin (Sluka et al. 2006). The administration of FSH (but not testosterone) for 7 
days to this model was sufficient to induce the re-establishment of the adherens junction and the 
ectoplasmic specialisation, with actin and espin re-colocalising at the latter (Sluka et al. 2006). As this 
model has therefore been successfully applied to the study of the adherens junctions and ectoplasmic 
specialisation, it may be presumed that such a model could be applied to studying the effects of 
hormone suppression and replacement on the nearby Sertoli cell TJ. 
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1.7.2 Hormone suppression by GnRH antagonism 
 The effect of GnRH antagonism is similar to GnRH immunisation in that LH/testosterone and 
FSH are suppressed to undetectable levels (Jiang et al. 2001, Broqua et al. 2002, Herbst et al. 2002, 
Hild et al. 2004, Matthiesson et al. 2005b, Porter et al. 2006) and germ cell numbers are significantly 
suppressed in the human (Herbst et al. 2002, Matthiesson et al. 2005b). Rather than stimulating an 
immune response against native GnRH like the immunogens, antagonists competitively bind to the 
GnRH receptor on the pituitary and block the GnRH signal for gonadotrophin release (for a review, 
see Herbst, (2003)). The GnRH antagonism model is preferred to GnRH agonism models, as these 
result in an initial gonadotrophin surge before suppression, and this may not be desirable (Herbst, 
2003). However, GnRH agonist models do appear to be useful, after the GnRH agonist leuprolide 
acetate was shown to support the formation of mouse donor germ cell colonies and the area they 
occupied in recipient infertile tubules (Dobrinksi et al. 2001). Given the similarities with the GnRH 
immunised model, hormone replacement techniques in the GnRH antagonised model are much the 
same. 
 Thousands of GnRH antagonists exist (Herbst, 2003) and while most of the major antagonists 
all suppress LH/testosterone and FSH to the same extent as each other, it is the duration of efficacy, 
and the affinity for the stimulation of histamine inflammation after administration that differs among 
them (Jiang et al. 2001, Broqua et al. 2002). Most antagonists, such as Nal-Glu, Cetrorelix, Abarelix, 
and Ganirelix, suppress gonadotrophins for 1 day after single doses of 2mg/kg in adult male rats 
(Kangasniemi et al. 1995, Jiang et al. 2001, Broqua et al. 2002), whereas Azaline B and Acyline, 
suppress hormones from 1-2 weeks after a single dose of 2mg/kg (Jiang et al. 2001, Hild et al. 2004, 
Porter et al. 2006). All of these peptide antagonists are based on native GnRH (Herbst, 2003). A newer 
antagonist, Degarelix, has been shown to suppress hormones for approximately 6 weeks, before 
hormones slowly return to control levels over the ensuing 6 weeks, after a single 2mg/kg dose into 
adult male rats (Jiang et al. 2001, Herbst, 2003). Newer antagonists such as acyline and Degarelix, 
have greater hydrophilicity and solubility, a lower propensity to form gels in aqueous solutions, 
reduced affinities for histamine release and a greater number of hydrogen bonds available, all of which 
appear to increase affinity for the GnRH receptor (Beckers et al. 2001, Jiang et al. 2001, Broqua et al. 
 46
2002). The design of newer antagonists is essential for potential application in the treatment of cancers 
in the human and also in male contraceptive treatments (Herbst, 2003). 
The GnRH antagonist induced suppression of circulating LH/testosterone and FSH also 
disrupts spermatogenesis. Hikim and Swerdloff (1995), showed that 4 weeks of Nal-Glu treatment, 
significantly suppressed preleptotene and pachytene spermatocytes to approximately 25% of control 
numbers. The elongated spermatids were only occassionally detectable and the numbers of the early 
type A and B spermatogonia did not change compared to control animals. FSH treatment partly 
restored pachytene spermatocyte and elongated spermatid numbers and also significantly increased the 
numbers of type B spermatogonia available to enter meiosis (Hikim and Swerdloff, 1995). Other 
studies looking at the effect of other GnRH antagonists on spermatogenesis are difficult to find as are 
studies looking at the effect of gonadotrophin (particularly androgen) replacement on spermatogenesis. 
As an exception, there are studies which have looked at the effect of GnRH antagonist treatment on 
irradiated testes which exhibit no spermatogenesis and abnormally high levels of LH/testosterone and 
FSH (Porter et al. 2006). After antagonist treatment, LH/testosterone and FSH levels return to normal 
and spermatogenesis resumes (Shetty and Meistrich, 2005, Porter et al. 2006). 
Studies which have used GnRH antagonism to suppress hormones and spermatogenesis have 
not analysed the effects of suppression on the Sertoli cell TJ or other testicular junctions in general. 
Considering that GnRH antagonism appears to be very similar to GnRH immunisation in terms of 
hormone suppression, decreases in testis weights and spermatogenic disruption, it can be presumed 
that the GnRH-antagonist treated rat model is also an appropriate model for analysing changes in the 
Sertoli cell TJ following hormone suppression. 
 
1.7.3 Hormone suppression by Testosterone/Estradiol administration 
 Testosterone/Estradiol (TE) treatment is a common, established method of LH/T suppression 
in male rats (Awoniyi et al. 1989, Mclachlan et al. 1994a, O’Donnell et al. 1994, O’Donnell et al. 
1996a, O’Donnell et al. 1996b, Meachem et al. 1998, Pratis et al. 2003). Low doses of testosterone 
and estradiol are administered via subcutaneous silastic implants (3cm testosterone and 0.4cm 
estradiol) which act to slightly increase endogenous serum testosterone and estradiol levels. This 
suppresses LH secretion from the pituitary to undetectable levels via a negative feedback system, 
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while leaving serum FSH at normal or partially reduced (70% of control) levels (Mclachlan et al. 
1994a, O’Donnell et al. 1994, O’Donnell et al. 1996a, O’Donnell et al. 1996b, Awoniyi et al. 1990). 
The reduced LH causes a reduction in intratesticular testosterone production to 3% of control levels 
(O’Donnell et al. 1994, O’Donnell et al. 1996a, O’Donnell et al. 1996b). Spermatogenesis is also 
suppressed following 8 weeks of TE treatment in rats and only proceeds to midspermatogenic germ 
cell types, with a complete block at the androgen-dependent step VII to step VIII round spermatid 
transition (Mclachlan et al. 1994a). The low dose of testosterone applied in this treatment can still 
support some spermatogenic activity, as application of the androgen receptor antagonist flutamide, 
resulted in a further decrease in germ cell types (Mclachlan et al. 1994a). Data collected from these 
models indicate that FSH alone is not sufficient to drive complete spermatogenesis (Mclachlan et al. 
1994a) and that testosterone is required for the latter part of spermatogenesis, at least from the 
conversion of round spermatids to elongated spermatids (Mclachlan et al. 1994a). When the TE 
implants were replaced with high dose (24cm) testosterone implants, intratesticular testosterone levels 
were restored to 7-12% of control levels, serum testosterone to 20-30% of control levels and serum 
FSH to controls levels (Awoniyi et al. 1989, Mclachlan et al. 1994a, O’Donnell et al. 1994). After 2-4 
days, high dose testosterone was sufficient to induce round spermatid maturation and restored 
elongated spermatid numbers to normal (Awoniyi et al. 1989, Awoniyi et al. 1990, Mclachlan et al. 
1994a, O’Donnell et al. 1994). Hence this model is principally one of androgen suppression and 
replacement, with FSH remaining at near normal levels. 
The effect of TE treatment on Sertoli cell TJs is unknown. However considering the points 
presented that FSH is not suppressed and that spermatogenesis proceeds as far as the round spermatid 
level, it can be assumed that the TJs are functional and as such this model does not appear to be 
appropriate for studying the role of hormone regulation on TJ function. 
 
1.7.4 The hypogonadal mouse 
 The hypogonadal (hpg) mouse involves a naturally occurring major deletion of 2 of the 4 
exons encoding the mouse GnRH gene, leaving it with infantile testes, undetectable FSH and < 10% of 
normal LH/testosterone levels (Cattanach et al. 1977, Charlton et al. 1983, Mason et al. 1986a, Huang 
et al. 1987, Allan et al. 2001). The reproductive tract however is functionally competent, in that 
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spermatogenesis and fertility can be initiated by transplantation of the GnRH gene (Mason et al. 
1986b), multiple injections of GnRH (Charlton et al. 1983) or by the application of testosterone by 
silastic implants (Haywood et al. 2003, Walker, 2003). Estradiol administration unusually induced 
FSH production in the hpg mice and this was able to establish qualitatively normal spermatogenesis 
also (Ebling et al. 2000, Baines et al. 2005). Allan et al. (2001), produced a hpg mouse model which 
contained a transgene for the α and β subunits of human FSH. These mice were produced to study the 
effect of FSH alone on spermatogenesis in the mouse in the absence of LH (Allan et al. 2001, 
Haywood et al. 2003). These transgenic hpg mice, exhibited phenotypes indicative of FSH treatment 
such as increased testis weights compared to hpg mice, mature Sertoli cells, mature postmeiotic germ 
cells and significantly higher levels of Sertoli cell cAMP production. 
Spermatogenesis in hpg mice produces spermatogonia and primary spermatocytes 
(preleptotene, leptotene and zygotene) at 11% and 2% respectively of wildtypes (Singh et al. 1995, 
Allan et al. 2004, Myers et al. 2005). FSH production in the hpg + tgFSH mice is sufficient to drive 
spermatogenesis to the round spermatid stage with the occasional appearance of early elongated 
spermatids (Allan et al. 2001, Allan et al. 2004). Androgen treatment alone to hpg mice initiates 
qualitatively normal spermatogenesis with fertile sperm, thereby displaying the requirement of 
androgens for complete spermatogenesis in the mouse. (Handelsman et al. 1999, Walker, 2003). The 
separate roles of FSH and androgens in regulating spermatogenesis in mice and rats are therefore 
conserved between the two species (Mclachlan et al. 1994a , Hikim and Swerdloff, 1995). 
With respect to the Sertoli cell TJ, some electron microscopy work has been conducted in hpg 
mice to visualise its structure and showed that TJ strands were discontinuous and incomplete (Charlton 
et al. 1983, Myers et al. 2005). No TJ specific proteins have been targeted in this model but the nearby 
ectoplasmic specialisation displayed weak espin staining in the hpg mice compared to wildtypes 
(Myers et al. 2005). 
 The hpg mouse therefore provides a unique opportunity to study the initiation of 
spermatogenesis and the formation of the TJ, as opposed to the GnRH immunised/antagonised and TE 
models, where studies are restricted to the maintenance of spermatogenesis and the TJs. 
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1.7.5 Hormone suppression in men 
 Male hormonal contraception is based on the use of testosterone or synthetic androgens to 
suppress LH and FSH, but particularly intratesticular testosterone to suppress spermatogenesis, while 
maintaining adequate androgen action at other sites within the body (Matthiesson et al. 2005b). 
Studies have successfully suppressed intratesticular testosterone by 98% by combining exogenous 
testosterone with some other hormonal treatment regimen (Morse et al. 1973, McLachlan et al. 2002c, 
Coviello et al. 2004, Matthiesson et al. 2005b, Matthiesson et al. 2005a), but very few studies have 
looked at the direct effects on spermatogonia number and their relationship with intratesticular 
testosterone levels (Matthiesson et al. 2005b). Three types of hormones have been combined with 
testosterone for hormonal suppression. The first types are the progestins such as Depot 
Medroxyprogesterone Acetate (DMPA) or Levonorgestrel (LNG) (Matthiesson et al. 2005b, 
McLachlan et al. 2002c, Matthiesson et al. 2005a). Progestins help to increase the rate, but not depth 
of spermatogenic suppression, and may also have some direct effects upon the Sertoli cell after the 
mRNA for progestin receptors was found there (Ebling et al. 2000, Gadkar-Sable et al. 2005, Shah et 
al. 2005). The second type of hormonal treatment is the 5α-reductase inhibitor. O’Donnell et al. 
(O’Donnell et al. 1999), proposed a role for the potent androgen dihydrotestosterone (DHT), a 
derivative of testosterone, in restoring the maturation of round spermatids when intratesticular 
testosterone levels were exceedingly low. The enzyme which converts testosterone to DHT is 5α-
reductase. When testosterone was administered to adult rats which had been hormonally suppressed 
with TE implants, spermatogenesis was restored, but the addition of a 5α-reductase inhibitor blocked 
the maturation of round spermatids into elongated spermatids (O’Donnell et al. 1999), suggesting a 
role for the enzyme in the amplification of residual androgen levels (O’Donnell et al. 1999). In men 
undergoing contraceptive treatment, some maintained a reduced level of sperm production despite 
suppressed LH and testosterone, and this may have been due to them converting testosterone through 
5α-reductase to DHT (Anderson et al. 1996, Anderson et al. 1997). The 5α-reductase inhibitors 
dutasteride and finasteride have been used therefore to suppress this conversion of testosterone to 
DHT in recent papers (Matthiesson et al. 2005b). The third type of hormonal treatment with 
testosterone is GnRH antagonism, most recently with acyline and cetrorelix, the actions of which were 
described in section 1.7.2. Another GnRH antagonist, Teverelix, has also been used in rhesus 
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monkeys, but was shown to be slightly less efficient at suppressing FSH than most other antagonists 
(Erb et al. 2000).  
 Matthiesson et al. (2005a) showed that when combining testosterone with i) LNG, ii) acyline, 
iii) LNG + acyline, iv) dutasteride, all germ cell types from Type B spermatogonia up, were 
significantly suppressed. Despite a further suppression in intratesticular androgens with dutasteride, 
there was no difference between the extent of germ cell suppression between any of the groups 
(Matthiesson et al. 2005a). Interestingly, the extent of germ cell suppression did not correlate with 
intratesticular testosterone levels, with some heterogeneity in germ cell response to all of the 
treatments, suggesting intrinsic differences in susceptibility to gonadotrophin suppression between 
individual men (Matthiesson et al. 2005b). This therefore requires more study of human 
spermatogenesis and its regulation. 
TJs in low levels of circulating gonadotrophins in men are permeable to the electron opaque 
tracer lanthanum and appear immature by electron microscopy (de Kretser and Burger, 1972). These 
phenotypes are restored upon the exogenous application of gonadotrophins (de Kretser and Burger, 
1972), indicating potential regulation of TJ structure and function in men. 
 
1.8 Knockdown of gene expression by RNA interference  
The previous section of this literature review looked at some hormone suppressed animal 
models and their application for studying spermatogenesis and the hormonal regulation thereof. In the 
literature, some of these models have lightly touched on the Sertoli cell TJ or other junctional types in 
the testis, and as discussed, some appear to be suitable for studying the effect of gonadotrophin 
suppression on the Sertoli cell TJ in more depth. However studying the Sertoli cell TJ would not 
involve the study of hormonal regulation exclusively, but also involve studying the relative 
contribution of protein constituents to the Sertoli cell TJ. One way of conducting this type of study, 
would be by RNA interference.  
Silencing of gene expression by RNA interference, involves the application of small 
interfering RNA (siRNA) strands to recipient cells, which eventually leads to the cleavage of a target 
mRNA strand. This method of gene silencing was only discovered in 1998 when double-stranded 
RNA (dsRNA) was injected into the nematode Caenorhabditis elegans leading to sequence-specific 
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gene silencing (Wang and Barr, 2005, Fire, 2007). Since this first example of gene silencing, siRNA 
has been successfully applied to block gene expression in plants, Drosophila, mouse oocytes and 
numerous other organisms (Baulcombe, 1999a, Baulcombe, 1999b, Svoboda et al. 2000). For a 
review, see Dykxhoorn and Lieberman (2005).   
 The RNA interference pathway (see Figure 1.12) is complex. Briefly, a long dsRNA strand is 
introduced into a cell where it is cleaved into small siRNA fragments by a Dicer complex, which is an 
RNase III family member (Dykxhoorn and Lieberman, 2005). These fragments are then unwound into 
single stranded antisense fragments by an RNA-inducing silencing complex (RISC). These single 
stranded fragments guide RISC to the target mRNA which is then cleaved, thereby silencing gene 
expression (Dykxhoorn and Lieberman, 2005). This entire process occurs within the cytoplasm 
(Hutvagner and Zamore, 2002a, Hutvagner and Zamore, 2002b, Zeng and Cullen, 2002, Kawasaki et 
al. 2003).  
One problem with mammalian cells, is that any dsRNA strand of greater than 30 nucleotides 
appears to induce a sequence non-specific interferon response within the cell, which effectively results 
in the cleaving of mRNA and a global shutdown of mRNA translation (Stark et al. 1998, Elbashir et 
al. 2001a, Elbashir et al. 2001b, Elbashir et al. 2001c). Most studies involving gene expression 
knockdown in mammalian cells therefore appear to adopt siRNA fragments of no greater than 23 
nucleotides in length (Stark et al. 1998, Elbashir et al. 2001a, Elbashir et al. 2001b, Elbashir et al. 
2001c).   
The potential importance of siRNA as a therapeutic agent has been demonstrated in an in vivo study 
using mice. Mice were injected intravenously with siRNA specific for Fas, a gene in the liver which 
promotes apoptosis (Kondo et al. 1997, Siegel and Fleisher et al. 1999). Mice injected with the 
siRNA, survived up to ten days while all control mice had died of liver failure and liver fibrosis within 
three days (Song et al. 2003).  
A more recent study has successfully applied RNA interference during spermatogenesis in 
mice, in vivo (Shoji et al. 2005). A DNA vector based system was used to deliver siRNA (in this case 
termed short hairpin siRNA (shRNA)) into the testes of prepubertal mice by electroporation (Shi, 
2003, Dorsett and Tuschl, 2004, Shoji et al. 2005). The siRNA was targeted against Dmc1, a gene 
which encodes a DNA recombinase and is functionally required in spermatocytes (Shoji et al. 2005).
  
 
 
 
 
 
 
Figure 1.12 The small interfering RNA mediated gene silencing pathway. 
 Small interfering RNA (siRNA) fragments are derived from longer double stranded DNA 
molecules which are cleaved into the smaller siRNA fragments by Dicer. These fragments then bind to 
RNA-inducing silencing complex (RISC), which unwinds the siRNA in an ATP dependent fashion. 
The now single stranded siRNA molecules guide the RISC complex to the target mRNA molecule and 
cleaves it in the cytoplasm, silencing its expression. Taken from Dykxhoorn and Lieberman (2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
        
 
 
 
 52
The silencing of the Dmc1 gene, led to meiotic defects in the spermatocytes and this was a similar 
result to what has been observed in the Dmc1 null mutant (Shoji et al. 2005). This indicates the 
necessity of Dmc1 in normal spermatogenesis. Other genes which have been silenced in the testis are 
hard to find, but another testicular gene which has been silenced in vivo is the androgen receptor 
(Compagno et al. 2007, Gonzalez-Herrera et al. 2006).  
Prostate cancers are initially androgen regulated and their growth is inhibited by castration or 
androgen antagonists, but later on they become resistant to such treatments (Compagno et al. 2007). 
Compagno et al. (2007) administered androgen receptor-specific siRNA via an intraperitoneal (ip) 
injection into mice bearing castration-resistant prostate tumours. The androgen receptor was silenced 
in the prostate, testis and in the tumours, which inhibited their growth and inhibited angiogenesis, 
indicating that even after the prostate becomes castration-resistant, they are still androgen sensitive 
(Compagno et al. 2007). These results demonstrated a possible therapeutic role for siRNA.  
A second study also silenced the androgen receptor in mice (Gonzalez-Herrera et al. 2006). 
Fibroblast growth factor 2 (FGF-2) is involved in testis development and maintenance, particularly 
with respect to gamete production and steroid synthesis (Gonzalez-Herrera et al. 2006). Its expression 
is controlled by an androgen regulated protein called IRES, which mediates translation (Gonzalez-
Herrera et al. 2006). The silencing of the androgen receptor (70% efficiency) led to a decrease in the 
protein expression of FGF-2 (Compagno et al. 2007). This study did not look any further at the effects 
of the reduced protein expression of FGF-2 with respect to testicular maintenance, which would be an 
interesting area to follow up and therefore requires more work.  
Importantly for this thesis and further research into the field, in vivo applications of siRNA 
mediated gene silencing can offer alternatives to gene knockout or mutation models when studying 
spermatogenesis and the TJs, and as mentioned previously, it also offers the possibility of studying the 
importance and contribution of specific protein components to the function of the TJ or other junctions 
during spermatogenesis, in vivo. 
Interestingly, the use of siRNA technology appears to be versatile as it has been successfully 
applied in vitro as well. The importance of claudin-4 to the respiratory epithelium has been presented 
by an in vitro pharmaceutical company. Following claudin-4 siRNA treatment, TJ function was 
decreased by 75% compared to controls as measured by TER (Johnson and Quay, 2005). Furthermore, 
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application of the siRNA to the same cultured human respiratory cells, prevented TJ formation 
(Johnson and Quay, 2005). In a cultured human colorectal cancer cell-line, siRNA against claudin-4 
increased the motility of invasive cancer cells (Ueda et al. 2007) in vitro. Conversely in a human 
ovarian cancer cell-line, siRNA targeted against claudin-3 and claudin-4 reduced the invasiveness and 
motility of the cancer lines, indicating potentially different roles for the same claudin protein (in this 
case claudin-4), in different epithelia (Agarwal et al. 2005). In recent years, the number of studies 
looking at the contribution of different claudins to the function of TJs in different cultured epithelial 
cells using siRNA technology has increased and has included analysis of claudins 1-4, 7 and claudin-
12 (see Hou et al. (2006) and Fujita et al. (2008)). Studies looking at the contribution of occludin to TJ 
function have also increased although not to the same extent as for the claudins. The silencing of 
occludin in the retinal pigment epithelium resulted in an increase in TJ permeability to the small 
molecular weight tracer tetramethylrhodamine (467Da) (Phillips et al. 2008) in vitro. In 
cultured MDCK II cells, the silencing of occludin had diverse effects on the function of the TJ 
and also the cytoskeletons within the epithelial cells (Yu et al. 2005). Thus far, the contributions 
of claudin-11 or occludin to the Sertoli cell TJ have not been analysed. 
The transmembrane proteins are not the only TJ proteins to have been studied. In cultured 
MDCK II cells, siRNA targeted against PALS1, a protein which interacts with ZO-1 of the 
cytoplasmic plaque and is important for cellular polarisation, also reduced TJ function as shown by 
TER in vitro (Straight et al. 2004).  
The above studies show that siRNA is a useful technique for analysing the contribution of the 
key transmembrane proteins, claudin-11 and occludin to the Sertoli cell TJ in vitro and potentially in 
vivo as well. 
 
1.9 Conclusion  
This review has looked at spermatogenesis and the processes involved to produce mature, 
fertile sperm. While the length and types of spermatogenic cycles vary across species (Roosen-Runge, 
1952, Clermont, 1963, França et al. 1998), the pivotal roles that Sertoli cells play in this process are 
conserved, in that in all species they mediate the provision of nutrients, hormonal signals and cell-cell 
interactions through junctional complexes, including the essential blood-testis barrier, the major 
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component of which is the Sertoli cell TJ (Griswold, 1998, Setchell, 2004). This review has covered 
work studying the proteins involved in TJ formation, regulation and function, as well as reviewing the 
necessity of TJs in the testis and their role in spermatogenesis. TJ strands are generally composed of 
two major proteins, occludin and claudin, with contributions from CAR and the junctional adhesion 
molecules (Bazzoni et al. 2000, Gonzalez-Mariscal et al. 2003, Mirza et al. 2007). These proteins 
interact with their counterparts on adjacent cells to effectively form a selectively permeable seal in 
epithelial cells. In forming this seal, compartments of distinct fluid and solute composition are formed 
(Mitic and Anderson, 1998, Cereijido and Anderson, 2001, Cheng and Mruk, 2002). In observations 
using freeze fracture electron microscopy, TJs appear as fibrils wrapping around the periphery of cells 
(Cereijido and Anderson, 2001, Gonzalez-Mariscal et al. 2003). Recently, it was determined that these 
fibrils are proteinaceous and these proteins (occludin and claudin) are linked to the cytoskeleton via 
the cytoplasmic plaque, a protein complex residing beneath the TJ membrane proteins (Itoh et al. 
1999, Lapierre, 2000, Gonzalez-Mariscal et al. 2003). Progress in understanding the testicular TJ has 
been made over the past two decades, however some areas still need to be researched further. The 
dilemma of how occludin localises to the TJ either via its C-terminal or its extracellular and/or 
transmembrane domains continues to be the subject of much debate. Several discrepancies also lie 
among separate findings in determining the regulatory role that kinases and phosphatases have on TJ 
formation. The finding that heavily phosphorylated occludin proteins are integrated into TJ fibrils 
which still have high paracellular flux, can possibly be explained by the inability of the C-terminal to 
interact with ZO-1 due to its phosphorylation state (Kale et al. 2003). Further research needs to look at 
the location of phosphorylation residues on occludin and determine if they are actually located on the 
C-terminal. The role of phosphorylation with respect to the claudins and ZO-1/ZO-2 is also an area 
which requires further research. 
Tracers have been used by many researchers since the late 1960s to analyse the function of the 
TJ both quantitatively and qualitatively in vivo and in vitro. Not only have these tracers demonstrated 
the loss of the function of a TJ by breaching the epithelium they protect, they have also displayed the 
size-selective nature of TJs and the roles specific proteins have in maintaining size-selectivity and 
thereby function. Some of the more interesting results have demonstrated that a TJ does not need to be 
completely ‘functional’ to complete its protective role, as was demonstrated in the claudin-5 knockout 
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mice (Nitta et al. 2003), where despite small molecular weight (443Da) tracers being able to cross the 
blood-brain barrier into the brain parenchyma, the mice were healthy and suffered no oedemas or 
bleeding. In the testis, spermatogenesis proceeded after TJs formed at day 15 in the rat, but a [51Cr]-
EDTA tracer was still able to cross the blood-testis barrier up until 10 days later (Setchell et al. 1981, 
Setchell et al. 1988), indicating that the Sertoli cell TJ did not need to be fully functional for 
spermatogenesis to commence either. These data have demonstrated that the function of the TJ does 
not work like an on/off switch, but there are shades of gray where TJ function can be reduced but TJ 
integrity is not altogether disrupted, and this suggests that considerable work needs to be done to 
understand the TJ. 
In the seminiferous tubules of the testis, TJs need to be constantly disassembled and 
reassembled to allow passage of early germ cells through to the protected adluminal compartment 
while maintaining blood-testis barrier integrity, thus providing a good model for studying the 
regulation of the TJ (Setchell, 1967, Zhou et al. 2002). It has been shown that a rise in gonadotrophin 
levels at puberty correlates with the formation of the inter-Sertoli cell TJ, which does not form 
beforehand (Russell and Peterson, 1985). Furthermore, androgens and FSH stimulate the expression 
and localisation of claudin-11 and localisation of occludin to the Sertoli cell TJ (Janecki et al. 1991, 
Florin et al. 2005, Meng et al. 2005, Tarulli et al. 2006, Kaitu’u et al. 2007, Tarulli et al. 2008). 
Several hormone suppression models which have successfully enabled the study of the contributions 
of testosterone and FSH alone or in combination with each other to spermatogenesis, have been 
presented in this review (Charlton et al. 1983, Mclachlan et al. 1994b, Mclachlan et al. 1994a, 
O’Donnell et al. 1994, Hikim and Swerdloff, 1995, O’Donnell et al. 1996a, O’Donnell et al. 1996b, 
Meachem et al. 1998, Handelsman et al. 1999, Allan et al. 2001, Jiang et al. 2001, Broqua et al. 2002, 
Herbst et al. 2002, Pratis et al. 2003, Allan et al. 2004, Hild et al. 2004, Matthiesson et al. 2005b, 
Porter et al. 2006, Sluka et al. 2006, Ruwanpura et al. 2008). While not a lot of these models have 
been used to analyse the role of TJs specifically in spermatogenesis, the fact that they suppress FSH 
and testosterone, and that both of these hormones regulate Sertoli cell TJ proteins makes them 
potentially suitable models to apply to the study of Sertoli cell TJs. 
 This review has also briefly looked at a gene silencing technique, RNA interference, which 
involves the use of small interfering RNA fragments to cleave specific mRNA strands in the 
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cytoplasm (327). While it has been highly effective in silencing gene expression in vitro, more 
recently, it has been successfully applied to silence the expression of genes important for 
spermatogenesis in vivo (Shoji et al. 2005). The implications of this work are that researchers have an 
alternative to gene knockout and mutation models, but more importantly to this thesis and this field, 
one can possibly ascertain the importance and contribution of specific TJ proteins to the function of 
the TJ and therefore spermatogenesis, and then apply this technique more broadly to other junctions in 
vivo.  
 
1.10 Hypothesis and aims  
 It is hypothesised that the function of the Sertoli cell TJ in the adult testis is regulated by 
gonadotrophins and that the TJ proteins claudin-11 and occludin are the major proteins regulated by 
gonadotrophins in vivo. Furthermore it is hypothesised that gonadotrophin suppression in men, as a 
consequence of male hormonal contraception, alters the Sertoli cell TJ. 
To address these hypotheses, the following specific aims are presented: 
i) To assess the relative contribution of claudin-11 and occludin to Sertoli cell TJ function by 
employing siRNA methodology to selectively ablate these proteins. The experiments to support this 
aim form Chapter 3 of this thesis. 
ii) To determine the extent to which hormone suppression and replacement in the rat in vivo, alters TJ 
function and TJ protein expression. The experiments to support this aim form Chapter 5 of this thesis. 
iii) To examine the effect of the FSH transgene in hpg mice as well as androgen DHT administration 
to hpg and hpg + tgFSH mice on the initiation of a functionally and structurally competent TJ. This 
study will also examine the development of the TJ in pubertal wildtype, hpg and hpg + tgFSH mice 
into adulthood. The experiments to support this aim form Chapter 6 of this thesis. 
iv) To determine the extent to which hormone suppression alters TJ protein localisation and expression 
in men given male hormonal contraceptive. The experiments to support this aim for Chapter 7 of this 
thesis. 
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Chapter 2. Materials and Methods 
This Chapter presents the materials and methods used throughout this thesis. In some cases, 
specific materials and methods were applied to, or optimised for specific Chapters, and details for 
those can be found within the relevant Chapters. 
 
2.1 Animals 
For animal specifics please see relevant Chapters. All animal work conducted within this 
thesis was approved by the appropriate animal ethics committees. Animals were only used when 
necessary and were killed humanely at the end of experimentation. Where whole animals or animal 
parts were not required for this thesis, they were made available to other researchers. Rat work 
(Chapters 3-5) was conducted under animal ethics numbers MMCB 2002/04, 2002/38 and 2006/19, 
through Monash Animal Services, Monash University, Clayton, VIC, Australia.  
Mouse work at the Anzac Research Institute in Concord, NSW, Australia (Chapter 6) was 
approved by the University of Sydney and Central Area Health Services Animal ethics committee.  
Testicular tissues used in the human study (Chapter 7) came from men who had given prior 
written consent to experimentation and testicular biopsies. All such work had been approved by the 
University of Washington, USA. 
 
2.2 Immunohistochemistry 
This section is relevant for Chapters 4-7. Immunocytochemistry was used in Chapter 3 for 
cultured cells and the protocol used for that process can be found in that Chapter. 
 
a. Fixed tissue 
The specific fixation methods for each study in preparation for immunohistochemistry can be 
found in the upcoming Chapters. This section details the procedures performed on all tissue after 
fixation in Chapters 4-7. 
Tissue was dehydrated by gradual ethanol incubations (70%, 2hours, 90%, 2 hours, 100%, 3 x 
2 hours) and cleared in histolene (2 x 2 hours) before paraffin wax embedding (2 x 2 hours). Tissues 
were then mounted on plastic blocks. 
 58
Sections were cut to 5μm using a microtome (Leica, Cat # RM 2155) and adhered onto 
Superfrost-Plus slides (HD Scientific, Melbourne, Australia) before being incubated overnight at 37oC 
to dry. 
Sections were de-waxed in two histolene washes (5 minutes each), and then rehydrated in 
gradual ethanol incubations (100%, 8 minutes, air-dried 8 minutes, 90%, 8 minutes, 70%, 8 minutes). 
This was followed by a 5 minute wash in phosphate-buffered saline (PBS, pH 7.4). Antigen retrieval 
was performed by heating the sections for 10 minutes in 600ml of 1mM EDTA-NaOH (pH 8.0) (Pileri 
et al. 1997) in an 800W microwave. Sections were then allowed to cool in the EDTA-NaOH solution 
for an hour before being washed for 5 minutes in MilliQ water. Primary antibodies and negative 
controls were then applied to the sections (at the same concentration as each other) for the appropriate 
length of time (see details in relevant Chapters for incubation times for all primary and secondary 
antibodies used in this thesis) in combination with 10% of the normal serum from the species that the 
secondary antibody was raised in. Sections were then washed in PBS and the secondary antibodies 
were applied before another wash in PBS. Sections were then subjected to a fluorescent or one of two 
light microscopy protocols. 
For fluorescent microscopy, sections were co-stained after the secondary antibody incubation 
with the fluorescent nuclear counterstains, DAPI (100nM in PBS/bSA) and TO-PRO-3 (1:100 in 
DAPI/PBS/bSA, Molecular Probes, Eugene, OR, USA) for 5 minutes before being washed twice in 
PBS and then mounted in FluorSave (Calbiochem, La Jolla, CA) under 22mm x 50mm coverslips (HD 
Scientific, Melbourne, Australia). Sections were visualised using a confocal microscope (Fluoview, 
FV300, Olympus Australia, Mt Waverley, VIC, Australia) or a fluorescent microscope (Olympus, BX-
50). Three filter cubes were used on the fluorescence microscope which used a mercury burner light 
source: i) U-MWG, BP510-550nm (excitation wavelength range), DM570, BA590 (suitable for 
TRITC and ALEXA-546); ii) U-MWU, BP330-385nm (excitation wavelength range), DM400, 
BA420, (suitable for DAPI); iii) U-MWB, BP450-480nm (excitation wavelength range), DM500, 
BA515 (suitable for ALEXA-488 and FITC). The confocal microscope uses the same burner/cube set 
up for visualising the slides, however for capturing images, laser lines of single wavelengths were 
used (thus no need for excitation filters) and these were 488nm (green) and 568nm (red). An 
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ultraviolet (UV) laser line was not available on the confocal microscope, hence the use of TO-PRO-3 
which fluoresces at 568nm. 
Two protocols were used at different stages for light microscopy in this thesis. Prior to the 
primary antibody incubations, endogenous peroxidases were inactivated with 3% H2O2 (Chemical 
Ajax, cat # 260) for 30 minutes, and then non-specific binding sites in the tissue were blocked with 
CAS block (Zymed, San Francisco, CA, USA) containing 10% of normal serum from the animal in 
which the secondary antibody was raised for a further 20 minutes. Primary and then secondary 
antibodies were then applied for the appropriate length of time, and it was from after this step that the 
two detection protocols diverged.  
The first protocol used DAB (DAKO, cat # K3466), which acts as a substrate to the HRP 
conjugated secondary antibodies. Its cleavage produces a brown precipitate which can be visualised by 
microscopy. The reaction occurs gradually, and so once the positive signal is clear enough, the 
reaction is stopped by briefly placing the slides into MilliQ water, so as not to enhance any 
background signal. Sections were then incubated for 30 seconds in hematoxylin (Sigma, St Louis, 
MO, USA) to highlight cell nuclei, chromatin and ribosomal structures and then rinsed with MilliQ 
water. Scott’s tap water (Sigma, cat # S5134) was then added for a further 30 seconds to enhance 
hematoxylin staining before a final rinse in MilliQ water. Sections were then dehydrated in 2 x 100% 
ethanol incubations (30 seconds each), 1 x 70% ethanol incubation (30 seconds), 2 x histolene 
incubations (5 minutes each). Afterwards the sections were mounted in DPX-resin (BDH, cat # 36029) 
and visualised and photographed under the fluorescent microscope (Olympus, BX-50) using a 
FujixHC-2000 high-resolution digital camera (Fujifilm, Tokyo, Japan). The second protocol used a 
Vecta/VIP (Vector Laboratories, CA, USA) system. Solution ABC (Elite, cat # DK-6100) was 
prepared by adding 20μl of reagent A to 1ml of PBS, followed by the addition of 20μl of reagent B. 
The solution was then left at room temperature for 30 minutes before being applied to the sections for 
1 hour. Sections were then washed twice in PBS and then incubated in Vecta/VIP (prepared by adding 
1 drop of each of four reagents to 1.67ml of PBS and mixing between each addition) for 
approximately 1 minute, or long enough to allow a clear positive pink signal become apparent under 
the microscope without letting the background appear. The sections were then washed in MilliQ water 
to stop the Vecta/VIP reaction. The sections were incubated in hematoxylin for 6 minutes, rinsed in 
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MilliQ water, incubated in Scott’s tap water for 1 minute and then rinsed a final time in MilliQ water. 
Dehydration and mounting of the tissue was conducted as per the DAB protocol above. 
 
b. Frozen tissue 
Frozen testes, microtome blades, slides and forceps were taken to a cryostat (Lecia, cat # CM 
1850) and allowed to equilibrate to its conditions (-20oC) for 30 minutes. Testes were then mounted in 
OCT resin (Optimal Cutting Temp Compound, Sakura, cat # 4583.118), and sectioned at 10μm with a 
microtome blade inside the cryostat at -20oC. The sections were then placed onto a slide, and a finger 
placed underneath the slide to warm it up just enough to allow the section to melt onto the slide. The 
slide was then re-frozen and fixed in 100% acetone for 10 minutes within the crytostat. Alternatively, 
the slide was stored at -80oC prior to fixation for later use. The fixed sections were allowed to air dry 
overnight at room temperature, and prior to immunohistochemistry were rehydrated in 2 x 5 minute 
washes of PBS. Slides were then blocked and followed the remainder of the above protocol for fixed 
tissue from the primary antibody incubation on. 
 
2.3 Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) analysis 
 
2.3.1 Total RNA extraction and isolation 
The following protocol was applied to each Chapter except all bar one of the human testis 
samples in Chapter 7, where mRNA was already available. mRNA from Chapter 7 underwent further 
preparation prior to the quantification protocol mentioned in Section 2.3.3. For details see Chapter 7. 
Total RNA was extracted from cultured cells or whole testis tissue using the Qiagen RNeasy 
total RNA Isolation Kit (Qiagen: Hildens, Germany) according to the manufacturer’s directions. Total 
RNA extraction involved lysing tissue and cells with Buffer RLT/1% β-mercaptoethanol (2-
Mercaptoethanol; BioRad Laboratories, CA, USA). Homogenisation was then conducted, which for 
tissue involved repeated passes through syringe needles of decreasing thickness, starting with a 19G 
needle, 21G needle, then a 25G needle. For cultured cells, homogenisation was conducted by mashing 
them with the plunger of a 1ml syringe while still in the culture wells, and then passing them through a 
pipette tip 5 times. One volume of 70% ethanol was then added to each solution and then mixed. Each 
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solution was then transferred to an RNeasy column stored in a 2ml collection tube. The column was 
centrifuged for 15 seconds at 10,000rpm (Microfuge) and the flow through discarded. For cultured 
cells, this procedure was repeated until each well of a particular treatment group was pooled into one 
RNeasy column. Buffer RW1 was then applied to wash the columns, and after further centrifugation at 
10,000rpm (Microfuge) for 15 seconds, the flow through was discarded. 500μl of Buffer RPE (volume 
of ethanol was added to the buffer beforehand according to manufacturer’s instructions) was then 
added to the RNeasy column and centrifuged for 2 minutes at 10,000rpm. Another 500μl volume of 
Buffer RPE was added to the columns and centrifuged for a further minute. The columns were then 
transferred to a 1.5ml collection tube. RNA was eluted from the columns by adding 30μl of RNase-
free water followed by a 1 minute centrifugation period at 10,000rpm. This last step was repeated 
again to have a final volume of 60μl, because a yield of greater than 30μg of total RNA was expected 
(manufacturer’s recommendations). The total RNA extracts were snap frozen and stored at -80oC. 
 
2.3.2 DNase-free treatment 
Any contaminating DNA was removed from the total RNA extracts via the use of a DNA-free 
kit (Ambion, cat# 1906) according to manufacturer’s directions. 6μl of 10x DNase 1 Buffer and 1μl of 
DNase 1 (2 units) were mixed into the RNA samples, which were then incubated for 20-30 minutes at 
37oC. Any condensation was removed by a quick centrifugation. DNase Inactivation reagent was 
resuspended before adding 6.7μl of it to the RNA samples. The samples were then incubated for 2 
minutes at room temperature with occasional flicking of the tubes to disperse the DNase Inactivation 
reagent. Following this, the tubes were centrifuged for 1 minute to pellet the inactivation reagent and 
then stored as above. 
 
2.3.3 Total RNA quantification  
 
a. Ultraviolet spectrophotometry 
RNA samples were diluted 1:20 in MilliQ water, with the remainder of the sample being snap 
frozen and stored at -80oC. 100μl of these dilutions were added into a plastic cuvette and read on an 
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ultraviolet spectrophotometer (BioPhotometer, Eppendorf) with OD set to 260/280nm. An OD reading 
of >1.82 was considered to indicate a pure sample of total RNA. Absorbance readings were taken as a 
means of quantitating the amount of RNA in a sample. 
 
b. RiboGreen Assay 
This assay for total RNA quantification was used in Chapter 3 only, as an addition to 
ultraviolet spectrophotometry RNA quantification. This assay employs a RiboGreen Quantification 
Reagent kit (Molecular Probes, Oregon, USA), a method which uses a fluorescent dye to bind to the 
RNA. A 96 well plate (Nunc Maxicorp, Denmark) was used for each assay, with each well 
accommodating 100μl of solution. A standard curve was constructed with amounts of RNA ranging 
between 0-80ng/well. The standards were constructed using Molecular Probes rRNA, whereby a stock 
solution of 100μg/ml was diluted 1:125 in 1 x TE Buffer (diluted 1:20 from stock; 200mM Tris, 
20mM EDTA buffer, pH 7.5) to achieve a solution of 800ng (RNA)/ml, or 80ng/100μl. This solution 
underwent a series of double dilutions to obtain standards of concentrations; 40, 20, 10, 5 and 
2.5ng/100μl. To ensure RNA samples were diluted so as to fit the standard curve, calculations were 
conducted based upon ultraviolet spectrophotometry results. A strong significant correlation between 
RiboGreen Assay and ultraviolet spectrophotometry had been determined previously but due to its 
extra sensitivity, the results obtained from RiboGreen were used for further analysis (Sluka et al. 
2002). Furthermore, quality controls of known RNA concentration were diluted 1:1000 and 1:2000 for 
the RiboGreen assay to check for consistency and reproducibility between assays. Following the 
addition of 100μl of each sample into the appropriate wells, 100μl of RiboGreen (diluted 1:500 in 1x 
TE Buffer) was added to each well. Plates were then agitated on a plate shaker for 5 minutes, at 
maximum speed. RNA was quantified by the use of a Victor 1420 multilabel counter (Perkin Elmer, 
Life Sciences). 
 
2.3.4 Reverse transcription 
The required volume of total RNA extracts to reverse transcribe into cDNA was 5.2μl, and in 
this volume 125ng-1000ng of RNA was needed. To achieve this, calculations were conducted based 
upon the amount of DNA in the extracts as determined by UV spectrophotometry (or RiboGreen 
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Assay for Chapter 3). Once determined, the appropriate amount of sample was removed from the total 
RNA extracts and made up to 5.2μl with DEPC-H2O (DEPC- diethylpyrocarbonate, inactivates 
RNase). The remainder of the total RNA was snap frozen and stored at -80oC. To each 5.2μl sample, 
14.8μl of master mix was added. The master mix was composed of 4μl of 5x RT Buffer (Roche, 
Germany), 8μl of deoxynucleoside triphosphates (dNTPS; dATP, dCTP, dTTP, dGTP; diluted 1:40 in 
DEPC-H2O from a 100mM stock to 2.5mM), 2μl of random hexamers [pd(N)6], 0.5μl AMV-RT 
(reverse-transcriptase) (25U/μl) and 0.3μl of RNasin (40U/μl). Samples were spun briefly and then 
incubated for 1.5 hours at 46oC. Afterwards, samples were boiled for 2 minutes and then snap frozen 
and stored at -20oC or -80oC. 
 
2.3.5 Real-time RT-PCR 
 
a. The LightCycler system 
The LightCycler (Roche, Germany) system provides convenient monitoring of PCR samples 
in real-time and so was used in preference to conventional PCR. The melting temperature of DNA is 
dependent on its GC content and so each PCR product has a unique melting temperature. This melting 
temperature is a good way of identifying the product (see Figure 2.1) and this is a feature of the 
LightCycler system. The LightCycler works by detecting a fluorescent dye which is added to each 
PCR sample and binds to DNA. The amount of DNA in each sample can therefore be quantified in 
comparison to standards which contain a known amount of DNA. The LightCycler system allows for 
calculating the starting amount of DNA in a sample by the use of a ‘crossing-point’ calculation. The 
crossing-point equals the number of PCR cycles it takes for the fluorescence of a sample to increase in 
a log linear fashion. The crossing points of each unknown DNA can be compared to a standard curve 
which enables the calculation of the starting concentration of DNA in each sample. For each study, a 
testicular cDNA standard from untreated animals was prepared and assigned arbitrary unitage (rats, 
mice, humans). Each primer set was amplified in conjunction with at least 3 doses of this standard, 
with two-fold differences between each dose, and the top dose typically assigned an arbitrary unitage 
of 100. Hence the resultant standard curve was linear over an 8-fold range. For real-time PCR, the 
  
 
 
 
 
 
Figure 2.1 LightCycler assessment of real-time polymerase chain reaction (RT-PCR). 
The LightCycler provides convenient monitoring of PCR samples in real time and has several 
useful features. The melting curve (panel A) is a good way to identify a particular product, since each 
product has a characteristic melting curve, seen here at 91oC. The peak at 81oC corresponds to primer 
dimerization. Multiple peaks, or broad single peaks can indicate a non-specific DNA product being 
amplified and so the solutions which were subjected to the PCR analysis can then be run on agarose 
gels to check. 
The LightCycler system works by detecting a DNA-binding fluorescent dye that is added to 
the PCR samples. By the use of a crossing point calculation (panel B), the LightCycler can determine 
the amount of DNA starting material in each of the samples. The crossing point calculation equals the 
number of PCR cycles it takes for the fluorescence of a sample to increase in a log linear fashion. The 
values obtained for this calculation are then fitted to a standard curve (panel C) from which the 
starting concentrations of DNA in each sample are obtained. 
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concentration of the standard was adjusted so that quantification occurred between cycles 25-30. As 
each primer set was quantified individually against the standard, differences in amplification 
efficiency were not an issue. 
A separate quality control was included in each run in triplicate, and analysed separately. 
Within assay variation was typically 7% (n = 3), while between assay variation varied from 3%-
13% (n = 3-4) depending on the primer set. 
 
b. Primer optimisation 
Oligonucleotide primers were designed using the Primer3 program online 
(http://frodo.wi.mit.edu/primer3/input.htm) or obtained from published sources (for details see Tables 
in relevant Chapters). Mg2+ concentration and annealing temperatures were all optimised on the 
LightCycler, and primers which produced a single product band on a DNA agarose gel, were 
processed for DNA Sequencing (see Section 2.4). 
 
c. Sample preparation for RT-PCR 
All cDNA samples were diluted in DEPC-H2O. A master mix was prepared by using the 
FastStart DNA Master SYBR-green 1 system (Roche Diagnostics, Mannheim, Germany). The master 
mix for each reaction contained the appropriate concentration of MgCl2, 1μl primer mix (equal 
volumes of forward and reverse primers had been mixed prior to addition to master mix), 1μl of 
FastStart SYBR green (FastStart solution contained Taq DNA polymerase, reaction buffer, dNTP mix, 
SYBR green I dye, 10mM MgCl2), and made up to 9μl final volume with DEPC-H2O. FastStart SYBR 
green was supplied in two vials; 1a and 1b, with 1b being kept in the dark at all times. To activate the 
FastStart SYBR green solution, 10μl of vial 1a was added to vial 1b. The remainder of the solution 
that was not used in the experiment was stored in the dark, at 4oC for up to 7 days. The master mix 
was flicked and then spun down before being added to capillaries in a cold block (9μl per capillary). 
1μl of each cDNA sample was added to the capillaries and these were capped. They were then 
centrifuged and loaded into a carousel and the LightCycler was activated. Cycle details for each 
primer set are also supplied in each relevant Chapter. 
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2.4 DNA sequencing 
 
2.4.1 DNA agarose gel 
Following each primer optimisation experiment, RT-PCR products were run on a DNA 
Agarose gel to determine if a single band, indicating a single product, was produced. The gel was 
prepared by dissolving 4.0g of agarose (Invitrogen, cat # 15510-027) in 200ml of TBE buffer (54g 
Tris-base (Sigma, cat # T-1503), 27.5g Boric Acid (BHT, Kilsyth, Victoria, Australia), 3.74g EDTA 
disodium salt (Merck), 1L MilliQ water) in an 800W microwave for 2 minutes. 12μl of 10mg/ml 
ethidium bromide (Sigma, cat # E-8751) was added to the boiling solution, mixed and then quickly 
poured into a sealed cassette, and a 20 lane comb was immediately inserted. The gel was then allowed 
to set at room temperature, for 30 minutes. 
The preparation of the samples, involved centrifuging the RT-PCR capillaries into 1.5ml 
eppendorf tubes (Sarstedt, Germany), which contained 2μl-3μl of sample loading buffer (4M  urea, 
50% sucrose, 50mM EDTA pH 8.0, and some bromophenol blue). 5μl of sample was then loaded into 
the wells formed by the comb into the set gel. The gel was then submerged in TBE buffer containing 
20μl ethidium bromide/L, and samples were run at 100V, for 50-70 minutes on a running apparatus 
(BioRad Laboratories, CA, USA) The gel was then imaged on a GelDoc (Ultraviolet Transilluminator; 
Bioimaging Systems, Upland, CA, USA), and pictures taken of the resultant bands. 
 
2.4.2 DNA sequencing 
Gels were imaged on an ultraviolet transilluminator. Single bands which corresponded to the 
expected product size for each PCR primer were cut out of the gel using scalpel blades, and placed 
into 1.5ml eppendorf tubes (Figure 2.2a). To extract DNA from the gels, the QIAquick Gel Extraction 
Kit was used (Qiagen, Germany) as per manufacturer’s directions. Six volumes (according to gel 
weight) of buffer QG was added to dissolve the gel in the eppendorf tubes, and incubated for 10 
minutes at 50oC with occasional vortexing, to produce a yellow-coloured solution. One gel volume of 
isopropanol was then added to the solution to enhance DNA recovery. The sample was then placed 
into a QIAquick column in a 2ml collection tube and centrifuged for 1 minute at 10,000rpm to bind 
  
 
 
 
 
 
 
Figure 2.2 DNA agarose gel and subsequent sequencing of RT-PCR primer products. 
Following primer optimisation by RT-PCR in this thesis, all primer products were run on a 
DNA agarose gels (panel A). When a single band was obtained (note 8 different products for 8 
different primers in panel A), it was cut, prepared for and then subjected to DNA sequencing analysis 
(panel B) to determine the gene product that had been amplified by RT-PCR, and that it matched what 
was expected for the primer pair. DNA sequencing was conducted at The Gandel Charitable Trust 
Sequencing Centre which adds fluorescently labeled ddNTPs to solutions containing the sample DNA, 
a single primer (either forward or reverse to target sequence) and a DNA polymerase. DNA fragments 
were separated by capillary electrophoresis where an analyzer detects the specific wavelengths of the 
labeled ddNTPs and assigns a color to the corresponding dNTP and produces the DNA sequence 
graph shown in the figure where blue = cytosine, black = guanine, red = thymine and green = adenine. 
The sequences were typed into a BLAST search engine to determine sequence homologies. 
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the DNA to the column. A further 500μl of QG was then added to the solution, and this was 
centrifuged for a further minute at 10,000rpm (microfuge). 750μl of Buffer PE was then added to the 
column and incubated at room temperature for 5 minutes, before a further 1 minute centrifugation. The 
flow-through was discarded and the column centrifuged again to remove any residual Buffer PE. The 
column was then placed into a clean 1.5ml eppendorf tube, and to elute the DNA, 30μl of Buffer EB 
was applied to the column, incubated at room temperature for 1 minute and then centrifuged for 1 
minute at 10,000rpm. To maximise yield of DNA, a further 10μl of Buffer EB was applied to the 
column and centrifuged through.  
The resultant solution of DNA was then quantified on the ultraviolet spectrophotometer. Samples were 
diluted 1:20 and the concentration of DNA calculated to μg/μl. 10ng of DNA along with 3.2pmol of 
either the forward or reverse primer of each pair was forwarded to the DNA sequencing laboratory 
(The Gandel Charitable Trust Sequencing Centre, Monash Medical Centre, Clayton, VIC, Australia). 
Resultant readouts (Figure 2.2b) were then BLAST searched, and if the sequence corresponded to the 
desired protein, the primer pair was used for all future RT-PCR analyses. 
 
2.5 Western blot analysis 
 
2.5.1 Protein extraction 
Protein was extracted from cultured Sertoli cells (Chapter 3) using boiling 2X SDS non-
reduced sample buffer (5.0ml MilliQ water, 5ml 0.5M Tris, pH 6.8, 5ml glycerol, 5ml 10% w/v SDS, 
bromophenol blue), or from frozen rat testes using a buffer containing 1% SDS (MP Biomedicals, 
Solon, Ohio, USA), 0.125M Tris (Sigma, cat # T-1503), 2mM  EDTA (Merck, Damstadt, Germany), 
2mM N-ethylmaleimide (Sigma, cat # E-3876), 2mM phenylmethylsulfonylfluoride (PMSF, Sigma, 
cat # P7626), 1mM sodium orthovanadate (Gordon, 1991), 0.1μM sodium okadate (Calbiochem, 
Germany) and 1.6% β-mercaptoethanol (BioRad, CA, USA)/water (reduced/non-reduced sample) on 
ice (pH 6.8, (Wong et al. 2004)).  
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Cultured cells were mashed with the plunger of a 1ml syringe in the extraction buffer and 
homogenized in the tip of a 1ml pipette. Samples were then centrifuged for 5 minutes at 10,000rpm, 
snap frozen and stored at -80oC. 
For frozen testis samples, 100mg of tissue was cut and homogenized with 19G, 23G and 26G 
needles in the extraction buffer before being centrifuged at 4oC at 10,000rpm for 10 minutes. Samples 
were then boiled for 3 minutes, centrifuged at room temperature for 10 minutes (10,000rpm) and then 
snap frozen and stored at -20oC short-term, or -80oC long-term. 
 
2.5.2 Protein quantification 
An aliquot of protein extract was diluted 1:80 in PBS and quantified for protein content using 
the BCA protein assay kit (Pierce, Rockford, IL, USA).  
 
2.5.3 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
Total protein (15μg and 40μg for occludin from Sertoli cell and whole testis protein extracts 
respectively (reduced), 120μg for claudin-11 from Sertoli cell and whole testis protein extracts (non-
reduced)) was diluted in 2X SDS non-reduced (or reduced) sample buffer and then separated by SDS-
PAGE on a 4%-20% pre-cast gel (BioRad, Cat # 345-0033) at 200V for 60-90 minutes. Proteins were 
then being transferred onto PVDF membranes (Immobilon-P, Millipore) for western blotting. 
Membranes were blocked in 5% skim-milk in PBS at 4oC overnight. Primary antibodies were rabbit 
anti-occludin (Zymed #71-1500, 2.0μg/ml) and rabbit anti-claudin-11 (CovalAb #284-BM8, 1:200), 
and were applied to the membranes for 2 hours and co-stained with rabbit anti-β-actin (Sigma #A-
2066, 1:1000). For band detection, Infrared 800-conjugated goat anti-rabbit secondary antibody 
(1:5000, Rocklands Immunochemicals, Inc., Gilbertsville, PA, USA, Cat # 610132121) was added 
following primary antibody incubation for a further 2 hours. The membranes were scanned onto an 
infrared imaging system (Odyssey IR imaging scanner, Li-Cor Biosciences, Lincon, NE, USA) at a 
resolution of 169μm and at an intensity of 5. Results were quantified by densitometry software 
provided with the system and normalised to β-actin. 
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2.6 Statistical analysis 
Data was tested for normal distribution and equal variance. If data was deemed normally 
distributed it was then subjected to ANOVA testing for differences (when comparing more than 2 
groups). When differences were detected, the post-hoc Student Newman-Keuls test was applied to 
determine where the differences lay. If the data was non-parametric, data was log10 treated and re-
tested for normal distribution and subjected to the same testing as above if successful. If the data 
remained non-parametric, the determination of differences between groups was determined by the 
Kruskal-Wallis test, followed by the post-hoc Newman-Keuls analogue (Equal N’s) or Dunn’s Method 
tests to determine where the differences lay.  
When comparing 2 groups, data was tested for normal distribution and equal variance before 
being subjected to a t-test. If the equal variance test failed, the t-test analogue Mann-Whitney Rank 
Sum test was conducted. 
All statistical analysis in this thesis was performed using the SigmaStat program for Windows 
Version 3.5 (Jandel Corporation, CA, USA). Presentation of the statistical analyses will be specified in 
each Chapter. 
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Chapter 3. The contribution of claudin-11 and occludin to the function of the Sertoli cell tight 
junction, in vitro 
 
3.1 Introduction 
The Sertoli cell TJ forms in mammals at puberty along with an increase in circulating 
gonadotrophins (FSH and testosterone), and plays an essential role in spermatogenesis as the major 
component of the blood-testis barrier, separating and protecting the adluminal germ cells from the 
general circulation (Russell and Peterson, 1985). Low levels of circulating gonadotrophins leading up 
to puberty results in the delay or prevention of TJ formation and a lack of spermatogenic activity, a 
phenotype which in men and hamsters can be reversed by the exogenous application of 
gonadotrophins (de Kretser and Burger, 1972, Tarulli et al. 2006, Tarulli et al. 2008). 
As mentioned in Chapter 1, the role of occludin in TJs is controversial. Evidence suggests that 
occludin may play a regulatory TJ role (Nusrat et al. 2000, Ban et al. 2003), in that it is extensive in 
‘tighter’ TJs such as the blood-brain barrier, but not in leakier junctions such as the intestine (Claude, 
1978, Hirase et al. 1997). Furthermore, the occludin knockout mouse displayed continuous TJ strands 
in the testis and was fertile until at least late adulthood (Saitou et al. 1998), showing that this protein is 
not essential for the onset of spermatogenesis. The claudin-11 knockout mouse model on the other 
hand is infertile (Gow et al. 1999), suggesting an important role for claudin-11 in TJ function.    
At the molecular level, testosterone has been shown to regulate the localisation of the key TJ 
transmembrane proteins, occludin and claudin-11 to the TJ in an immature rat Sertoli cell culture 
model, with testosterone also regulating the mRNA expression of the latter protein (Kaitu’u et al. 
2007). Furthermore, in the Sertoli cell specific androgen receptor knockout mouse model, claudin-11 
mRNA expression is significantly reduced in vivo as is TJ function (Meng et al. 2005, Tan et al. 
2005). However, claudin-11 staining is still present at the TJ in this model and Meng et al. (2005) 
showed that another claudin (claudin-3) may also play an important role in the mouse Sertoli cell TJ, 
as its mRNA expression is disrupted and localisation to the TJ absent in the same model. Interestingly 
however, claudin-3 is not expressed at the rat Sertoli cell TJ as shown by RT-PCR and 
immunocytochemical analysis (Kaitu’u et al. 2007). In cultured mouse Sertoli cells, FSH has also 
been shown to play an important role in regulating the mRNA expression of claudin-11 (Hellani et al. 
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2000). Therefore, it appears that occludin and claudin-11 may contribute to the function of the Sertoli 
cell TJ but to what extent each protein does so is unknown. It is thus hypothesised that both claudin-11 
and occludin contribute to the rat Sertoli cell TJ in vitro, with claudin-11 contributing significantly 
more so.  
The aim of the work described in this Chapter is to determine the relative contribution of 
occludin and claudin-11 to Sertoli cell TJ function in vitro by selectively silencing gene expression 
with siRNA targeted specifically against both proteins separately, and in combination.  
This Chapter will use an established immature rat (19-21 days old) Sertoli cell primary culture 
model. Proliferation of Sertoli cells stops at 15 days of age in the rat (Orth, 1984), hence the number of 
Sertoli cells will remain constant throughout the cultures. Transepithelial electrical resistance (TER) 
will be used to monitor TJ development from the day of culture up to and including days 5-6 of culture 
when siRNA will be added. At the end of the culture, cells will either be fixed for 
immunocytochemical analysis of claudin-11 and occludin localisation, as well as the localisation of β-
catenin to the nearby adherens junction, or be extracted for real-time RT-PCR or western blot 
analyses. 
 
3.2 Materials and Methods 
 
3.2.1 Animals 
Twelve male Sprague-Dawley outbred rats aged 19-21 days were used for all cultures. Rats 
were obtained from Monash Animal Services, Monash University Clayton as approved by the Animal 
Ethics Committee (ethics numbers: MMCB 2002/04 and MMCB 2002/38), Monash Medical Centre 
Clayton.  
 
3.2.2 Immature Sertoli cell isolation  
The method used for immature rat Sertoli cell isolation follows that of Perryman et al (1996), 
as recently applied to the study of rat Sertoli cell TJs (Kaitu’u et al. 2007).  A detailed protocol is 
provided in Appendix 1.1. In brief, the 12 rats for each culture were sacrificed by carbon dioxide 
asphyxiation, and testes were removed, decapsulated and chopped finely before being digested in 
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trypsin (in Dulbecco’s Phosphate Buffer Saline- PBS; Gibco, NY, USA) to remove interstitial tissue. 
Digestion lasted 25 minutes at 37oC using an orbital shaker at 90rpm. Digestion was stopped by the 
addition of PBS/DNase containing 10% foetal calf serum (FCS; Trace Biosciences, Sydney Australia). 
Seminiferous tubules were separated by unit gravity sedimentation, after which tubules were washed 
once in 10% FCS in PBS/DNase and three times in DNase (20μg/ml)/PBS. The tubules were allowed 
to sediment between each wash and after the last wash, the seminiferous tubules were resuspended in 
PBS containing 1% (w/v) bSA (Sigma, cat# A-7906) and 10μg/ml DNase. Cells were then 
homogenised by slow depression through a sterile glass/Teflon tissue homogeniser tube with a pistle 
eight times by hand. Following homogenisation, cells were pelleted by a 5 minute centrifugation 
process at 1000rpm (94g). The pellet was resuspended in PBS before being filtered through sterile 
nylon mesh (80μm). The filtered cells were centrifuged again as above, washed twice in PBS and 
centrifuged further after each wash. After the final wash, the pellet was resuspended in 10ml of 
appropriate culture medium. 20μl of this solution was diluted 1:2 in Trypan Blue (Trace Biosciences, 
Sydney, Australia) for cell counting and analysis of viability with the use of a haemocytometer. Cells 
were then plated in media (DMEM/F12, Sigma, cat# D-2906) as described below. 
 
3.2.3 Cell plating  
 
a. Plating for transepithelial electrical resistance and immunocytochemistry  
Millicell-PCF bicameral chambers (Millipore, MA, USA) were used for cell culturing for TER 
measurements and immunocytochemistry. These bicameral chambers had small PCF filters (12mm 
diameter, 0.4μm membrane pore size), and fitted easily into wells of a 24-well plate. 50μl of matrigel 
diluted 1:8 in medium was added to the chambers and spread with a syringe plunger. Both the apical 
and basal chambers of the bicameral units were filled with a final volume of 600μl of solution. Cells 
were then incubated at 37oC in a humidified incubator with 5% CO2 and 95% air throughout the 
culture. 
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b. Plating for western blot and total RNA extraction  
Cells were plated into regular 24-well plates which had been coated with 20μl of matrigel 
diluted 1:8 in medium and spread with a syringe plunger. Excess matrigel was then removed, and the 
plates allowed to set for at least an hour in an incubator at 37oC. Cells were plated at a density of 5.0 x 
106 cells/ml, with 250μl of the cell suspension per well, for a final cell density at plating of 0.625 x 106 
cells/cm2. The final volume of solution in the wells was 1ml.  
For details of mRNA and protein extraction from these cells, see sections 2.3 and 2.5. 
 
3.2.4 Hypotonic shock  
Contaminating germ cells were removed on day 3 of culture by using a low salt medium to 
deliver a hypotonic shock. Sterile MilliQ H2O containing 10% DMEM/F12 was administered to all 
cells for 45 seconds. For bicameral TER wells, 300μl of this low salt solution was added to the apical 
side of the bicameral chamber, and then washed out with 300μl of prepared culture medium. The wash 
was then replaced with 600μl of culture medium on both sides of the bicameral chamber. Similarly for 
western blot/RNA extraction wells in 24 well plates, 500μl of low salt medium was added, and then 
washed with 500μl of prepared culture medium before finally being replaced with 1ml of medium 
containing treatments.  
 
3.2.5 Measuring transepithelial electrical resistance  
Transepithelial electrical resistance (TER) was measured daily with the use of a Millipore 
Millicell- ERS system (Millipore, MA, USA) from the day of cell plating through to the last day of 
culture. Before measuring TER, the Millicell-ERS electrodes were sterilised for 10 minutes in 70% 
ethanol, and then equilibrated in DMEM/F12 for 20 minutes at room temperature. Cells were 
equilibrated to room temperature during the half hour preparation of the Millicell-ERS apparatus. For 
TER measurements, the long arm of the electrodes sat between the bicameral chamber and the wall of 
the culture well with the short arm inside the bicameral chamber (see Figure 3.1). An alternating 
current was applied across the Sertoli cell monolayer until a stable resistance reading was recorded. 
Each well was read twice. Electrodes were rinsed briefly in 70% ethanol, PBS and then DMEM/F12 
between each treatment group.  
  
 
 
 
 
 
 
Figure 3.1 Measuring transepithelial electrical resistance (TER). 
Diagrammatic representation of TER measurements. Electrode arms are inserted into the 
inside and outside of the bicameral chamber (panel A). An electrical current is applied across the cells 
and as tight junctions form (red) the resistance met by the current increases giving a direct indication 
of tight junction function. Tight junctions will only form if cells are plated densely (panel B) and this 
will result in a high TER. If cells are not dense enough (panel C), tight junctions will not form thus 
giving low TER readings. Modified from Onoda et al. (1990) 
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Final TER results were determined by averaging each of the two resistance (Ω) readings from 
each culture well recorded. The average of TER readings recorded for bicameral chambers coated with 
matrigel but containing no cells was subtracted from the averages of the wells that did have cells. This 
final result was then divided by 0.6, the surface area of the bicameral chamber (0.6cm2), to give the 
TER results in units of Ω/cm2. Means and standard deviations were determined from triplicate culture 
wells.  
 
3.2.6 siRNA cultures 
siRNA for claudin-11 had been designed previously, and the ratio to which the siRNA was to 
be diluted in transfection reagent before administration to Sertoli cells optimised (McCabe, 2003). In 
that study, a range of siRNA:transfection reagent ratios were tested from 1:3 to 1:9 according to the 
manufacturer’s directions (McCabe, 2003). While each of the ratios reduced the function of the 
cultured Sertoli cells significantly after 3 days of treatment, as measured by TER, ratios greater than 
1:3 were seen to be toxic to the cells as shown by immunocytochemistry (McCabe, 2003). The density 
of the Sertoli cells was low and their nuclei appeared shrivelled and bright (McCabe, 2003). The 1:3 
ratio however displayed healthy, dense cells and so this ratio was chosen for all further experiments 
(McCabe, 2003). Subsequently, 1μg of siRNA was diluted in 3μl of transfection reagent before being 
added to the culture media which was administered to Sertoli cells for 2 days, a time course 
recommended by the manufacturer (McCabe, 2003). siRNA fragments of 21 nucleotides in length had 
been designed for claudin-11 using the web-based siRNA design program through the Whitehead 
Institute (http://jura.wi.mit.edu/bioc/siRNAext/home.php; “siRNA selection program,” Whitehead 
Institute for Biomedical Research). Two strands which were specific for mouse claudin-11 (accession 
number: NM_008770) which is exactly the same as rat claudin-11 (accession number: NM_053457) 
were selected and obtained from Qiagen (Germany) and designated Clau-11-A and Clau-11-B (see 
Table 3.1). For this thesis, two siRNA strands were also designed for occludin using the same 
software. These fragments were also obtained from Qiagen (Germany) and were specific for rat 
occludin (accession number: NM_031329), and were designated Occ-A and Occ-B (Table 3.1). All 
sequences underwent a BLAST search to show that they only corresponded to the desired gene and no 
other. Several design aspects of the siRNA fragments needed to be taken into consideration as
  
 
 
 
 
Table 3.1 siRNA designs. 
siRNA for silencing claudin-11 and occludin was designed on a web-based siRNA design 
program through the Whitehead Institute (http://jura.wi.mit.edu/bioc/siRNAext/home.php; “siRNA 
selection program,” Whitehead Institute for Biomedical Research). The program’s design settings 
were left at default. Two fragments of 21 nucleotides in length were designed for each protein and 
were obtained from Qiagen. The G/C content, typically between 30%-70%, needed to be taken into 
consideration according to the manufacturer. These details, as well as the siRNA are presented in this 
table.  
siRNA fragment Species/Accession number Target DNA Sequence (5’-3’) G/C % 
Clau-11-A Mouse                       
NM_008770 
AAACCGTTTCTATTACTCTTC 33 
Clau-11-B Mouse                      
NM_008770 
GACTGCGTCATGGCCACTGGT 62 
Occ-A Rat                        
NM_031329 
AACGATAACCTAGAGACACCT 43 
Occ-B Rat                        
NM_031329 
AATTATCACACATCAAGAGGA 33 
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recommended by the manufacturer such as G/C content (Table 3.1) and the absence of triplicate 
nucleotides. According to the manufacturer, there was an 88% chance that one of the two specific 
siRNA fragments for either protein would knockdown gene expression. 
For the negative control, siRNA directed against Lamin A/C was also obtained from Qiagen. Lamin 
A/C, which is present in Sertoli cells, is part of the nuclear lamina and its main function is to provide 
strength and support in the nucleus of developing animals, although it is not an essential protein (Moss 
et al. 1993, Vester et al. 1993, Stuurman et al. 1998, Harborth et al. 2001). In the McCabe (2003) 
study, fluorescent siRNA was also used as a positive control to show that cells had taken up the 
siRNA as shown by immunocytochemistry. This test was not repeated in this thesis, but all siRNA 
preparation and treatment protocols used in McCabe (2003) were followed in this thesis. 
In brief, immature rat Sertoli cells were cultured and allowed to form TJs over 5-6 days, with 
TJ formation being monitored daily by TER. At the end of this period, the siRNA was prepared for 
administration. This involved adding 1ml of Sterile Suspension Buffer (Qiagen, Germany) to the 
claudin-11 and occludin siRNA, and 0.25ml of Sterile Suspension Buffer to the Lamin A/C siRNA, 
bringing all of the fragments to a final concentration of 20μM. These fragments were heated for 1 
minute at 90oC and then incubated for 1 hour at 37oC. Following this step, fragments could either be 
frozen and stored at -20oC, or used.  
The next step was to prepare the siRNA/transfection reagent (TransiFect, Qiagen, Germany) 
solution at the appropriate ratio (see Appendix 1.2 for detailed calculations). The calculated amount of 
siRNA was then added to phenol-red free DMEM/F12 culture media (Sigma, catalogue # D-2906), 
which according to the manufacturer, was necessary as the phenol red interfered with the fluorescent 
siRNA positive control. While this was not an issue for this thesis as the positive control was not used 
as already mentioned, the phenol red-free media was still used to keep with the established protocol 
from McCabe (2003). The solution was vortexed briefly. The appropriate amount of transfection 
reagent was then added to achieve the desired 1:3 siRNA:transfection reagent ratio. This solution was 
again vortexed for 10 seconds and allowed to incubate for 10-15 minutes at room temperature to allow 
transfection reagent-siRNA complexes to form. During this incubation, media was removed from all 
culture wells, and 450μl of siRNA/transfection reagent free media added to the inside and outside of 
bicameral chambers, and 750μl added to RT-PCR/western blot wells. The transfection reagent-siRNA 
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complexes were then added drop-wise into the appropriate wells; 150μl into the inside and outside of 
bicameral chambers and 250μl into the RT-PCR and western blot wells.  
Claudin-11 specific and occludin specific siRNA fragments were added individually at the 
same concentration as each other. Additional treatments included i) combining the two types of 
claudin-11 siRNA together, ii) combining the two types of occludin siRNA together and iii) 
combining Clau-11-B with Occ-B to silence the genetic expression of both claudin-11 and occludin at 
the same time. The final total siRNA concentration of the mixed samples equalled that of the 
individual samples. 
For controls, cells either received i) additional siRNA/transfection reagent free media, or ii) 
media with transfection reagent alone or iii) media containing Lamin A/C siRNA and transfection 
reagent at the same ratio as the other siRNA:transfection reagent treatments. 
Treatments were added for two days and changes in TJ function monitored by TER. At the 
end of the treatment period, cells in bicameral units were fixed for immunocytochemical analysis (see 
section 3.2.5), and the localisation of claudin-11, occludin and the adherens junction related protein β-
catenin analysed. This was done to assess the response of TJ components, or components of nearby 
junctions to the siRNA fragments. It was also considered, that should the localisation of either 
occludin or claudin-11 to the TJ be reliant on the presence of the other, that knocking one of them out 
by siRNA interference could give a false negative result of the specificity of the siRNA fragment. It 
was thought that β-catenin would be a better indicator of the specificity of the TJ siRNA. 
Cells in conventional 24 well plates which received the siRNA treatments at the same time 
points as the TER cells, had total RNA extracted for RT-PCR analysis and protein extracted for 
western blot analysis 2 days after treatment addition. 
 
3.2.7 Immunocytochemistry  
 
a. Cell fixation procedure  
Cells on PCF membrane filters were pre-extracted on ice for 2 minutes in 0.2% Triton X-100 
in phosphate buffer saline (PBS: 0.01M PBS with 0.9% NaCl). Following this, they were then fixed in 
3% paraformaldehyde (paraformaldehyde: 3g dissolved in 100ml PBS at 60oC, filtered, wrapped in 
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foil and stored at room temperature) for 30 minutes in the dark, at room temperature. After the fixing 
procedure, cells were permeabilised on ice with 0.05% TX-100 (0.5ml Triton X-100 in 100ml PBS). 
Cells were then washed three times in PBS and stored at 4oC until use. 
 
b. Preparation of fixed cells for immunocytochemical analysis  
PCF membrane filters containing the fixed cells, were cut into quarters with a scalpel blade. 
One quarter was placed into one well of a 48-well plate, with the remaining quarters being stored in 
PBS at 4oC for later use. The quarter in the well was then washed in 150μl of Phosphate Buffer Saline 
(PBS)/bSA (0.01M/0.1% w/v bSA/0.9% w/v NaCl) twice for 5 minutes each. Following the washes, 
the membrane quarter was incubated for 20 minutes in 150μl of CAS block (Zymed, San Francisco, 
CA, USA) in 10% normal sheep serum to block non-specific binding sites. Quarters were allowed to 
incubate in 150μl of primary antibody or negative control (at the same concentration as each other) 
overnight at room temperature (see Table 3.2 for primary and secondary antibody details for this 
Chapter). Quarters then underwent two 5 minute washes in PBS/bSA before being incubated for one 
hour in the secondary antibody in the dark. The quarters were then subjected to two 5 minute washes 
in PBS again before being counterstained with the fluorescent nuclear counterstains, DAPI (100nM in 
PBS/bSA) and TOPRO-3 (1:100 in DAPI/PBS/bSA from a 1mM stock in DMSO; Molecular Probes, 
Eugene, USA) for 5 minutes. Quarters were then washed three times for 5 minutes in PBS/bSA and 
mounted with FluorSave (Calbiochem, Germany) reagent. Quarters were visualised and photographed 
using a confocal microscope (Fluoview, FV300, Olympus Australia, Mt Waverley, VIC, Australia). 
 
3.2.8 Real-time RT-PCR analysis 
Total RNA extraction through to RT-PCR analysis was conducted as outlined in Section 2.3 
for cultured cells. Primers for claudin-11, occludin and GAPDH had been previously optimised (Tso et 
al. 1985, Drummond et al. 2000, Chung et al. 2001, Lui et al. 2001, Kaitu’u et al. 2007) and so no 
DNA agarose gels or sequencing was conducted. Details for the primers used in this Chapter are 
displayed in Table 3.3. 
  
 
 
 
 
 
 
Table 3.2 Antibodies used for immunohistochemical analysis. 
Tabulated data for the antibodies used in Chapter 3 of this thesis include details regarding the 
primary and secondary antibody hosts, working concentrations (conc.)/dilutions, incubation (Inc.) 
times and company details with catalogue numbers. 
Protein Primary 
(1o) 
antibody 
host 
Company         
(cat #) 
Conc. 
(μg/ml) 
Negative 
control 
1o Inc. 
time 
Secondary 
(2o) 
antibody 
Company 2o 
Dilution 
2o Inc. 
time 
(mins) 
Claudin-11 Rabbit Zymed           
(36-4500) 
2.0 Normal 
rabbit 
IgG 
Overnight Goat α 
rabbit 
Alexa-488 
Molecular 
Probes 
(Oregon, 
USA) 
1:400 of 
stock 
60 
Occludin Rabbit Zymed           
(71-1500) 
2.5 Normal 
rabbit 
IgG 
Overnight Goat α 
rabbit 
Alexa-488 
Molecular 
Probes 
(Oregon, 
USA) 
1:400 of 
stock 
60 
β-catenin Mouse BD Transduction 
Laboratories       
(610154) 
0.5 Normal 
mouse 
IgG 
Overnight Goat α 
mouse 
Alexa-488 
Molecular 
Probes 
(Oregon, 
USA) 
1:400 of 
stock 
60 
 
 
 
 
 
 
 
 
 
Table 3.3 Primer sequences and real-time RT-PCR conditions for the analysis of siRNA 
mediated gene silencing of claudin-11 in cultured Sertoli cells. 
Primers were obtained against TJ proteins claudin-11 and occludin to analyse the effect on the 
mRNA expression of both proteins after silencing claudin-11 siRNA. A primer pair was also obtained 
for the housekeeper protein GAPDH which was used to form ratios with claudin-11 and occludin for 
analyses. Data included in the table are forward and reverse primer sequences, Mg2+ concentration, 
and annealing and acquisition temperatures. 
Protein Species/Accession 
number 
Primer sequences (5’- 3’) Product 
size 
(bp) 
[Mg2+]   
(mM) 
Anneal  
temp. (oC) 
Acquisition 
temp. (oC) 
Claudin-11 
(Chung et al. 
(2001)) 
Rat         
NM_053457 
Forward: TTAGACATGGGCACTCTTGG 
Reverse: ATGGTAGCCACTTGCCTTC 
624 2.5 68 85 
Occludin 
(Lui et al. 
(2001)) 
Rat      
NM_031329 
Forward: CTGTCTATGCTCGTCATCG 
Reverse: CATTCCCGATCTAATGACGC 
 
294 2.5 64 72 
GAPDH 
(Tso et al.  
(1985)) 
Mouse         
NM_008084 
Forward: GACCCCTTCATTGACCTCAAC 
Reverse: GATGACCTTGCCCACAGCCTT 
 
560 2.5 60 72 
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3.2.9 Western blot analysis 
Protein was extracted from culture wells with 2 X non-reduced sample buffer as outlined in 
Section 2.5. 15μg of protein was loaded into gel lanes for occludin protein analysis, whereas claudin-
11 protein was difficult to detect and needed further optimisation in this Chapter. For antibody details 
used for western blot analysis in this Chapter, see Table 3.4. Protein detection for occludin and 
claudin-11 used ECL (Western Blotting Detection Reagents, Amersham Biosciences) chemicals, 
which were added to membranes after the wash following the secondary antibody incubation for 5 
minutes. Films (Amersham Hyper) were exposed to the membranes for 30 seconds and 1, 2, and 5 
minutes and then developed.  
 
3.2.10 Statistical analysis 
Triplicate culture wells were used per treatment with 2-3 cultures conducted for each 
endpoint. Differences in TER and RT-PCR between treatments within cultures were measured as 
outlined in section 2.6 and expressed as mean ± SD. If no statistical differences between the siRNA 
treatments were observed within cultures, data was grouped and then tested for differences between 
cultures by t-test (n = 2 cultures) or ANOVA (n = 3) cultures. If still no statistical differences between 
the cultures were observed for the siRNA treatments, the final mean and SD were calculated based on 
the compared cultures’ data.  
 
3.3 Results 
 
3.3.1 Effect of claudin-11 siRNA on tight junction function 
TJ function increased from the day of cell plating to the day of claudin-11 siRNA addition 
(day 6) (Figure 3.2a). When claudin-11-A and claudin-11-B siRNA were added to Sertoli cells either 
separately, or in combination, a decrease of 47%, 76% and 58% respectively (p < 0.01, n = triplicate 
wells/treatment) in TJ function over 2 days of treatment was observed (Figure 3.2a). Over three 
cultures, differences between the effect of any of the siRNA treatments on TJ function were not 
significant with each other, giving a final decrease in TJ function of approximately 55% (p < 0.01). 
The graph presented in Figure 3.2a is representative of three separate cultures. When the siRNA 
  
Table 3.4 Antibodies and conditions used for western blot analysis. 
Tabulated data for the antibodies used in Chapter 3 of this thesis include details regarding the primary and secondary antibody hosts, working concentrations 
(conc.)/dilutions, incubation (Inc.) times and company details with catalogue numbers. 
Protein Primary 
(1o) 
antibody 
host 
Company 
(cat #) 
Conc. 
(μg/ml) 
Negative 
control 
Tween20  
(v/v) (%) 
1o 
Inc. 
time 
(hrs) 
Secondary (2o) 
antibody 
Company 2o Dilution 2o 
Inc. 
time 
(hrs) 
Claudin-11 Rabbit Zymed 
(36-4500) 
2 Normal 
rabbit 
IgG 
0.1% primary 
and secondary  
2 Goat α-rabbit 
HRP conjugated 
or goat α-rabbit 
IRDye 800 
Silenus (Melbourne 
Australia) or Rockland 
Immunochemicals 
(Pennsylvania, USA) 
1:10000 of 
stock (HRP) 
or 1:5000 of 
stock 
(IRDye) 
2 
Claudin-11 Rabbit AbCam 
(ab7474) 
1:200 of 
antiserum 
Normal 
rabbit 
serum 
0.1% primary 
and secondary 
2 As above As above As above 2 
Claudin-11 Rabbit CovalAb 
(pep0006) 
1:200 of 
antiserum 
Normal 
rabbit 
serum 
0.1% primary 
and secondary 
2 As above As above As above 2 
Occludin Rabbit Zymed 
(71-1500) 
1 Normal 
rabbit 
IgG 
0.1% primary 
and secondary 
2 Goat α-rabbit 
HRP-conjugated  
Silenus (Melbourne, 
Australia) 
1:10000 of 
stock 
2 
β-actin Mouse Sigma 
ascites 
fluid 
(A4700) 
1:1000 of 
stock 
Normal 
mouse 
IgG 
0.1% primary 
and secondary 
2 Goat α-mouse 
HRP conjugated 
or goat α-mouse 
IRDye 800 
Silenus (Melbourne, 
Australia) or Rockland 
Immunochemicals 
(Pennsylvania, USA) 
1:10000 of 
stock (HRP) 
or 1:5000 of 
stock 
(IRDye) 
2 
 
  
 
 
 
 
 
 
 
Figure 3.2 Effect of claudin-11 siRNA on TJ function. 
Immature rat Sertoli cells were cultured and allowed to develop TJs over 5-6 days as 
measured by transepithelial electrical resistance (●). At day 6 of one culture as indicated by the arrow 
(panel A), one group of cells was treated with siRNA transfection reagent alone (○), while the other 
three treatments received clau-11-A siRNA (□), clau-11-B siRNA (∆) or both siRNA strands together 
(◊) for 2 days (panel A). In a separate culture at day 5 as indicated by an arrow (panel B), cells either 
received siRNA transfection reagent alone (○) or the Lamin A/C specific siRNA (х) for 2 days. At the 
end of the treatment period, cells were fixed for immunocytochemical analysis. Data is mean ± SD, n 
= triplicate wells/treatment. ** = p < 0.01 compared to day of treatment addition. 
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transfection reagent or the non-TJ specific Lamin A/C siRNA (Figure 3.2a/b) were added for two days 
of culture, no decrease was seen in response to the transfection reagent, but a small, non-significant 
22% decrease was observed for Lamin A/C siRNA. 
 
3.3.2 Effect of claudin-11 siRNA on claudin-11 localisation 
The same cultured Sertoli cells that gave the changes in TER in Section 3.3.1 were fixed at the 
end of the culture and processed for immunocytochemical analysis. In medium-only treated cells, or 
cells treated with the siRNA transfection reagent, or Lamin A/C specific siRNA, claudin-11 
localisation to the TJ was extensive (Figure 3.3) although claudin-11 and nuclear staining were less 
intense in the latter treatment group. After treatment with claudin-11-A or claudin-11-B siRNA 
separately, or in combination, claudin-11 localisation to the TJ was markedly reduced, with only 
punctate staining apparent at the TJ (Figure 3.3). 
 
3.3.3 Effect of claudin-11 siRNA on the localisation of other junction proteins 
The effect of claudin-11 specific siRNA on the localisation of occludin to the TJ, and β-
catenin to the nearby adherens junction was also analysed after two days of treatment. The localisation 
of occludin (Figure 3.4c) and β-catenin (Figure 3.4e) was extensive in the siRNA transfection reagent 
alone treatment but was partially reduced after claudin-11 siRNA treatment (Figure 3.4d/f), although 
not to the same extent as was observed for claudin-11 after claudin-11 specific siRNA (Figure 3.4a/b). 
 
3.3.4 Effect of claudin-11 siRNA on claudin-11 and occludin mRNA expression 
Note that unless otherwise stated, all statistical analyses in the ensuing paragraph are 
comparisons between the time of transfection reagent/siRNA addition and 2 days after exposure, when 
the Sertoli cell culture was stopped.  
Total RNA was extracted from cultured Sertoli cells two days after siRNA treatment. 
Transfection reagent had no negative impact on claudin-11 or occludin mRNA expression in the 
claudin-11-A and claudin-11-B samples (Figure 3.5 top panels) but caused a significant (p < 0.05) 
30% decrease in claudin-11 mRNA expression and a 55% decrease (p < 0.01) in occludin mRNA 
expression in the combined claudin-11-A and claudin-11-B samples (Figure 3.5 bottom panels). 
  
 
 
 
 
 
 
 
Figure 3.3 Effect of claudin-11 siRNA on claudin-11 localisation to the TJ. 
Immature rat Sertoli cells were fixed in paraformaldehyde 2 days after claudin-11 siRNA 
treatment and analysed by confocal microscopy. Claudin-11 (green) localisation to the TJ around the 
Sertoli cell nuclei (red) was stained in control cells which received medium alone (panel A), 
transfection reagent alone (panel B), Lamin A/C specific siRNA (panel C), as well as in cells which 
received clau-11-A siRNA (panel D), clau-11-B siRNA (panel E) or both siRNA strands in 
combination with each other (panel F). Bar = 50μm. Inset = negative control for claudin-11. 
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Figure 3.4 Effect of claudin-11 siRNA on the localisation of occludin to the TJ and β-catenin to 
the adherens junction. 
Cultured immature rat Sertoli cells were fixed after 2 days of claudin-11 siRNA treatment. 
Immunocytochemical analysis was conducted on claudin-11 (green) localisation around the periphery 
of Sertoli cell nuclei (red) at the TJ in cells which received transfection reagent alone (panel A) or 
clau-11-A/B siRNA treatment (panel B). Staining for occludin (green) at the Sertoli cell TJ was also 
conducted in transfection reagent (panel C) and clau-11-A/B siRNA treated cells (panel D). To test for 
any effects of claudin-11 siRNA on other junctional types, β-catenin (green) of the adherens junction 
was also stained in transfection reagent (panel E) and siRNA (panel F) treated cells. Bar = 50μm. Inset 
= negative controls for claudin-11, occludin and β-catenin. 
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Figure 3.5 Real time RT-PCR analysis of the effect of claudin-11 siRNA on the mRNA 
expression of claudin-11 and occludin. 
Claudin-11 siRNA was added to cultured immature rat Sertoli cells at day 6 of culture. Total 
RNA was extracted two days after addition and processed for RT-PCR analysis of changes in claudin-
11 (left graphs) and occludin (right graphs) mRNA expression. The treatment groups analysed in the 
top graphs were the siRNA transfection reagent alone (○), Lamin A/C siRNA (x), clau-11-A siRNA 
(□) and clau-11-B siRNA (∆). In the lower graphs are transfection reagent (○) and the effects of the 
combined siRNA strands (◊). Data is mean ± SD, n = 3 wells/treatment. Data has been expressed as a 
percent versus the GAPDH ratio at the day of siRNA addition (day 0) until the day of total RNA 
extraction (day 2). ns = not significant, * = p < 0.05, ** = p < 0.01. 
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Claudin-11 mRNA expression in response to siRNA treatment was reduced by 71% (p < 0.01, n = 
triplicate wells/treatment, n = 3 cultures (Figure 3.5). The graphs shown in Figure 3.5 are 
representative of the data obtained from the 3 cultures. The decrease in claudin-11 mRNA expression 
in response to claudin-11-A + B was significantly greater (p < 0.01) than the decrease induced by the 
transfection reagent. Furthermore, the decrease (p < 0.01) in occludin mRNA expression in the same 
treatment group was of the same magnitude as that induced by the transfection reagent alone (Figure 
3.5), ie) the presence of claudin-11 siRNA had no further effect on occludin mRNA expression. Lamin 
A/C had no effect on the mRNA expression of either protein (Figure 3.5). 
 
3.3.5 Effect of claudin-11 siRNA on claudin-11 and occludin protein expression 
Protein was extracted from cultured Sertoli cells two days after siRNA treatment. Claudin-11 
protein was undetectable by Western blot analysis in control or siRNA treated extracts, indicating that 
further optimisation would be required (see section 3.3.6). Occludin protein expression appeared at a 
consistent level between controls and claudin-11 siRNA treatment (Figure 3.6). 
 
3.3.6 Western blot optimisation for claudin-11 detection in Sertoli cell extracts 
Claudin-11 was not detected in any of the Sertoli cell extracts which had been treated with ± 
claudin-11 siRNA, so a series of optimisation experiments was conducted, some of which are 
displayed in Figure 3.7. The first experiment examined three different claudin-11 antibodies from 
Zymed (Goat anti-rabbit, cat # 36-4500), CovalAb (Goat anti-rabbit, cat # pep0006) and AbCam (Goat 
anti-rabbit, cat # ab 7474), using mouse brain and rat testis tissue as positive controls (Figure 3.7a). 
Claudin-11 was never detected in reduced samples and was only detected at 22kDa in mouse brain 
extracts in non-reduced samples using the CovalAb and AbCam primary antibodies. Claudin-11 was 
not detected in the rat testis extracts with any of these antibodies 
Given the failure to detect claudin-11 in the testis protein extract from 2 X non-reduced 
sample buffer, three other protein extraction buffers were used. These were the 1% SDS buffer 
outlined in section 2.5.1 (Wong et al. 2004), RIPA buffer (25mM Tris.HCl (Sigma), 150mM NaCl 
(Merck), 1% NP-40 (Sigma), 1% sodium deoxycholate, 0.1% SDS, pH 7.6) and RW buffer (20mM 
PBS, pH 7.2, 150mM NaCl (Merck), 50mM NaF (Sigma, cat # S-1504), 0.5mM Na3VO4 (MP 
  
 
 
 
 
 
 
Figure 3.6 Western blot analysis of changes in the protein expression of occludin in response to 
claudin-11 siRNA treatment. 
Protein was extracted from cultured immature rat Sertoli cell cultures two days after siRNA 
treatment with combined clau-11-A and clau-11-B siRNA. Claudin-11 was undetectable and so was 
omitted from this figure, but further optimisation pictures are presented in Figure 3.7. Occludin was 
positively stained at 64kDa as indicated by the arrow. Numbers above the western blot correspond to 
the lanes which consisted of the following: 1) control extract on day of siRNA addition; 2) control 
extract 2 days after siRNA addition; 3) siRNA treated extract on the day of siRNA addition; 4) siRNA 
treated extract 2 days after siRNA addition. 
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Figure 3.7 Optimisation of western blot analysis for claudin-11 protein expression. 
Following the inability to detect claudin-11 in Sertoli cell extracts, several experiments were 
conducted to optimise conditions for its detection in Sertoli cells, three of which are shown in this 
figure. The first experiment (panel A) was to detect claudin-11 in mouse brain as a control tissue, and 
rat testis extracts, with claudin-11 primary antibodies as follows: Lanes 1-2 are Zymed; Lanes 3-4 are 
CovalAb and Lanes 5-6 are AbCam. Lanes 7-8 are the negative controls for the mouse brain and rat 
testis respectively. Claudin-11 is indicated by the asterisk at 22kDa. 
In the next experiments (panel B), three different protein extraction buffers were used to 
solubilise protein from mouse brain and rat testis, and the presented data in this Figure is for the 
AbCam antibody for claudin-11 detection. Lanes 1-3 are mouse brain extracts, with RIPA buffer, 1% 
SDS buffer, RW buffer. Lanes 4-6 are rat testis extracts with the buffers in the same order as for the 
mouse. Positive claudin-11 bands at 26kDa and 22kDa are indicated by the asterisks. Lane 7 is the 
negative control from a rat testis extract. 
A final experiment attempted to detect claudin-11 (with the AbCam primary antibody) and β-
actin as a loading control. Increasing amounts of protein from Sertoli cells extracted in 1% SDS were 
loaded as follows: 1) 7.5μg protein; 2) 15μg protein; 3) 30μg protein; 4) 60μg protein; 5) 120μg 
protein and 6) 120μg protein from a 1% SDS extract of rat testis. Claudin-11 staining at 22kDa and β-
actin staining at 43kDa are indicated by asterisks. 
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Biomedicals, cat # 159664), 2% Triton-X100 (Sigma, cat # 57H0650) and 1 protease inhibitor 
complex tablet (PIC; EDTA-free, Roche, cat # 1873580), pH 7.2 (Chapin et al. 2001)). Each of the 
three new buffers contained protease inhibitors to stop degradation of protein in the extracts which 
may have been hindering claudin-11 detection. This second part of the experiment also used 
fluorescent second antibody detection with Odyssey software (section 2.5.3) instead of ECL.  
Each of the three antibodies were again used in this part of the experiment and the result for AbCam is 
shown in Figure 3.7b. No claudin-11 staining was detected in either the mouse brain or rat testis 
extracts in RIPA buffer. Positive bands at 26kDa for the mouse brain and at 22kDa in the rat testis 
were obtained in the 1% SDS and RW buffers (Figure 3.7b). Staining was similar for the CovalAb 
antibody, but no positive staining was obtained using the Zymed antibody. Western blots for the latter 
two antibodies are not included in the Figure. 
Based on this experiment, the 1% SDS buffer was chosen as the buffer of choice for extracting 
proteins from cultured Sertoli cells and the next experiment tested Sertoli cell extracts with doubling 
amounts of total sample protein concentration, using the AbCam primary antibody (Figure 3.7c). No 
claudin-11 was seen in any of the Sertoli cell extracts, despite increasing amounts of β-actin staining 
as a loading control. The rat testis positive control stained for both β-actin and claudin-11 (Figure 
3.7c). 
Subsequent westerns attempted protein extraction from Sertoli cells with RIPA and RW 
buffers, both to no avail. Further westerns were attempted to concentrate protein extracts, alter primary 
antibody and blocking protein preparations, alter incubation times, as well as treating extracts with 
endonucleases to rid samples of contaminating DNA. While claudin-11 was always detected in the rat 
testis, it was never detected reliably in Sertoli cell extracts. It was therefore decided to omit this 
endpoint from this study. It is noted that clear differences in claudin-11 expression could be observed 
by immunocytochemistry of these same cells. 
 
3.3.7 Effect of occludin siRNA and combined claudin-11/occludin siRNA on tight junction function 
Occludin specific occ-A and occ-B siRNA fragments were added separately or in combination 
with each other to cultured Sertoli cells with established TJs (Figure 3.8). After two days of treatment, 
TJ function had decreased by 51% for all three siRNA treatments (p < 0.01, n = 3 wells/treatment, n = 
  
 
 
 
 
 
 
 
Figure 3.8 Effect of occludin siRNA, and combined claudin-11/occludin siRNA on TJ function. 
Immature rat Sertoli cells were cultured and allowed to develop TJs over 6 days as measured 
by transepithelial electrical resistance (●). At day 6 as indicated by the arrow, one group of cells was 
treated with siRNA transfection reagent alone (○), while the other three treatments received occ-A 
siRNA (□), occ-B siRNA (∆), both occludin siRNA strands together (◊) or a mixture of clau-11-B and 
occ-B siRNA () for 2 days. At the end of the treatment period, cells were fixed for 
immunocytochemical analysis. Data is mean ± SD, n = triplicate wells/treatment. ** = p < 0.01 
compared to day of treatment addition. 
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2 cultures). The effect of treating Sertoli cells for 2 days with combined claudin-11-B siRNA and 
occludin-B siRNA was a 62% (p < 0.01, n = 3 wells/treatment, n = 1 culture) decrease in TJ function 
(Figure 3.8). This decrease was significant (p < 0.01) compared to the total 51% and 55% decrease in 
TJ function induced by occludin siRNA and claudin-11 siRNA separately over multiple cultures. 
 
3.3.8 Effect of occludin siRNA and combined claudin-11/occludin siRNA on protein localisation 
Cultured Sertoli cells were fixed after two days of siRNA treatment. Occludin siRNA reduced 
occludin localisation to the TJ (Figure 3.9). Claudin-11 localisation was extensive at the TJ and β- 
catenin was also extensive at the adherens junction yet appeared more punctate than seen in Figure3.4. 
The combination of claudin-11 siRNA with occludin siRNA reduced the localisation of both proteins 
to the TJ, while β-catenin was still extensive at the adherens junction (Figure 3.9). 
 
3.4 Discussion 
The aim of the work described in this Chapter was to determine the contribution of claudin-11 
and occludin to rat Sertoli cell TJ function in vitro, using specific siRNA-mediated gene silencing. The 
immature rat Sertoli cell culture model was chosen as it is a well established culture model (Perryman 
et al. 1996, Kaitu’u et al. 2007), and because at 19-21 days of age, the only contaminating germ cells 
that are isolated along with the Sertoli cells are the most immature types (Chung et al. 1998), which 
were removed a few days after culturing by hypotonic shock treatment with a low-salt media. Hence, 
this method provides high purity Sertoli cells (>90% (Perryman et al. 1996)), with the remaining cells 
being predominantly peritubular myoid cells (Perryman et al. 1996). 
Cultured Sertoli cells formed stable TJs 5-6 days after plating as shown by high TER readings. 
When the siRNA transfection reagent was added to the cells for 2 days, there was no decrease in TJ 
function demonstrating that it was not toxic to the cells over this time period. In response to 2 days of 
treatment with the siRNA control which targeted Lamin A/C, a protein of the nuclear envelope and 
unrelated to the TJ (Moss et al. 1993, Vester et al. 1993, Stuurman et al. 1998, Harborth et al. 2001), a 
non-significant reduction in TJ function of 22% was observed, thus indicating that any changes in TJ 
function with the TJ specific siRNA was not due to other non-specific effects. Other studies have also 
reported no significant effects of Lamin A/C-specific siRNA on TER (Mandell et al. 2005). 
  
 
 
 
 
 
 
Figure 3.9 Effect of occludin siRNA and combined claudin-11/occludin siRNA on protein 
localisation to the TJ and adherens junction. 
Cultured immature rat Sertoli cells were fixed after 2 days of occludin siRNA treatment and a 
combination of claudin-11 and occludin siRNA treatment. Immunocytochemical analysis was 
conducted for occludin, claudin-11 and the adherens junction protein β-catenin (all green) in response 
to the siRNA transfection reagent alone, occ-A siRNA and clau-11-B/occ-B siRNA. Sertoli cell nuclei 
are highlighted in red. Bar = 50μm. Inset = negative controls for occludin, claudin-11 and β-catenin. 
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When claudin-11-specific siRNA was added to stable TJs for 2 days, a decrease of 55% was 
recorded in TJ function as measured by TER. Similarly, a decrease of 51% in TER was observed after 
the addition of occludin-specific siRNA to established TJs, indicating the contribution of both proteins 
to TJ function was approximately 50%. This percentage figure could be argued as being relative to the 
experimental model, as the experiment had limitations on the siRNA:transfection reagent ratio and 
treatment time course (McCabe, 2003). As mentioned earlier, the McCabe (2003) study showed that 
breaching the 1:3 siRNA:transfection reagent ratio or using the ideal ratio for any longer than 2 days 
caused Sertoli cell death and their sloughing from the bicameral membranes. Therefore, it can only be 
concluded that both claudin-11 and occludin contribute to the function of the Sertoli cell TJ 
significantly, and that while this contribution may not be able to be given an empirical value in this 
model, the contribution of both proteins to TJ function is similar to each other.  
This result was surprising, as it was expected that claudin-11 would have contributed more to 
TJ function than occludin, given the infertile phenotype of the claudin-11 knockout mouse (Gow et al. 
1999), and the fertile phenotype seen in the young occludin knockout mouse (Saitou et al. 2000). In 
the claudin-11 and occludin knockout models, the ablation of either protein would have been 100%, 
and while no functional assays were conducted in those studies, to induce infertility it is presumed that 
knocking out claudin-11 reduced TJ function sufficiently. The percentage of claudin-11 or occludin 
ablation in the immature rat Sertoli cell culture model used herein could not be measured, although in 
the immunocytochemical analyses of protein localisation to the TJ following silencing, some staining 
of the ‘silenced’ protein was still apparent, albeit markedly reduced compared to controls (discussed 
later), thereby indicating that the ablation of claudin-11 or occludin was not 100%. This could have 
indicated the need to expose the cultured cells to the siRNA solution for longer but as already 
mentioned this was not feasible. The results obtained herein therefore raises the questions as to what 
extent claudin-11 needs to be removed from the TJ before its function is sufficiently suppressed to 
induce infertility, and also whether there are any differences between the contribution of claudin-11 
and occludin to the TJ. The immature rat Sertoli cell culture model cannot answer the first question 
and due to the limitations on the methodologies used herein it cannot answer the second question 
either.  
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With the development of targeted delivery of siRNA to the testis in vivo (Shoji et al. 2005), it 
may be possible to deliver claudin-11 or occludin specific siRNA and observe the effect on 
spermatogenesis. With the increasing use of tracers (see Chapters 5 & 6) for TJ functional analysis, 
changes in TJ function both qualitatively and quantitatively could therefore be determined in vivo. As 
outlined in Chapter 1 (Section 1.4.2), tracers can provide a more detailed indication of changes in TJ 
function than TER. While TER measures fluctuations in TJ permeability, the use of tracers of varying 
sizes can measure changes in the size-selectivity of the TJ (Fanning et al. 1999).  
It was expected in this study that silencing both claudin-11 and occludin in combination with 
each other would have caused a much greater suppression of TJ function than silencing either one of 
these proteins alone. This was not the case, with only a 62% decrease in TJ function recorded after 2 
days of siRNA treatment against both proteins. Several reasons could be attributed to this result. 
Firstly, in order to maintain the appropriate siRNA:transfection reagent ratio, the experimental design 
employed in this Chapter was that the total siRNA component was comprised of a 50:50 mix of 
claudin-11 and occludin, thereby treating the cells with less than optimal amounts of either siRNA 
fragments and reducing the overall ablation of both proteins. Secondly, the treatment time may not 
have been long enough to completely silence both genes, and an extended time may have been 
required for the reduced amounts of siRNA, which was not feasible. Thirdly, the failure to completely 
suppress TJ function in vitro could have been due to other components of the TJ which contribute to 
its function. Such components could have been JAM-A, where siRNA targeted against this protein for 
three days in a human intestinal cell-line induced an 80% decrease in TER and a 5-fold increase in 
permeability to FITC-dextran (4kDa) (Mandell et al. 2005). Recently, another transmembrane protein 
called tricellulin was localised to the TJ at tricellular contacts between epithelial cells (Ikenouchi et al. 
2005). While little work has been published with respect to tricellulin, siRNA targeted against it in a 
cultured mammary cell-line prevented TJ formation as shown by basal TER values compared to 
controls which had high TER readings (Ikenouchi et al. 2005). Furthermore, the permeability of the 
tricellulin-specific siRNA treated cells was 12-15 fold greater than controls to 4kDa FITC-dextran but 
not 250kDa FITC-dextran (Ikenouchi et al. 2005), indicating the potential contribution that tricellulin 
has to mammary TJ function. Ikenouchi et al. (2005) also showed that in the absence of tricellulin at 
the mammary TJ in vitro, occludin and claudin-3 staining had been altered suggesting that tricellulin 
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might maintain TJ structure and organisation as a whole. Similar findings were observed at the insect 
TJ analogue. Gliotactin, which is localised at tricellular contacts within the septate junction, was 
shown to establish its overall organisation (Schulte et al. 2003), suggesting a conserved trend for TJs 
and its analogues between different species. In the human, mutations in the tricellulin gene has been 
shown to cause deafness (Riazuddin et al. 2006, Chishti et al. 2008). These interesting findings 
present another possible protein contributing to the function of the Sertoli cell TJ, and while tricellulin 
has thus far not been localised to the Sertoli cell TJ, further analyses into its presence and/or role in the 
seminiferous epithelium should be conducted. 
 Cultured Sertoli cells were fixed 2 days after siRNA treatment for immunocytochemical 
analysis of claudin-11 and occludin, as well as any effects on the nearby adherens junction using β-
catenin as the marker. The localisation of all three proteins was extensive in cells treated with the 
transfection reagent and Lamin A/C siRNA as also seen previously (Mandell et al. 2005). 
Interestingly, claudin-11 staining was marginally less intense in the Lamin A/C treatment group which 
may have reflected the non-significant 22% decrease in TJ function as recorded by TER. However 
staining was still extensive and these results therefore indicate that the Lamin A/C siRNA and 
transfection reagent had no significant effects on TJ or adherens junction structure. When cells were 
treated with claudin-11 siRNA for 2 days, claudin-11 staining was markedly reduced from the TJ 
compared to the controls, although not completely absent. Occludin and β-catenin staining were also 
partially reduced compared to controls although not to the same extent as claudin-11, thereby 
suggesting that the reduction of claudin-11 at the TJ may have some local effects on other TJ protein 
components such as occludin, and also have knock-on effects on other junctional types such as the 
adherens junction. 
Similar data was obtained with the occludin siRNA treatment, where all three proteins were 
extensively stained in controls, but occludin staining was markedly reduced following 2 days of 
treatment. Claudin-11 and β-catenin localisation were also partially reduced compared to controls, 
indicating that the removal of occludin may also have some local and broader effects on other 
junctional types. When siRNA was targeted against both claudin-11 and occludin, the localisation of 
both proteins was reduced at the TJ, whereas β-catenin staining was still apparent at the adherens 
junction.  
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Total RNA was extracted from the cultured Sertoli cells 2 days after claudin-11 siRNA 
addition for RT-PCR analysis of changes in mRNA expression. The transfection reagent and Lamin 
A/C siRNA controls had zero to minor effects on claudin-11 mRNA expression, yet following 
claudin-11 siRNA treatment, there was a marked 71% reduction in claudin-11 mRNA expression. 
While occludin mRNA decreased in the claudin-11 siRNA treated cells, it also decreased in the 
control cells demonstrating that the decrease in the former treatment was not due to a non-specific 
effect of the siRNA. The reduction of claudin-11 mRNA expression was in good agreement with the 
reduction of claudin-11 protein localisation to the TJ, which caused the significant loss in TJ function. 
Unfortunately, the relationship between changes in mRNA and protein expression as a result 
of the claudin-11 specific siRNA could not be determined. Several different methods of attempting to 
optimize claudin-11 detection by western blot analysis failed to provide a suitable method for the 
quantitation of this protein in cultured Sertoli cells. These methods included i) use of different 
extraction buffers containing various  detergents to solubilise claudin-11 from the cultured cells, ii) the 
inclusion of protease inhibitors to prevent protein digestion in the extracts, iii) the addition of DNA 
endonucleases to prevent the ‘sticky’ genetic material of the cells that is released after lysing from 
interfering with protein extraction, iv) modifying extracting conditions (boiled buffers versus room 
temperature), protein reduction or non-reduction, use of different claudin-11 antibodies in conjunction 
with various  incubation conditions and detection protocols and v) concentrating protein samples 
within extracts to maximize detection. Some of the results from these experiments were displayed in 
Figure 3.7, but none of these methods worked to enable claudin-11 detection from Sertoli cells, and so 
this endpoint was not completed. Claudin-11 expression was observed in rat testis, hence it is 
presumed that the issue was related to sensitivity, but this was not proven.  
In contrast, occludin was much easier to detect by western blot analysis, and showed no 
change in response to 2 days of claudin-11 siRNA treatment, again displaying the specificity of the 
siRNA for claudin-11. The expected result for the claudin-11 western would have been a marked 
reduction in claudin-11 protein expression. This appears to be a feasible assumption as claudin-11 
siRNA reduced claudin-11 mRNA expression and protein staining in the Sertoli cells, which points to 
a reduction in protein content as well. Interestingly, when testis quality controls (QCs) were included 
in the western blot optimisation experiments, claudin-11 was easily detectable. It may be simply that 
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the number of plated Sertoli cells was not enough to provide detectable claudin-11. It may also be 
plausible in future to conduct an siRNA study in vivo as mentioned previously and analyse changes in 
claudin-11 expression in the whole testis where it is easier to detect. In the testis, claudin-11 is only 
localised to the Sertoli cell TJ (Lapierre, 2000), so any positive staining would be specific for this site, 
and not other testicular cell types. 
Interestingly, this was not the first study to apply siRNA targeted against epithelial TJ 
proteins. PALS1 is a protein involved in a complex that binds to ZO-3 of the cytoplasmic plaque and 
is involved in establishing cellular polarity (Straight et al. 2004). siRNA targeted against PALS1 in 
MDCKII cells, delayed the polarisation of the MDCKII cells and TJ formation as shown by basal TER 
values compared to control in vitro (Straight et al. 2004). Interestingly, the loss of PALS1 also 
disrupted the localisation and expression of another protein (PATJ) involved in the same complex and 
disrupted complex-complex interactions essential for polarisation establishment. It is interesting that 
siRNA targeted against one protein can indirectly effect the expression of another. Similarly in this 
study, the localisation of occludin was effected by the reduction of claudin-11 localisation at the 
Sertoli cell TJ. Neither of these results appeared to be due to non-specific siRNA effects. Hence, it is 
hypothesised that a further use of siRNA could be to indirectly enhance the understanding of protein-
protein and even complex-complex interactions by observing what happens to some proteins after the 
loss of another.  
siRNA targeted against claudin-4 in cultured human respiratory epithelial cells, caused an 
approximate 75% reduction in TJ function as measured by TER in vitro (Johnson and Quay, 2005). 
Furthermore, claudin-4 specific siRNA was able to inhibit TJ formation in freshly cultured cells 
(Johnson and Quay, 2005). It was the aim of that study to determine how siRNA could aid in changing 
the function of the TJ for potential nasal drug deliveries. In the testis, siRNA has also significantly 
reduced TJ function when targeted against claudin-11 and occludin. It may also therefore provide a 
tool at identifying a suitable Sertoli cell TJ target protein for hormonal based contraception in men. As 
reviewed in Chapter 1 (Section 1.8), several studies have now analysed the contributions of other 
claudins and occludin to other epithelial types and have shown that both proteins have significant roles 
in maintaining TJ function and integrity (Agarwal et al. 2005, Yu et al. 2005, Hou et al. 2006, Ueda et 
al. 2007, Fujita et al. 2008, Phillips et al. 2008). 
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In conclusion, claudin-11 and occludin contribute significantly to the function of the Sertoli 
cell TJ in vitro. Selective knock-down of claudin-11 and occludin has indicated that both proteins 
appear important to the role of the TJ in maintaining its functional and structural integrity. Given that 
both proteins contributed approximately 50% to TJ function in vitro after 2 days of siRNA treatment 
in this model, it is necessary to conduct further studies to i) analyse the contribution of other integral 
transmembrane components such as JAM-A and possibly tricellulin to TJ function and/or ii) to 
conduct in vivo siRNA studies to further define the role of these proteins to Sertoli cell TJ function 
with the use of quantitative tracers. 
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Chapter 4. The optimisation and application of tracers for tight junction functional analysis, in 
vivo 
 
4.1 Introduction 
The previous Chapter revealed the importance of claudin-11 and occludin to the function of 
the Sertoli cell TJ in vitro, after selective ablation of both proteins using siRNA- mediated gene 
silencing. The ensuing three Chapters of this thesis will look at the in vivo changes in protein 
localisation, protein expression and/or mRNA expression of TJ proteins in the absence of circulating 
hormones, and what happens when hormones are given or replaced. As well as these endpoints, a 
functional test is needed to analyse the changes in TJ function following hormone withdrawal and 
replacement in vivo.  
In the previous Chapter, TER was used to analyse TJ function in vitro. For in vivo analyses, 
small molecular weight tracers have been used for the past several decades to analyse changes in TJ 
function induced by various causes (Egan et al. 1976, Setchell et al. 1981, Pelletier, 1986, Pelletier, 
1988, Setchell et al. 1988, Eng et al. 1994, Setchell et al. 1996, Lustig et al. 2000, Furuse et al. 2002, 
Nitta et al. 2003, Meng et al. 2005, Hutcheon et al. 2007, Tarulli et al. 2008). These have included 
genetic knockouts (Furuse et al. 2002, Nitta et al. 2003, Meng et al. 2005) and keratectomy (Hutcheon 
et al. 2007) among other causes (for full details, see Chapter 1, Section 1.4). For example, low 
molecular weight tracer biotin (~600Da) could not penetrate intact TJs in wildtype mice but readily 
crossed the blood-brain barrier in the claudin-5 knockout mice (Nitta et al. 2003) and the epidermal TJ 
in the claudin-1 knockout mice (Furuse et al. 2002). The application of a tracer (Gd-DTPA; 742Da) 
detectable by MRI to the claudin-5 null blood-brain barrier showed that TJ function had decreased by 
15% (Nitta et al. 2003), thus providing an in vivo model in which TJ function had been analysed both 
qualitatively with the biotin tracer, and quantitatively with the MRI tracer (Nitta et al. 2003). 
In the testis, tracers for the qualitative assessment of TJ function such as HRP (44kDa) 
(Pelletier, 1986, Pelletier, 1988, Lustig et al. 2000) and biotin (~600Da) (Tarulli et al. 2008, Meng et 
al. 2005) are both restricted to the interstitium and only enter the seminiferous tubules as far as the 
Sertoli cell TJ in various control animal models which are undergoing normal spermatogenesis 
(Pelletier, 1986, Pelletier, 1988, Lustig et al. 2000, Meng et al. 2005, Tarulli et al. 2008). These results 
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indicate the presence of functional TJs. Yet, when spermatogenesis ceases in the same animal models, 
either due to seasonal testicular regression or genetic knockouts, both tracers have been seen to 
permeate throughout the tubules indicating dysfunctional TJs (Pelletier, 1986, Pelletier, 1988, 
Pelletier, 1994, Meng et al. 2005, Tarulli et al. 2008). 
Quantitative TJ functional analyses as outlined in Chapter 1 often utilise radiolabelled tracers 
such as [3H]methoxy-inulin (~5kDa), to allow a measure of functionality to be made. A 10-fold 
increase in the accumulation of the [3H]methoxy-inulin tracer compared to controls, has been observed 
in the seminiferous tubules from rats whose Sertoli cell TJs were disrupted via an intratesticular 
injection of glycerol (Eng et al. 1994). 
The aim of the work presented in this Chapter is to optimise methodologies to allow Sertoli 
cell TJ function to be assessed both qualitatively and quantitatively in vivo, for use in the ensuing 
Chapters of this thesis. These methodologies will include an assessment of the administration route for 
the tracers, as well as subsequent testis processing for optimal TJ function analyses.  
For quantitative TJ functional analyses, this Chapter will use the published glycerol-treated rat 
model to open testicular TJs (Eng et al. 1994), in an attempt to replicate the results obtained for 
[3H]methoxy-inulin accumulation in seminiferous tubules after 4 weeks of glycerol treatment. 
 
4.2 Materials and Methods 
 
4.2.1 Animals 
Male outbred-Sprague Dawley rats at 9 days of age (juvenile) and 75-90 (adult) days of age 
were obtained from Monash University Animal Services, Monash University (Melbourne, Australia). 
All experimental work conducted on rats was approved by the Monash Medical Centre Animal Ethics 
Committee (ethics number: MMCB 2006/19). Following experimentation, rats were killed by CO2 
asphyxiation. Nine day old rats were killed by cervical dislocation.  
 
4.2.2 Experimental design for qualitative tight junction function analysis 
Immediately after death, testes were dissected from rats and injected with 30mg/ml HRP 
(Type II (Sigma cat # P8250)) in saline (Lustig et al. 2000) or 10mg/ml Biotin (EZ-Link Sulfo-NHS-
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LC-Biotin (Pierce, cat # 21335, Rockford, IL, USA) in PBS + 1mM CaCl2 (Meng et al. 2005) at 10% 
testis volume. This volume was approximately 200μl for adult rat testes using a 1ml syringe (Becton 
Dickinson, Singapore) attached to a 26G needle (Terumo, Tokyo, Japan), and 2μl into juvenile (9 day 
old) rat testes using a displacement syringe (5μl, SGE, Australia). 
Testes were then left at room temperature for 30 minutes to allow the tracer to spread 
throughout (Russell et al. 1989, Meng et al. 2005). For the HRP tracer, testes were then snap frozen on 
dry ice, or fixed in one of the following fixatives; Bouin’s (Meachem et al. 1996), paraformaldehyde 
(3g paraformaldehyde (BDH-Merck, Kilsyth, Vic, Australia) in 100ml PBS), formalin (10g 
formaldehyde (BDH-Merck, Kilsyth, Vic, Australia) in 100ml PBS), carnoys (10% acetic acid 
(Merck, Damstadt, Germany), 60% ethanol (Ajax Finechem, Seven Hills, NSW, Australia), 30% 
chloroform (BDH, Poole, England, UK) and methacarn (10% acetic acid, 60% methanol (Merck, 
Damstadt, Germany), 30% chloroform) for varying lengths of time at room temperature (except for 
methacarn which was done on ice). For the biotin tracer, testes were snap frozen or fixed for 5 hours in 
Bouin’s or paraformaldehyde at room temperature. 
Testes were then processed for immunohistochemistry as outlined in Section 2.2, and stained 
for HRP or biotin, and sometimes occludin as the TJ marker. For HRP and occludin antibody 
incubation details, see Table 4.1. Light and fluorescent microscopy were conducted on the sections. 
Staining for biotin was conducted directly using the streptavidin SA Alexa-488 (diluted 1:100 
(adult) and 1:800 (9 day old); Molecular Probes, Eugene, USA) probe. When co-staining with another 
protein (ie. occludin), the SA Alexa-488 was diluted into the secondary antibody solution for that 
protein. When staining for biotin alone, SA Alexa-488 was diluted in PBS and administered to the 
tissue section after antigen retrieval for 30 minutes. Afterwards, the sections were washed three times 
in PBS and mounted as per the desired immunohistochemistry protocol in Section 2.2. 
 
4.2.3 Experimental design for quantitative tight junction functional analysis 
Adult rats were anaesthetised with isofluorane (Abbott, UK) and received intratesticular 
injections of 20% glycerol to open the blood testis barrier, or vehicle (sterile saline) (n = 5/group) at a 
volume of 10% of the testis weights using a 26G needle attached to a 1ml syringe (Eng et al. 1994). It 
was assumed that the testis weights for these animals would have been approximately 2.0g, based on 
  
 
 
 
 
 
 
Table 4.1 Antibodies used for immunohistochemical analysis. 
Tabulated data for the antibodies used in Chapter 4 of this thesis include details regarding the 
primary and secondary antibody hosts, working concentrations (conc.)/dilutions, incubation (Inc.) 
times and company details with catalogue numbers. 
Protein Primary 
(1o) 
antibody 
host 
Company 
(cat #) 
Conc. 
(μg/ml) 
Negative 
control 
1o Inc. 
time 
Secondary (2o) 
antibody 
Company 2o Dilution Inc. 
time 
(mins) 
Occludin Rabbit Zymed     
(71-1500) 
2.0 Normal 
rabbit 
IgG 
30 minutes Goat α rabbit 
Alexa-488 
Molecular 
Probes 
1:400 of 
stock 
30 
HRP Mouse AbCam     
(ab8326) 
5.0 Normal 
mouse 
IgG 
Overnight Goat α mouse 
Alexa-546 or 
goat α mouse 
HRP conjugated 
Molecular 
Probes 
(Alexa) 
or Silenus 
1:400 
(Alexa) or 
1:100 
(Silenus) 
30 
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published data (Meachem et al. 1998). To minimize localised pain, rats received a subcutaneous 
injection of the analgesic carprofen (Rimadyl: Lypard, cat # ZEKE, Victoria, Australia) at 5mg/kg in 
the shoulder immediately after the glycerol injection, while still anaesthetised. Rats were then allowed 
to recover, and monitored daily for 3 days, and thereafter every 3 days for 4 weeks to check for any 
adverse reactions to the intratesticular injections. No such reactions were ever observed.  
Four weeks after the glycerol injection, rats were killed by CO2 asphyxiation. Testes were 
dissected from 4 of the rats/group and trimmed of all connective tissue, fat and epididymides and then 
weighed. The testes from the fifth rat from each group was also trimmed and then injected with biotin 
for qualitative TJ functional analysis as outlined above.  
The first set of testes from above were decapsulated in a tissue culture laminar flow cabinet 
and seminiferous tubules were isolated. Three segments of approximately 80mg were taken from each 
isolated clump of seminiferous tubules and incubated in 1ml of [3H]methoxy-inulin  (0.5μCi; MP 
Biomedicals, cat # 0127029H-2) in Krebs Ringer Phosphate Buffer (KRP: 130mM NaCl, 5mM KCl, 
1.3mM CaCl2, 1.3mM MgSO4, 10mM Na2HPO4, pH 7.4) (Chaika et al. 1999) at 34oC for 1 hour. 
Tubules were then rinsed three times in cold KRP and then suspended in 5ml of MilliQ water in 15ml 
Falcon tubes (Sarstedt, South Australia, Australia). The suspensions were then homogenised 
(Polytron, PT 10 20 3500, top speed, 10 seconds) and a 0.5ml aliquot taken and resuspended in 1.5ml 
of tissue solubilizer (Soluene-350, PerkinElmer, Boston, MA, USA) overnight at room temperature. 
The remainder of the homogenate was snap frozen and stored at -20oC. The following day, the 
homogenate/tissue solubiliser solution was incubated at 50oC in a water bath for 5 hours to dissolve 
the tissue. At the end of this period, 2 x 100μl additions of 3% H2O2 was pipetted into the solutions 
and left to incubate for a further 30 minutes at 50oC. Afterward, 10ml of scintillation fluid (LSC 
Cocktail, Perkin Elmer, cat # 6013389) was added to the solution, which was vortexed vigorously and 
left at room temperature for 24 hours, before the radioactivity that had accumulated in the 
seminiferous tubules was read and quantified on a scintillation spectrophotometer (Packard, 2500TR 
Liquid scintillation analyser, Amersham Biosciences (GE)). 
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4.2.4 Statistical analysis 
Statistical analysis was conducted as outlined in Section 2.6 for 2 samples. Data has been 
presented as mean ± SD with n = 4 rats/group. 
 
4.3 Results 
 
4.3.1 Qualitative tracer optimisation 
 
a. Intratesticular injection of Trypan Blue dye 
Methods of delivering substances to the testis have included whole body perfusions through 
other arteries or veins (Meachem et al. 1996, Setchell et al. 1996, Meachem et al. 1998, Tao et al. 
2000) or perfusions directly into the testicular artery (Lustig et al. 2000, Cambrosio et al. 2003), which 
is easily distinguishable in rats, mice and rabbits due to its wavy or coiled morphology (Chubb and 
Desjardins, 1982). The latter method was attempted with some success (Figure 4.1) however 
replicating the results was difficult so an alternative method was sought. 
 The intratesticular injection was considered to be the easiest and most direct means of tracer 
administration to the testis. The efficacy of injecting a tracer into a freshly isolated testis of a dead 
adult rat at 10% testis weight was analysed using Trypan Blue dye (Figure 4.2). The dye immediately 
spread throughout the testis and could be seen through the scrotum. The testis was then frozen and 
10μm sections cut on a microtome in the cryostat, which showed the inner part of the testis as a pale 
blue color. This test established that intratesticular injection was a suitable technique for delivery of 
dye-containing solutions throughout the organ. 
 
b. Detection of HRP tracer in frozen and Bouin’s fixed testes by fluorescent microscopy 
 TJ qualitative tracer HRP was probed in frozen and paraformaldehyde- or Bouin’s-fixed rat 
testes to determine which tissue fixation method was best for detection (Figure 4.3). No HRP staining 
was apparent in the sections using either fixation protocol although high background was detected in 
the paraformaldehyde-fixed testis. HRP was co-localised with the TJ protein occludin which was 
detected in each of the fixed testes (Figure 4.3). In the frozen testes, bright HRP staining was observed  
  
 
 
 
 
 
 
Figure 4.1 Testicular artery perfusions. 
 A direct method of administering tracers to the testis is through the testicular artery itself, 
either by cannulating it or perfusing into it via a thin haematocrit tube. The testis is dissected, trimmed 
of all fat and connective tissue and placed so that the testicular artery (arrow) is facing up at the 
researcher (panel A). The haematocrit tube (panel B) is rubbed along the artery with saline running 
through until it ruptures as indicated by the release of blood. At this point, the haematocrit is held in 
position and the saline or tracers are released directly into the testis through the perforated artery. A 
successful perfusion is indicated by the drainage of the artery and all testicular veins which turns the 
testis into an opaque white (panel C, right). 
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Figure 4.2 Intratesticular injection of Trypan Blue dye. 
 For the intratesticular injection, the testis was held under a bright lamp and the testicular artery 
visualized for orientation (panel A). A 26G needle was inserted through to one pole of the testis and 
the solution injected while withdrawing the needle through the other pole. Trypan blue dye was 
injected into the left testis (asterisk, panel B) of a freshly killed adult rat at 10% testis volume (200μl) 
with PBS being injected into the right testis. The extent of spread was apparent after the testis was 
dissected out of the animal and trimmed of all fat and connective tissue (panel C, left). To check that 
the dye had spread throughout the inside of the testis and not just around the edge, the testis was 
frozen, and cut on the cryostat. The internal color of the Trypan Blue injected testis (panel D) was 
compared with the internal color of the PBS injected testis (panel E). 
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Figure 4.3 HRP tracer localisation in frozen and paraformaldehyde, and Bouin’s fixed testes. 
 HRP was administered to testes via an intratesticular injection at 10% testis weight before 
testes were frozen (panel A), or fixed in paraformaldehyde (panel B) or Bouin’s (panel C) for 5 hours. 
HRP (red, asterisk) was co-localised with occludin (green, arrows) to mark the Sertoli cell TJs. The 
co-localisation of HRP with occludin gives a yellow color. Bar = 50μm. Inset = negative controls for 
HRP and occludin except in panel B, where left and right insets are separate negatives for occludin 
and HRP respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 92
 
 
 
 
 
 
 
 
 
                                         
 
 
 
 
 
 
 
A 
* 
*
*
B 
C 
 93
in the interstitium and only permeated the seminiferous tubules as far as the TJ as highlighted by 
occludin (Figure 4.3). The negative control displayed a duller version of the HRP stain in the 
interstitium. 
 
c. Detection of HRP tracer in frozen and fixed testes by light microscopy 
 As the previous experiment had shown that HRP staining was sensitive to fixation, an 
additional experiment was conducted to monitor HRP immunoactivity in  testes which had been fixed 
for varying lengths of time in various aldehyde containing fixatives (Bouin’s, paraformaldehyde, 
formalin), non-aldehyde containing fixatives (carnoys, methacarn), and in testes which had been snap 
frozen on dry ice (Table 4.2). HRP was not detectable in any of the fixed testes at any of the fixation 
time points, despite heavier background being apparent in some sections (Table 4.2). However, HRP 
staining was readily apparent in the interstitium of the frozen testes, and this staining did not permeate 
throughout the seminiferous tubules (Table 4.2). The negative control for the frozen testis displayed a 
fainter version of the positive control, indicating the probable presence of endogenous peroxidases in 
the interstitium. This experiment indicated that HRP staining was only detectable in frozen testis 
tissues.  
 
d. Detection of Biotin tracer in frozen and fixed testis 
 Biotin was probed with streptavidin Alexa-488 in adult frozen testes as well as Bouin’s and 
paraformaldehyde fixed testes. In each testis, biotin stained strongly in the interstitium and did not 
enter the seminiferous tubules (Figure 4.4). By light microscopy, biotin was seen entering the 
seminiferous tubules only as far as the spermatogonia (Figure 4.4d and e). 
 
e. Detection of Biotin in a prepubertal rat testis 
 To ensure that biotin could access the entire seminiferous epithelium in situations where TJs 
were not functional, testes from immature (day 9) rats which lack TJs were examined. Biotin was 
probed in a Bouin’s fixed, 9 day old rat testis, and co-stained with occludin for fluorescent 
microscopy. No occludin staining was visible, and biotin was extensive in the interstitium and 
permeated throughout the seminiferous tubules (Figure 4.5a). In tubules which were injected with the 
  
 
 
Table 4.2 Localisation of HRP tracer in fixed or frozen testes. 
Testes were extracted from adult rats and injected with 30mg/ml HRP at 10% testis weight 
and left at room temperature for 30 minutes. The testes were then either snap frozen on dry ice or fixed 
in Bouin’s, paraformaldehyde, formalin, carnoys or methacarn for different lengths time as indicated 
in the table. Testes were then processed for immunohistochemical analysis of HRP localisation 
(asterisk), using the DAB light microscopy protocol. Bar = 50μm. Inset = negative control. 
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Figure 4.4 Biotin tracer localisation in frozen and paraformaldehyde and Bouin’s fixed testes. 
Biotin was administered to rat testes at 10% testis weight and incubated for 30 minutes at 
room temperature. The testes were then i) snap frozen on dry ice (panel A), ii) fixed in 
paraformaldehyde for 5 hours (panel B) or iii) fixed in Bouin’s for 5 hours (panel C) before being 
processed by immunohistochemistry. Analysis was conducted by fluorescent microscopy (panels A-C) 
for biotin (green, asterisk) and occludin (red, arrow, with co-localisation giving a yellow appearance. 
Analysis was also conducted by VIP light microscopy (panel D) for biotin (arrow heads) localisation 
with respect to different germ cell types. A higher magnification of a biotin perfused testis analysed by 
light microscopy is shown in panel E. Bar = 50μm. Inset = negative control 
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Figure 4.5 Biotin localisation in prepubertal rat testes. 
 Biotin was administered to the testes of a 9 day old rat at 10% testis weight, which was then 
fixed in Bouin’s fixative and processed for immunohistochemistry. Streptavidin was used to probe 
biotin by fluorescent microscopy (panel A, green, asterisk), and co-localised with occludin (red). 
Testes had also been injected with PBS as vehicle control and were also probed for biotin (only) as a 
negative control (panel B). In addition, Vector VIP light microscopy was conducted for biotin 
detection in testes which had been injected with biotin (panel C, brown, asterisk), or with the PBS 
vehicle control (panel D). Bar = 50μm. Inset = negative control. Note that panel A is a confocal 
micrograph. 
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biotin vehicle control (PBS) and probed for biotin only, no biotin was detected (Figure 4.5b). By light 
microscopy, biotin staining was visible in the interstitium, and inside the seminiferous tubules (Figure 
4.5c). The PBS vehicle control showed no biotin staining by light microscopy (Figure 4.5d). 
 
4.3.2 Quantitative tracer optimisation 
Eng et al. (1994) demonstrated with [3H]methoxy-inulin tracer (~5kDa) that TJ function had 
quantitatively decreased 10 fold following an intratesticular injection of 20% glycerol. This was 
coincident with occludin no longer localised at the Sertoli cell TJ (Wiebe et al. 2000). Maximal 
disruption was achieved within 2 weeks of glycerol treatment with no further changes to TJ function 
over one year (Eng et al. 1994). This Chapter follows the experimental design of Eng et al. (1994) to 
determine the suitability of [3H]methoxy-inulin for quantitative TJ functional analyses and the use of 
the glycerol treated rat model as a positive control for Chapter 5. 
 
a. Effect of glycerol treatment on testis weights and seminiferous tubule accumulation of [3H]methoxy-
inulin 
 As mentioned above, maximal disruption of TJ function was achieved 2 weeks after 20% 
glycerol treatment in a published study, with no further changes in proceeding weeks (Eng et al. 
1994). A dose higher than 20% caused damage to seminiferous tubules (Igdoura and Wiebe, 1994), 
therefore for this thesis, a dose of 20% glycerol for four weeks was chosen for experimentation.  
Four weeks after glycerol treatment body weights had not changed, but testis weights were 
reduced to 61% (p < 0.001) of controls (Figure 4.6a and b respectively). Glycerol treatment reduced 
TJ function to 55% of controls (p < 0.001) as shown by a 45% greater accumulation of the 
[3H]methoxy-inulin tracer in the glycerol treated seminiferous tubules (Figure 4.6c). 
 
b. Effect of glycerol treatment on tubule morphology and biotin permeation into the seminiferous 
tubules 
 Four weeks after glycerol treatment varying degrees of seminiferous tubule disruption were 
seen. Four common phenotypes were observed; i) morphologically normal seminiferous tubules with 
extensive biotin permeation throughout (Figure 4.7a), ii) morphologically normal tubules with some 
  
 
 
 
 
 
Figure 4.6 Effect of glycerol treatment on TJ function. 
 20% glycerol or saline was injected directly into the testis at 10% of testis weights 
while animals were under isofluorane anaesthesia. Four weeks after the injection, rats were 
killed and body weights (panel A) and testis weights (panel B) measured. Seminiferous tubules were 
then isolated and exposed to the radioactive tracer [3H]methoxy-inulin for 1 hour at 34oC. Tracer 
accumulation in glycerol and control tubules was measured by scintillation spectrophotometry (panel 
C). Data is mean ± SD, n = 4/group, *** = p < 0.001. 
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Figure 4.7 Effect of glycerol on seminiferous tubule morphology and biotin migration 
across Sertoli cell TJs. 
 Four weeks after an intratesticular injection of 20% glycerol, testes were collected 
from adult rats, fixed in Bouin’s fixative and processed for confocal immunohistochemical 
analysis of biotin (green) and TJ protein occludin (red) localisation. Several phenotypes were 
observed and are displayed here. Bar = 50μm. Inset = negative control.  
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biotin permeation (Figure 4.7b), iii) shrunken tubules with no lumens and extensive biotin permeation 
(Figure 4.7c), and iv) tubules with large lumens and very few cell types with extensive biotin 
permeation (Figure 4.7d). This positive control further demonstrated that the biotin permeability 
technique worked as expected. 
 
4.4 Discussion 
Studies presented in this Chapter aimed to optimise tracers for qualitative and quantitative TJ 
functional analysis in the testis for the ensuing in vivo studies.  
In order to achieve the above aim, it was necessary to optimise a route of administration for 
the tracers. While the perfusion of the tracers into the testis through the testicular artery proved 
difficult, the ease and feasibility of directly injecting the tracer into the testis was shown after a Trypan 
Blue dye injection spread immediately throughout the testes. This result was similar to published data 
which showed that a smaller injection of Trypan Blue spread 2cm through the testes within 5 minutes, 
and throughout the testes within 2 hours (Russell et al. 1987). Russell et al. (1987) further 
demonstrated that the injection itself caused no damage to the seminiferous tubules (Russell et al. 
1987). Injection volumes vary in the literature from 40-400μl/g testis weight, with most studies using 
100-200μl/g (O’Shaughnessy, 1980, Russell et al. 1987, Eng et al. 1994, Chung et al. 2001, Melaine 
et al. 2003). The amount used in studies presented herein were 100μl/g, which was a value in the 
middle of the range of published injection volumes. 
For qualitative TJ functional analysis, HRP was the first attempted tracer optimisation. HRP 
was undetectable in testes which had been fixed in Bouin’s or paraformaldehyde for 5 hours, but was 
visible in frozen testes. The use of frozen tissue was not ideal however, as the negative controls gave a 
weaker version of the positive stain in the interstitial tissue, and the testis morphology was poor, which 
is a typical feature when using frozen tissue sections (Whiteland et al. 1997).  
For better morphology, it was considered necessary to fix the testes, and so a follow up 
experiment tested the ability to detect HRP in testes fixed for varying lengths of time (1, 2 and 5 hrs, 
and overnight) in Bouin’s, paraformaldehyde and formalin, as well as in the non-aldehyde containing 
fixatives carnoys and methacarn. For better visualisation of the tracer with respect to the germ cells in 
the seminiferous epithelium, HRP was stained using the DAB light microscopy protocol. HRP was 
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undetectable in any of the fixatives at any of the time-points, although morphology was generally well 
preserved. This result was surprising particularly for carnoys and methacarn, as further review of the 
literature found that fixation in aldehyde containing fixatives for greater than 50 minutes destroys the 
HRP signal which accounted for why the tracer was undetectable in Bouin’s, paraformaldehyde or 
formalin.  In the frozen testes, HRP was visible in the interstitium, only permeating the tubules around 
the spermatogonia as seen previously by electron microscopy (Pelletier, 1986, Pelletier, 1988, 
Pelletier, 1994). Again the morphology was sub-optimal and biotin was sought as a better alternative.  
The biotin tracer technique has recently been successfully applied to evaluate blood-testis 
barrier function in the Sertoli cell specific androgen receptor knockout mouse model (Meng et al. 
2005). The testis sections in that study were again frozen. This Chapter was able to replicate those 
results successfully in adult rat testes, as shown by strong biotin staining in the interstitium and 
permeation into the seminiferous tubules only as far as the TJ marker occludin. However, the 
morphology was again sub-optimal as evidenced by the shrunken appearance of the seminiferous 
tubules. In contrast, in testes fixed in either Bouin’s or paraformaldehyde, a similar biotin staining 
pattern was observed to the frozen testes, but with ideal morphology. This was in direct contrast with 
the HRP tracer which was undetectable in the fixed testis sections. Light microscopy displayed biotin 
staining at the TJ just above the early spermatogonial cells, with no biotin staining adluminally to the 
spermatogonia, indicating fully functional TJs (Pelletier, 1986, Pelletier, 1988, Lustig et al. 2000, 
Meng et al. 2005).  
As a positive control for TJ function, biotin localisation was assessed in a 9 day old 
prepubertal rat testis, which lacks TJs. Biotin staining localised extensively in the interstitium and 
permeated throughout the seminiferous tubules, and this was coincident with an absence of occludin 
staining. Based on the success of the biotin localisation in conjunction with the good morphology in 
Bouins-fixed tissues, this tracer technique was chosen for all in vivo qualitative TJ functional analysis 
in this thesis. 
 [3H]methoxy-inulin was assessed as a tracer for the quantitative functional analysis of 
testicular TJs, based on its previous application to testicular tissues (Eng et al. 1994). To determine the 
effectiveness of this tracer, it was necessary to employ a model which is known to disrupt TJs as a 
positive control. Testicular glycerol treatment has been associated with the restructuring of 
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cytoskeleton to which the TJ is indirectly linked, so in effect, causes TJ disassembly (Wiebe et al. 
2000). These tissues displayed an absence of occludin localisation to the TJ after a 2 week treatment 
period with 20% glycerol, and this phenotype persists for at least 1 year, despite glycerol reportedly 
being cleared from the general circulation within 24 hours (Wiebe et al. 1986, Eng et al. 1994, Wiebe 
et al. 2000). Various glycerol concentrations had been tested in previous studies ranging from 10%-
70% (Eng et al. 1994, Igdoura and Wiebe, 1994, Wiebe et al. 2000). An injection of 70% glycerol 
resulted in focal destruction of tubules, and some of these were acellular (Weinbauer et al. 1985, 
Wiebe et al. 1986), whereas in testes which received smaller glycerol concentrations (10%-20%), 
spermatogenesis was suppressed without damage to the tubules (Igdoura and Wiebe, 1994). Therefore, 
an injection directly into the tests containing 20% glycerol was chosen for this study. At no stage did 
the rats display any sign of pain or discomfort as a result of the injection. 
 Four weeks after glycerol treatment to adult rats no effect on body weights compared to 
controls was observed, but testis weights were significantly reduced 39%. This was comparable with a 
37% decrease in testis weights obtained in a separate study using 20% glycerol (Igdoura and Wiebe, 
1994). These authors also analysed testis weights at 1, 2, 8 and 56 weeks after glycerol administration, 
and found no differences across this time course (Igdoura and Wiebe, 1994), suggesting that extending 
the exposure of rats in this study to glycerol would have had no additional effect on the testes. Some 
scarring at the injection site and among the seminiferous tubules in the immediate vicinity of the 
injection site was apparent in this study, but nothing was visible deeper within the testis. 
Seminiferous tubules were isolated from glycerol-treated and control- (vehicle treated) testes 
and exposed to [3H]methoxy-inulin according to a published protocol (Eng et al. 1994). Accumulation 
of the tracer in glycerol tubules was approximately 2 fold higher than in control tubules, suggesting a 
quantitative disruption in TJ function after 4 weeks of glycerol treatment. The degree of disruption 
however, was somewhat lower than expected, as in the Eng et al. (1994) study a 10-fold accumulation 
of the tracer was observed in tubules following 4 weeks of glycerol treatment. This difference between 
the results could be due to the experimental protocol which appeared to be crude in design. Other 
means of measuring [3H]methoxy-inulin penetration of the TJ would technically have been possible to 
improve this design, such as collecting and measuring tracer accumulation in rete testis fluid, 
seminiferous tubule fluid, interstitial fluid or the whole testis (Eng et al. 1994).  
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Alternatively, the extent to which glycerol had induced TJ disruption may have been 
important. Fluorescent microscopy of the glycerol treated testes which received the biotin tracer, 
showed disruption of TJ function qualitatively as indicated by the permeation of biotin into the 
seminiferous tubules. Interestingly, it was also seen that four phenotypes or degrees of tubule and/or 
spermatogenic disruption existed (see Figure 4.7), which were comparable to similar phenotypes 
previously published (Wiebe et al. 2000). 
As shown in Figure 4.7 of this Chapter, ‘normal’ spermatogenesis appeared to be taking place, 
with all germ cell types adluminal to the TJ present (Figure 4.7a). However, biotin had readily 
permeated through the TJ and was surrounding these adluminal germ cell types, suggesting that the TJ 
was not entirely functional, and that it did not need to be entirely functional for spermatogenesis to 
continue. In other words, the effect of glycerol had not disrupted TJs sufficiently to disrupt their 
function in some tubules. Other studies have also demonstrated that the TJ in the blood-testis-barrier, 
as well as in the blood-brain-barrier does not need to be fully functional to main barrier integrity 
(Setchell et al. 1981, Setchell et al. 1988, Nitta et al. 2003). This possibility may also explain why the 
quantitative difference in TJ function between glycerol and control testes was so small, in that inulin 
(5kDa) was too large to cross the marginally disrupted TJ, which had become permeable to biotin 
(~600Da). More definitive experiments are needed to confirm this hypothesis. Also evident, were 
some tubules in Figure 4.7 appeared completely disrupted, with an apparent acellular morphology as 
reported with higher doses of glycerol (Weinbauer et al. 1985, Wiebe et al. 1986). The biotin 
accumulation in these tubules was great, and it would be expected that inulin accumulation in those 
tubules would also be great. The other two pictures in Figure 4.7 displayed phenotypes which 
appeared to be in between ‘normal’ spermatogenesis and completely disrupted spermatogenesis. The 
final outcome on quantitative TJ functional analysis would therefore depend on the proportion of 
tubules with completely disrupted TJs compared to those with marginally disrupted TJs. This 
proportion was not determined in this thesis, but may be required in the future with similar 
experiments. Regardless, the [3H]methoxy-inulin tracer will be used for quantitative TJ functional 
analysis in the next Chapter, which will look at the effect of hormone suppression and replacement on 
the TJ in vivo.  
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 In conclusion, methods to assess the qualitative and quantitative function of testicular TJs in 
vivo have been examined, with biotin tracer and [3H]methoxy-inulin respectively chosen as the two 
methods to be used. Biotin was readily detectable in Bouin’s fixed tissue, which is important as 
Bouin’s maintains good tubule morphology and allows easy identification of germ cell types and 
biotin localisation. HRP on the other hand would only work in frozen tissue sections, which does not 
maintain good morphology. [3H]methoxy-inulin accumulation in glycerol treated testes was 2-fold 
higher than in control testes, suggesting its availability as a quantitative TJ functional marker for the 
next study. 
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Chapter 5. Hormonal regulation of the Sertoli cell tight junction in the gonadotrophin releasing 
hormone (GnRH)-antagonist treated rat, in vivo 
 
5.1 Introduction 
 Hormone suppression using various animal models has been used in the past to analyse the 
regulatory roles of testosterone and/or FSH on spermatogenesis (see Chapter 1 section 1.7). GnRH is a 
hormone released from the hypothalamus and stimulates the pituitary to release i) FSH, which 
interacts directly upon Sertoli cells, and ii) LH, which stimulates testicular Leydig cells to produce 
testosterone which then acts on Sertoli cells. GnRH antagonism involves inhibiting the GnRH stimulus 
at the pituitary level by administration of a GnRH antagonist, typically by subcutaneous injection.  
 All published GnRH antagonists suppress LH/testosterone and FSH to basal levels soon after 
the initial injection, and given that hormonal suppression is maintained, the testis regresses with 
reductions in germ cell numbers, leading to a cessation of spermatogenesis (Jiang et al. 2001, Broqua 
et al. 2002, Herbst et al. 2002, Hild et al. 2004, Matthiesson et al. 2005b, Porter et al. 2006). Where 
GnRH antagonists vary is in their duration of effectiveness after a single dose (Jiang et al. 2001, 
Broqua et al. 2002) and propensity to stimulate histamine release (Jiang et al. 2001, Broqua et al. 
2002) Most antagonists such as Nal-Glu, Cetrorelix, Abarelix and Ganirelix, suppress gonadotrophins 
for 1 day (Kangasniemi et al. 1995, Jiang et al. 2001, Broqua et al. 2002) therefore requiring multiple 
doses to maintain suppression for any given period of time. Degarelix, which is a relatively new 
GnRH antagonist, suppresses gonadotrophins for 6 weeks after a single dose (Jiang et al. 2001, 
Herbst, 2003) but at the time of experimentation, this antagonist was not commercially available.  
 Another GnRH antagonist acyline, has very low histamine release properties (Jiang et al. 
2001, Broqua et al. 2002), and is relatively long acting at suppressing hormones, where a single 
subcutaneous dose in the rat suppresses LH/T for approximately 10 days (Porter et al. 2006). 
Furthermore, it is still effective at fully suppressing hormones after multiple doses (Hild et al. 2004). 
Acyline treatment has been applied to rats (Jiang et al. 2001, Hild et al. 2004, Porter et al. 2006) and 
humans (Herbst, 2003, Matthiesson et al. 2005b). Hence, its effects on spermatogenesis are well 
known, which makes it a good candidate for studying the effect of hormone suppression on the rat 
Sertoli cell TJ in vivo. 
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It is hypothesised that gonadotrophin suppression with acyline in adult rats will disrupt Sertoli 
cell TJ function and structure and that short-term hormone replacement will restore TJ function and 
structure. The aim of the work presented in this Chapter is therefore to determine the effect of 
gonadotrophin suppression and subsequent short-term hormone replacement on Sertoli cell TJ 
function and structure.  
Gonadotrophin suppression will be induced by weekly doses of acyline to groups of rats for 7-
8 weeks to fully suppress spermatogenic activity. This time-point was chosen as rats were rendered 
azoospermic and infertile after 8 weeks of GnRH immunisation in a previous study using a similar 
model (Awoniyi et al. 1992b, Awoniyi et al. 1993). Furthermore, these rats displayed testis weights 
which were comparable to another study which used the same GnRH immunisation protocol for 12 
weeks (Meachem et al. 1998). Therefore, 7-8 weeks of acyline treatment was considered sufficient to 
cause maximal suppression of spermatogenesis which was thought necessary to induce changes in the 
Sertoli cell TJ. Following hormone suppression, hormones will be selectively replaced via a short-term 
(1 week) treatment regimen using i) human recombinant FSH (hrFSH) (Pratis et al. 2003, McLachlan 
et al. 1995); ii) human chorionic gonadotrophin to stimulate testicular production of testosterone and 
FSH (Pratis et al. 2003) and iii) human chorionic gonadotrophin + FSH antibody to stimulate the 
testicular production of testosterone alone. This short-term replacement regimen was chosen based on 
published protocols from very similar GnRH immunisation models (McLachlan et al. 1995, Meachem 
et al. 1998, Pratis et al. 2003), which have quantified changes in germ cell numbers and 
serum/testicular steroids and FSH thus potentially drawing some interesting and useful parallels 
between this study and the GnRH immunisation studies.   
For qualitative and quantitative TJ functional analysis, the biotin and [3H]methoxy-inulin 
tracers which were optimised in the previous Chapter, will be used respectively. Changes in TJ protein 
localisation as well as protein and mRNA expression will be monitored by immunohistochemistry, 
western blot analysis and real-time RT-PCR analysis after hormone suppression and short-term 
replacement. Results from this Chapter will describe the role hormones have in maintaining the Sertoli 
cell TJ.  
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5.2 Materials and Methods 
 
5.2.1 Animals 
Male outbred-Sprague Dawley rats at 75-90 days of age were obtained from Monash 
University Animal Services, Monash University (Melbourne, Australia). All experimental work 
conducted on rats was approved by the Monash Medical Centre Animal Ethics Committee (ethics 
number: MMCB 2006/19). Following experimentation, rats were killed by CO2 asphyxiation. 
 
5.2.2 Experimental design 
FSH and LH/T were suppressed by weekly subcutaneous injections of acyline (donated by Dr 
Richard Blye, National Institute of Health, MD, USA) for 7 weeks into adult rats at 1.5mg/kg in sterile 
5% mannitol/MilliQ water (Porter et al. 2006), administered as single injections to the hind flank or 
shoulder (500µl/site). Control rats received a subcutaneous injection of the vehicle alone (n = 10). The 
preparation of acyline involved dissolving 0.3g of acyline powder (which had been stored at 4oC until 
use) in 100ml of sterile 5% mannitol/MilliQ water in a tissue culture laminar flow cabinet. This gave a 
final concentration for acyline of 3mg/ml. 10ml aliquots were snap frozen on dry ice and stored at -
20oC for the duration of the experiment (maximum = 8 weeks). Aliquots were only thawed once when 
required for use, with residual amounts being re-frozen and stored at -20oC in case extra acyline was 
required. 
After gonadotrophin suppression, rats (n = 10/group) in the eighth week received an additional 
dose of acyline in conjunction with short-term hormone replacement (daily, for 7 days) by 
subcutaneous injections with one of the following; i) hrFSH (25 IU/kg) (Puregon; Organon, Holland) 
(Meachem et al. 1998, Pratis et al. 2003), ii) hCG (2.5 IU/kg) (Pregnyl; Organon, Holland) + FSH 
Antibody (Ab) (sheep anti-rat, 2mg/kg) to investigate testicular production of testosterone alone 
(Meachem et al. 1998) and iii) hCG (2.5 IU/kg) + normal sheep immunoglobulins (2mg/kg) to 
investigate testosterone and FSH production (Meachem et al. 1998). Three more groups of rats (n = 
10/group) continued to receive i) acyline vehicle, ii) acyline + FSH Ab (daily, sheep anti-rat, 2mg/kg) 
to suppress residual FSH, and iii) acyline + normal sheep immunoglobulins (daily, 2mg/kg) (Meachem 
et al. 1998, Pratis et al. 2003), daily for a further week. Note that the dose of FSH Ab chosen has 
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previously been shown to neutralise >90% of circulating FSH in a very similar rat model (Meachem et 
al. 1998). Note also that the acyline + normal sheep immunoglobulin group meant that one of the rat 
groups in this study, received acyline alone for a total of 8 weeks.  
hrFSH, hCG, FSH Ab and normal sheep immunoglobulins were all prepared fresh on the day 
of use and were injected into the hind flank or shoulder in a 0.5ml volume. Preparation details were as 
follows: 150 IU hrFSH was dissolved in 1ml of saline (0.9% NaCl in MilliQ water). This was then 
diluted in 5ml of saline to give a final concentration of 25 IU/ml. 500 IU of hCG was dissolved in 1ml 
of saline and then diluted 1:10 to give a final concentration of 50 IU/ml. This was then diluted a 
further 1:20 to give a final concentration of 2.5 IU/ml. 10mg of FSH Ab and 20mg of normal sheep 
immunoglobulins was weighed out and dissolved in saline at volumes of 5ml and 10ml respectively to 
give final concentrations of 2mg/ml for both products. 
At the end of the experiment, rats were killed and testes were excised and weighed 
immediately. The right testis from each animal was processed for quantitative TJ functional analysis 
using [3H]methoxy-inulin (n = 10/group) (see section 4.2.3 for the protocol). Five of the left testes per 
treatment group were snap-frozen in dry ice for RT-PCR and western blot analyses. The remaining 5 
left testes from each group were injected pole to pole with either the qualitative TJ functional tracer 
biotin (10mg/ml, EZ-Link Sulfo-NHS-LC-Biotin, Pierce, Rockford, IL, USA) (n = 4) (Meng et al. 
2005) in a volume of 10% testis weight, or the biotin vehicle (PBS + 1mM CaCl2) (n = 1) at 10% testis 
weight. Testes were then incubated at room temperature for 30 minutes (Meng et al. 2005) before 
immersion fixation in fresh Bouin’s fixative for 5 hours. Testes were then randomly sampled by a 
systematic uniform approach (Wreford, 1995) for stereological or immunohistochemical assessment.  
Shortly after killing rats, blood was taken by cardiac puncture with an 18G needle connected 
to a 10ml syringe, and stored overnight at 4oC before being spun down in a centrifuge at 1288g 
(2,500rpm, Beckman Coulter, Model J-6B) for 15 minutes. Serum was then collected by 
centrifugation, aliquotted, snap-frozen and then stored at -80oC for analysis of FSH, LH and androgen 
concentrations. 
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5.2.3 Glycerol Intratesticular injection 
 The glycerol treatment that was used in the previous Chapter for biotin-functional tracer 
optimisation (n = 10/group (glycerol and control)), was again used in this Chapter as a positive control 
to decrease TJ function. The treatment protocol was conducted as outlined in section 4.2.3.  
 
5.2.4 Immunohistochemistry 
 Bouin’s-fixed, paraffin-embedded tissue underwent the immunohistochemistry protocol 
outlined in section 2.2 with confocal/fluorescent microscopy as the endpoints. Primary and secondary 
antibody incubation conditions for occludin, claudin-11, claudin-3, JAM-A and ZO-1, as well as the 
macrophage markers ED1 and ED2 are presented in Table 5.1. When probing for biotin, the 
Streptavidin Alexa-488 probe was diluted into the secondary antibody solutions as outlined in section 
4.2.2. Biotin negative controls simply omitted the probe from the secondary solutions. All images are 
confocal microscopy unless otherwise stated. 
 
5.2.5 Western blot analysis 
 Protein was extracted from frozen rat testes and prepared for western blot analysis of occludin 
and claudin-11 protein expression as outlined in section 2.5. Primary and secondary antibody 
conditions are presented in Table 5.2. 
 
5.2.6 Real-time RT-PCR analysis 
 Total RNA was extracted from frozen rat testes and prepared for RT-PCR analysis as outlined 
in section 2.3. Primers for occludin, claudin-11, JAM-A, ZO-1, the androgen-regulated protein INSL-
3, or housekeepers GAPDH and β-actin, were either taken from published sources or designed using 
the online Primer3 program (http://frodo.wi.mit.edu/primer3/input.htm) and parameters are presented 
in Table 5.3. 
 
5.2.7 Stereology 
 The total number of cells per testis was calculated using the optical dissector method 
as previously described (Wreford, 1995, Meachem et al. 1998). Germ cells were identified using the  
  
 
 
 
 
 
 
Table 5.1 Antibodies used for immunohistochemical analysis. 
Tabulated data for the antibodies used in Chapter 5 of this thesis, including details regarding 
the primary and secondary antibody hosts, working concentrations (conc.)/dilutions, incubation (Inc.) 
times and company details with catalogue numbers. 
Protein Primary 
(1o) 
antibody 
host 
Company 
(cat no.) 
Conc. 
(μg/ml) 
Negative 
control 
1o 
Inc. time 
(mins) 
Secondary 
(2o) antibody 
Company 2o 
Dilution 
2o Inc. 
time 
(mins) 
Claudin-
11 
Rabbit Zymed  (36-
4500) 
2.0 Normal 
rabbit 
IgG 
60  Goat α rabbit 
Alexa-488 or 
Alexa-546 
Molecular 
Probes 
1:400 of 
stock 
30 
Occludin Rabbit Zymed     
(71-1500) 
2.5 Normal 
rabbit 
IgG 
30  Goat α rabbit 
Alexa-488 or 
Alexa-546 
Molecular 
Probes 
1:800 of 
stock 
30 
ZO-1 Rabbit Zymed     
(61-7300) 
1.25 Normal 
rabbit 
IgG 
60 Goat α rabbit 
Alexa-488 or 
Alexa-546 
Molecular 
Probes 
1:800 of 
stock 
30 
JAM-A Rabbit Zymed       
(36-1700) 
0.625 Normal 
rabbit 
IgG 
Overnight Goat α rabbit 
Alexa-488 or 
Alexa-546 
Molecular 
Probes 
1:400 of 
stock 
30 
ED1 Mouse Serotec 
(MCA341)* 
1:200 
into 
ED2 
Normal 
mouse 
IgG 
Overnight Goat α mouse 
Alexa-488 
Molecular 
Probes 
1:400 of 
stock 
30 
ED2 Mouse Suspended 
in 
supernatants 
from 
hybridoma 
cultures* 
Neat Normal 
mouse 
IgG 
Overnight Goat α mouse 
Alexa-488 
Molecular 
Probes 
1:400 of 
stock 
30 
* Monash Institute of Medical Research, courtesy of Dr Mark Hedger (see Dijkstra et al. (1985)) 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Table 5.2 Antibodies and conditions used for western blot analysis. 
Tabulated data for the antibodies used in Chapter 5 of this thesis, including details regarding 
the primary and secondary antibody hosts, working concentrations (conc.)/dilutions, incubation (Inc.) 
times and company details with catalogue numbers.  
Protein Primary 
(1o) 
antibody 
host 
Company 
(cat no.) 
Conc. 
(μg/ml) 
Negative 
control 
Tween20 
(v/v) (%) 
1o 
Inc. 
time 
(hrs) 
Secondary 
(2o) 
antibody 
Company 2o 
Dilution 
2o 
Inc. 
time 
(hrs) 
Claudin-11 Rabbit AbCam 
(ab7474) 
1:200 
of 
antisera 
Normal 
rabbit 
serum 
0.1% 
secondary 
only 
2 Goat α 
rabbit 
IRDye 800 
or goat α 
rabbit 
Alexa-680 
Rocklands 
Immunochemicals 
or Molecular 
Probes 
1:5000 of 
either 
secondary 
2 
Occludin Rabbit Zymed 
(71-1500) 
2 Normal 
rabbit 
IgG 
0.1% 
primary 
and 
secondary 
2 As above As above As above 2 
Β-actin Mouse Sigma 
ascites 
fluid     
(A4700) 
1:1000 
of 
stock 
Normal 
mouse 
IgG 
0.1% 
primary 
and 
secondary 
2 Goat α 
mouse 
IRDye 800 
Rocklands 
Immunochemicals 
1:5000 of 
stock 
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.3 Primer sequences and real-time RT-PCR conditions for the analysis of mRNA 
expression in the GnRH-antagonist-treated rat. 
 Primers were designed against the TJ proteins claudin-11, occludin, JAM-A, and the 
cytoplasmic plaque protein ZO-1, to quantitate mRNA expression following hormone suppression and 
short-term replacement. Primers were also designed against insulin-like 3 (INSL-3) which is androgen 
regulated and served as a useful positive control for hormone suppression on mRNA expression. The 
housekeepers used in this study were GAPDH and β-actin. Data included in the table are forward and 
reverse primer sequences, Mg2+ concentration, and annealing and acquisition temperatures. 
Protein Species 
Accession  
no. 
Primer Sequences (5’- 3’) Product  
size (bp) 
[Mg2+]  
(mM) 
Anneal 
temp. 
(oC) 
Acquisition 
temp. 
(oC) 
Claudin-11 
(Chung et al. 
(2001)) 
Rat 
NM_053457 
Forward: TTAGACATGGGCACTCTTGG 
Reverse: ATGGTAGCCACTTGCCTTC 
624 2.5 68 85 
Occludin  
(Lui et al. 
(2001)) 
Rat 
NM_031329 
Forward: CTGTCTATGCTCGTCATCG 
Reverse: CATTCCCGATCTAATGACGC 
294 2.5 64 75 
JAM-A  
(Primer3) 
Mouse 
NM_172647 
Forward: TATAGCCGTGGATACTTT  
Reverse: GTCAGCCCAGCCACTATTACT 
425 2.5 64 72 
ZO-1  
(Primer3) 
Rat 
NM_009386 
Forward: AGAGAGGAAGAGCGAATGTCTA 
Reverse: TTCATGCTGGGCCTAAGTA 
248 3.0 60 72 
β-actin  
(Primer3) 
Rat 
NM_031144 
Forward: CCGTAAAGACCTCTATGCCAACA 
Reverse: GCTAGGAGCCAGGGCAGTAATC  
103 2.0 67 72 
INSL-3  
(Primer3) 
Rat 
NM_053680 
Forward: CTTCCTCACCAGGCTTCTCA 
Reverse: CTGTGGTCCTTGGTTTCTGG 
241 2.0 58 72 
GAPDH 
(Tso et al. 
(1985)) 
Mouse 
NM_008084 
Forward: GACCCCTTCATTGACCTCAAC  
Reverse: GATGACCTTGCCCACAGCCTT 
560 2.5 60 72 
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criteria of Russell et al. (1990) as published previously (McLachlan et al. 1995) and approximately 
100 germ cells of each type was counted per animal (Gundersen, 1986). 
Germ cells were divided into subgroups including type A/intermediate spermatogonia, type 
B/preleptotene spermatocytes, leptotene/zygotene spermatocytes, pachytene spermatocytes (associated 
with stages I-VIII and IX-XIV), round spermatids and elongated spermtids (associated with stages I-
VIII and IX-XIV). 
Cell counting was performed using a 100X objective lens on an Olympus BX-50 microscope 
(Tokyo, Japan) with a microcator (Heideinhain D83301: Traunreut, Germany) attached to the stage to 
measure the depth scanned. A Pulinix TMC-6 video camera coupled to a Pentium personal computer 
captured the image. The software package DH CASTGRID version 1.10 (Olympus, Munich, 
Germany) was used to superimpose a set of unbiased counting frames (of known areas) on to the video 
image. Unbiased fields were selected within the frames by a systematic uniform random sampling 
method for cell counting (McLachlan et al. 1995, Meachem et al. 1998). The number of assigned 
fields for each germ cell type was determined by their frequency (Meachem et al. 1998). Estimation of 
the number of cells per testis was determined by dividing the total number of cells by the total volume 
sampled. Volume sampled was determined by multiplying the total number of fields counted by the 
volume sampled in each field (volume sampled in each field equals the area of the unbiased frames 
multiplied by the depth scanned (10μm)). This is then multipled by the total testis volume. The final 
screen magnification was 2,708X and no correction for tissue shrinkage was necessary as determined 
previously (McLachlan et al. 1995, Meachem et al. 1996, Meachem et al. 1998).  
All cell counting for this experiment was conducted by Mrs Georgia Balourdos at Prince 
Henry’s Institute of Medical Research, Clayton, Victoria, Australia. 
 
5.2.8 Serum hormone analyses 
 
a. LH 
 Serum LH assay was conducted by Mrs Enid Pruysers at Prince Henry’s Institute of Medical 
Research according to a published protocol (Robertson et al. 2001). The assay kit used was the Delfia 
hLH assay (Wallac). 96 well plates (Wallac) were coated with the B1 LH antibody which detects the 
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LHβ subunit. In brief, plates were washed with wash buffer and rLH standards (diluted 1:2 in buffer 
(TSA/5% bSA) from a starting concentration of 500pg/25μl to 7.8pg/25μl) and serum samples (diluted 
1:2 over 5 doses in buffer (TSA/5% bSA) added to appropriate wells in triplicate in 25μl volumes. The 
plate was then incubated at room temperature for 2 hours while shaking and then washed twice. 
Europium (Eu)-labelled A2 antibody (targeted against the LHα subunit) was then added overnight at 
room temperature without shaking. The plate was then washed six times with wash buffer and 
enhancement solution added prior to reading on a time resolved Wallac 1234 Fluorometer. Assay 
sensitivity was 0.012ng/ml and cross-reactivity with hCG was 4% (Haavisto et al. 1993). 
 
b. Total androgens 
 The concentration of serum total androgens was determined using a published protocol 
(O’Donnell et al. 1996b) and performed by Ms Fiona McLean at Prince Henry’s Institute of Medical 
Research. Serum samples were loaded into separate homogenisation tubes for total androgen 
(testosterone, DHT, 5α-androstane-3α,17β-diol (Adiol)) extraction. To follow androgen recoveries 
throughout processing, 5000cpm radiolabelled [1α,2α-N-3H]T], (DuPont, New England Nuclear, 
Melbourne, Australia; SA, 40-60Ci/nmol) was added to each sample. Homogenates were centrifuged 
(20 minutes, 9391g, 4oC (10,000rpm, Eppendorf, Germany)) and the supernatants kept on ice. Pellets 
were resuspended in homogenisation buffer, vortexed, sonicated for 3 minutes and then centrifuged as 
above. Combined supernatants were diluted 1:3 in HPLC-grade deionised H2O and 0.1% 
trifluoroacetic acid and loaded onto Sep-Pak C18 disposable columns (MilliQ system, Millipore, 
Milford, MA, USA). Androgens were eluted with 0.1% (vol/vol) trifluoroacetic acid and 60% 
acetonitrile and lyophilised. The O’Donnell et al. (1996b) study then separated the individual 
androgenic steroids by HPLC, with subsequent quantification by radioimmunoassay (RIA) using a 
primary antibody that cross-reacted with all androgens. This Chapter aimed to determine total 
androgen content in the serum without HPLC separation, hence samples were analysed directly by 
RIA as per the O’Donnell et al. (1996b) protocol. Samples were suspended in assay buffer (0.1% 
wt/vol gelatine in 0.1M PBS (0.154M NaCl), pH 7.4). Primary antibody Cox 0457 (Sirosera, Sydney, 
Australia) diluted 1:400,000 in 1:800 normal sheep serum was added to the solutions along with the 
tracer iodinated histamine-T (10,000cpm/100μl) (O’Donnell et al. 1996b). The assay was incubated 
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overnight at 4oC and then the secondary antibody (100μl donkey antisheep IgG diluted 1:20 in assay 
buffer) was added for 30 minutes at room temperature. Following this, 1ml of 6% Polyethylene Glycol 
6000 (Merck, Darmstadt, Germany) was added and incubated for 30 minutes at 4oC, after which an 
additional aliquot of potato starch was added to ensure pelletisation. Tubes were then centrifuged (40 
minutes, 1503g, 4oC (4,000rpm, Eppendorf)), drained and counted on a Wallac (Turku, Finland) γ-
counter. The assay sensitivity was 0.013ng/ml. 
 
c. FSH 
 Serum rat FSH assay was conducted as previously published (Robertson et al. 2001) by Mrs 
Enid Pruysers at Prince Henry’s Institute of Medical Research. The assay used was a sensitive 
immunofluorometric assay (Delfia, rFSH kit no. A0710201). Briefly, 96 well plates pre-coated with 
the FSH monoclonal antibody 36306 were obtained from Wallac (Robertson et al. 2001) and washed 
once with wash solution. Rat FSH standard (diluted 1:2 in buffer (TSA-SM) from a starting 
concentration of 2000pg/100μl to 1.95pg/100μl) or the serum samples (diluted 1:2 in buffer (TSA-
SM) over 5 doses) were added to the wells (in triplicate at 100μl) and incubated at room temperature 
for 3 hours, with shaking. Wells were then washed twice and Eu-labelled FSH monoclonal antibody 
(50ng/well, BD10) added and incubated for a further 30 minutes without shaking. Plates were washed 
6 times before enhancement solution was added prior to determining fluorescence in a time resolved 
fluorometer. The assay sensitivity was 0.015ng/ml. Cross-reactivity with human FSH was 1.3% 
(Jimenez et al. 2005). 
 
5.2.9 Statistics 
Statistical analysis was conducted as outlined in Section 2.6. Data has been presented as mean 
± SD unless otherwise stated, and the total number of animals/group is outlined in each result section 
of this Chapter.  
Note that raw data for serum hormone assays and stereology of germ cell numbers have been 
supplied in Appendices 1.3 and 1.4 respectively and are on CD inside the back cover of this thesis. 
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5.3 Results 
 
5.3.1 Testis and body weights 
 At the end of the hormonal or glycerol treatment protocols, freshly killed rats were weighed to 
obtain body weights (n = 10/group). No change in body weight was obtained in response to hormone 
suppression or replacement, and no change in body weight was obtained in response to the glycerol 
intratesticular injection compared to control (Table 5.4). 
 Testes were then excised, trimmed of all fat and connective tissue and then weighed before 
further experimentation. Hormone suppression with acyline for 7 weeks resulted in a significant 
decrease (p < 0.001) in testis weights to 19% of controls (Table 5.4). No further significant decrease 
was observed after the addition of the FSH Ab for another week, where testis weights were at 17% of 
control.  
 Short-term hormone replacement with hrFSH, hCG + FSH Ab (to observe the effect of 
testosterone alone) or hCG + control IgG (to observe the effect of both testosterone and endogenous 
rat FSH) all gave a significant (p < 0.001) partial recovery in testis weights to 24%-27% of controls 
(Table 5.4). 
 Four weeks after a single intratesticular injection of glycerol, testis weights had significantly 
decreased to 68% (p < 0.001) of control weights (Table 5.4). 
 
5.3.2 Serum hormone levels 
 
a. LH 
Hormone suppression with acyline significantly decreased serum levels of rat LH to 16% (p < 
0.05) (Figure 5.1a) of control, and the addition of the FSH Ab in the eighth week resulted in a further 
decrease in serum LH of 11% (p < 0.05). Short-term hrFSH and hCG replacement had no effect on 
suppressed serum LH levels, whereas short-term replacement of hCG + FSH Ab resulted in a further 
significant decrease of rat LH (p < 0.05). 
 
 
  
 
 
 
 
Table 5.4 Body and testis weights. 
 Rats were killed after 8 weeks of hormone suppression/replacement, or 4 weeks after an 
intratesticular injection of glycerol. Body weights were measured, after which testes were excised, 
trimmed of all fat, connective tissue and epididymides, and then weighed. Data for the hormone 
experiment is presented in Table A, and the glycerol experiment in Table B. All data is mean ± SD, n 
= 10/group. Difference between letters is p < 0.001. 
 
A 
 
Treatment Control Acyline Acyline + FSH 
Ab 
Acyline + FSH Acyline + hCG + 
FSH Ab 
Acyline + 
hCG 
Body weights 
(g) 
438.6 ± 37.7 402.7 ± 21.7 401.8 ± 37.3 415.9 ± 39.9 412.5 ± 13.7 418.6 ± 20.3 
Testis weights 
(mg) 
1754.5 ± 90.6a 331.5 ± 44.4b 299.2 ± 46.6b 425.8 ± 33.0c 432.9 ± 53.5c 481.5 ± 
74.4c 
 
 
B 
 
Treatment 
 
Control Glycerol 
Body weights 
(g) 
409.0 ± 12.4 388.5 ± 25.1 
Testis weights 
(mg) 
1752.2 ± 89.0a 1195.8 ± 
241.7b 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 5.1 Effect of hormone suppression and short-term replacement on serum LH, androgens 
and FSH. 
Serum concentrations of LH (panel A), androgens (panel B) and rat FSH (panel C) in control 
rats, animals suppressed with acyline for 8 weeks, and in animals suppressed with both acyline and 
given short-term hormone replacement for 7 days. Full details of treatment groups are given in Section 
5.2. Data is mean ± SD, n = 9-10 rats/group (serum androgens), 6-8 rats/group (serum FSH), 5-8 
rats/group (serum LH). Significant differences (p < 0.05 or greater) between treatment groups are 
indicated by letters, as specified in Results. NA = not assessed.  
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b. Androgens 
 Acyline treatment reduced serum total androgens to 13% (p < 0.001) of control, and the 
addition of the FSH Ab caused no further decrease (Figure 5.1b). Short-term hormone replacement 
with hrFSH had no effect on serum androgen levels, but a significant recovery was achieved with 
short-term replacement of hCG which lifted serum androgens to 30% of control (p < 0.01), and hCG + 
FSH Ab which lifted serum androgens to 35% of control (p < 0.001). 
 
c. FSH 
 Serum FSH was reduced to 12% (p < 0.01) of controls in response to acyline treatment 
(Figure 5.1c). The FSH Ab interfered with the assay and so the effect of this treatment on serum FSH 
alone, and in combination with hCG could not be measured. However, the short-term replacement of 
hrFSH further decreased serum rat FSH levels to 7% of control (p < 0.05), whereas the addition of 
hCG induced a significant recovery to 25% of control (p < 0.001).  
 
5.3.3 Stereological assessment of germ cell types and numbers 
 
a. Type A/Intermediate spermatogonia 
 Hormone suppression with acyline for 8 weeks significantly (p < 0.001) reduced Type A and 
intermediate spermatogonia to 66% of controls, and the addition of the FSH Ab caused a further 
significant reduction compared to acyline alone (p < 0.05) of these cell types to 46% of controls 
(Figure 5.2). Short-term hormone replacement with FSH, or the stimulation of testicular production of 
testosterone ± FSH kept germ cell numbers at values significantly lower than the controls (p<0.001), 
or acyline treated (p<0.05) but no differences were observed between the replacement groups and the 
Acyline + FSH Ab group (Figure 5.2). 
 
b. Type B/Preleptotene spermatocytes 
 No significant decrease (p = 0.242) following acyline treatment with germ cells at 76% of 
control (Figure 5.2). The addition of the FSH Ab did achieve a significant (p < 0.05) reduction in type 
B/preleptotene spermatocytes to 65% of control levels. Short-term FSH replacement restored  
  
 
 
 
 
 
 
Figure 5.2 Stereological assessment of germ cell types and numbers. 
 Stereological assessment by the optical dissector method was used to determine the effect of 
the various hormone treatments on germ cell types and numbers. Germ cells were divided into the 
following subgroup; i) Type A/intermediate spermatogonia, ii) Type B/preleptotene spermatocytes, iii) 
Leptotene/zygotene spermatocytes, iv) Pachytene spermatocytes stages I-VIII, v) Pachytene 
spermatocytes stages IX-XIV, vi) Round spermatids stages I-VIII, all of which are presented in the 
Figure. For elongated spermatids (stages I-VIII and IX-XIV) and Sertoli cell numbers, see Table 5.5. 
A full description of the treatment groups is given in Section 5.2. Data is Mean ± SD, n = 5 
rats/group. Significant differences (p < 0.05 or greater) between treatment groups is denoted by 
different letters, with full details given in the text. Note the logarithmic y-axes for the 2 lower right 
graphs. 
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germ cell numbers to control levels (p < 0.001 versus FSH Ab) but the stimulation of testosterone 
alone had no effect on type B/preleptotene spermatocytes recovery (Figure 5.2). Germ cell numbers 
did not change from suppressed levels following the stimulation of both testosterone and endogenous 
rat FSH in the hCG-alone group, however these numbers were also no longer significantly different to 
control levels either (Figure 5.2).   
 
c. Leptotene/Zygotene spermatocytes 
 Acyline reduced leptotene/zygotene spermatocyte numbers to 50% of control (p < 0.001), and 
the addition of the FSH Ab caused a further decrease to 34% of control (p < 0.001 versus control, p < 
0.01 versus acyline alone) (Figure 5.2). None of the short-term hormone replacements induced 
significant recoveries in these germ cell types from acyline induced numbers. This was despite  
increases to 61% of control numbers in response to FSH replacement, 51% response to the effect of 
testosterone alone (as determined with hCG + FSH Ab treatment group) and 60% following the 
simulation of both testosterone and endogenous rat FSH with hCG.  
 
d. Pachytene spermatocytes Stages I-VIII 
 Acyline decreased pachytene spermatocytes in stages I-VIII to 15% (p < 0.001) of controls, 
and the addition of the FSH Ab further reduced numbers to 8% of control (p < 0.001 versus control, p 
< 0.05 versus acyline) (Figure 5.2). hrFSH-alone replacement increased germ cell numbers 
significantly (p < 0.001 versus acyline) to 64% of control, while testosterone alone (induced by hCG + 
FSH Ab treatment) also significantly (p < 0.001) increased pachytene spermatocyte (stages I-VIII) 
numbers to 29% of control, but this result was significantly (p < 0.001) lower than the hrFSH-induced 
recovery. The stimulation of both testosterone and endogenous rat FSH with hCG treatment resulted in 
a recovery of germ cell numbers to 51% of control, which was significantly higher than the recovery 
induced by testosterone alone (p < 0.001) but significantly lower than the recovery induced by hrFSH 
alone (p < 0.001) (Figure 5.2).  
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e. Pachytene spermatocytes Stages IX-XIV 
 Acyline treatment reduced pachytene spermatocytes at stages IX-XIV to 3% of control (p < 
0.001), with a further significant suppression to 2% of control numbers with the FSH Ab treatment (p 
< 0.05 versus acyline) (Figure 5.2). rhFSH treatment stimulated a  recovery in these germ cells to 18% 
of control numbers (p < 0.05). Testosterone alone (induced by hCG + FSH Ab treatment) resulted in a 
recovery to 9% of control values (p < 0.05), which was significantly less (p < 0.05) than rhFSH alone. 
The stimulation of both testosterone and endogenous rat FSH using hCG treatment resulted in a 
recovery of germ numbers to 11% of control (p < 0.05) (Figure 5.2). Data testing for each treatment 
group was found to be non-parametric. This was after log10 treatment of the raw data which did not 
result in a normal distribution. The differences between groups were then determined by the Kruskal-
Wallis test, followed by the post-hoc Newman-Keuls analogue (Equal N’s) to determine where the 
differences lay. 
 
f. Round spermatids Stages I-VIII 
 Acyline treatment resulted in a significant (p < 0.001) reduction in round spermatids at stages 
I-VIII to 0.4% of control numbers, with  no further significant reduction following treatment with the 
FSH Ab (Figure 5.2). rhFSH treatment resulted in a partial but significant (p < 0.05)  recovery of germ 
cell numbers to 6.5% of controls (Figure 5.2). Testosterone alone (induced by hCG + FSH Ab 
treatment) also stimulated a significant (p < 0.05) recovery to 1.4% of control numbers, but this was 
significantly (p < 0.05) less than the numbers obtained with hrFSH alone. The stimulation of both 
testosterone and endogenous rat FSH with hCG treatment resulted in a significant (p < 0.05) germ cell 
recovery to 3.1% of controls, but this was still significantly (p < 0.05) less than the germ cell numbers 
reached with rhFSH alone replacement (Figure 5.2). Data testing for each treatment group was non-
parametric. As above, this was determined after log10 treatment of the raw data which did not result in 
a normal distribution. Subsequently, a Kruskal-Wallis test was conducted to determine if there were 
any differences between the groups and the Newman-Keuls analogue (Equal N’s) tests was then 
conducted to determine where the differences lay.  
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g. Elongated spermatids Stages I-VIII 
 Acyline treatment ± FSH Ab completely suppressed the elongated spermatids at stages I-VIII 
with none detected (p < 0.001). Short-term replacement with any of the hormone treatment groups 
gave no recovery in numbers, with no germ cells detected (Table 5.5). 
 
h. Elongated spermatids Stages IX-XIV 
 Acyline reduced the number of elongated spermatids at stages IX-XIV to 0.2% of control (p < 
0.001), with no further significant reduction obtained with the FSH Ab. None of the hormone 
replacements gave any recovery in these germ cell numbers (Table 5.5). 
 
i. Sertoli cell numbers 
 Sertoli cell numbers were unchanged with hormone suppression or short-term replacement 
compared to the control (Table 5.5). 
 
5.3.4 Effect of hormone suppression and short-term replacement on tight junction 
structure/localisation and function 
 Control rats displayed large seminiferous tubules with lumens, extensive occludin staining at 
the TJ and biotin functional tracer staining restricted to the interstitium and only entering the tubules 
as far as the TJ (Figure 5.3a). Occasional endogenous biotin staining was visible within the control 
seminiferous tubules and the occludin antibody cross-reacted with the spermatid heads in the same 
animals. Non-specific staining in the interstitium was also occasionally visible. 
In acyline treated and FSH Ab treated (Figures 5.3b and 5.3c respectively) testes, tubule and 
lumen diameters had markedly decreased. Occludin staining was undetectable and biotin permeated 
throughout the tubules and surrounded all remaining germ cell types which based on stereological 
analysis were spermatogonia, leptotene/zygotene spermatocytes and some pachytene spermatocytes. 
Short-term hormone replacement for 7 days with either hrFSH, hCG + FSH Ab or hCG alone 
(Figure 5.3d-f) gave increased tubule and lumen diameters with some positive but limited occludin 
staining at the TJ (mostly in panels E and F). Biotin generally permeated throughout the tubules, but in 
some cases was excluded to the interstitium (Figures 5.3g-i) The proportion of tubules excluding 
  
 
 
 
 
 
 
 
Table 5.5 Stereological assessment of elongated spermatid and Sertoli cell numbers. 
Stereological data for elongated spermatids (stages I-VIII and IX-XIV) and Sertoli cell 
numbers. Quantification was conducted as per the earlier germ cell types presented in Figure 5.2. Data 
is mean ± SD, n = 5 rats/group 
        Treatment 
Germ cell 
Control Acyline Acyline + FSH 
Ab 
Acyline + FSH Acyline + hCG 
+ FSH Ab 
Acyline + hCG 
Elongated 
spermatids 
stages I-VIII 
3.63E+08        
±              
5.86E+07a 
0.00E+00        
±            
0.00E+00b 
0.00E+00        
±            
0.00E+00b 
0.00E+00        
±            
0.00E+00b 
0.00E+00        
±            
0.00E+00b 
0.00E+00        
±            
0.00E+00b 
Elongated 
spermatids 
stage IX-XIV 
9.45E+07        
±            
8.35E+06a 
1.42E+05        
±          
1.93E+05b 
2.39E+04        
±          
3.48E+04b 
3.69E+05            
±           
4.10E+05b 
1.22E+05        
±          
2.42E+05b 
3.32E+05       
±            
4.04E+05b 
Sertoli cells 4.11E+07        
±          
3.06E+06a 
4.44E+07        
±         
8.81E+06 
4.71E+07        
±         
1.51E+07 
5.18E+07        
±          
1.17E+07 
5.54E+07        
±           
1.64E+07 
5.18E+07       
±           
1.15E+07 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 5.3 Effect of hormone suppression and replacement on testicular TJ function and 
structure. 
 Immunofluorescence of occludin (red) and biotin functional tracer (green) in testes from rats 
given hormone suppression and replacement. TJ structure and function was initially visualised in a 
normal control testis (panel A), and compared to testes which had been hormonally suppressed with 
acyline alone for 8 weeks (panel B) or with acyline for 7 weeks plus the FSH Ab for an additional 
week (panel C). Following hormone suppression the effect of short-term hormone replacement with 
hrFSH alone (panel D), hCG + FSH Ab to investigate the effect of testosterone alone (panel E) and 
hCG to stimulate both testosterone and endogenous rat FSH (panel F) on TJ function and structure was 
analysed. Panels G-I represent a much smaller proportion of TJ phenotypes observed with each of the 
short-term hormone treatments listed above respectively. Such phenotypes were never observed for 
acyline treatment alone. Bar = 50μm. Inset = negative control with positive nuclear stain. Note this 
Figure presents conventional fluorescent micrographs (not confocal). 
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biotin was not able to be quantitated, but qualitative observation indicated that this was low (<5% of 
tubules/cross-sections). This phenotype was never observed in the acyline treatment groups. 
In control rats, the localisation of claudin-11 and JAM-A was extensive at the TJ, as was ZO-1 
localisation at the cytoplasmic plaque (Figure 5.4). Under hormone suppressed conditions, claudin-11 
protein remained present, but was localised to adluminal Sertoli cell cytoplasm in the tubules. JAM-A 
localisation responded in a similar manner to claudin-11 in hormone suppressed animals (acyline, 
acyline + FSH Ab) and was cytoplasmic and adluminal. ZO-1 staining was cytoplasmic and appeared 
more adluminal than in controls (Figure 5.4). 
ZO-1 of the cytoplasmic plaque had re-localised toward the outer edge of the seminiferous 
tubules in each of the short-term hormone replaced treatments (Figure 5.4).  
 
5.3.5 Quantitative analysis of TJ function in response to hormone suppression and short-term 
replacement 
 
a. Tracer accumulation in hormone suppressed and glycerol treated testes 
 Unexpectedly, the accumulation of [3H]methoxy-inulin in seminiferous tubules from the 
acyline-treated testes was significantly (p < 0.05) lower than in control testes  at 80% of control values 
(Figure 5.5a). Inulin accumulation remained at control levels in the acyline + FSH Ab treatment group, 
and was 52% and 20% greater than controls in the short-term replaced hrFSH and hCG + FSH Ab 
groups respectively. Inulin accumulation in the hCG-treated group was the same as control (Figure 
5.5a).  
 Four weeks of glycerol treatment resulted in a significant (p < 0.001) 27% greater 
accumulation of [3H]methoxy-inulin accumulation in seminiferous tubules compared to control 
(Figure 5.5b).  
 
b. Comparative tracer accumulations in control, glycerol treated and prepubertal testes 
 The absence of any quantitative difference in [3H]methoxy-inulin accumulation in the 
seminiferous tubules of the hormone suppressed testes compared to controls, and the small difference 
obtained for the glycerol-treated testes, led to a subsequent repeat experiment which tested the 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Effect of hormone suppression and replacement on the localisation of claudin-11 and 
JAM-A to the testicular TJ, and ZO-1 to the cytoplasmic plaque. 
 Immunohistochemical analysis of the localisation of claudin-11 (green) and JAM-A (red) to 
the TJ, and ZO-1 (red) to the cytoplasmic plaque in control, hormone-suppressed, and short-term 
replaced groups. Bar = 50μm. Inset = negative control. 
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Figure 5.5 Quantitative analysis of TJ function in response to hormone suppression, short-term 
hormone replacement, and glycerol treatment. 
 Testes were excised from freshly killed rats which had undergone hormone suppression with 
acyline and short-term hormone replacement (panel A), or rats which had undergone 4 weeks of 
glycerol treatment as a positive control for TJ disruption (panel B). Seminiferous tubules were 
incubated in 0.5μCi of [3H]methoxy-inulin for 1 hour at 34oC, before being homogenised and 
dissolved. Solutions were made up with scintillation fluid before final radioactive counts were 
determined for each treatment by scintillation spectrophotometry. Data is mean ± SD, n = 5/group. 
Difference between letters is p < 0.05. *** = p = 0.001. Note that the controls between the two panels 
are different vehicle controls for acyline (panel A) and glycerol (panel B). Therefore no statistical 
analyses were conducted between these two different experiments. 
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accumulation of [3H]methoxy-inulin and that of a much lower molecular weight tracer [14C]mannitol 
(182Da, 0.5μCi; Amersham Biosciences (GE), cat # CFA-238)) in the seminiferous tubules of control, 
and glycerol-treated adult rats (n = 6/group). An additional group (n = 6) of prepubertal (9 day old) 
juvenile rats was included in this experiment as a positive control to examine tracer permeability in 
tubules from testes in which TJs had not yet formed. It was hypothesised that the testicular TJ is size-
selective for tracers. The protocols for glycerol administration and tracer incubations were the same as 
outlined in section 4.2.3, with tubules from the right testes being incubated in wells containing both 
[3H]methoxy-inulin and [14C]mannitol tracers in combination. As the prepubertal testes were very 
small, tubules isolated from each testis were not fragmented into 3 sections, rather they were put 
whole into the tracer wells. An addition to the standard protocol was an intratesticular injection into 
each left testis of a solution containing both tracers at 10% testis volume. This was conducted to 
mimic the methodology of the biotin-permeation experiment as closely as possible. The testes were 
incubated for 30 minutes at room temperature following the injection, before tubules were isolated and 
rinsed in KRP prior to suspension in 5ml of MilliQ water as outlined in section 4.2.3.  
Glycerol treatment for 4 weeks reduced testis weights to 67% of control (p < 0.001). 
Prepubertal testis weights were 3% (p < 0.001) of adult control testis weights as shown in the table 
below: 
Rat group Control Glycerol treated 9 day old Juvenile 
Testis weights (mg) 1885 ± 117 1289 ± 385 53 ± 8 
  
When glycerol-treated seminiferous tubules were incubated in the tracers, the accumulation of 
either [3H]methoxy-inulin or [14C]mannitol was not significantly different to the accumulation in the 
control tubules (Figure 5.6a). However, the accumulation of [14C]mannitol in glycerol and control 
tubules was always significantly (p < 0.05) greater than [3H]methoxy-inulin accumulation. When 
seminiferous tubules from juvenile testes were incubated in the tracers, there was a significant 1.6 fold 
and 1.3 fold greater accumulation of [3H]methoxy-inulin and [14C]mannitol respectively compared to 
controls (Figure 5.6a). 
In testes which received an intratesticular injection of the tracers, glycerol-treated tubules 
accumulated a non-significant (p = 0.098) 1.5 fold greater amount of [3H]methoxy-inulin and a non-
  
 
 
 
 
 
 
Figure 5.6 Comparison of [3H]methoxy-inulin and [14C]mannitol accumulation in  testes from 
control and glycerol treated adult rats, and in juvenile rats. 
 Testes were excised from controls (white bars), glycerol-treated (4 weeks) (black bars) and 9 
day old juvenile rats (grey bars) to compare differences in the accumulation of [3H]methoxy-inulin and 
[14C]mannitol in testes within each group, and for any differences between the groups. Seminiferous 
tubules were isolated from the right testis of each animal and incubated in a solution containing both 
tracers (panel A) for 1 hour at 34oC before being homogenised, solubilised and quantitated by 
scintillation spectrophotometry. The left testis from each animal was injected with a solution 
containing both tracers (panel B) at 10% testis weight and incubated and processed as per the right 
testis. Data is mean ± SD, n = 6 testes/group. Difference between letters is p < 0.05, ** = p < 0.01, *** 
= p < 0.001. 
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significant (p = 0.133) 1.6 fold greater amount of [14C]mannitol compared to controls (Figure 5.6b). 
Juvenile testes accumulated a significant (p < 0.001) 49 fold greater amount of [3H]methoxy-inulin  
and 71 fold greater amount of [14C]mannitol in their tubules compared to controls following the 
intratesticular injection (Figure 5.6b).  
 
5.3.6 Testicular macrophage localisation following hormone suppression and replacement 
 An autoimmune response to hormone suppression and replacement was analysed by targeting 
ED1 and ED2 macrophage antigens (Figure 5.7). Control rat testes had very few macrophages which 
appeared predominantly localised in the blood vessels. Most tubules had very few macrophages 
surrounding them (Figure 5.7). In acyline treated rats, macrophage numbers appeared to qualitatively 
increase and had localized to the outer edges of the seminiferous tubules or in same cases had 
penetrated into the seminiferous epithelium (Figure 5.7). Rats treated with acyline + FSH Ab 
displayed a very similar macrophage number and localisation to the acyline alone treated group 
(Figure 5.7). Each of the short-term hormone replacement treatments appeared to result in a qualitative 
decrease in macrophage numbers compared to acyline treated (Figure 5.7), although these were still 
localized to the outer edges of the seminiferous tubules and were in greater number than in control. 
Glycerol treatment (to open TJs) when compared to the acyline treatment, appeared to stimulate a 
similar or marginally greater increase in macrophage number around the seminiferous tubules (Figure 
5.7). 
 
5.3.7 Western blot analysis 
 Control rat testis protein extracts displayed single bands corresponding to occludin at 64 kDa 
(Figure 5.8a) and claudin-11 at 22 kDa (Figure 5.8b). The latter protein was co-stained with β-actin 
(43kDa) to ensure consistent protein loadings across each sample. Fainter bands were also present in 
each of the gels but were also detectable in the negative control. Hormone suppression resulted in a 
marked decrease in occludin protein expression to beyond the limit of detection with the Odyssey 
system (Figure 5.8a). Recoveries in protein expression for occludin remained undetectable following 
short-term hormone replacement (Figure 5.8a). Similarly for claudin-11, protein expression was 
suppressed to beyond the limit of detection following hormone suppression (Figure 5.8b), with no 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 Effect of hormone suppression and replacement on macrophage localisation in 
hormone suppressed and replaced testes. 
 Bouin’s fixed testes were processed for immunohistochemical analysis of the macrophage 
markers ED1 and ED2, which labels all resident and circulating macrophages of the testis. 
Macrophages (green) were visualized by confocal microscopy with transillumination to highlight the 
seminiferous tubules in control testes, hormone suppressed testes, short-term hormone replaced testes 
and glycerol treated testes acting as positive control for open TJs. The bottom right panel is another 
control testis section taken at a lower magnification to display whole seminiferous tubules (dashed 
black line) and the number of macrophages (arrow) surrounding them. Bar = 50μm. Inset is negative 
control. 
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Figure 5.8 Effect of hormone suppression and replacement on TJ protein expression. 
 Western blot analysis of occludin (40μg total protein per lane, reducing conditions, 
Panel A, 64kDa) and claudin-11 (120μg total protein per lane, non-reducing conditions, Panel 
B, 22kDa). Detection of both proteins with fluorescently labeled secondary antibodies with 
Odyssey software. The house-keeping protein β-actin (43kDa) was also probed in each lane 
on the claudin-11 gel. Lanes are: 1) control, 2) acyline, 3) acyline + FSH Ab, 4) Acyline + 
FSH, 5) Acyline + hCG + FSH Ab, 6) Acyline + hCG, 7) Glycerol testis control, 8) Glycerol, 
9) Negative control. 
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detectable recovery following any of the short-term hormone replacement regimens. β-actin protein 
expression did not change with any of the treatments compared to control (Figure 5.8b). 
 
5.3.8 Real-time RT-PCR analysis 
 Hormone suppression with acyline resulted in a significant (p < 0.001) ~4 fold increases in 
claudin-11 and occludin mRNA expression, and an approximate 3 fold (p < 0.001)  increase in JAM-A 
mRNA expression (Figure 5.9). Short-term hormone replacement with each of the treatments resulted 
in another significant (p < 0.001) change in both claudin-11 and occludin mRNA expression levels, 
back towards control levels. It was noteworthy that both claudin-11 and occludin expression levels 
decreased to the same extent regardless of the short-term replacement group (FSH alone, hCG +FSH 
Ab, or hCG). However, JAM-A levels remained high in all treatment groups (Figure 5.9). Hormone 
suppression and short-term replacement had no effect on ZO-1 mRNA expression compared to the 
controls (Figure 5.9). Androgen regulated INSL-3 mRNA expression was suppressed 12 fold 
following hormone suppression (Figure 5.9). Short-term hormone replacement with hrFSH had no 
effect on suppressed levels of INSL-3 whereas stimulation of androgen production with either hCG or 
hCG + FSH Ab resulted in a recovery of INSL-3 back to control levels (Figure 5.9). β-actin mRNA 
expression remained unchanged following hormone suppression and replacement compared to control 
(Figure 5.9).  
 
5.4 Discussion 
 The hormones LH/T and FSH were suppressed in the studies presented in this Chapter by the 
use of a GnRH antagonist-treated rat model, and then selectively replaced in the short-term, with the 
aim of studying potential changes in the function and structure of the Sertoli cell TJ. The antagonist 
acyline had no major effects on the animals’ health as shown by a lack of change in body weights 
compared to controls. Acyline has previously been used in rat and human studies (Herbst et al. 2004, 
Hild et al. 2004, Porter et al. 2006), and has been shown to have no propensity to stimulate histamine 
release, which is a problem associated with other GnRH antagonists (Herbst, 2003). After 8 weeks of 
treatment, testis weights had decreased by 81% of control weights. The addition of the FSH Ab to 
suppress any remaining FSH (Meachem et al. 1998) had no further significant effect on testis weights 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9 Effect of hormone suppression and replacement on TJ mRNA expression. 
Real-time RT-PCR quantitation was conducted for the TJ proteins claudin-11 (panel 
A), occludin (panel B) and JAM-A (panel C) as well as the cytoplasmic plaque protein, ZO-1 
(panel D). As a positive control for hormone suppression and replacement, RT-PCR analysis 
was also conducted on the androgen regulated gene INSL-3 (panel E), which is plotted on a 
log-scale. All data has been presented as a ratio with the housekeeper GAPDH. To check for 
any changes in GAPDH mRNA across the various treatment groups, an additional ratio was 
made between GAPDH and a second housekeeper, β-actin (panel F). Data is mean ± SD, n = 
5/group. Differences between letters is p < 0.001. 
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which were at 17% of controls after a further week of treatment. The level of suppression achieved in 
this Chapter was marginally better or similar to other data which used a GnRH immunogen to suppress 
hormones, with testis weights being reduced by 71%-81% (Mclachlan et al. 1994b, Meachem et al. 
1998, Pratis et al. 2003). Most studies analysing the effect of acyline on rat testis weights in the 
literature have not looked at normal healthy rats (Hild et al. 2004, Porter et al. 2006). However recent 
studies using short-term administration of acyline in normal rats, have shown decreases in testis 
weights to 47% of control after 14 days in Sprague Dawley rats (Vera et al. 2006), and 33% of control 
after 10 days of treatment in another rat species (Pareek et al. 2007). The TE suppression model, 
which suppresses testosterone but not FSH, generally reduced testis weights by 67%-68% in other 
studies (O’Donnell et al. 1999, Pratis et al. 2003).  
 Serum hormone levels were significantly suppressed following treatment with acyline, with an 
84% reduction in LH, an 87% reduction in androgens and an 88% reduction in FSH. The addition of 
the FSH Ab caused a further significant reduction in serum LH but had no effect on the level of serum 
androgens. Due to antibody interference with the FSH assay, serum FSH was not analysed in response 
to this treatment. However, other data obtained in this study from testis weights and stereology 
demonstrated that the FSH Ab had suppressed residual FSH successfully. The suppression of LH in 
response to the FSH Ab treatment compared to acyline alone, while unexpected, was reported in 
another GnRH immunogen study which combined the FSH Ab with hCG (Pratis et al. 2003). On its 
own, the immunogen suppressed LH to a similar extent to acyline (Pratis et al. 2003). In the hCG + 
FSH Ab treatment in the Pratis et al. (2003) study, the LH concentration was lower than the 
immunogen alone treatment but did not achieve significance. In this study, the FSH Ab alone or in 
conjunction with hCG stimulated decreases in LH which were significantly lower than the acyline-
induced concentration. The cause of such a decrease in response to the FSH Ab is not readily available 
in the literature and so the reasons remain uncertain, although it may be possible that there is some 
cross-talk between the FSH and LH signalling systems.  
 Acyline suppression of serum LH (84%) and serum androgens (87%) was similar to studies 
which used the GnRH immunogen where an 88% decrease in serum LH (Pratis et al. 2003) and 92% 
decrease in serum testosterone (Meachem et al. 1998) were obtained. These decreases were in line 
with other antagonist studies using acyline, as well as other antagonists (Jiang et al. 2001, Broqua et 
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al. 2002, Herbst, 2003, Hild et al. 2004, Matthiesson et al. 2005b, Porter et al. 2006, Vera et al. 2006, 
Pareek et al. 2007). Where the antagonist differed from the immunogen was in the suppression of 
FSH. While FSH was suppressed to just 12% of controls with acyline, FSH was still at 34%-54% of 
controls in the immunogen studies (Meachem et al. 1998, Pratis et al. 2003), which demonstrates that 
GnRH antagonism is more effective at suppressing hormones, and therefore spermatogenesis, 
compared to GnRH immunisation,  which is expected to account for the smaller testes observed in this 
Chapter as well.  
Most studies in recent years using acyline and other GnRH antagonists in rats have not looked 
at the effects of antagonism on serum FSH (Jiang et al. 2001, Broqua et al. 2002, Herbst, 2003, Hild et 
al. 2004, Matthiesson et al. 2005b, Porter et al. 2006). An exception to this is one recent study in rats 
which showed that 48 hours of acyline treatment reduced serum FSH to ~20% of controls (Pareek et 
al. 2007), which was marginally higher than the suppression obtained herein. In studies conducted in 
the 1980s and 1990s which used the GnRH antagonist Nal-Glu in rats, serum FSH was seen to 
significantly decrease below the assay sensitivities, although these were less sensitive than the assay 
used in this Chapter (Rea et al. 1986, Bhasin et al. 1987, Arslan et al. 1989, Rodin et al. 1989, 
Dubourdieu et al. 1993). In more recent human studies, acyline was seen to have a dose dependent 
effect on serum FSH suppression, with a maximal dose of 300μg/kg suppressing FSH to 10% of 
control values (Herbst, 2003, Herbst et al. 2004). This compares well with the suppression of FSH to 
12% of control values achieved with rats in this study. 
Short-term hormone replacement had some differential effects on the serum hormones studied. 
When hrFSH was replaced for 7 days, no effect on suppressed levels of LH or androgens was 
obtained. In GnRH immunised models, hrFSH replacement also had no effect on suppressed LH or 
androgen (Meachem et al. 1998, Pratis et al. 2003). hrFSH administration in this study however saw a 
further significant reduction in endogenous production of FSH. This was possibly a result of the 
hrFSH suppressing the residual endogenous FSH via a negative feedback system, which may have 
been produced via the GnRH-independent pathway (Rea et al. 1986, Bhasin et al. 1987). Increases in 
testis weights and germ cell numbers (described later) seen in response to hrFSH treatment in this 
Chapter were therefore most likely due to the exogenously applied hormone alone. The Meachem et 
al. (1998) and Pratis et al. (2003) studies did not look at the effects of hrFSH on suppressed FSH 
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levels due to concerns of interference with the rat FSH assay, but further investigations (Jimenez et al. 
2005) showed that the hrFSH as used in this Chapter had a low 1.3% cross reactivity with the rat FSH 
assay (Jimenez et al. 2005), and hence was no cause for concern on data obtained herein.   
The stimulation of testicular testosterone alone using hCG required the addition of the FSH 
Ab to suppress endogenous rat FSH levels which rise under the influence of testosterone stimulation 
(Rea et al. 1986, Bhasin et al. 1987). The result for hCG + FSH Ab for LH was interesting, in that 
levels were again suppressed to the same extent as observed in animals treated with acyline plus FSH 
Ab. This appears to be a specific effect of the FSH antibody itself, as when FSH was suppressed with 
hrFSH, LH levels were not. Further investigations need to be conducted into the FSH antibody used in 
this study to determine if it has any LH content. Again, the FSH Ab used in this particular treatment 
meant serum FSH levels could not be determined, but the endogenous stimulation of testosterone with 
hCG did increase serum androgens (3-fold), as was expected based on previous studies using the same 
hormone dose  (Pratis et al. 2003). 
When hCG (which has a low 4% cross-reactivity with the rat LH assay used herein (Haavisto 
et al. 1993)) was used to stimulate both testosterone and FSH production, no effect was seen on 
suppressed LH levels, but serum androgens and endogenous rat FSH levels increased significantly as 
expected (Meachem et al. 1998, Pratis et al. 2003). Suppressed rat FSH levels recovered 2 fold to 25% 
of control levels in this study. In the GnRH immunised rat, hCG or androgen testosterone 
administration for the same period of time led to similar fold increases in FSH, although the final 
concentration was much higher than this study (Meachem et al. 1998, Pratis et al. 2003). This would 
have been due to the far greater suppression of FSH induced by acyline compared to the GnRH 
immunogen and so similar recoveries in FSH would have required longer hCG administration which 
was not possible (Meachem et al. 1998, Pratis et al. 2003). 
The effect of hormone suppression on germ cell numbers in this study was analysed by optical 
dissector stereology. This form of stereology is assumption free and unbiased, and is also good for 
quantifying non-spherical objects such as spermatogonia and spermatids (Wreford, 1995, Meachem et 
al. 1998).  
Acyline treatment significantly reduced the numbers of the early type A/intermediate 
spermatogonia to 66% of controls, but did not achieve a significant suppression of type B/preleptotene 
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spermatocyte numbers, despite a reduction to 76% of controls. The addition of the FSH Ab resulted in 
a further suppression of these germ cell types which was significantly greater than acyline alone, 
showing the requirement to fully suppress FSH to achieve better spermatogenic suppression.  
In a closely related study examining the effect of GnRH immunisation on testicular germ cell 
numbers, type A/intermediate spermatogonia and type B/preleptotene spermatocytes were all 
suppressed to approximately 50% of control levels (Meachem et al. 1998) which was a greater 
suppression than that obtained in this study. This was despite the similar reductions in testis weights 
and serum androgens between the two studies, and a greater suppression of serum FSH in this study. It 
has been suggested that the presence of FSH promotes cell survival (McLachlan et al. 1995, Shetty et 
al. 1996), and so with the lower amounts of serum FSH following acyline treatment compared to 
immunogen treatment (Meachem et al. 1998, Pratis et al. 2003), it was expected that the early germ 
cell types in this study would have been similar to, if not lower than the numbers obtained in the 
immunogen study. The failure of this to be the case demonstrates that the GnRH-antagonist treated rat 
model is different to the GnRH immunised rat model. Alternatively, the GnRH studies suppressed 
hormones for 12 weeks (Mclachlan et al. 1994b, McLachlan et al. 1995, Meachem et al. 1998, Pratis 
et al. 2003) as opposed to the 8 week suppression conducted herein. It is possible that full 
spermatogenic suppression was not achieved after 8 weeks of acyline treatment hence the higher 
numbers of these spermatogonia and preleptotene spermatocytes. Another possibility is that 
distinguishing type A/intermediate spermatogonia from Type B/preleptotene spermatogonia can be 
difficult due to the severely regressed tubules encountered in GnRH immunised or antagonist treated 
rats (Meachem et al. 1998), and errors could have been made in the count. Future studies could benefit 
from an additional endpoint as back-up for final germ cell number results. 
Short-term hormone replacement with hrFSH kept the type A/intermediate spermatogonia at 
the same levels as observed for the acyline + FSH Ab treatment group, which again was unexpected. 
The same phenotype was seen in the hCG + FSH Ab treatment group, and the hCG alone group. In the 
Meachem et al. (1998) GnRH immunisation study, exogenous FSH and/or testosterone stimulated a 
significant recovery in these germ cell types compared with the GnRH immunised group. It may be 
possible in this GnRH antagonist model that FSH initiated a survival mechanism in the early 
spermatogonia by promoting their conversion to type B spermatogonia. This mechanism is supported 
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by a recovery back to control numbers after short-term hrFSH replacement or stimulation of FSH 
production with hCG, but not with testosterone stimulation alone. This is a potential novel finding for 
a role for FSH in type A spermatogonial maturation. Interestingly, this appears to be similar to effects 
observed in a hormone-suppressed human model, where spermatogenesis was suppressed using T plus 
the progestin DMPA (Matthiesson et al. 2006). In that study, 6 weeks of hormone suppression led to a 
17% reduction in type A spermatogonia compared to controls. Even though the difference was not 
significant, short-term hormone replacement with FSH and hCG, kept type A spermatogonia at 
approximately 17% of control values as well (Matthiesson et al. 2006), meaning that type A 
spermatogonial numbers were not effected by either hormone treatment (Matthiesson et al. 2006). The 
type B spermatogonia were significantly suppressed in that study with T + DMPA, and hormone 
replacement led to recoveries back to control levels (Matthiesson et al. 2006). It appears therefore that 
the GnRH-antagonist treated rat model mimics responses observed in the human model for early 
spermatogonial maturation.  
Suppression of leptotene/zygotene spermatocytes, as well as pachytene spermatocytes and 
round spermatids, with acyline in this study was significant and comparable with the extent of 
suppression observed with the GnRH immunogen (Meachem et al. 1998). Each short-term hormone 
replacement regimen did not give significant recoveries in leptotene/zygotene spermatocyte numbers 
compared to the acyline-treated group (50% of control). Numbers also remained significantly lower 
than controls. These results appeared to reflect those obtained in the Meachem et al. (1998) study.  
The reduction in pachytene spermatocyte numbers to 15% (stages I-VIII) and 3% (stages IX-
XIV) of control as well as the later germ cell types with acyline occurred in tubules where a marked 
disruption in blood-testis barrier function was demonstrated. Interestingly, treatment with the FSH Ab 
resulted in further significant suppression in pachytene spermatocyte numbers at both stages I-VIII, 
and IX – XIV as well, reinforcing the need for FSH in pachytene spermatocyte maturation. 
Encouragingly, all short-term hormonal treatments appeared to stimulate significant recoveries in 
pachytene spermatocytes. hrFSH alone appeared to give significantly better recoveries of pachytene 
spermatocytes than the hCG treatments. The same significant recovery was seen for round spermatids 
which was probably a flow on effect of the increase in pachytene spermatocyte number (Meachem et 
al. 1998). The extent of flow-on in the spermatogenic wave is dictated by the number of days of short-
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term treatment (Meachem et al. 1998). The maturation of step 8 round spermatids into elongated 
spermatids takes 13 days (Meachem et al. 1998) and so no change in elongate numbers was expected 
after 7 days of short-term hormone replacement. The increase in round spermatids was again largely 
FSH driven, although the stimulation of testosterone alone also gave a significant recovery. Similar 
results were obtained in the Meachem et al. (1998) study. Interestingly, hrFSH stimulated significantly 
greater numbers of type B spermatogonia/preleptotene spermatocytes, early pachytene spermatocytes 
and round spermatids than the hCG-induced rat FSH suggesting that the former treatment had greater 
biological effect than the latter treatment. The data obtained has demonstrated the importance of FSH 
in spermatogenesis and while testosterone alone can maintain spermatogenesis albeit at a reduced 
capacity (Singh et al. 1995), it appears that FSH is an essential hormone in early to mid 
spermatogenesis. 
 Immunohistochemical analysis showed that the suppression of hormones with acyline 
treatment disrupted TJs both functionally and structurally. In control testes, the localisation of 
occludin, claudin-11 and JAM-A at the TJ and ZO-1 at the cytoplasmic plaque was extensive in the 
control animals. This was coincident with a functional barrier as shown by extensive biotin staining in 
the interstitium and permeation into the seminiferous tubules only as far as the occludin marked TJ. 
Acyline treatment for 8 weeks resulted in marked changes in occludin, claudin-11 and JAM-A 
localisation. Occludin became difficult to detect by confocal-immunofluorescence whereas claudin-11 
and JAM-A both localised to the Sertoli cell cytoplasm. Some JAM-A staining continued at the basal 
aspect of the Sertoli cells and this may have been spermatogonial as seen in the Djungarian hamster 
model (Tarulli et al. 2008). ZO-1 staining was also disrupted in this model and had become more 
adluminal with respect to the basement membrane of the tubules. The localisation of each of these 
proteins was similar to that seen in the gonadotrophin deplete testis of the short-day Djungarian 
hamster model (Tarulli et al. 2006, Tarulli et al. 2008) except for occludin, where staining continued 
and had re-localised to the Sertoli cell cytoplasm as per the other proteins (Tarulli et al. 2008). The 
disruption in TJ protein localisation in this study was associated with the disruption of TJ function as 
shown by extensive penetration of biotin throughout the seminiferous tubules to surround any 
remaining pachytene and round spermatid germ cells. These results were indicative of the observations 
made in the Sertoli cell specific androgen receptor knockout mouse model (Meng et al. 2005), the 
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prepubertal rat testis displayed in the previous Chapter (recall Figure 4.5) and the seasonally regressed 
testis of the Djungarian hamster (Tarulli et al. 2008). The TJ in the short-day hamster model had 
originally been shown to be non-functional with the use of tracers and electron microscopy 
(Bergmann, 1987). Interestingly, occludin and claudin-11 were present at the TJ in the Sertoli cell 
specific androgen receptor knockout mouse (Meng et al. 2005) and the change in TJ function was 
attributed to the loss of claudin-3 (Meng et al. 2005). As mentioned in the previous Chapter, claudin-3 
mRNA expression and localisation at the rat Sertoli cell TJ were undetectable in another study 
(Kaitu’u et al. 2007). These data point to some inter-species differences between Sertoli cell TJ 
components and their response to hormonal fluctuations (Meng et al. 2005, Tarulli et al. 2006).  
Short-term hormone replacement led to a partial re-localisation of occludin, claudin-11, JAM-
A and ZO-1 to their respective junctions, although this was not complete, presumably because a longer 
period of stimulation was needed. Following ten days of FSH treatment in gonadotrophin suppressed 
hamsters, claudin-11 had largely re-localised to the Sertoli cell TJ (Tarulli et al. 2006, Tarulli et al. 
2008). Furthermore, these hamster TJs had become functional again by their ability to exclude biotin 
tracer. In the acyline study presented here, biotin still largely permeated beyond the TJ and throughout 
the seminiferous tubules after 7 days of short-term hormone replacement. This suggested that despite 
some re-establishment of TJ structure, TJs were still non-functional. The effect of hormone 
administration on TJ structure and function had also been observed in an immature Sertoli cell culture 
model, where hormone treatment lead to claudin-11 and occludin localisation to the TJ as well as an 
increase in TJ function as measured by TER (Kaitu’u et al. 2007). Therefore, there are similarities 
between the localisation of TJ proteins and subsequent functional phenotypes in both normal and 
disrupted spermatogenesis in two different species. 
Marked decreases in tubule diameters and the disappearance of lumens was apparent in 
immunofluorescent micrographs following hormone suppression. This has been associated with 
disrupted TJ function in the past (Tarulli et al. 2006, Tarulli et al. 2008, Bergmann, 1987, Pelletier, 
1990). Short-term hormone replacement with each of the treatments also led to the re-establishment of 
tubule lumens which indicated the reformation of functional TJs (Bergmann, 1987, Tarulli et al. 2006, 
Tarulli et al. 2008). As mentioned above however, the majority of tubules were still readily permeable 
to biotin, and this was despite significant increases in the numbers of pachytene spermatocytes and 
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round spermatids indicating some spermatogenic restoration, which reportedly requires functional TJs 
(Bergmann, 1987, Chung and Cheng, 2001, Chung et al. 2001, ). However, this data suggests 
otherwise, and that the Sertoli cell TJ does not need to be fully functional for spermatogenesis to 
proceed. Rather it needs to be dynamic to allow spermatogenesis to proceed into the meiotic stages of 
germ cell development. This dynamic activity may be directly related to changes in the size-selective 
nature of the Sertoli cell TJ. The data presented for biotin suggests that spermatogenesis can proceed 
even when the TJ cannot selectively-exclude tracers of at least 600Da in size. Interestingly, a recent 
study showed that small molecular weight immunosuppressive molecules (496Da-522Da) are present 
in the testes (Foulds et al. 2008). While this paper looked at the role of these molecules in adult rats 
which exhibit normal spermatogenesis and TJs, one might hypothesise that these molecules effectively 
protect germ cells at the initiation of spermatogenesis in younger rats, when the TJ is not completely 
functional. Other examples of TJs not being fully functional to maintain epithelial integrity have 
already been documented in this thesis for biotin in the blood-brain barrier (Nitta et al. 2003), and 
51Cr-EDTA permeation across the blood-testis barrier in young rats just beginning the spermatogenic 
cycle (Setchell et al. 1981, Setchell et al. 1988).  
Occasionally complete occludin localisation to the TJs and complete biotin exclusion was seen 
after just one week of hormone replacement in this model. While the percentage of tubules displaying 
this ‘repaired’ phenotype was not determined, it appeared very small, and could therefore not account 
for the large recoveries of pachytene and round spermatid germ cells that were observed. The presence 
of these ‘repaired’ tubules could be explained as either a more rapid recovery of tubular function under 
hormonal stimulus, or by an incomplete suppression in all tubules by the acyline treatment. As no 
evidence for this latter point was observed, it is suggested that tubule recovery was heterogeneous. A 
quick restoration of TJ function has been reported in the past for wounded eye epithelia (Hutcheon et 
al. 2007), and suggests that a longer term hormone replacement experiment (7 to 21 days) should be 
conducted following suppression to see if TJ disruption is completely reversible. With the current 
experimental design, this would not be possible because of antibody response to heterologous protein 
hormones (McLachlan et al. 2002b). A recent study has administered recombinant rat FSH (rrFSH) in 
the long term to GnRH immunised rats, but this failed to rescue reduced testis weights or suppressed 
serum hormone (including FSH) levels (Ruwanpura et al. 2008). This was despite significant 
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recoveries for type A/intermediate spermatogonia, leptotene/zygotene and early pachytene 
spermatocytes (Ruwanpura et al. 2008). However, no assessment of blood-testis barrier function or TJ 
protein localisation was attempted in this particular study. 
 As mentioned in the literature review, one of the key roles of the blood-testis barrier is to 
ensure that adluminal germ cell antigens are sequestered from the immune system (see Chapter 1, 
Section 1.2.2). It was therefore expected in this model that the disruption in TJ function and 
subsequent significant losses of adluminal germ cells could in some part be attributed to an 
immunological response. Immunohistochemistry was therefore conducted for the macrophage-specific 
markers ED1 and ED2 (Gerdprasert et al. 2002). ED2 highlights the majority of the macrophages in 
the testis, whereas ED1 highlights the remaining circulating monocytes/macrophages which are ED2 
negative (Gerdprasert et al. 2002). In the control rat testes of this Chapter, very few macrophages, 
surrounded the seminiferous tubules, and none were observed on the adluminal side of the BTB. In the 
hormone-suppressed testes, there qualitatively appeared to be higher numbers of macrophages 
surrounding the tubules, although very few had actually entered them. Macrophage numbers appeared 
to decrease again following short-term hormone replacement. These results are similar to another 
study which used bacterial lipopolysaccharide (LPS) to induce an immune response in the adult rat 
testis (Gerdprasert et al. 2002). As a result, increased numbers of ED1+ macrophages were seen 
proliferating in the interstitium and lining up on the outside of the seminiferous tubules after LPS 
treatment, compared with control tissues. This information has been reprinted here in this Chapter 
(Figure 5.10), and compared with the response seen for acyline suppression.  
LPS reportedly lowers testosterone levels by blocking LH production and Leydig cell 
steroidogenesis (Gerdprasert et al. 2002). One of the key roles of the testicular Leydig cells is to 
regulate pro- and anti-inflammatory cytokines of the testis and recruit macrophages (Hedger et al. 
2005). Testosterone has been shown to regulate the levels of the anti-inflammatory cytokines, 
including macrophage migrating inhibitory factor, interferon-γ, transforming growth factor (TGF)-β 
and activin A (Hedger et al. 2005) in the rat testis. These cytokines are highly expressed in control and 
inflamed testes, which attenuates the propensity of the macrophages to stimulate the release of pro-
inflammatory cytokines including tissue necrosis factor (TNF)-α and interleukin-1 (IL-1)-α/β (Hedger, 
  
 
 
 
 
 
Figure 5.10 Macrophage localisation in control and disrupted testes. 
 Comparative immunohistochemical analysis of macrophage localisation in adult rat 
testes from Gerdprasert et al. (2002) (panels A and B), and the GnRH antagonist study 
presented herein (panels C and D). Inflammation was induced by bacterial lipopolysaccharide 
(LPS) treatment in the Gerprasert et al. (2002) study and macrophages (purple) were stained 
for ED1 and ED2. Comparisons were made between the normal control testis (panel A) and 
LPS treated testis (panel B). Macrophages from this GnRH antagonist study were also stained 
for ED1 and ED2 (green) and comparison drawn between the normal control testis (panel C) 
and the hormone suppressed testis (panel D). Bar = 10μm. 
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2002, Hedger et al. 2005, O’Bryan et al. 2005). This phenomenon is not observed in other tissues 
including the liver, which deems the testis an immunologically privileged site which helps protect the 
germ cells (Hedger et al. 2005). In low testosterone levels induced by LPS treatment, the testis mounts 
an overt pro-inflammatory response, which is reversed by the exogenous application of  testosterone 
(Gerdprasert et al. 2002, Hedger et al. 2005, O’Bryan et al. 2005). 
It is reasonable therefore considering the phenotypic similarities of macrophage localisation 
and suppressed/replaced testosterone in the LPS study, and the acyline study with its concomitant low 
levels of testosterone presented in this Chapter, that these low androgen concentrations could have 
caused a pro-inflammatory response with cytokines possibly including TNF-α and IL-1α/β, both of 
which are known to disrupt testicular TJ structure and function (Cheng and Mruk, 2004, Lui and Lee, 
2006, Sarkar et al. 2008). It is therefore hypothesised that the Sertoli cells and remaining germ cells 
may have been exposed to factors derived from the immune system in the acyline-treated rat testis, 
which in turn could have played a part in germ cell decline. For more conclusive results, it would be 
necessary to conduct quantitative analysis of macrophage numbers in the hormone 
suppressed/replaced testis, with additional mRNA/protein expression analysis of the main candidate 
pro- and anti-inflammatory cytokines. Furthermore, it would also be interesting to analyse the 
response of the small molecular weight (496Da-522Da) immunosuppressive molecules (Foulds et al. 
2008) mentioned above to hormone suppression and short-term replacement. 
 The disruption of the TJ structure as demonstrated by immunohistochemistry was also 
associated with a decrease in occludin and claudin-11 protein expression as shown by western blot 
analysis. Short-term hormone replacement did not appear to stimulate any recovery in either protein’s 
expression despite their apparent re-localisation to the TJ as shown by immunohistochemical analysis. 
This may have been a detection sensitivity issue of the Odyssey software used for analysis. 
Alternatively, the poor cross-reactivity of the primary antibodies with the SDS protein extracts could 
also have been a reason for the limit detectability. An increased protein load was attempted but to not 
avail. Therefore, no quantitative analysis was conducted on protein expression due to these difficulties, 
which were outlined in Chapter 3.  
In contrast to the protein responses, mRNA levels of occludin and claudin-11 both 
significantly increased in response to hormone suppression, and short-term hormone replacement led 
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to further significant changes back toward control levels. Such a result is difficult to explain, as it goes 
against the trend for function and localisation, but it may be that the Sertoli cells were trying to re-
establish the blood testis barrier by producing more protein through a rescue mechanism, but hormone 
suppression had put a block at the protein translation point and/or at protein localisation. Several 
studies have shown the existence of cytoplasmic pools of TJ proteins (Ando-Akatsuka et al. 1999, Lu 
et al. 2001, Bruewer et al. 2003, Ivanov et al. 2004, Bruewer et al. 2005, Meng et al. 2005, Morimoto 
et al. 2005, Tarulli et al. 2008). Claudin-11 and JAM-A were also seen in the cytoplasm of the acyline 
treated rats in this study. In a recent report, testosterone was shown to enhance the internalisation of TJ 
proteins occludin and JAM-A (Yan et al. 2008) and the recycling of these proteins back to the TJ as a 
possible mechanism of disassembling and then reassembling TJs as germ cells cross the blood testis 
barrier (Yan et al. 2008). Despite the resolution of the images presented herein not being sufficient 
enough to observe these proteins in defined cytoplasmic vesicles, the data is strong enough to allow 
the hypothesis that testosterone and FSH may be doing the same thing in this acyline-treated rat 
model. The mRNA data obtained herein was shown to hold true for two different housekeepers (β-
actin and GAPDH), as there were no significant differences in the ratio of these two transcripts across 
the various treatments, despite the very large changes in testicular weights, and germ cell types and 
numbers between the various treatment groups. No changes in Sertoli cell specific GATA-6 mRNA 
expression were also observed in the Djungarian hamster model despite large fluctuations in testis 
weights in response to hormone suppression/replacement in those animals (Tarulli et al. 2008). 
Furthermore, the mRNA expression of the known androgen-regulated protein INSL-3 significantly 
decreased 10 fold after hormone suppression, and recovered to control levels only in the androgen-
stimulated treatment groups, confirming that the real-time RT-PCR expression analysis method used 
in this model was not suffering from artefacts. 
 Differences between the protein and mRNA expression could be explained by the recycling of 
TJ proteins between the TJ and the cytoplasm, rather than decreases in their protein expression. 
Following hormone withdrawal as seen in this study, or the seasonally regressed Djungarian hamster 
testis (Tarulli et al. 2008) or the pro-inflammatory cytokine treated rat testis (Sarkar et al. 2008), 
cytoplasmic localisation of claudin-11 and/or occludin was observed. Upon restoration of TJ function, 
the protein appears to be recycled and re-localised to the new TJ, and may not involve the translation 
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of any new protein. This could be due to phosphorylation events occurring within the Sertoli cells, 
which has been shown to recruit certain TJ components to the TJ (Gonzalez-Mariscal et al. 1985, Sim 
and Scott, 1999, Matter and Balda, 2003, Gonzalez-Mariscal et al. 2008), indicating an interplay 
between phosphorylation and hormonal control of the TJ. 
Quantitative TJ functional analysis with [3H]methoxy-inulin in this Chapter showed no great 
change in TJ function in response to hormone suppression or replacement. While various significant 
differences were recorded across the treatments (recall Figure 5.5), this was most likely due to the high 
number of samples per group used, making minor differences between groups significant. Given that 
biotin readily permeated TJs after hormone suppression, this Chapter had already qualitatively shown 
that TJ function was disrupted and so it was expected that quantitatively there would have been a 
significant increase in [3H]methoxy-inulin accumulation within the seminiferous tubules. However, 
there were unexpected problems with the quantitative tracer technique. In the previous Chapter, blood-
testis barrier disruption with glycerol resulted in a limited 2 fold accumulation of [3H]methoxy-inulin 
compared with controls, whereas in this Chapter, only a 1.2 fold increase was observed, despite a 
similar testis weight reduction. Hence, the dynamic range of this test was not sufficient to quantitate 
permeability changes in the acyline study. It was suggested in the previous Chapter that this small 
increase in tracer accumulation could have been due to tracer size and crude protocol techniques, and 
so in a separate study conducted in this Chapter, the accumulation of [3H]methoxy-inulin in control, 
glycerol treated and pre-pubertal rat testes was compared to the accumulation of the much smaller 
tracer [14C]mannitol. The tracer administration method was also modified to allow comparisons 
between tubules incubated with the tracers (as done previously), or direct injection via an 
intratesticular injection as per the biotin technique.  
When seminiferous tubules from control, glycerol treated and pre-pubertal rats were incubated 
in the tracers, the accumulation of [14C]mannitol was significantly higher by 18% and 14% than that of 
[3H]methoxy-inulin in the control and glycerol testes respectively, but not in the juvenile testes, which 
were yet to form TJs as they were prepubertal (Russell and Peterson, 1985, Russell et al. 1989). The 
data suggested that the tubules were more permeable to the smaller tracer than the larger one, which 
would be expected. However, when testes from each rat group were injected with the tracers, tubules 
were equally permeable to [14C]mannitol as they were to [3H]methoxy-inulin for reasons unclear. Pre-
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pubertal testes always accumulated significantly more of either tracer on a dpm/g testis basis than the 
adult control and glycerol testes, which was expected due to the lack of TJs in these tissues (Russell 
and Peterson, 1985, Russell et al. 1989). However, it was of concern that no differences were seen 
between glycerol-treated or control rats for either tracer. This result was in contrast to the studies 
presented in this and the previous Chapters and was in despite of testis weights having decreased by 
comparable amounts. Given the discrepancy in tracer accumulation and the relatively small difference 
testing [14C]mannitol accumulation made, it appears that the experimental protocol itself needs further 
optimisation rather than the tracer size being the issue. A measure of tracer uptake efficiency should 
be included in future experiments using this protocol. Compounding this point was a recently 
published paper, which showed increased inulin-fluorescein labelled isothiocyanate accumulation in 
seminiferous tubules after treatment with IL-1α to disrupt TJ function (Sarkar et al. 2008). While that 
study was qualitative in nature, it demonstrated that a molecule the size of inulin could cross a 
disrupted TJ barrier. A second potential improvement would be to administer the tracer via the jugular 
vein, which is a popular route of tracer administration in other studies (Setchell et al. 1981, Setchell et 
al. 1988) including the Sarkar et al. (2008) report. In summary, the failure to achieve a quantitative 
difference in TJ function in response to hormone suppression was not due to i) a fully functional TJ in 
the absence of hormones as shown by biotin permeation or ii) inappropriate molecular weight of the 
[3H]methoxy-inulin tracer used, but due to experimental techniques which need further optimisation.  
 In conclusion, the data reported in this Chapter demonstrates that the rat Sertoli cell TJ is 
regulated by hormones in vivo. Hormone suppression resulted in a decrease in TJ function as shown 
by an increased permeability to biotin, which was coincident with a change in TJ protein localisation 
and expression and loss of tubule lumens, as well as a loss of adluminal germ cells and a qualitative 
increase in macrophage number surrounding the seminiferous tubules. Short-term hormone 
replacement with FSH and/or hCG partially reversed the suppressive effects of acyline. This was 
demonstrated by the renewed proliferation of adluminal germ cell types, some relocalisation of TJ 
proteins to the TJ, reappearance of tubule lumens and some biotin exclusion from the seminiferous 
tubules, which were all indicative of a partial restoration of TJ function. Finally, this Chapter has 
demonstrated the essential roles that both FSH and testosterone have in regulating the TJ both 
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functionally and structurally in vivo, in terms of protein expression and localisation as well as mRNA 
expression, and how essential the TJ is to successful spermatogenesis. 
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Chapter 6. Hormonal regulation of the Sertoli cell tight junction in the hypogonadal (hpg) 
mouse, in vivo. 
 
6.1 Introduction 
The previous Chapter used a GnRH-antagonist treated rat model to determine the effects of 
gonadotrophin suppression and short term gonadotrophin replacement on TJ function and structure. 
Upon gonadotrophin suppression, TJ structure was disrupted as shown by changes in protein 
expression and localisation to the TJ, as well as changes in mRNA expression. Furthermore, the 
function of the TJ was disrupted following gonadotrophin suppression, as shown by a marked 
permeation of the tubule by the qualitative TJ functional tracer, biotin. Short-term gonadotrophin 
replacement partially restored TJ structure and function in some cases. These results demonstrated a 
role for gonadotrophins in the maintenance of Sertoli cell TJ structure and function in the adult rat. 
However, the extent to which gonadotrophins are required for the initiation of TJ structure and 
function remains to be determined. Several lines of evidence associate increases in gonadotrophins 
with the first appearance of TJ proteins at the basal aspect of Sertoli cells in vivo, as reviewed in 
Chapter 1.6.1 and 1.6.2d. Sertoli cell TJs do not form until puberty which is associated with an 
increase in circulating gonadotrophins (Russell and Peterson, 1985). Furthermore, in the absence of 
circulating gonadotrophins, TJ formation is delayed or prevented (Nitta et al. 2003). Men displaying 
low levels of circulating gonadotrophins also displayed an immature TJ phenotype, which was 
reverted to a mature phenotype upon the exogenous application of gonadotrophins (de Kretser and 
Burger, 1972). In order to study the role of FSH and LH/T in the initiation of TJ structure and 
function, it was decided to employ the hpg mouse model which lacks spermatogenesis due to an 
absence of GnRH action at the pituitary level.   
The hpg mouse is deficient in circulating gonadotrophins due to a large mutation in the GnRH 
gene resulting in the deletion of two of the four GnRH exons (Mason et al. 1986a, Handelsman et al. 
1999), and offers a unique naturally occurring animal model of spermatogenic inactivity. 
Spermatogonia and primary spermatocytes are arrested at 11% and 2% of wildtype respectively (Singh 
et al. 1995, Ebling et al. 2000, Myers et al. 2005). The production of human FSH in hpg mice via the 
insertion of a transgene (hpg + tgFSH) resulted in the stimulation of spermatogenic activity through to 
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the production of round spermatids and a few elongated spermatids, but no further (Allan et al. 2001, 
Allan et al. 2004). Androgen (DHT or testosterone) application to hpg mice via Silastic implants 
induced qualitatively normal spermatogenesis with fertile sperm (Singh et al. 1995, Handelsman et al. 
1999). These studies demonstrated that inactive spermatogenesis could be stimulated via the 
application of gonadotrophins. While TJ strands have been observed by electron microscopy in the 
hpg mouse model (Charlton et al. 1983, Myers et al. 2005), they appeared disorganised in comparison 
with control tissues, and were presumably dysfunctional, due to the absence of spermatogenesis and 
the markedly reduced testis weights compared to wildtype mice (Charlton et al. 1983, Myers et al. 
2005). It is hypothesised in this thesis that the administration of gonadotrophins to hpg mice will result 
in the formation of functionally and structurally competent Sertoli cell TJs containing claudin-11 and 
claudin-3. While the claudin-11 knockout mouse is infertile (Gow et al. 1999), the Sertoli cell 
androgen receptor knockout prevents the localisation of claudin-3 to TJs in mice during germ cell 
migration (Meng et al. 2005). However, a claudin-3 knockout is still required for elucidating its role at 
the TJ and during spermatogenesis. It is thereforefurther hypothesised that the initiation of TJ 
formation in this model will lead to the recruitment of claudin-3 to the blood-testis barrier (Meng et al. 
2005).  
The aims of studies presented in this Chapter are to i) study the development of the TJ  in 
wildtype, hpg, and hpg mice which are transgenic for FSH (tgFSH), at both puberty (20 days of age) 
and into adulthood, and ii) determine the effect of administration of the pure androgen 
dihydrotestosterone (DHT) on the establishment of TJ function and the recruitment of claudin-3 into 
the TJ in hpg,  and hpg + tgFSH mice in the short-term (2 days) and longer-term (10 days). A Silastic 
implant of 1.0cm in length was chosen as the DHT dose based on published data which showed that 
this dose gave maximal stimulation of serum DHT and round spermatid numbers (Singh et al. 1995). 
In the photoregulated Djungarian hamster model, changes in TJ structure was observed within 2 days 
with FSH treatment (Tarulli et al. 2006, Tarulli et al. 2008), and therefore it was hypothesised that any 
changes in TJ structure and/or function in the mouse could also occur within 2 days, hence this short-
term time point.  
For both of the above aims, endpoints will include immunohistochemical localisation and real-
time RT-PCR quantification of the TJ proteins claudin-11, occludin and claudin-3. TJ function 
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analysis will use the biotin tracer technique as employed in the GnRH-antagonist treated rat 
experiment in Chapter 5.  
Experiments in this Chapter were conducted in collaboration with Dr Charles Allan, who 
provided access to the hpg colony at the Anzac Research Institute, Concord Hospital, Concord, 
Sydney, NSW, Australia. 
 
6.2 Materials and Methods 
 
6.2.1 Animals 
All experimental mouse work except for biotin administration was conducted by Dr Charles 
Allan at the Anzac Research Institute in Concord, NSW, Australia and was approved by the University 
of Sydney and Central Area Health Services Animal ethics committee. In brief, operative procedures 
were conducted under 0.5% ketamine (Parke-Davis, Caringbah, NSW, Australia) and xylazine (Bayer 
Australia Ltd, Botany, NSW, Australia) anaesthesia which was administered by an intraperitoneal (ip) 
injection (0.01ml/g body weight) (Handelsman et al. 1999). At the end of experimentation, mice were 
killed by anaesthetic overdose (Handelsman et al. 1999). 
 
6.2.2 Experimental design 
Part 1 of this Chapter used testis sections from pubertal (20 days old) and adult mice which 
were either wildtype, hpg or hpg + tgFSH. These sections were provided by Dr Charles Allan from 
archived sources and required no experimental work to be conducted on animals. 
Part 2 of this study required some animal work prior to experimentation. The pure androgen 
DHT (Merck, Darmstadt, Germany), was administered to adult hpg and hpg + tgFSH mice via a 
SILASTIC implant (1.0cm, Dow Corning, Midland, MA, USA) for 2 days or 10 days (n = 3/group). 
These mice, along with controls (consisting of wildtype and hpg and hpg + tgFSH minus the DHT 
implant (n = 3/group)) were killed on the same day. Testes were then excised, trimmed of all fat and 
connective tissue and then weighed. Biotin was then administered (see below) to the left testis of each 
animal, which were then incubated for 30 minutes at room temperature before being fixed for 4 hours 
in Bouin’s fixative. One of the control testes was administered PBS/CaCl2 as the biotin negative 
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control. The right testis from each mouse was immediately snap frozen in liquid nitrogen for RT-PCR 
analysis. All testes were then transferred to Prince Henry’s Institute of Medical Research in 
Melbourne for further analysis. 
As most of the testes were too small for an intratesticular injection of 10% testis weight, a new 
method for administration had been previously optimised at Prince Henry’s Institute of Medical 
Research in Melbourne using control adult mouse testes. These testes were administered biotin 
(10mg/ml) either by i) intratesticular injection (as a positive control), ii) slit on the tunica and then 
incubated whole in the biotin-containing solution, or iii) placed straight into the biotin containing 
solution after extraction without slitting the tunica. Testes were processed for immunohistochemistry 
and probed for biotin as outlined in section 2.2 and 5.2.4. Results of this pilot study are presented in 
the results section of this Chapter. After the Bouin’s fixation procedure, all testes were stored in 70% 
ethanol. 
 
6.2.3 Immunohistochemistry 
Fixed testes from Part 2 of this study were processed on the histokinette for 
immunohistochemical analysis as outlined in section 2.2. All sections, including those from Part 1 of 
this study were processed for TJ protein localisation by confocal fluorescent microscopy as outlined in 
Section 2.2. Biotin was probed in Part 2 testes as outlined in Section 4.2.2. For all antibody incubation 
details see Table 6.1. 
 
6.2.4 Real-time RT-PCR analysis 
RT-PCR analysis was conducted on the Part 2 testes. As most of the testis weights were 
around 20mg or less, total RNA was extracted from whole testes except for wildtype. The protocol 
followed was identical to that outlined in section 2.3. According to the RNeasy kit manufacturer 
(Qiagen), testis samples weighing less than 20mg required 350μl of RLT buffer rather than the 
standard amount of 600μl to extract RNA.   
Primers were optimised and sequenced according to section 2.3. Details of the primers used in 
this study are shown in Table 6.2. 
  
 
 
 
 
 
 
Table 6.1 Antibodies used for immunohistochemical analysis. 
Tabulated data for the antibodies used in Chapter 6 of this thesis include details regarding the 
primary and secondary antibody hosts, working concentrations (conc.)/dilutions, incubation (Inc.) 
times and company details with catalogue numbers. 
Protein Primary 
(1O) 
antibody 
host 
Company  
(cat #) 
Conc. 
(μg/ml) 
Negative 
control 
1o Inc. 
time 
Secondary 2o 
antibody 
Company 2o 
Dilution 
2o 
Inc. 
time 
(mins) 
Claudin-11 Rabbit Zymed           
(36-4500) 
1.25 Normal 
rabbit 
IgG 
Overnight Goat α rabbit 
Alexa-488 or 
Alexa-546 
Molecular 
Probes 
1:400 of 
stock 
30 
Claudin-3 Rabbit Zymed           
(34-1700) 
1.25 Normal 
rabbit 
IgG 
Overnight Goat α rabbit 
Alexa-488 or 
Alexa-546 
Molecular 
Probes 
1:400 of 
stock 
30 
ZO-1 Rabbit Zymed           
(61-7300) 
1.25 Normal 
rabbit 
IgG 
Overnight Goat α rabbit 
Alexa-488 or 
Alexa-546 
Molecular 
Probes 
1:400 of 
stock 
30 
β-catenin Mouse BD Transduction 
Laboratories       
(610154) 
1.25 Normal 
mouse 
IgG 
Overnight Goat α mouse 
Alexa-546 
Molecular 
Probes 
1:400 of 
stock 
30 
Connexin-43 Mouse Sigma ascites 
fluid (C8093) 
1:400 of 
stock 
Normal 
mouse 
IgG 
Overnight Goat α mouse 
Alexa-546 
Molecular 
Probes 
1:400 of 
stock 
30 
Vinculin Mouse Sigma ascites 
fluid (V4505) 
1:400 of 
stock 
Normal 
mouse 
IgG 
Overnight Goat α mouse 
Alexa-546 
Molecular 
Probes 
1:400 of 
stock 
30 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Table 6.2 Primer sequences and real-time RT-PCR conditions for the analysis of mRNA 
expression in the hpg, and hpg + tgFSH mice treated with DHT. 
Primers were designed against the TJ proteins claudin-11, occludin and claudin-3, as well as 
androgen-regulated INSL-3 and the housekeeper protein β-actin, to check for changes in their mRNA 
expression following DHT treatment for 2 and 10 days. Data included in the table are forward and 
reverse primer sequences, Mg2+ concentration, and annealing and acquisition temperatures. 
Protein Species/  
Accession 
number 
Primer sequences (5’- 3’) Product 
size (bp) 
[Mg2+]   
(mM) 
Anneal 
temp.   
(oC) 
Acquisition 
temp. (oC) 
Claudin-11 
(Primer3) 
Mouse         
NM_008770 
Forward: CTACGTGCAGGCTTGTAGAGC 
Reverse: GGCACATACAGGAAACCAGATG 
208 2.5 64 72 
Occludin 
(Primer3) 
Mouse         
NM_008756 
Forward: TTTTTGCTGTGAAAACCCGAAG 
Reverse: CTGTCAACTCTTTCCGCATAGT 
178 2.5 64 72 
Claudin-3 
(Primer3) 
Mouse        
NM_009902 
Forward: AACTGCGTACAAGACGAGACG 
Reverse: GGCACCAACGGGTTATAGAAAT 
143 2.5 64 72 
β-actin 
(Primer3) 
Rat 
NM_031144 
Forward: CCGTAAAGACCTCTATGCCAACA 
Reverse: GCTAGGAGCCAGGGCAGTAATC 
103 2.0 67 72 
INSL-3 
(Primer3) 
Mouse         
NM_013564 
Forward: CAGTGCCGCCACCAACGCT 
Reverse: AGGTCATGATGGGGCTTCTTGG 
240 2.0 64 72 
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6.2.5 Statistical analysis 
Statistical analysis was conducted as outlined in section 2.6. Data presented herein is either 
mean ± SD or SEM, n = 3 mice/group. 
 
6.3 Results 
 
6.3.1 Developmental localisation of claudin-11 and claudin-3 to the tight junction and ZO-1 to the 
cytoplasmic plaque in pubertal and adult mice 
The developmental changes in localisation of various junction proteins was first investigated 
in pubertal and adult mice from the hpg, and hpg + tgFSH models, to give an indication of other 
junctional types which may have been altered by the absence of gonadotrophins in the hpg model, and 
how these changed in the hpg + tgFSH mice. Claudin-11, claudin-3 and ZO-1 were co-localised with 
the adherens junction marker β-catenin, the gap junction marker connexin-43 and the ectoplasmic 
specialisation protein vinculin respectively. 
The intention of this Chapter was to also localise occludin in these mice by 
immunohistochemistry, however staining was undetectable using two different antibodies (Rabbit 
anti-occludin (Zymed, cat # 71-1500) and Mouse anti-occludin (Zymed, cat # 33-1500) (Figure 6.1) 
when using EDTA-NaOH antigen retrieval as outlined in Section 2.2a. A second type of antigen 
retrieval (0.01M citrate buffer (Na-citrate, citric acid, pH 6.0 (Pileri et al. 1997)) was attempted. The 
immunohistochemistry protocol was as per that outlined in Section 2.2 except with the different 
antigen retrieval buffer. Occludin staining with the Mouse anti occludin primary antibody generally 
gave no staining for occludin, although occasional positive staining at the outer edges of the section 
was detected (Figure 6.1c). Due to the inability to reproduce consistent occludin immunostaining, it 
was decided to omit this endpoint from this study. This was simply an antibody issue and not due to 
occludin being absent at the mouse Sertoli cell TJ as it was occasionally seen herein as mentioned 
above and has been successfully stained in mouse testes in another study (Meng et al. 2005). 
 
 
  
 
 
 
 
 
 
 
Figure 6.1 Occludin staining in control wildtype mouse testes. 
Detection of occludin (green, arrow) was attempted in Bouin’s fixed, paraffin embedded adult 
control mouse testis sections with rabbit anti occludin (Zymed, panel A) and mouse anti occludin 
(Zymed, panel B) primary antibodies in sections treated with EDTA-NaOH for antigen retrieval. A 
follow up experiment also using the mouse anti occludin primary antibody was subjected to citrate-
buffer antigen retrieval (panel C). Bar = 50μm. 
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a. Wildtype  
Wildtype (wt) pubertal mice, which were all 20 days of age and beginning to form round 
spermatids indicating active spermatogenesis (Sasagawa et al. 1998, McCarrey et al. 1999, Marh et al. 
2003, Xu et al. 2004), displayed extensive claudin-11 staining which was just adluminal to the 
spermatogonia (Figure 6.2). β-catenin staining was extensive at the inter-Sertoli cell adherens junction 
and surrounded spermatogonia, but did not co-localise with claudin-11. Adherens junction staining 
was also positive around the adluminal germ cells including the pachytene spermatocytes and round 
spermatids. No claudin-3 was detectable in the wt pubertal mice, whereas connexin-43 was extensive 
toward the outer edge of the tubules at inter-Sertoli cell gap junctions (Figure 6.2). ZO-1 in the wt 
pubertal mouse was extensive at the cytoplasmic plaque toward the outer edge of the tubules, and 
vinculin staining was extensive throughout the tubules from the basement membrane toward the tubule 
lumens (Figure 6.2). 
In wt adult mice all proteins were localised extensively at their respective junctions (Figure 
6.2), and this included the appearance of positive staining for claudin-3. All protein ‘pairs’ co-
localised with each other, giving a yellow appearance toward the basement membranes of the tubules, 
consistent with localisation at inter-Sertoli cell junctions. Of note was that pubertal tissues appeared to 
display higher levels of background staining than adult tissues, which gave clearer 
immunohistochemical results. This phenomenon was also apparent in the hpg and hpg + tgFSH tissue. 
 
b. hpg 
In hpg pubertal mice, claudin-11 staining was in cytoplasmic pools and disorganised at the 
centre of the seminiferous tubules (Figure 6.2). In contrast, β-catenin was predominantly localised 
toward the outer edge of the tubules as per the wt mice (Figure 6.2). Claudin-3 was undetectable in 
pubertal hpg testes, and connexin-43 localisation was generally cytoplasmic as per claudin-11, 
extending toward the outer edge of the tubules. ZO-1 was localised to the cytoplasmic plaque at the 
outer edge of the tubule, with some cytoplasmic staining evident also. Vinculin staining was 
predominantly cytoplasmic. 
In the adult hpg mice, claudin-11 staining was still cytoplasmic and unlike the wt, did not co-
localise with β-catenin, which was still at inter-Sertoli cell adherens junctions at the outer edge of the 
  
 
 
 
 
 
 
Figure 6.2 Protein localisation in pubertal (20 day old) and adult hpg and hpg + tgFSH mice. 
Bouin’s fixed, paraffin embedded testis sections were obtained from pubertal and adult 
wildtype, hpg and hpg + tgFSH mice. Sections were processed by immunohistochemistry and stained 
for TJ proteins claudin-11 (page A) and claudin-3 (page B), as well as the cytoplasmic plaque protein 
ZO-1 (page C) (all green). These proteins were co-stained with β-catenin (adherens junction), 
connexin-43 (gap junction) and vinculin (ectoplasmic specialization) (all red) respectively. Bar = 
50μm. Inset = negative control. 
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tubules (Figure 6.2). Claudin-3 staining was absent in the adult hpg, but connexin-43 stained well at 
the gap junction toward the basement membrane of the tubules, and was not localised to the cytoplasm 
unlike the pubertal hpg mice, thus resembling the wt adult mice (Figure 6.2). ZO-1 localisation was 
similar to wt mice, with staining at the cytoplasmic plaque at the basement membrane, whereas 
vinculin staining was cytoplasmic and resembled staining in the pubertal wt mice (Figure 6.2). 
 
c. hpg + tgFSH 
In pubertal hpg + tgFSH mice, claudin-11 appeared to be re-distributing from the cytoplasm 
toward the TJ and appeared slightly more organised than the pubertal hpg testes, but much less so than 
the pubertal wt mice (Figure 6.2). β-catenin staining was similar to the hpg and wt tissue, and was 
localised at the adherens junction toward the basal aspect of tubules. Claudin-3 staining was also 
absent, but connexin-43 had begun localising toward the gap junction. Staining was less cytoplasmic 
compared to hpg staining but more so than in pubertal wt mice. ZO-1 staining was at the cytoplasmic 
plaque toward the basal aspect of tubules, and was similar to staining in the hpg and wt tissue. 
Vinculin was still cytoplasmic and very similar to the pubertal hpg and wt testes. 
Claudin-11 in the adult mice formed TJs which appeared continuous but irregular compared to 
the wt in that they were more cytoplasmic. This staining resembled the pubertal wt mice. β-catenin was 
extensive at the adherens junction and basal to claudin-11, as per the wt pubertal mice (Figure 6.2). 
Claudin-3 was generally absent in this mouse model, but connexin-43 was present at the gap junction 
and resembled the wt and hpg phenotypes. ZO-1 staining was again very similar to its staining in the 
wt and hpg testes. Vinculin localisation appeared less concentrated in the cytoplasm compared to hpg 
mice and seemed to be re-localising toward the ectoplasmic specialisation at the basement membrane 
(Figure 6.2). 
 
6.3.2 Administration optimisation of biotin to the hpg mouse testis 
Testes from adult wt mice were administered biotin by i) intratesticular injection, ii) slit tunica 
and then incubated in a 10mg/ml biotin solution or iii) intact testis incubation in a 10mg/ml biotin 
solution (Figure 6.3). In each case, biotin successfully entered the testes and was seen extensively 
staining the interstitium of each testis, and only entering the tubules as far as the basal germ cells. It 
  
 
 
 
 
 
 
Figure 6.3 Optimization of biotin administration into mice testes. 
Testes from adult wildtype mice were excised from freshly killed animals and trimmed of all 
fat and connective tissue. Testes were then either injected with the biotin (10mg/ml) tracer at 10% 
weight (panel A), or incubated in the tracer with a slit tunica (panel B), or intact tunica (panel C). 
Testes were processed by immunohistochemistry and probed for biotin (green) with streptavidin alexa-
488. Bar = 50μm. Inset = negative control. 
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was noted that background staining was present in the incubated testes but absent in the biotin injected 
testes (Figure 6.3). As a result of these images, it was decided for Part 2 of this study to administer 
biotin by slitting the tunica and incubating the whole testes in a 10mg/ml biotin solution. 
 
6.3.3 Testis weights of adult wt mice and hpg and hpg + tgFSH mice after ± DHT treatment 
Untreated hpg testis weights were at 2.5% (p < 0.001) of wt testis weights, while the untreated 
hpg + tgFSH testis weights were at 17.0% of wt testis weights (p < 0.001) (Figure 6.4). The difference 
is testis weights between the untreated hpg and untreated hpg + tgFSH mice was also significant (p < 
0.01).  
No change in testis weights was observed in hpg mice until 10 days of DHT treatment, when 
the testes had increased to 7.8% of wt (p = 0.016 compared to hpg control) and were no longer 
significantly different to the untreated hpg + tgFSH testes (Figure 6.4). 
DHT treatment to the hpg + tgFSH testes resulted in no significant change in testis weights 
after either time point compared to the untreated control (Figure 6.4). 
 
6.3.4 Development of TJ functionality and protein localisation in hpg and hpg + tgFSH mice treated 
with DHT 
 
a. Wildtype 
Biotin tracer staining was extensive in the interstitium of wt testes, and only entered the 
seminiferous tubules as far as the TJ, which stained extensively for claudin-11 and claudin-3 (Figure 
6.5). 
 
b. hpg  
In hpg testes, biotin staining was extensive in the interstitium and permeated throughout the 
seminiferous tubules, where it co-localised with claudin-11 which was cytoplasmic and in the centre 
of the tubules (Figure 6.5). Claudin-3 staining was essentially undetectable in the seminiferous 
epithelium. The presence of staining in the interstitium was also detected in the negative control as 
shown with the wt picture (Figure 6.5). 
  
 
 
 
 
 
 
Figure 6.4 Mouse testis weights following androgen DHT treatment. 
Testes from wildtype, hpg, and hpg + tgFSH mice treated with DHT for 2 and 10 days were 
dissected from the mice and trimmed of all fat, epididymides and connective tissue immediately after 
death and weighed prior to further treatment. Data is mean ± SD, n = 3/group. a v b/c, p < 0.001, b v c, 
p < 0.01. Note the log-scale on the y-axis. 
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Figure 6.5 TJ functional and structural analysis following DHT treatment to hpg, and hpg + 
tgFSH mice. 
hpg and hpg + tgFSH mice were treated with DHT for 2 and 10 days before being killed by 
anaesthetic overdose. Testes were excised, trimmed of all connective tissue and fat, and then weighed. 
Tunicas were then slit with a scalpel and testes incubated in biotin at 10mg/ml for half and hour, 
before being fixed in Bouin’s for 4 hours. Testes were then processed by immunohistochemistry for TJ 
functional analysis with biotin (green) and structural analysis using the TJ markers claudin-11 (page 
A) and claudin-3 (page B) (both red). Bar = 50μm. Inset = negative control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
              
Wildtype 
hpg 
hpg + 2d DHT 
hpg + 10d DHT 
hpg + tgFSH 
hpg + tgFSH + 2d DHT 
hpg + tgFSH + 10d DHT 
A 
 
B 
hpg + 10d DHT hpg + tgFSH + 10d DHT 
hpg + 2d DHT hpg + tgFSH + 2d DHT 
hpg hpg + tgFSH 
Wildtype 
 139
c. hpg + 2 days DHT 
Biotin staining was still extensive in the interstitium and centre of tubules of hpg animals 
treated with DHT for 2 days. Biotin staining no longer co-localised with claudin-11 which had re-
distributed basally (Figure 6.5). Claudin-3 staining was still not detectable. 
 
d. hpg + 10 days DHT 
Biotin staining was excluded from most of the tubules and remained in the interstitium of hpg 
animals treated with DHT for 10 days, which were extensively stained with claudin-11 and claudin-3 
at basal inter-Sertoli cell TJs (Figure 6.5). 
 
e. hpg + tgFSH 
Biotin staining was extensive in the interstitium of the hpg + tgFSH testes, and permeated 
throughout some of the seminiferous tubules but was excluded from the remaining tubules (Figure 
6.5). Claudin-11 staining was extensive at the TJ just adluminal to the basement membrane, and 
claudin-3 was generally absent. In some cases, minor staining for claudin-3 was visible in these testes 
where it was observed to co-localise with biotin (Figure 6.6). 
 
f. hpg + tgFSH + 2 days DHT 
Biotin staining was excluded from most of the seminiferous tubules of the tgFSH mouse 
treated with DHT for 2 days, and entered them only as far as claudin-11 staining which was extensive 
(Figure 6.5). Claudin-3 had become more prominent at the TJ at this time point but staining was not 
extensive (Figure 6.5). 
 
g. hpg + tgFSH + 10 days DHT 
Biotin staining in the hpg + tgFSH mice treated with DHT for 10 days was phenotypically 
similar to the 2 day DHT treatment where it was excluded from most tubules and remained in the 
interstitium (Figure 6.5). Claudin-11 staining was extensive at the TJ as also seen in the 2 day DHT 
treatment group (Figure 6.5), although was more basally located, in that the cytoplasmic staining 
  
 
 
 
 
 
 
Figure 6.6 Claudin-3 staining in hpg + tgFSH mice testes. 
Testes were dissected from adult hpg + tgFSH mice which had not received any DHT 
treatment. Testes were trimmed of all fat, connective tissue and epididymides and fixed in Bouin’s 
fixative for 4 hours. Testes were then processed by immunohistochemistry for biotin (green) and 
claudin-3 (red) detection. Panel A represents the most common phenotype observed with no claudin-3 
staining. In some instances however, minimal claudin-3 staining was apparent (panel B) co-localising 
with the biotin tracer (yellow, arrow). Bar = 50μm. 
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component seen in day 2, had gone by day 10. Claudin-3 staining had become extensive in some but 
not all tubules (Figure 6.5). 
 
6.3.5 Effects of DHT treatment on mRNA expression in hpg and hpg + tgFSH mice 
This section addresses RT-PCR analysis of mRNA expression of the TJ proteins claudin-11, 
occludin and claudin-3, as well as the androgen-regulated INSL-3 in hpg and hpg + tgFSH mice in 
response to 2 and 10 days of DHT treatment. The RNA extraction protocol of one of the original 
control hpg testes failed as demonstrated by the inability to amplify any products by RT-PCR from 
original and repeat cDNA samples produced from the RNA extract concerned. As RNA had originally 
been extracted from the entire testis, this reduced the number of hpg control samples to 2. Fortunately, 
2 more cDNA samples from control hpg testes of the same age as the original testes were donated by 
Dr Charles Allan, Anzac Research Institute, Sydney. 
Claudin-11 mRNA levels in hpg and hpg + tgFSH control mice were not different to wt levels 
(Figure 6.7). The same result was obtained for occludin, although the difference between wt and hpg 
mice fell just short of significance (p = 0.057). Administration of DHT to hpg mice led to a non-
significant increase in claudin-11 mRNA expression after two days of treatment. After 10 days of 
treatment, there was a significant decrease (p < 0.05) back to control levels of claudin-11 mRNA 
expression (Figure 6.7). Occludin mRNA expression levels did not change after 2 days of DHT 
treatment to hpg mice. After 10 days of DHT treatment, mRNA expression levels non-significantly 
decreased toward wt levels (Figure 6.7). DHT treatment to hpg + tgFSH mice had no effect at the 2 
day or 10 days time-point on claudin-11 or occludin mRNA expression levels compared to the hpg + 
tgFSH control (Figure 6.7). 
Claudin-3 levels in wt mice were significantly (p < 0.05) greater than in hpg control mice, 
where it was barely detectable. DHT treatment for 2 and 10 days in hpg mice did not result in 
significant (p = 0.084) changes in claudin-3 mRNA expression (Figure 6.7). Claudin-3 mRNA 
expression levels in hpg + tgFSH mice were significantly (p < 0.05) lower than in wt mice and equal to 
the levels of claudin-3 expressed in the hpg control mice (Figure 6.7). There was no difference in 
claudin-3 mRNA expression in hpg + tgFSH mice compared to hpg mice which received DHT for 2
  
 
 
 
 
 
 
Figure 6.7 Real-time RT-PCR analysis of tight junction mRNA expression in response to DHT 
treatment to hpg and hpg + tgFSH mice. 
Total RNA was extracted from frozen testes and reverse transcribed for real time RT-PCR 
analysis of claudin-11, claudin-3, occludin and androgen-regulated INSL-3, in adult wildtype mice, 
adult hpg, and hpg + tgFSH mice which had received the androgen DHT for 2 days and 10 days. Data 
is mean ± SEM, n = 3/group. Exception is hpg – DHT where n = 4. Differences between letters are 
specified in results. * = p < 0.05. 
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and 10 days. DHT treatment to the hpg + tgFSH mice led to no significant changes in claudin-3 
mRNA levels (Figure 6.7). 
The androgen-regulated gene INSL-3 was 15 fold (p < 0.01) lower in hpg control mice and 23 
fold lower in hpg + tgFSH control (p < 0.05) compared to wt mice (Figure 6.7). Expression of INSL-3 
increased significantly in hpg mice after DHT treatment for 2 days (p < 0.05) and 10 days (p < 0.05). 
mRNA expression levels of INSL-3 in hpg + tgFSH mice remained at control levels following DHT 
treatment for 2 and 10 days, although expression did increase sufficiently to no longer be significantly 
different to wt levels either. 
 
6.4 Discussion 
The aims of studies in this Chapter were to i) analyse the development of the TJ from pubertal 
to adult in wildytpe, hpg and hpg + tgFSH mice, and ii) to analyse the changes in TJ function and 
protein localisation, including the recruitment of claudin-3 to the TJ, in response to DHT treatment for 
2 days and 10 days in adult hpg and hpg + tgFSH mice. 
In the first part of the experiment, claudin-11 and claudin-3 were co-localised with the 
adherens junction marker β-catenin and the gap junction marker connexin-43 respectively, to observe 
differences in the localisation of proteins to other junctional types in hpg and hpg + tgFSH mice. In 
addition, ZO-1 of the cytoplasmic plaque was co-localised with the ectoplasmic specialisation marker 
vinculin. It would have been useful to include occludin in the immunohistochemistry endpoint, 
however as mentioned previously, an antibody could not be optimised for its detection in Bouin’s 
fixed tissue. 
In adult wt mice, claudin-11 staining was extensive at the inter Sertoli cell TJs which were 
fully functional as shown by complete exclusion of the biotin tracer from the seminiferous tubules. 
Such staining resembled that obtained in the wt mice in the Sertoli cell androgen receptor knockout 
model (Meng et al. 2005), long day Djungarian hamster (Tarulli et al. 2008), and in the control adult 
rat as seen in the previous Chapter. In addition, claudin-11 in the adult wt mice presented in this 
Chapter co-localised with β-catenin at the adherens junction. In the 20 day old pubertal wildtypes, 
claudin-11 staining was extensive but partly adluminal compared to adults, and did not co-localise 
with β-catenin which was still at the outer edge of the tubules. This data suggested that at 20 days of 
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age, the Sertoli cell TJ has not fully formed in the mouse. In adult and pubertal hpg mice, claudin-11 
was disorganised and located in the cytoplasm of the Sertoli cells toward the centre of the tubules. 
This phenotype for claudin-11 localisation in an animal lacking gonadotrophins was also displayed in 
the acyline-suppressed rat testis (Chapter 5), and has also been observed in the short-day Djungarian 
hamster testis (Tarulli et al. 2008), thereby displaying a conserved trend for claudin-11 localisation 
across several rodent species and a conserved regulatory role for gonadotrophins with respect to 
localisation. Biotin analysis in the adult hpg mice showed that TJs were completely dysfunctional as 
demonstrated by their inability to excluded biotin from the seminiferous tubules. Interestingly, 
adherens junctions were not disrupted in hpg mice when compared to wt mice with β-catenin still 
extensive at the basal aspect of the tubules, indicating that its localisation is not regulated by 
gonadotrophins. 
hpg + tgFSH adult mice, which produce physiological levels of human FSH (Haywood et al. 
2003), showed extensive claudin-11 localisation at the TJ which was slightly adluminal compared to 
the adult wt, and closely resembled the phenotype observed in the pubertal wt mice. Biotin tracer 
analysis showed variation in the functionality of the TJs with some tubules able to exclude the tracer 
and others being permeable to the tracer, with biotin actually seen adluminal to claudin-11. This result 
is in direct contrast to the Djungarian hamster model, where regardless of the localisation of claudin-
11 and the functional state of the TJ, biotin was never adluminal to claudin-11 (Tarulli et al. 2008). In 
the same model, claudin-11 redistribution to the TJ as induced by FSH treatment was always 
associated with the formation of a functional barrier as shown by biotin exclusion (Tarulli et al. 2008). 
The results obtained in the hamster study and in the hpg + tgFSH mice presented herein, could be 
directly attributable to the size-selective nature of TJs and differences between the models in obtaining 
this property. Watson et al. (2001) presented data demonstrating the existence of size-selective pores 
and the role claudins have in maintaining these pores. If this is the role of claudin-11 at the Sertoli cell 
TJ, then one may expect that biotin will penetrate through the seminiferous epithelium only as far as 
claudin-11 whether it be localised at the TJ, or in cytoplasmic pools. The data in the hamster seems to 
support this role for claudin-11. This is in contrast to the mouse. Data presented herein suggests that if 
claudin-11 is important for size-selective pore formation in the mouse testis, it must be localised at the 
TJ and in sufficient supply of hormonal regulation to obtain its size-selectivity against low molecular 
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weight tracers such as biotin. While FSH may play a large role in regulating this property in the mouse 
as in the hamster, there appears to be a requirement for other regulatory mechanisms, such as 
androgens in the mouse. Further analyses into this feature of the Sertoli cell TJ are required. 
In pubertal hpg + tgFSH mice, claudin-11 was cytoplasmic but was observed to be re-
distributing toward the TJ. The difference between these mice and the hpg mice was that pools of 
claudin-11 were not localised at the centre of the tubule, indicating a role for FSH alone in the 
localisation of claudin-11 from the Sertoli cell cytoplasmic pools to the TJs at the basal aspect. Again, 
β-catenin was localised to the outer edge of the tubules in the adult and pubertal animal. 
The similarity between claudin-11 localisation in adult hpg + tgFSH mice and the 20 day old 
pubertal wt mice is interesting. At 20 days of age, wt mice are beginning to display round spermatid 
production in their seminiferous tubules (Sasagawa et al. 1998, McCarrey et al. 1999, Marh et al. 
2003, Xu et al. 2004). The production of FSH alone in the hpg + tgFSH mouse, is sufficient to drive 
spermatogenesis past meiosis to the round spermatid level, and also initiate spermiogenesis as 
indicated by the presence of some elongated spermatids (Allan et al. 2001, Haywood et al. 2003, Allan 
et al. 2004). At that point, spermatogenesis ceases (Allan et al. 2001, Haywood et al. 2003, Allan et al. 
2004), due to the absolute need for androgen to complete spermiogenesis (Zhengwei et al. 1998, Allan 
et al. 2001, McLachlan et al. 2002b, Haywood et al. 2003, Allan et al. 2004, Matthiesson et al. 
2005b). It appears that spermatogenesis in the adult hpg + tgFSH mouse is frozen at approximately the 
same spermatogenic stage that 20 day old wt mice are undergoing. In that case, one might expect that 
TJ phenotypes between these two mice would be similar, and the data presented herein suggests it is. 
Furthermore, the tubules in the hpg + tgFSH mice which most closely resembled those in the 20 day 
old wt mice with respect to claudin-11 localisation, were also functional, suggesting that the tubules in 
the 20 day old wt mice, were already functional, hence the appearance of the round spermatids (Allan 
et al. 2001, Haywood et al. 2003, Allan et al. 2004). The difference between the 20 day old mice and 
the adult hpg + tgFSH mice, is that the latter mice lack androgen.  
The administration of testosterone to hpg + tgFSH mice and hpg mice is sufficient to drive 
qualitatively normal spermatogenesis with fertile sperm (Singh et al. 1995, Handelsman et al. 1999, 
Haywood et al. 2003). The effect of androgens on TJs was looked at in the second part of this Chapter, 
and it was shown in hpg and hpg + tgFSH mice that 2 days of DHT treatment was sufficient to at least 
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initiate the redistribution of claudin-11 from the cytoplasm of the Sertoli cells toward the basally 
located TJs. After 10 days of DHT treatment, claudin-11 was extensive at the TJ in both mouse 
models and this was coincident with a functional barrier as shown by biotin exclusion. It therefore 
appears that in order for the Sertoli cell TJ to achieve its size-selective nature in the mouse as 
mentioned before, it requires androgen.  
RT-PCR analysis was also conducted on the response of claudin-11 mRNA expression to 
DHT treatment. Claudin-11 expression was no different in the hpg and hpg + tgFSH mice ± DHT 
treatment, suggesting that the mRNA expression of claudin-11 may not be hormonally regulated in the 
mouse. However, there did appear to be an initial surge in its mRNA expression after 2 days of DHT 
treatment in hpg mice, but this did not achieve significance. The presence of an outlyer in this group of 
three animals caused a large error bar thus possibly preventing differences from being significant. 
Therefore future experimental designs should include larger numbers of animals per group (n = 5-7) to 
avoid this problem. In the acyline treated rat model of the previous Chapter, and in the Djungarian 
hamster model (Tarulli et al. 2008), mRNA expression levels were significantly higher in the hormone 
suppressed states compared to the controls. In the mouse, hpg claudin-11 mRNA levels were not 
significantly different to wt levels, indicating a differential response in mice to the absence of 
hormones with respect to mRNA expression. Interestingly in the Sertoli cell specific androgen 
receptor knockout mouse, claudin-11 mRNA expression did decrease, but the decrease in claudin-3 
(discussed shortly) mRNA expression was much greater (Myers et al. 2005, Tan et al. 2005). 
Furthermore, the localisation of claudin-11 to the TJ in the same model was retained while claudin-3 
localisation was absent (Myers et al. 2005). These data suggest that the regulation of claudin-11 is 
different to the regulation of claudin-3 and differences between these proteins was further indicated as 
shown by the localisation of claudin-3 being more basal than that of claudin-11 (Myers et al. 2005). 
The mRNA expression of occludin was also analysed in response to DHT and showed a 
relatively similar profile to claudin-11. Again, no differences in occludin mRNA expression were 
obtained between hpg and hpg + tgFSH ± DHT mice, despite high levels of mRNA in the hpg control. 
Large error bars most likely contributed to the inability to achieve significance. There was also no 
significant change in occludin mRNA expression after 2 or 10 days of DHT treatment in hpg mice, 
despite an apparent decrease to wt levels in response to the latter treatment. Similarities between 
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claudin-11 and occludin mRNA expression in this Chapter, were also seen in the previous Chapter and 
in the Djungarian hamster model (Tarulli et al. 2008), demonstrating shared responses to changes in 
circulating gonadotrophins. 
The testis weights of the hpg and hpg + tgFSH untreated mice at 3mg and 18mg respectively 
were comparable to published data (Haywood et al. 2003, Allan et al. 2004). The commencement of 
spermatogenesis in the hpg mice was shown with significant (p = 0.016) increases in testis weights 
after 10 days of DHT treatment. In a similar study, 8 weeks of DHT treatment in hpg mice also 
stimulated qualitatively normal spermatogenesis which produced fertile sperm (Singh et al. 1995). 
Interestingly, testis weights in hpg + tgFSH mice did not change even after 10 days of DHT treatment. 
This was an unexpected result. While there are no other studies which have treated hpg + tgFSH mice 
with DHT, there has been a study looking at the effect of the androgen testosterone in hpg + tgFSH 
mice (Haywood et al. 2003). After 6 weeks of treatment, a significant increase in testis weights was 
observed, from approximately 16% of wt testis weights to 55% of wt testis weights (Haywood et al. 
2003). While testosterone and DHT are different androgens, hpg mice treated with either androgen 
recorded similar increases in testis weights (Singh et al. 1995), suggesting that DHT and testosterone 
should work similarly, at least with respect to testis weights in hpg + tgFSH mice. Subsequent RT-
PCR analysis in this study, showed that androgen regulated INSL-3 mRNA expression increased 6 
fold after 10 days of DHT treatment in hpg mice, but only increased 4 fold in the hpg + tgFSH mice. 
The differences between the levels of INSL-3 mRNA expression in the DHT treated hpg and hpg + 
tgFSH mice were not significant. The DHT implants used in the hpg mice to generate the observed 
changes in testis weights and mRNA expression in those mice were the same implants used in the hpg 
+ tgFSH mice, meaning that the implants themselves were working. The proportion of functional 
tubules to non-functional in DHT treated hpg + tgFSH testes also seemed to increase, although some 
quantitative analysis would be required to confirm this. Further means to show that the implant had 
worked though not attempted here, would have been to determine serum androgens and monitor 
changes in other androgen-dependent organ weights such as seminal vesicle or prostate weights. 
Hence, the reason(s) for the lack of testis weight response remain unknown, but suggests some other 
confounding factor. The same factor may have been responsible for the lack of change in claudin-11 
and occludin mRNA expression in response to DHT in the hpg + tgFSH mice. 
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Claudin-3 was the next protein of the TJ to be analysed. In adult wt mice, its localisation to the 
TJ was extensive in some seminiferous tubules and absent in others. This was to be expected as 
claudin-3 is only expressed at stage VIII of the spermatogenic cycle which is when basal germ cells 
cross the blood-testis barrier into the adluminal region, and any given testis cross section displays 
various seminiferous tubules undergoing different stages of spermatogenesis (Leblond and Clermont, 
1952a, Meng et al. 2005). Its expression in the testis is androgen dependent as shown by its absence in 
the Sertoli cell specific androgen receptor knockout mouse model (Meng et al. 2005). No claudin-3 
was detectable in pubertal wt mice in this study or hpg mice regardless of age. Furthermore, claudin-3 
mRNA expression was very low in hpg mice, showing that claudin-3 is largely absent in these mice. 
Its absence in this model, which has basal levels of circulating androgen and FSH (Cattanach et al. 
1977, Charlton et al. 1983, Mason et al. 1986a, Allan et al. 2001), is consistent with the known 
androgen dependency of this protein (Meng et al. 2005). In addition, spermatogenesis is arrested with 
just 11% and 2% of wt spermatogonia and primary spermatocyte (leptotene and zygotene) populations 
respectively (Singh et al. 1995, Ebling et al. 2000, Myers et al. 2005). TJs are discontinuous and 
incomplete as revealed by electron microscopy and espin staining at the ectoplasmic specialisation (a 
component of the blood-testis barrier) is weak in hpg mice (Charlton et al. 1983, Myers et al. 2005). 
Since TJs do not form, and spermatogenesis does not proceed in this animal, the requirement for 
claudin-3 at the TJ was not present in these mice. DHT treatment to hpg mice for 2 days did not result 
in a significant change in claudin-3 mRNA expression, despite an apparent 5-fold increase (p = 0.084).  
By 10 days of DHT treatment, claudin-3 mRNA expression levels had decreased again. This 
expression profile for claudin-3 followed similar patterns to claudin-11 and occludin obtained in this 
Chapter, suggesting the possibility of conserved regulation of each of these proteins. 
Claudin-3 was largely undetectable in the presence of FSH in the hpg + tgFSH mice, although 
was occassionally localised to the TJ, indicating that FSH may play a minor role in the localisation of 
claudin-3 to the TJ. Androgen DHT treatment to hpg mice and hpg + tgFSH mice stimulated the 
appearance of claudin-3 protein and its subsequent localisation to the TJ within 2 days in the hpg + 
tgFSH mice and within 10 days in the hpg mice. The more rapid appearance of claudin-3 in the hpg + 
tgFSH mice suggests that FSH may play a priming role in the localisation of claudin-3 to the TJ. Such 
a priming role for FSH has been well documented in the literature in relation to the regulation of other 
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Sertoli cell junctions (Muffly et al. 1994, Cameron et al. 1998, Zhang et al. 2003). Supporting 
information for this argument is also provided by the claudin-11 staining pattern in the pubertal hpg + 
tgFSH model, which appeared to be much more immature than the pubertal wt which has both FSH 
and androgens. These data reinforce the need for both gonadotrophins in maintaining successful 
spermatogenesis at the level of the TJ. 
Low levels of claudin-3 mRNA expression were detected in the untreated hpg + tgFSH mice, 
showing that FSH can to some extent regulate its expression. DHT treatment in these mice had no 
effect on claudin-3 mRNA expression, but as outlined for claudin-11, occludin and INSL-3, this could 
have been due to some confounding factor(s) in the testes of these mice.  
The absence of claudin-3 staining in pubertal wt mice was unexpected. It was hypothesised 
that the initiation of spermatogenesis which occurs at puberty, would involve the recruitment of 
claudin-3 to the TJ. TJs need to disassemble to allow germ cells to cross the blood-testis barrier, and 
then reform underneath them to maintain the integrity of the adluminal compartment (Setchell, 1967, 
Zhou et al. 2002). Currently it is unknown whether claudin-3 is a transient member of disassembling 
TJs, or a member of reassembling TJs, or both (Meng et al. 2005). The absence of claudin-3 at puberty 
when spermatogenesis is starting and TJs are forming suggests that it is not a member of assembling 
TJs, but could be a member of disassembling TJs. An argument against this point is that the pubertal 
mice used in this Chapter were 20 days of age. These animals already have some round spermatids 
inside the adluminal compartment of the seminiferous tubules, hence TJ formation had probably 
already occurred. Biotin analysis in tubules which displayed phenotypic similarities to the 20 day old 
wt mice also suggested that these tubules were functional. At 13 days of age, the earliest pachytene 
spermatocytes appear in the wt mouse (Marh et al. 2003) and so around this time and each day 
thereafter until the end of the first spermatogenic wave may be suitable periods to stain for claudin-3 
to determine whether it is a member of assembling TJs. Alternatively, one could stain for claudin-3 at 
the end of the first spermatogenic wave when germ cells are again crossing the TJ.  
Claudin-3 was also co-stained with connexin-43 of the inter Sertoli cell gap junction. In wt 
mice, connexin-43 was always at the outer edge/basal aspect of the tubule regardless of age, and in the 
adult, co-localised with claudin-3. Connexin-43 localisation was cytoplasmic in pubertal hpg mice, yet 
was present at basal gap junctions in the adult hpg animal. This indicated that the localisation of 
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connexin-43 to the gap junction was independent of gonadotrophins. Previous studies have shown that 
thyroid hormone stimulates connexin-43 action in the Sertoli cells, where it has an important role for 
normal testicular development and spermatogenesis (St-Pierre et al. 2003, Gilleron et al. 2006, Brehm 
et al. 2007, Sridharan et al. 2007a, Sridharan et al. 2007b). In adult and pubertal hpg + tgFSH mice, 
connexin-43 was always localised at the basal gap junctions, indicating that FSH may have a partial 
role in its localisation.  
The cytoplasmic plaque protein ZO-1 was also looked at this Chapter. While staining was not 
as clear as that for the other proteins already mentioned, its localisation tended to be basal in each 
mouse genotype, adult or pubertal. While further study may be required to confirm this, it is postulated 
that the cytoplasmic components of the TJ are appropriately expressed in the absence of 
gonadotrophins, but that localisation of the key transmembrane TJ proteins (claudin-11, claudin-3 and 
potentially occludin) require gonadotrophin support. 
ZO-1 was co-stained with vinculin of the ectoplasmic specialisation. The phenotype for 
vinculin localisation supported previous studies that this junction is gonadotrophin-regulated (Muffly 
et al. 1993, Cameron et al. 1998, Myers et al. 2005, Wong et al. 2005, Sluka et al. 2006). Hence, 
vinculin staining was extensive at the ectoplasmic specialisation in adult wt mice, but was cytoplasmic 
in Sertoli cells from hpg mice. This pattern was partially rescued by FSH in the hpg + tgFSH mice, 
where vinculin was seen to be re-distributing toward the ectoplasmic specialisation, in a manner 
similar to the pubertal wt animal. 
In the GnRH-antagonist treated rat in the previous Chapter, TJs were shown to be 
dysfunctional by extensive biotin permeation throughout the seminiferous tubules. The hamster, rat 
and hpg mouse models therefore all exhibit dysfunctional and structurally compromised TJs, with 
significantly reduced or inactive spermatogenesis. Collectively, these data indicate the vital role that 
TJs have in the maintenance of spermatogenesis. The role gonadotrophins have in regulating the 
formation of TJ function and structure in hpg mice was demonstrated by DHT administration. Within 
2 days of DHT treatment, claudin-11 mRNA expression had partially increased and cytoplasmic 
claudin-11 had begun re-distributing and appeared to have shifted basally toward the TJ, which was 
still not fully functional as shown by biotin. In the presence of FSH alone, claudin-11 had also shifted 
basally toward the TJ which varied in functional status as already mentioned. Further evidence that 
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claudin-11 had shifted basally in response to gonadotrophin treatment was shown by the presence of 
biotin alone in the centre of the seminiferous tubules, ie) it no longer co-localised with claudin-11. 
This basal movement of claudin-11 in response to a hormonal stimulus was also observed in the 
Djungarian hamster model after FSH administration (Tarulli et al. 2008). After 10 days of DHT 
treatment to hpg mice, TJs were predominantly functional with biotin being completely restricted from 
most seminiferous tubules. 
The hpg mouse provides a different means to study hormone regulation of the TJ compared 
with the GnRH-antagonist treated rat and also the Djungarian hamster. This is because hpg mice have 
never had circulating hormones in contrast to the other two models, hence the hpg mouse is purely a 
model of TJ formation, and not a TJ maintenance study. The GnRH antagonist treated rat model in the 
previous Chapter concluded that the maintenance of Sertoli cell TJ function and structure is 
hormonally regulated in vivo. The hpg model has added to this knowledge by showing that hormones 
also regulate the initial formation of the Sertoli cell TJ in vivo. While it can be argued that the 
depletion of circulating gonadotrophins and subsequent regression of the TJ in the seasonally 
regressed testis of the Djungarian hamster can also demonstrate TJ formation, the fact that these 
animals had prior exposure to gonadotrophins means that one could argue that the Djungarian hamster 
model is also a maintenance model. No such argument could be made about the hpg mouse model. 
Either way, it is interesting and noteworthy that, in situations where circulating levels of 
gonadotrophins are reduced, either through congenital defect or induced through suppression, the key 
Sertoli cell TJ proteins such as claudin-11 and occludin (as shown in the hamster (Tarulli et al. 2006, 
Tarulli et al. 2008)) are always present, albeit localised away from the TJ in the centre of the 
seminiferous tubules. Presumably occludin was also present at all times in this hpg mouse study as 
well. It appears therefore that the key role of gonadotrophins is to redistribute these proteins to the 
Sertoli cell TJ. 
It is concluded that gonadotrophins (both FSH and LH/testosterone) stimulate the formation of 
a functionally and structurally competent Sertoli cell TJ by redistributing claudin-11 and claudin-3 to 
the TJ from Sertoli cell cytoplasmic pools. This redistribution from the cytoplasm is regulated in a 
very similar manner to that observed for the maintenance of TJs by gonadotrophins. It is further 
concluded that while FSH is sufficient to stimulate partial TJ formation, androgens are absolutely 
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required for complete TJ formation and function, and subsequent spermatogenic activity. Although not 
proven in this study because of low group numbers, the data also suggests that gonadotrophins are able 
to regulate claudin-11, occludin and claudin-3 mRNA expression.  
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Chapter 7. Hormonal regulation of the Sertoli cell tight junction in the gonadotrophin 
suppressed human, in vivo. 
 
7.1 Introduction 
The previous Chapters have shown that gonadotrophins regulate both the structure and 
function of Sertoli cell TJs in vitro and in vivo, and that gonadotrophins maintain TJ integrity and also 
stimulate its formation. 
In order to study gonadotrophin regulation of spermatogenesis in men and to ascertain the 
specific points of spermatogenesis which testosterone and/or FSH regulate, male hormonal 
contraception has been induced in several studies through the addition of testosterone or synthetic 
androgens to suppress LH and FSH but particularly intratesticular testosterone to suppress 
spermatogenesis (see Chapter 1, Section 1.7.5), while maintaining adequate androgen action at other 
sites in the body (McLachlan et al. 2002a, McLachlan et al. 2002b, Matthiesson et al. 2005b, 
Matthiesson et al. 2005a). Following gonadotrophin suppression, spermatogenesis is stopped in most 
individuals with LH/testosterone and FSH levels at basal levels and germ cell numbers significantly 
decreased (Herbst, 2003, Herbst et al. 2004, Matthiesson et al. 2005b). These features are similar to 
the GnRH-antagonist treated rat, for which this thesis has demonstrated changes in TJ structure and 
function following gonadotrophin suppression, indicating that TJ maintenance is gonadotrophin-
dependent. However, the extent to which gonadotrophin suppression alters human testicular TJ 
function is not known. A direct demonstration of the importance of gondotrophins in the initiation of 
human Sertoli cell TJ function is provided by a study with hypogonadotrophic hypogonadal men, who 
have naturally low levels of circulating gonadotrophins, and display a prepubertal TJ phenotype as 
determined by electron microscopy (de Kretser and Burger, 1972). Following the exogenous 
application of gonadotrophins, the Sertoli TJ assumed a mature phenotype, with subsequent 
spermatogenesis and fertility (de Kretser and Burger, 1972).  
The aim of the work presented in this Chapter is to determine the effect of gonadotrophin 
suppression on the localisation and mRNA expression of human Sertoli cell TJ proteins. In addition, 
the effects of gonadotrophin suppression on the localisation and mRNA expression of protein markers 
of nearby junction types will also be analysed. These include β-catenin (adherens junction), connexin-
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43 (gap junction), vinculin (ectoplasmic specialisation), ZO-1 (cytoplasmic plaque) and β-actin 
(cytoskeleton). Finally, RT-PCR of the androgen-regulated protein INSL-3 was included as a means to 
confirm androgen suppression in these men.  
To undertake this study, archived human testis fragments and wax-embedded testis sections 
were generously provided by Drs K Matthiesson and R McLachlan at the Monash Medical Centre 
(Clayton, Victoria), from a study which examined the effects of various gonadotrophin suppression 
treatments on germ cell numbers, serum hormones, and sperm output (Matthiesson et al. 2005b). It 
was hypothesised that gonadotrophin suppression would lead to changes in TJ mRNA and protein 
localisation in the human testis. 
 
7.2 Materials and Methods 
While the only work conducted in this thesis on the human testis tissue was 
immunohistochemistry and RT-PCR, it is necessary to provide the background of the tissue that was 
used, and its preparation. A brief outline of the experimental design that led to the provision of the 
tissue samples is provided below. Full experimental details are published in Matthiesson et al. 
(2005a). 
 
7.2.1 Human testis tissue 
Samples for this study came from archived Bouin’s fixed human testes or frozen human testis 
mRNA from a previous study (Matthiesson et al. 2005b). Briefly, the samples were obtained from 29 
healthy men who were planning to undergo elective vasectomy through media advertisement 
(Matthiesson et al. 2005b). For details regarding consent, and inclusion/exclusion criteria, see 
Matthiesson et al. (2005b). Briefly, the Institutional Review Board at the University of Washington, 
USA, approved all experimental protocols, and subjects gave written informed consent before 
screening (Matthiesson et al. 2005a). 
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7.2.2 Experimental design 
 
a. Hormone suppression 
The Matthiesson et al. (2005a) study was divided into three phases, these being a 2 week 
screening phase, an 8 week treatment phase, and a 4 week recovery phase. After the screening phase, 
men were randomly assigned to one of the four hormone suppressive treatments (n = 5-6/group) or to 
a control group (n = 7) (Matthiesson et al. 2005b). The treatment groups were: 100mg Testosterone 
enanthate (T; Delstestryl, Bristol-Myers, Squibb, Princeton, NJ, USA), injected intramuscularly, 
weekly + i) 125μg progestin Levonorgestrel (LNG; Wyeth, Madison, NJ, USA), orally, daily (n = 5), 
ii) LNG + 0.5mg 5α-reductase inhibitor Dutasteride (D; GlaxoSmithKilne, Research Triangle Park, 
NC, USA), orally, daily (n = 6), iii) 300μg/kg GnRH antagonist Acyline (A; Multiple Peptide 
Systems, San Diego, CA, USA), subcutaneously, fortnightly (n = 6), or iv) LNG + A (Matthiesson et 
al. 2005b). 
Following the treatment phase, testicular biopsies were taken from each man in conjunction 
with a pre-planned vasectomy (Matthiesson et al. 2005b). Biopsies were also taken from control men 
who went straight through to the surgery (Matthiesson et al. 2005b). Biopsies were then either fixed in 
Bouin’s for 3 hours and embedded in paraffin wax and kept at room temperature, or used for total 
RNA extraction and kept at -80oC. 
 
7.2.3 Immunohistochemistry 
Bouin’s fixed, paraffin embedded testes from Matthiesson et al. (2005a) were cut and 
processed by immunohistochemistry for confocal fluorescent microscopy analysis as outlined in 
section 2.2. For primary and secondary antibody incubation details see Table 7.1. Note that all pictures 
were taken with the same fluorescent illumination intensities. 
 
7.2.4 RNA preparation 
Total RNA had already been extracted from all the archived testis tissue samples from the Matthiesson 
et al. (2005a) study and quantified. As only two prepared control samples were available, it was 
necessary to extract RNA from a third frozen control human testis biopsy which had been set 
  
 
 
 
 
 
 
Table 7.1 Antibodies used for immunohistochemical analysis. 
Tabulated data for the antibodies used in Chapter 7 of this thesis, including details regarding 
the primary and secondary antibody hosts, working concentrations (conc.)/dilutions, incubation (Inc.) 
times and company details with catalogue numbers. 
Protein Primary 
(1o) 
antibody 
host 
Company Conc. 
(μg/ml) 
Negative 
control 
1o Inc. time 
(mins) 
Secondary 
(2o) antibody 
Company Dilution 2o Inc. 
time 
(mins) 
Claudin-11 Rabbit Zymed     
(36-4500) 
2.0 Normal 
rabbit 
IgG 
        60  Goat α rabbit 
Alexa-488 
Molecular 
Probes 
1:400 of 
stock 
30 
Claudin-3 Rabbit Zymed     
(34-1700) 
1.25 Normal 
rabbit 
IgG 
60  Goat α rabbit 
Alexa-488 
Molecular 
Probes 
1:400 of 
stock 
30 
ZO-1 Rabbit Zymed        
(61-7300) 
1.25 Normal 
rabbit 
IgG 
Overnight Goat α rabbit 
Alexa-488 
Molecular 
Probes 
1:800 of 
stock 
30 
β-catenin Mouse Transduction 
Laboratories 
(610154) 
0.33 Normal 
mouse 
IgG 
60  Goat α mouse 
Alexa-488 
Molecular 
Probes 
1:400 of 
stock 
30 
Connexin-43 Mouse Sigma 
ascites fluid 
(C8093) 
1:800 of 
stock 
Normal 
mouse 
IgG 
60  Goat α mouse 
Alexa-488 
Molecular 
Probes 
1:400 of 
stock 
30 
Vinculin Mouse Sigma 
ascites fluid 
(V4505) 
1:400 of 
stock 
Normal 
mouse 
IgG 
60  Goat α mouse 
Alexa-488 
Molecular 
Probes 
1:400 of 
stock 
30 
β-actin C4 
clone 
Mouse MP 
Biomedicals 
(69100) 
1:200 of 
stock 
Normal 
mouse 
IgG 
60  Goat α mouse 
Alexa-488 
Molecular 
Probes 
1:400 of 
stock 
30 
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aside from the Matthiesson et al. (2005a) study. Total RNA extraction through to quantification by 
UV spectrophotometry was conducted as outlined in Section 2.3.1 to 2.3.3. Also, a commercially 
available total RNA human testis extract was purchased (100μg, Ambion, Cat # 7972) to be the QC 
and standard curve for the PCR experiments. 
As each RNA sample was precious and amount limited (~45μg-140μg in total/sample), a 
method of RNA amplification was employed to maximise usage and availability of the samples for 
these and other studies. 
 
7.2.5 RNA Amplification 
RNA from the human testis samples was amplified using the MessageAmp II aRNA 
Amplification Kit (Ambion, Cat # 1751) according to the manufacturer’s directions. A detailed 
protocol is outlined below, but in brief, the RNA samples were incubated with a T7 Oligo(dT) primer 
and reverse transcription enzyme to produce the typical RNA-cDNA hybrid. The T7 Oligo (dT) 
primer binds to the poly-A tail of mRNA, and this primer initiates the reverse transcription process. 
The next step was a second reverse transcription process which replaced the RNA component of the 
hybrid with DNA, producing double stranded DNA molecules. This was purified and an in vitro 
transcription experiment carried out to produce amplified RNA by linear amplification of the double 
stranded DNA. The amplified RNA was then reverse transcribed again for final RT-PCR analysis, 
using random hexamers (as per the reverse transcription protocol outlined in section 2.3.4) instead of 
the T7 Oligo (dT) due to the loss of the poly-A tail following the initial reverse transcription 
experiments. 
The amplification kit used a reverse transcription enzyme called M-MLV RT Array Script 
(Ambion, cat # 2048) for the first and second round reverse transcription experiments, which 
according to the manufacturer has excellent ‘processitivity’ compared to other reverse transcription 
enzymes. This means that as the enzyme starts reverse transcribing the RNA molecule from the T7 
primer at the 3’ end, it will advance further along the RNA toward the 5’ end than other commercially 
available reverse transcription enzymes. It still however displays 3’ bias, and so after each reverse 
transcription event, of which there are three to produce the final cDNA product for RT-PCR, the 
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molecule becomes progressively shorter from the 5’ end. This meant that it was essential to design the 
primers for RT-PCR analysis, toward the 3’ end of the target molecules.  
 
a. First strand cDNA synthesis 
1μg of RNA was taken from each sample (based on UV spectrophotometry quantification 
results), except for the Ambion-supplied human testis RNA sample, from which 4μg was taken and 
transferred into a non-stick, sterile, RNase-free 0.5ml tube, in a volume not exceeding 10μl. 1μl of T7 
Oligo(dT) primer was added to the mixture and the final volume brought to 12μl with nuclease-free 
water before being centrifuged for 1 minute at 10,000rpm (9391g, Eppendorf, Germany). The samples 
were then incubated for 10 minutes in a thermal cycler (Applied Biosystems, Gene Amp PCR System 
9700, Australia) at 70oC, and then centrifuged briefly to collect condensation at the bottom of the tube. 
The final volume of the tube was brought to 20μl with the addition of the reverse transcription 
master mix (2μl 10X first strand buffer, 4μl dNTP mix, 1μl RNase inhibitor, 1μl ArrayScript), which 
was mixed into the solution, gently vortexed and then centrifuged briefly and placed on ice. Tubes 
were then incubated for 2 hours at 42oC in a hybridisation oven (Carbolite, UK), and placed on ice. 
 
b. Second strand cDNA synthesis 
Each of the solutions were then made up to 100μl with the addition of a second strand master 
mix (63μl nuclease-free water, 10μl 10X second strand buffer, 4μl dNTP mix, 2μl DNA Polymerase, 
1μl RNase H), which was mixed by gentle vortexing and brief centrifugation. The tubes were then 
incubated for 2 hours at 16oC in the thermal cycler, before being placed on ice. These samples were 
safe to store at this point if desired, at -20oC. 
 
c. cDNA purification 
The nuclease-free water bottle supplied with the kit was preheated to between 50oC-55oC, 
being careful not to go over 58oC as directed by the manufacturer. 
250μl of cDNA binding buffer was added to each sample and mixed thoroughly, before the 
entire sample was loaded into the centre of a cDNA filter cartridge. This was centrifuged for 1 minute 
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at 10,000rpm (9391g) and the flow through discarded. 500μl of wash buffer (a volume of ethanol was 
added to the buffer beforehand according to manufacturer’s instructions) was then added to each 
cartridge and centrifuged for a further minute at 10,000rpm. The cartridges were then centrifuged 
again for 1 minute to remove any trace amounts of wash buffer, before they were transferred to a 
cDNA elution tube. 
10μl of the heated nuclease-free water was added to the cDNA filter cartridge, left for 2 
minutes at room temperature and then centrifuged for 1.5 minutes at 10,000rpm. A second 10μl dose 
of nuclease-free water was added and centrifuged, leaving the double stranded cDNA in the eluate in 
an approximate volume of 16μl. This final aliquot was sub-aliquotted into 4 x 4μl in free standing 
screw tubes (0.5ml, Astral Scientific, cat # I2120-00, Gymea, NSW, Australia) with screw-cap and o-
ring lids (I2001-00 Astral Scientific, Gymea, NSW, Australia), snap frozen and stored at -80oC for 
extra double stranded cDNA storage. 
 
d. In vitro transcription (IVT) to synthesise amplified RNA (aRNA) 
One of the 4μl double stranded DNA sub-aliquots from each sample was subjected to this next 
protocol. They were made up to 16μl in accordance to manufacturer’s requirements. 
Each sample was made up to 40μl by the addition of an IVT master mix (4μl T7 ATP 
(75mM), 4μl T7 CTP (75mM), 4μl GTP (75mM), 4μl T7 UTP (75mM), 4μl T7 10X Reaction buffer, 
4μl T7 Enzyme mix) which was mixed well by vortexing and brief centrifugation, before being placed 
on ice. 
Tubes were then incubated at 37oC for 8 hours in the hybridisation oven. According to the 
manufacturer, the incubation times are important for maximal RNA amplification. Toward the end of 
this period, the supplied nuclease-free water bottle was heated to 50oC-60oC. 
The amplification reaction was stopped by the addition of 60μl of heated nuclease-free water. 
 
e. aRNA purification 
Nuclease-free water was preheated to 50oC-60oC before proceeding. An aRNA filter cartridge 
was placed into an aRNA collection tube. 350μl of aRNA binding buffer was added to the 100μl 
 157
aRNA sample. 250μl of ACS grade 100% ethanol was immediately added to the solution and mixed 
by pipetting up and down 3 times. The samples were not vortexed or centrifuged as per manufacturer’s 
instructions. 
The solutions were then immediately transferred onto the centre of an aRNA filter cartridge, 
which was then centrifuged for 1 minute at 10,000rpm (9391g). The flow-through was discarded, and 
650μl of wash buffer added to the cartridge, and centrifuged for a further minute at 10,000rpm. Any 
trace amount of wash buffer was removed by another 1 minute centrifugation at 10,000rpm. 
Filter cartridges were then transferred to aRNA collection tubes. 100μl of the preheated 
nuclease-free water was added to the centre of the tube, left at room temperature for 2 minutes and 
then centrifuged for 1.5 minutes at 10,000rpm, leaving the aRNA in the collection tube. This was sub-
aliquotted at 10 x 10μl and stored in screw-cap eppendorf tubes, snap frozen and stored at -80oC. 
 
f. aRNA quantification and reverse transcription 
The protocols for these next experiments which dealt with quantifying the aRNA and reverse-
transcribing it into cDNA for RT-PCR analysis were not part of the manufacturer’s directions and 
were the same protocols used as per the rest of this thesis. See Sections 2.3.3-2.3.4.  
 
7.2.6 Real-time RT-PCR analysis 
All RT-PCR work and primer design was conducted as outlined in Section 2.3.5. For primer 
details, see Table 7.2.  
 
7.2.7 Statistical analysis 
Statistical analysis was performed as outlined in Section 2.6 with data expressed as mean ± 
SEM. Numbers ranged from 3-5 per group. See results section for further details. 
 
 
 
 
  
 
 
 
Table 7.2 Primer sequences and real-time RT-PCR conditions for the analysis of mRNA 
expression in the human gonadotrophin suppressed testis. 
 Primers were designed or obtained from published sources against the TJ proteins claudin-11, 
claudin-3, occludin, JAM-A and the cytoplasmic plaque protein ZO-1, as well as against adherens 
junction protein β-catenin, ectoplasmic specialisation protein vinculin and gap junction protein 
connexin-43. Further analysis was done with the housekeeper and cytoskeletal protein β-actin and 
androgen-regulated protein INSL-3. Data included in the table are forward and reverse primer 
sequences, Mg2+ concentration, and annealing and acquisition temperatures. 
Protein Species/   
Accession 
number 
Primer sequences (5’- 3’) Product 
size         
(bp) 
[Mg2+]   
(mM) 
Anneal 
temp.   
(oC) 
Acquisition 
temp. (oC) 
Claudin-11 
(Primer3) 
Human         
NM_005602 
Forward: CTGGTGGACATCCTCATCCT 
Reverse: AGCTAGAGCCCGCAGTGTAG 
391 3.0 64 72 
Occludin 
(Ghassemifar 
et al. (2002) 
Human         
NM_002538 
Forward: ACAAGGAACACATTTATGAT 
Reverse: ATTGTAAGCTCTTGTATTCC 
438 3.0 61 72 
Claudin-3 
(Primerbank 
database) 
Human        
NM_001306 
Forward: AACACCATTATCCGGGACTTCT 
Reverse: CGCGGAGTAGACGACCTTG 
183 2.0 64 72 
β-actin 
(Primer3) 
Human         
NM_001101 
Forward: CGAGCGCGGCTACAGCTT 
Reverse: TCATACTCCTGCTTGCTGATCC 
506 3.5 64 72 
β-catenin 
(Primer3) 
Human 
NM_001904 
Forward: CCCACTAATGTCCAGCGTTT 
Reverse: CTCACGATGATGGGAAAGGT 
324 3.0 60 72 
Connexin-43 
(Chen et al. 
(2006) 
Human 
NM_000165 
Forward: CCTTCTTGCTGATCCAGTGGTAC 
Reverse: ACCAAGGACACCACCAGCAT 
154 4.0 64 72 
JAM-A 
(Primer3) 
Human 
NM_016946 
Forward: GGACCCTTCTCTGCCCTTAC 
Reverse: TATTGGCATGTGACCCTTGA 
254 4.0 61 72 
Vinculin 
(Primer3) 
Human 
NM_014000 
Forward: ATTTCCCAGCACATGAAACC 
Reverse: AAAGCACATCCGGCATAAAG 
396 2.0 64 72 
ZO-1 
(Primer3) 
Human 
NM_003257 
Forward: GGGAGGGTGAAGTGAAGACA 
Reverse: ACCACCAAATGCACAACGTA 
270 3.0 64 72 
INSL-3 
(Primer3) 
Human         
NM_005543 
Forward: GGGATGGGTGCTCACTATCT 
Reverse: TTTCTGCTTTGGGTCGTTTA 
228 2.5 64 72 
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7.3 Results 
 
7.3.1 Effects of gonadotrophin suppression on tight junction protein localisation 
The localisation of claudin-11 at the TJ in each of the control men (n = 3) was extensive and 
formed continuous stained bands toward the basement membranes of the seminiferous tubules (Figure 
7.1). Within each gonadotrophin suppression treatment [T+A (n = 3), T+LNG (n = 2), T+LNG+A (n = 
2), T+LNG+D (n = 2)], the staining pattern of claudin-11 was heterogeneous between men receiving 
the same treatment. The extent of claudin-11 localisation varied from a marked loss of protein staining 
at the basal aspect of the tubules which appeared very punctate, to a continuous staining resembling 
the controls (Figure 7.1). For example a comparison between man 102 and man 122 in the T+A group 
shows claudin-11 as punctate at the TJ in man 102 and continuous at the TJ in man 122 (Figure 7.1). 
Similar variability in claudin-11 staining patterns was observed in the other treatment groups (Figure 
7.1), with no particular treatment producing consistently suppressed claudin-11 staining. It was also 
noted that, in contrast to the gonadotrophin-suppressed rat model, claudin-11 staining did not appear in 
Sertoli cell cytoplasm in gonadotrophin-suppressed men. All immunohistochemical experiments were 
conducted at the same time and repeated up to 3 times with consistent results. 
Occludin, JAM-A and claudin-3 were undetectable in the testes sections with the primary 
antibodies employed, expected to be due to cross-reactivity issues and the type of fixation (Bouin’s 
fixative). However, it was possible to examine the localisation of the cytoplasmic plaque protein ZO-
1, and this remained unchanged in any of the men from any of the hormone suppressing treatments, 
compared with controls (Figure 7.2). 
Immunofluorescent images presented in this Chapter are representative of the results observed 
within treatment groups (typically n = 2-5 per group), and so data from all of the men examined are 
not shown herein. Furthermore, occasional artefact staining of the basement membrane was detectable 
in some immunoblots. Images for all men are presented in Appendix 1.5 and CD in cover. 
 
 
 
 
 
 
 
 
Figure 7.1 Localisation of claudin-11 in control and hormone suppressed human testes. 
 Bouin’s fixed, paraffin embedded human testis biopsies were processed by 
immunohistochemistry and stained for the TJ protein claudin-11 (green). Biopsies came from men (♂) 
with hormone suppression induced by T+A, T+LNG, T+LNG+A and T+LNG+D, as well as control 
men. Presented in this Figure are several of the phenotypes observed within each treatment. Biopsies 
from different individuals are indicated by patient numbers which were allocated by Matthiesson et al. 
(2005a). Note that another channel (grey) has been added to the confocal microscope for the 
T+LNG+A #136 man to highlight the localisation of claudin-11 with respect to the seminiferous 
tubules in the cross section. Bar = 50μm. Inset = negative control. 
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Figure 7.2 Localisation of ZO-1 in control and hormone suppressed human testes. 
 Bouin’s fixed, paraffin embedded human testis biopsies were processed by 
immunohistochemistry and stained for the cytoplasmic plaque protein ZO-1 (green). Biopsies came 
from men (♂) with hormone suppression induced by T+A, T+LNG, T+LNG+A and T+LNG+D, as 
well as control men. Presented in this figure are the same biopsies used for claudin-11 in Figure 7.1, 
where different staining phenotypes were observed within treatments. Biopsies from different 
individuals are indicated by numbers which were allocated by Matthiesson et al. (2005a). Note that 
another channel (grey) has been added to the confocal microscope for the T+LNG+D #107 man to 
highlight the localisation of ZO-1 with respect to the seminiferous tubules in the cross section. Bar = 
50 μm. Inset = negative control. 
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7.3.2 Effects of gonadotrophin suppression on other junctional protein localisation 
The effect of hormone suppression on human spermatogenesis was extended to include other 
junctional markers such as β-catenin (adherens junction), vinculin (ectoplasmic specialisation), 
connexin-43 (gap junction), and β-actin (cytoskeleton) (Figure 7.3). Each of the above proteins were 
localised at their respective junctions extensively in the control men (Figure 7.3). Following 
gonadotrophin suppression with each of the treatments, the localisation of β-actin and vinculin was 
largely unchanged, although tubule shrinkage appeared to ‘squash’ the proteins inward. β-catenin 
staining appeared partly reduced particularly in the T+A treatment group, but was overall unchanged. 
Connexin-43 staining appeared more diffuse than in control and possibly more cytoplasmic, but was 
overall similar to the control testes (Figure 7.3). 
 
7.3.3 Comparison of germ cell numbers with claudin-11 localisation  
Quantitative data describing the changes in germ cell types and numbers in each of the human 
testis biopsies used in this Chapter has previously been published (Matthiesson et al. 2005b). A 
notable feature from the Matthiesson et al. (2005a) study was the considerable difference observed in 
the extent of germ cell suppression between men within the same treatment group. In particular, those 
germ cells normally found within the adluminal region (leptotene, zygotene and pachytene 
spermatocytes, round spermatids) remained at 30-50% of controls (Figure 7.4) in some suppressed 
men, whereas in others this range dropped to < 5-20% It was therefore hypothesised that the extent of 
TJ protein suppression would be maximal in men who exhibited the greatest suppression of these germ 
cell types.  Changes in claudin-11 localisation were therefore qualitatively compared to the extent of 
adluminal germ cell (in particular leptotene, zygotene & pachytene spermatocytes) suppression in each 
biopsy analysed in each treatment (Figure 7.4).  
 
a. T+A treatment group 
Men analysed in this treatment group were assigned the numbers 101, 102, 114, 116, 122 and 
137. Man number 114 was not available for immunofluorescent analysis. Men 101 and 116 had 
suppressed leptotene, zygotene and pachytene spermatocytes to < 5% of controls (Figure 7.4a), and 
claudin-11 staining in these men was very punctate at the TJ. This staining pattern for claudin-11 was 
  
 
 
 
 
 
Figure 7.3 Effect of hormone suppression on different junctional types in the human testis. 
 Bouin’s fixed, paraffin embedded human testis biopsies were processed by 
immunohistochemistry and stained for i) cytoskeletal protein β-actin, ii) adherens junction protein β-
catenin, iii) ectoplasmic specialisation protein vinculin and iv) gap junction protein connexin-43 (all 
green). Biopsies came from men (♂) with hormone suppression induced by T+A, T+LNG, T+LNG+A 
and T+LNG+D, as well as control men. The hormone suppressed biopsies presented in this figure are 
from men who showed maximal claudin-11 localisation disruption, demonstrated by the degree of 
punctate staining. Biopsies from different individuals are indicated by numbers which were allocated 
by Matthiesson et al. (2005a). Bar = 50μm. Inset = negative control. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
T+LNG+D:  
♂ 107 
T+LNG+A:  
♂ 136 
Control: 
♂ 133 β-actin Vinculin Connexin-43β-catenin
T + A:  
♂ 102  
T + LNG:  
♂ 109 
  
 
 
 
 
 
 
Figure 7.4a Comparison of claudin-11 protein localisation with extent of spermatocyte 
suppression in T+A treated men. 
 Germ cell data for leptotene, zygotene and pachytene spermatocytes (arrows) in men treated 
with T+A was obtained from Matthiesson et al. (2005a), and compared to claudin-11 (green) 
localisation in testis biopsies obtained from the same men (♂). Different individuals were allocated 
numbers by Matthiesson et al. (2005a) which were 101 (■), 102 (●), 114 (▲), 116 (♦), 122 (□) and 
137 (2). Note that number 114 was not available for immunohistochemical analysis. Germ cell types 
presented are: All A type spermatogonia (All A), type A dark spermatogonia (Ad), type A pale 
spermatogonia (Ap), type B spermatogonia (B), preleptotene spermatocytes (Pl), leptotene/zygotene 
spermatocytes (L-Z), pachytene spermatocytes (PS), round spermatids (rS), step 3-6 elongating 
spermatids (3-6 ST), step 7-8 elongating spermatids (7-8 ST) and sperm. Bar = 50μm. 
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also apparent in man 102, whose spermatocytes had only decreased to approximately 20% of controls. 
Claudin-11 staining at the basal aspect of tubules was more extensive in men 137 and 122 (particularly 
in the latter) where spermatocytes had decreased to approximately 30% of controls (Figure 7.4a). 
 
b. T+LNG treatment group 
Men treated with T+LNG were assigned the numbers 105, 106, 109, 123, 131, although only 
numbers 109 and 131 were available for immunofluorescent analysis. Leptotene, zygotene and 
pachytene spermatocytes in man number 109 had suppressed to < 5% of controls (Figure 7.4b), and 
gave claudin-11 staining that was punctate at the TJ (Figure 7.4b). In contrast, man number 131 had 
suppressed spermatocytes to approximately 40% of controls, yet the claudin-11 staining was punctate 
and very similar to man 109 although some patches of more continuous staining were present (Figure 
7.4b). 
 
c. T+LNG+A treatment group 
Men treated with T+LNG+A were assigned the numbers 104, 117, 126, 136 and 141. Only 
numbers 117, 126 and 136 were available for immunofluorescent analysis. Each of these men had 
suppressed leptotene, zygotene and pachytene spermatocyte number to 10%-15% of controls (Figure 
7.4c). Claudin-11 staining in man 117 varied between punctate and continuous staining at the TJ (see 
two panels in Fig 7.4c), although the total claudin-11 staining appeared low. Man number 126 
displayed extensive but punctate claudin-11 staining at the TJ although it was also partly continuous in 
areas (Figure 7.4c). Number 136 displayed a more punctate phenotype of claudin-11 staining at the TJ 
than men number 117 and 126 (Figure 7.4c). 
 
d. T+LNG+D treatment group 
Men in this treatment group were assigned the numbers 107, 108, 120, 124, 127 and 132. Only 
numbers 107, 120 and 132 were available for immunofluoescent analysis. The extent of leptotene, 
zygotene and pachytene spermatocyte suppression between these men differed. Man number 120 had 
suppressed spermatocytes to < 5% of controls (Figure 7.4d). The testis biopsy section was poor but 
displayed punctate staining of claudin-11, which was also continuous in areas. Number 107 had 
  
 
 
 
 
 
Figure 7.4b Comparison of claudin-11 protein localisation with extent of spermatocyte 
suppression in T+LNG treated men. 
 Germ cell data for leptotene, zygotene and pachytene spermatocytes (arrows) in men treated 
with T+LNG was obtained from Matthiesson et al. (2005a), and compared to claudin-11 (green) 
localisation in testis biopsies obtained from the same men (♂). Different individuals were allocated 
numbers by Matthiesson et al. (2005a) which were 105 (■), 106 (●), 109 (▲), 123 (♦), 131 (□). Only 
numbers 109 and 131 were available for immunohistochemical analysis. Germ cell types presented 
are: All A type spermatogonia (All A), type A dark spermatogonia (Ad), type A pale spermatogonia 
(Ap), type B spermatogonia (B), preleptotene spermatocytes (Pl), leptotene/zygotene spermatocytes 
(L-Z), pachytene spermatocytes (PS), round spermatids (rS), step 3-6 elongating spermatids (3-6 ST), 
step 7-8 elongating spermatids (7-8 ST) and sperm. Bar = 50μm. 
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Figure 7.4c Comparison of claudin-11 protein localisation with extent of spermatocyte 
suppression in T+LNG+A treated men. 
 Germ cell data for leptotene, zygotene and pachytene spermatocytes (arrows) in men treated 
with T+LNG+A was obtained from Matthiesson et al. (2005a), and compared to claudin-11 (green) 
localisation in testis biopsies obtained from the same men (♂). Different individuals were allocated 
numbers by Matthiesson et al. (2005a) which were 104 (■), 117 (●), 126 (▲), 136 (♦), 141 (□). Only 
numbers 117, 126 and 136 were available for immunohistochemical analysis, with the grey channel of 
the confocal microscope provided for man 136 to highlight claudin-11 localisation with respect to the 
seminiferous tubules. Germ cell types presented are: All A type spermatogonia (All A), type A dark 
spermatogonia (Ad), type A pale spermatogonia (Ap), type B spermatogonia (B), preleptotene 
spermatocytes (Pl), leptotene/zygotene spermatocytes (L-Z), pachytene spermatocytes (PS), round 
spermatids (rS), step 3-6 elongating spermatids (3-6 ST), step 7-8 elongating spermatids (7-8 ST) and 
sperm. Bar = 50μm. 
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Figure 7.4d Comparison of claudin-11 protein localisation with extent of spermatocyte 
suppression in T+LNG+D treated men. 
 Germ cell data for leptotene, zygotene and pachytene spermatocytes (arrows) in men treated 
with T+LNG+D was obtained from Matthiesson et al. (2005a), and compared to claudin-11 (green) 
localisation in testis biopsies obtained from the same men (♂). Different individuals were allocated 
numbers by Matthiesson et al. (2005a) which were 107 (■), 108 (●), 120 (▲), 124 (♦), 127 (□), 132 
(2). Only numbers 107, 120 and 132 were available for immunohistochemical analysis. Germ cell 
types presented are: All A type spermatogonia (All A), type A dark spermatogonia (Ad), type A pale 
spermatogonia (Ap), type B spermatogonia (B), preleptotene spermatocytes (Pl), leptotene/zygotene 
spermatocytes (L-Z), pachytene spermatocytes (PS), round spermatids (rS), step 3-6 elongating 
spermatids (3-6 ST), step 7-8 elongating spermatids (7-8 ST) and sperm. Bar = 50μm. 
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suppressed spermatocyte numbers to approximately 20% of controls, and also demonstrated punctate 
claudin-11 staining at the TJ. In man number 132, spermatocyte numbers remained at 50% of control. 
The biopsy section was again poor, but claudin-11 formed continuous TJ strands which resembled that 
seen in the previous control images (Figure 7.4d). 
 
7.3.4 RNA Amplification with MessageAmp II kit for RT-PCR analysis 
Amplification of each testis mRNA sample was successful. The amplification of the human 
testis QC extract from Ambion was 100 fold, which was the fold-amplification expected for an 8 hour 
incubation in the IVT buffer for aRNA synthesis (see Section 7.2.5c). 
 
7.3.5 RT-PCR validation 
After reverse-transcribing the amplified RNA into cDNA, RT-PCR was conducted using 
human β-actin primers, and the products separated on an agarose gel. A single band for β-actin was 
obtained at the expected molecular weight and subsequent DNA sequencing analysis confirmed the 
identity of the gene. It was therefore concluded that the cDNA produced from the amplified RNA was 
suitable for subsequent RT-PCR analyses. 
 
7.3.6 Effects of gonadotrophin suppression on junctional mRNA expression 
Gonadotrophin suppression did not alter the mRNA expression of any of the TJ proteins tested 
(claudin-11, claudin-3, occludin, JAM-A), or the cytoplasmic plaque protein ZO-1 (Figure 7.5). A 
decreasing trend in occludin mRNA expression was evident but this did not achieve significance (p = 
0.203). Gonadotrophin suppression also had no effect on the mRNA expression of any of the other 
junctional proteins tested; vinculin, connexin-43 or β-catenin (Figure 7.5).  
β-actin mRNA levels remained consistent across the groups (Figure 7.6). Androgen regulated 
INSL-3 decreased 20-fold (p < 0.001) in each of the suppressing treatments compared to control 
(Figure 7.6). 
 
 
  
 
 
 
 
 
 
Figure 7.5 RT-PCR analysis of mRNA expression in hormone suppressed human testes. 
 mRNA was supplied from control men and men treated with T+A, T+LNG, T+LNG+A and 
T+LNG+D from Matthiesson et al. (2005a). mRNA was amplified to maximise availability, before a 
final reverse transcription was conducted to produce the cDNA required for RT-PCR. Responses to 
hormone suppression were analysed for the TJ proteins claudin-11, occludin, JAM-A and claudin-3 as 
well as for proteins from different junctional types, including ZO-1 (cytoplasmic plaque), vinculin 
(ectoplasmic specialisation), β-catenin (adherens junction) and connexin-43 (gap junction). Data is 
mean ± SEM, n = 3-5/group as shown. 
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Figure 7.6 RT-PCR analysis of androgen regulated INSL-3 and housekeeper protein β-actin 
mRNA expression in response to hormone suppression in men. 
 mRNA was supplied from control men and men treated with T+A, T+LNG, T+LNG+A and 
T+LNG+D from Matthiesson et al. (2005a). mRNA was amplified to maximise availability, before a 
final reverse transcription was conducted to produce the cDNA required for RT-PCR. Responses to 
hormone suppression were analysed for the androgen-regulated protein INSL-3 (note logarithmic y-
axis) as well as the housekeeper protein β-actin. Data is mean ± SEM, n = 3-5/group. a versus b = p < 
0.001. 
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7.4 Discussion 
The aims of studies presented in this Chapter were to i) determine the effects of gonadotrophin 
suppression on the Sertoli cell TJ, as well as other nearby junctional types in men with respect to 
protein localisation and mRNA expression and ii) determine whether intrinsic differences in germ cell 
response within each treatment group as reported in Matthiesson et al. (2005a) were associated with 
changes in TJ protein localisation, using claudin-11 as the TJ marker. 
Previous data has shown in hypogonadotrophic hypogonadal men that TJs are immature in 
appearance (de Kretser and Burger, 1972), and this Chapter has shown that at the molecular level, 
claudin-11 localisation to the TJ is disrupted by gonadotrophin suppression. In the most severely germ 
cell-deplete testes according to the Matthiesson et al. (2005a) study, claudin-11 staining was reduced 
to a phenotype of primarily punctate staining at the outer edge of the seminiferous tubules. This 
phenotype was conserved across each gonadotrophin suppression treatment, all of which used a 
testosterone implant to promote negative feedback at the pituitary in conjunction with different modes 
of suppression such as GnRH antagonism (acyline), progestin (levonorgestrel) to inhibit androgen 
production, and a 5α-reductase inhibitor (dutasteride) to block the conversion of testosterone to the 
more potent androgen DHT (Matthiesson et al. 2005b, Matthiesson et al. 2005a). This suppressed 
claudin-11 phenotype also marks a departure from the cytoplasmic localisation of claudin-11 and other 
TJ proteins which occurs in the absence of gonadotrophins in rodent species, as displayed in the rat 
and mouse in this thesis, and also in the hamster (Tarulli et al. 2008).  
As there were no significant differences in germ cell numbers for type B spermatogonia and 
later germ cell types between the various treatments (Matthiesson et al. 2005b), it was expected that 
the claudin-11 localisation would also be similar between these groups. However, within each 
treatment group, there was some heterogeneity observed in claudin-11 localisation response between 
men, from a phenotype with very limited punctate staining at the basal aspect of tubules, to an almost 
continuous TJ staining phenotype resembling the human control testes. To some extent, this result 
matched the extent of germ cell suppression for those germ cell types which normally reside within the 
blood-testis barrier, these being leptotene, zygotene and pachytene spermatocytes (Matthiesson et al. 
2005b).  
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Interestingly, it generally appeared that when the numbers of these germ cells were at their 
lowest (typically <5% of control values), the regressed claudin-11 phenotype was at its most punctate. 
For example, in men numbered 122 and 137 who had received T+A for 8 weeks, leptotene, zygotene 
and pachytene spermatocytes were at approximately 30% of control numbers and claudin-11 was more 
extensive at the TJ, compared to other men in the same treatment group (numbers 101, 116) who had 
spermatocytes at < 5% of control and punctate claudin-11 staining. The same pattern was seen in the 
T+LNG treatment group for man number 131 who had leptotene, zygotene and pachytene 
spermatocyte numbers at 40% of control and more extensive claudin-11 staining than man 109, who 
had lower spermatocyte numbers (< 5% of control) and more punctate claudin-11 staining. Again in 
the T+LNG+D group, spermatocyte numbers were at 50% of control in man number 132, and claudin-
11 staining was more extensive at the TJ. In the other two men from this group, spermatocyte numbers 
were lower and claudin-11 staining was punctate. In T+LNG+A, all spermatocyte numbers were 
between 10%-15% of control values, and claudin-11 varied from punctate to continuous staining in 
each of the men. While there seems to be an apparent trend in the data, not all samples conformed to 
this trend. Man number 102 (T+A treated) presented punctate claudin-11 staining at the TJ despite 
having leptotene, zygotene and pachytene spermatocyte numbers of approximately 20% of control, 
which was well above the ~5% of control spermatocyte numbers that men numbers 101 and 116 (from 
the same treatment group) presented along with reduced claudin-11 staining, and within the range of 
men who presented with more extensive claudin-11 staining. Therefore this study is an important first 
indication that the structure of the human TJ may be altered by gonadotrophin suppression, but 
additional studies will be needed to determine if this is true such as functional testing of the TJ in 
similar primate models.  
It is hypothesised from the data presented herein that there may be a threshold at which once a 
particular amount of claudin-11 has been ‘lost’ form the Sertoli cell TJ in men, adluminal germ cells 
including leptotene, zygotene and pachytene spermatocyte numbers decrease and this may be directly 
related to an existence of a TJ functional threshold. While all men showed reduced spermatocyte 
numbers, the differences in degrees of reduction may suggest that some men in the treatment groups 
crossed this hypothesised threshold earlier than others. It may also suggest that the intrinsic 
differences in germ cell response to hormone suppression in men receiving the same treatment in the 
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Matthiesson et al. (2005a) study was actually attributable to intrinsic differences in TJ response to 
hormone suppression between men. 
Further work is required to confirm the above speculation especially considering that changes 
in TJ protein localisation induced by gonadotrophin suppression in this Chapter was observed for just 
a single protein (claudin-11). While the claudin-11 knockout mouse is infertile (Gow et al. 1999), it is 
possible that another TJ protein could be maintaining TJ function and integrity to some extent and 
could also be accounting for the apparent intrinsic differences in TJ response to hormone suppression 
with the same treatment between men. Occludin was not able to be immunolocalised in this Chapter 
and the staining for claudin-3 was the same in the negative control (Figure 7.7). However the mRNA 
for both proteins was shown to be present in the testis. Claudin-3 was detected in the hamster positive 
control testis, but only stained the blood vessels in the rat (Figure 7.7) which supported the findings of 
Kaitu’u et al. (2007) where claudin-3 mRNA expression or protein localisation could not be detected 
in rat Sertoli cells in vitro. Alternatively, electron microscopy could be used as an additional 
assessment of changes in TJ structure in response to gonadotrophin suppression. This technique was 
successfully applied in the past to analyse the state of the Sertoli cell TJ in hypogonadotrophic 
hypogonadal men (de Kretser and Burger, 1972). It is hypothesised that in the men analysed in this 
study, the TJ would display an immature phenotype as it did in the de Kretser and Burger (1972) 
study. 
Evidence for a functional threshold mentioned above of the Sertoli cell TJ was seen in the rat 
and mouse studies presented in Chapters 5 and 6 respectively. In some seminiferous tubules, 
spermatogenesis was seen to be proceeding, yet biotin tracer could still cross the TJ indicating it was 
not completely functional. However, it was functional enough that it was above the threshold for 
successful spermatogenesis. Unfortunately, this Chapter could not test for changes in TJ function in 
response to gonadotrophins suppression in men as the testis samples had already been processed 
previously for immunohistochemical and RT-PCR work.  
Future studies investigating hormonal regulation of Sertoli cell TJs in men will therefore need 
to include a test of TJ function to address the points raised above. The nature of this test is not 
immediately clear, as the current biotin administration technique will not be practical. However, it 
may be possible that changes in TJ function in vivo could be qualitatively assessed using a testis
  
 
 
 
 
 
 
Figure 7.7 Localisation of claudin-3 in hamster, human and rat testes. 
 Hamster testis tissue (panel A) which had been fixed in Bouin’s, as well as control human 
testis (panel B) tissue from Matthiesson et al. (2005a) was analysed by immunohistochemistry for 
claudin-3 (green, arrows) localisation to the Sertoli cell TJ. An adult control rat testis section (panel C) 
was also analysed for claudin-3 (green, arrows) localisation in seminiferous tubules (highlighted by 
red hashed line) using a blood vessel (centre) as the positive control. Bar = 50μm. Inset = negative 
control. 
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biopsy (~100mg) in conjunction with the biotin tracer technique as conducted in the previous two 
Chapters. To test this suggestion, a testis biopsy was conducted on a control adult rat testis by slitting 
the tunica albuginea to expose a portion of the seminiferous tubules to excise and incubate in biotin 
and then fix in Bouin’s for immunohistochemical analysis via the established protocol. The biopsy 
experiment was conducted to replicate the means by which the human testis samples were obtained. 
Biotin staining was not only extensive in the interstitium and basal part of the seminiferous tubules, 
but was also present throughout the seminiferous tubules (Figure 7.8), indicating that the biotin tracer 
had entered through the severed ends of the tubules. In the intratesticular injection procedure, the 
tubules remain intact which prevents this problem.  
Hence, the use of biotin as a qualitative TJ functional marker on human testis biopsies would 
not work. An alternative means could be to conduct experiments on primates and administer biotin to 
the testis via arterial perfusion. Or, for more direct administration to the testis, biopsied seminiferous 
tubules could be ligated to close the severed ends and then incubated in biotin. While the latter 
procedure would be more difficult, the ligation of efferent ducts in another study induced the retention 
of testicular fluid within the testis (Tao et al. 2000) and so this technique could be applied to the 
seminiferous tubules as well. 
This Chapter has also shown that gonadotrophin suppression in men appears to specifically 
affect the TJ but generally not the nearby junctional types. No changes in immunofluorescent 
localisation of markers for the adherens junction, ectoplasmic specialisation or cytoplasmic plaque 
were observed after 8 weeks of suppression, with marginal changes seen in the localisation of 
connexin-43 to the gap junction. These results appear similar to those observed in the hpg mouse in 
Chapter 6, although in that model some disruption of vinculin localisation to the ectoplasmic 
specialisation was noted. Arguably, an extended period of gonadotrophin suppression to further 
suppress spermatogenesis and germ cells may result in changes in the other junctional types. 
Connexin-43 is important to Sertoli-Sertoli cell and Sertoli-germ cell interactions (Drummond et al. 
2000, Sridharan et al. 2008) and the loss of germ cells may have led to the changes in connexin-43 
localisation observed. Its continued presence could have been due to some residual FSH in the 
treatment groups (0.5%-0.8% of control (Matthiesson et al. 2005a)), or thyroid hormone which has  
  
 
 
 
 
 
 
Figure 7.8 Biotin localisation in an adult rat testis biopsy. 
 One adult rat was killed by CO2 asphyxiation and one of the testes was excised. The tunica 
was nicked to expose the seminiferous tubules and a small portion of these were cut from the testis and 
incubated in biotin (10mg/ml) tracer for 30 minutes before being fixed in Bouin’s fixative for 5 hours. 
The tissue was then embedded in paraffin wax and processed by immunohistochemistry with 
streptavidin alexa-488 to probe for biotin (green) localisation. Biotin localised basally to the TJ is 
indicated by arrows and adluminally localised biotin has been indicated by asterisks. Bar = 50μm. 
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also been shown to regulate connexin-43 (Stuurman et al. 1998, Harborth et al. 2001, Sridharan et al. 
2008). 
ZO-1 localisation to the cytoplasmic plaque in this study was unaffected by gonadotrophin 
suppression. This may have been an expected result, as unlike in the rodent models in this thesis, 
claudin-11 which binds to the cytoplasmic plaque, did not redistribute to the cytoplasm and so there 
may not have been a requirement for ZO-1 to redistribute either. β-catenin was still localised at the 
adherens junction in this model, and the adherens junction also binds to the cytoplasmic plaque (Yan 
and Cheng, 2005). This may also explain the continued presence of ZO-1 at the cytoplasmic plaque in 
the hpg mouse which was also coincident with continued β-catenin staining. 
The response of junctional mRNA expression to gonadotrophin suppression in men was also 
analysed. RNA samples from the Matthiesson et al. (2005a) study were amplified to maximise 
availability for these studies and was shown to be successful through the production of RNA which 
was viable for RT-PCR. This was after reverse transcription gave a single band for housekeeper 
protein β-actin on a DNA agarose gel at the expected molecular weight and DNA sequence. Viability 
was further demonstrated after RT-PCR analysis showed that the mRNA expression levels of β-actin 
did not change across the treatment groups.  
Expression of the androgen-regulated protein INSL-3 was decreased by approximately 20-fold 
in the gonadotrophin suppressed groups, and is consistent with the low levels of intratesticular 
androgens as measured in the Matthiesson et al. (2005a) study. This INSL-3 mRNA data also 
resembled the results obtained in the previous two Chapters presented in this thesis, although it is 
noteworthy that the magnitude of the suppression was considerably greater in humans (22 fold) 
compared to rats (12 fold) and mice (15 fold).  
The mRNA expression of TJ proteins claudin-11, occludin, JAM-A and claudin-3 was 
unaffected by gonadotrophin suppression. Occludin mRNA expression did appear to decrease with 
hormone suppression, but this result did not achieve significance (p = 0.203). In addition, the mRNA 
expression of markers of the nearby junctional types was also unaffected. The result for claudin-11 
was unexpected as protein staining while still at the TJ, was markedly reduced compared to controls. 
In the rat and mouse Chapters presented herein, mRNA expression levels for claudin-11 and/or 
occludin tended to increase when TJ protein localisation to the TJ was disrupted in the absence of 
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circulating hormones. A similar result was seen in the hamster, where like in the rat, the mRNA 
expression of claudin-11 and occludin increased in reduced hormone levels (Tarulli et al. 2008),  
indicating that the mRNA expression of both proteins respond differently to hormone suppression in 
the human than in rodents. This role for gonadotrophin regulation of TJ protein localisation has now 
been demonstrated in rats, mice and humans which demonstrates a conserved trend of hormonal 
regulation of the TJ among mammalian species and suggests that the regulation of mRNA expression 
is mediated by something else either separately to or in conjunction with gonadotrophins, such as local 
factors. 
In the Matthiesson et al. (2005a) study, spermiogenesis failed demonstrating the regulatory 
mechanism of gonadotrophins (particularly androgens) during this point of spermatogenesis. It was 
argued that since decreases were seen in late spermatid and round spermatid numbers in two other 
studies which used TE + progestin depot medroxyprogesterone acetate (DMPA) (Zhengwei et al. 
1998, McLachlan et al. 2002a) that decreases in earlier spermatogonia was a flow on effect of the loss 
of the spermatids. Indeed, when claudin-11 was stained in testis biopsies which had been obtained 
from one of these studies (McLachlan et al. 2002a), its localisation at the TJ, while more diffuse, 
remained extensive and generally continuous at TJs even after 12 weeks of TE + DMPA treatment and 
despite large germ cell losses as mentioned (Figure 7.9). Staining was not punctate like that obtained 
in this thesis. However, as already mentioned in this thesis, the Sertoli cell TJ is essential for 
spermatogenesis and its absence results in infertility Chung and Cheng, 2001, Chung et al. 2001). 
Given that this Chapter has suggested that gonadotrophins may regulate the Sertoli cell TJ in men and 
that gonadotrophins also regulate spermiogenesis in men (Zhengwei et al. 1998, McLachlan et al. 
2002a, Matthiesson et al. 2005b), it can be argued that the loss of germ cell types in the human 
seminiferous epithelium as a response to gonadotrophin suppression is a combined effect of the loss of 
TJ integrity and spermiogenesis. Differences in claudin-11 localisation in response to TE+DMPA and 
TE+treatments form this study suggests a different mode of action for the progestin DMPA compared 
to other treatments used herein. To reinforce this contribution of the TJ, on needs to conduct functional 
testing in a follow up study.  
  
 
 
 
 
Figure 7.9 Claudin-11 localisation in TE+DMPA and T+A treated men. 
Claudin-11 (green) was probed in Bouin’s fixed control human testes (panel A) and 
testes which had been treated with TE+DMPA for 12 weeks (obtained from McLachlan et al. 
(2002a)) (panel B). Immunohistochemical analyses on these testes was conducted by Gerard 
Tarulli at Prince Henry’s Institute of Medical Research, Melbourne and are representative of 
all testes probed in these treatment groups. These immunofluorescence micrographs have 
been presented here as a comparison with the control (panel C) and T+A treated testes 
(obtained from Matthiesson et al. (2005)) (panel D) conducted in this Chapter. Note that 
claudin-11 in panel A and B was co-stained with gap junction protein connexin-43 (red), 
hence the yellow staining. 
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In conclusion, evidence is presented here to show that gonadotrophins can regulate the 
localisation of claudin-11 to the Sertoli cell TJ in men. Intrinsic differences in claudin-11 localisation 
response to gonadotrophin suppression between men within the same treatment group was observed 
and seems to be associated with the intrinsic differences observed in germ cell suppression 
(Matthiesson et al. 2005b). The suppression of circulating gonadotrophins resulted in the reduction of 
protein staining at the TJ and the cessation of spermatogenesis. The structural integrity of the Sertoli 
cell TJ in men, is therefore essential for successful spermatogenesis and thus it is speculated that the 
Sertoli cell TJ could prove to be a potential target of hormonal contraception in men.  
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Chapter 8. General discussion 
The aims of the studies described in this thesis were to assess the relative contribution of the 
integral transmembrane proteins claudin-11 and occludin to the Sertoli cell TJ in vitro, and to 
determine the roles that gonadotrophins have in maintaining and stimulating the formation of Sertoli 
cell TJ function and structure in the rat and mouse in vivo. Furthermore, this thesis aimed to analyse 
gonadotrophin regulation of the Sertoli cell TJ in gonadotrophin-suppressed men. 
Studies in the first part of this thesis demonstrated that both claudin-11 and occludin had 
important roles in maintaining TJ function in an immature rat Sertoli cell culture model, in vitro. The 
genetic silencing of claudin-11 or occludin with siRNA resulted in a decrease in TJ function of 
approximately 50% in vitro as measured by TER, while silencing both proteins in combination 
decreased TJ function by 62% in vitro. It was concluded that silencing both proteins together had no 
additive effect on TJ function compared to silencing either protein in isolation as the difference 
between the results, while significant, was marginal. The disruption to TJ function due to the silencing 
of claudin-11 in vitro is consistent with the infertility phenotype of the claudin-11 knockout mouse 
(Gow et al. 1999). Future studies to determine whether a similar 50% knockdown of claudin-11 in 
vivo would be sufficient to cause a loss of TJ function in an established adult mouse/rat model where 
spermatogenesis is ongoing would be interesting. Such methodologies could involve the use of siRNA 
to selectively silence its expression, in conjunction with molecular tracers of varying sizes to establish 
changes in permeability of the epithelium. The significant TJ functional role found for occludin in 
vitro, was more surprising given that its knockout is fertile in young adults (Saitou et al. 2000), which 
had led to the hypothesis that its contribution to Sertoli cell TJ function would be significantly less 
than that of claudin-11. In fact, in the in vitro Sertoli cell culture both TJ proteins were comparable, at 
least in terms of TER. The in vivo studies using siRNA mentioned above for claudin-11 should also be 
applied for studying the contribution of occludin to Sertoli cell TJ function in vivo. 
The literature however, does point to changes in TJ function induced by experiments targeting 
the occludin protein. For example, the treatment of cultured Xenopus embryo epithelial cells or 
cultured rat Sertoli cells with synthetic peptides corresponding to one of the extracellular loops of 
occludin increased paracellular permeability in vitro (Wong and Gumbiner, 1997, Chung et al. 2001). 
Furthermore the intratesticular injection of one of these peptides into adult rat testes resulted in 
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massive germ cell loss in vivo (Chung et al. 2001). A similar increase in paracellular flux was seen in 
cultured MDCK cells when chicken occludin lacking the entire C-terminal domain was transfected 
into them Balda et al. 1996). Conversely, the over-expression of wildtype occludin in the same cells 
simulated TER Balda et al. 1996). These data implicate a role for occludin in the regulation of TJ 
function as outlined in Chapter 1 (see Section 1.4.4a). Such regulatory roles for occludin are evident in 
that ‘tighter’ TJs such as those found in the bladder epithelium contain more occludin protein than 
‘looser’ TJs such as the intestine, with the Sertoli cell TJ considered to be one of the ‘tighter’ TJs in 
the mammalian body (Dym and Fawcett, 1970, Hirase et al. 1997, Sluka et al. 2006). No such variable 
phenotype for the claudins has been found with respect to the tightness of TJs. Therefore, the silencing 
of occludin at the Sertoli TJ with siRNA, may have resulted in a ‘looser’ TJ, which equated to 
decreased transepithelial electrical resistance and therefore decreased TJ function, in vitro. 
However, a recurring theme in this thesis showed that reduced Sertoli cell TJ function does 
not necessarily equate with spermatogenic inactivity, and that there may be a TJ functional threshold 
above which spermatogenesis continues to function normally, but below which loss of germ cells and 
Sertoli cell function occurs. The phenotype of the claudin-11 knockout indicates that the absence of 
claudin-11 at the Sertoli cell TJ breaches this threshold. The occludin knockout mouse model is less 
clear (Gow et al. 1999). These mice displayed normal spermatogenesis at 6 weeks of age, but by 40 
weeks of age, seminiferous tubules displayed atrophy and contained Sertoli cells only (Gow et al. 
1999). While the reasons for this are uncertain, the authors suggested that the ablation of downstream 
signalling mechanisms potentially mediated by occludin, could have led to a gradual onset of 
infertility (Gow et al. 1999). This meant that the TJ functional threshold was gradually breached 
somewhere between 6 weeks and 40 weeks of age. As mentioned earlier, the role of occludin at the TJ 
still needs to be fully elucidated. While several studies have shown that cytokines or environmental 
toxicants can affect the function of the Sertoli cell TJ (Lui et al. 2001, Lui et al. 2003a, Siu et al. 2003, 
Cheng and Mruk, 2004, Lui and Lee, 2006, Zhang et al. 2008), no other models apart from the 
knockouts provide evidence of a functional threshold at the Sertoli cell TJ with respect to active 
spermatogenesis in vivo.  
The fact that spermatogenesis does not depend upon a fully functional TJ is very interesting. When 
spermatogenic activity was suppressed in the GnRH-antagonist treated rat and arrested in the hpg 
 171
mouse, low molecular weight biotin tracer was present on the adluminal side of the Sertoli cell TJ 
indicating disrupted TJ function (Figure 8.1). This was coincident with reduced-to-absent tubule 
lumens, which is taken as a good morphological indicator about the functionality of testicular TJs 
(Bergmann, 1987, Pelletire, 1990). When hCG, which stimulates testicular testosterone production, 
and/or FSH were selectively replaced, spermatogenic activity re-initiated as shown by larger tubule 
diameters with the reappearance of tubule lumens, and reappearance of adluminal germ cells. This was 
all in the presence of a ‘leaky’ Sertoli cell TJ as shown by the continued presence of biotin in the 
adluminal compartment of the seminiferous tubules (Figure 8.1). In the human, some meiotic and 
post-meiotic germ cell types were present in hormone-suppressed testes, despite markedly reduced 
claudin-11 staining at the TJ. While no functional analyses were carried out in the human study, it is 
hypothesised based on the rat and mouse data that the human Sertoli cell TJ was not fully functional, 
but that sufficient function remained to allow some spermatogenic activity.  
Work in this thesis has therefore demonstrated that Sertoli cell TJ functionality should not be 
regarded as an ‘on-off switch’ in terms of spermatogenesis in the adult animal, but rather that 
functionality can vary over a range commensurate with ongoing spermatogenic activity. However, this 
is not a particularly novel finding for the Sertoli cell TJ, or for TJs in other epithelia, as illustrated by 
the following examples. The low molecular weight tracer [51Cr]-EDTA (341Da) was still detectable on 
the adluminal side of the blood-testis barrier in post-pubertal rats at 25 days of age (Setchell et al. 
1981, Setchell et al. 1988), which is well into spermatogenesis as shown by the presence of post-
meiotic round spermatids in the epithelium (Meachem et al. 1996). In the claudin-5 knockout mouse, 
the blood-brain barrier was disrupted as shown by the penetration of a low molecular weight biotin 
tracer (443Da) into the brain parenchyma indicating altered TJ function (Nitta et al. 2003). However, 
these mice were apparently healthy and did not suffer any bleeding or oedemas (Nitta et al. 2003). In 
this same claudin-5 knockout model, a larger microperoxidase tracer (1.9kDa) was excluded by the 
blood-brain barrier, indicating that the claudin-5 deficient TJ retained a size-selective phenotype. 
Watson et al. (2001) showed that the permeability of cultured Caco-2 and T84 intestinal cells was 
inversely proportional to the increasing size of 24 polyethylene glycols ranging from 252Da-1255Da 
in vitro, with a cut-off in TJ permeability to tracers of greater than 458Da. In a similar study, mannitol 
treatment to cultured brain cells induced a significantly higher permeability to the smallest of
  
 
 
 
 
 
 
Figure 8.1 Tight junction function and active spermatogenesis. 
Testes from the GnRH-antagonist treated rat study (panels A – C) and the hpg mouse study 
(panels D – F) were stained for biotin (green, arrow head) and TJ proteins occludin (rat, red, arrow) or 
claudin-11(mouse, red, arrow). Treatment groups presented in this figure are cross-sections through i) 
control rat and mice testes (panels A and D respectively); ii) acyline treated rat testes (8 weeks) and 
hpg mouse testes (panels B and E respectively) and iii) hCG + FSH Ab treated (7 days) rat testes and 
hpg + tgFSH mouse testes treated with 10 days of androgen DHT (panels C and F respectively). Bar = 
50μm. Inset = negative control. 
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three tracers ([14C]sucrose, 342Da) employed, compared with the next smallest tracer ([3H]inulin, 
5kDa) in vitro, whereas the third and largest tracer (Evan’s Blue Dye, 67kDa) remained impermeable 
(Deli et al. 1995). None of the tracers were permeable to the TJ in the untreated cells (Deli et al. 
1995). Hence, TJs are size-selective, and the removal of certain protein components alters this size-
selective nature (Watson et al. 2001, Nitta et al. 2003 ). Most of the literature suggests that the 
claudins contribute to the size-selectivity of TJs (Watson et al. 2001) although changes in the size-
selectivity of the Sertoli cell TJ or other epithelial TJs in the occludin knockout mouse, were not 
analysed (Gow et al. 1999), so the contribution of occludin to size-selectivity is not known. 
The threshold at which TJ function is completely disrupted is therefore the point at which the 
TJ cannot selectively maintain the integrity of the microenvironment(s) or compartment(s) it regulates 
either side of any given barrier. Examples of this include massive transepidermal water loss in the 
claudin-1 knockout mouse (Furuse et al. 2002), and Mg2+ and Ca2+ wastage in some human renal 
diseases where claudin-16 failed to localise to the TJ (Simon et al. 1999, Kausalya et al. 2006, Muller 
et al. 2006, Gonzalez-Mariscal et al. 2008). In the testis, a loss of blood-testis barrier integrity could in 
theory lead to the induction of macrophages or immuno-modulatory factors including TGFβ3, TNFα, 
IL-1 (α/β) and interferon-γ (Gerdprasert et al. 2002, Hedger, 2002, Hedger et al. 2005, O’Bryan et al. 
2005), or possibly an autoimmune response to adluminal germ cell antigens which are normally 
sequestered from the immune system by the TJ Chung and Cheng, 2001, Chung et al. 2001), although 
evidence for this needs to be elucidated.  
In the GnRH antagonist-treated rat study, a greater number of macrophages appeared to 
increase and localise to the periphery of the seminiferous tubules, with the occasional macrophage 
actually penetrating into the lumen of some tubules. A similar induction of macrophage localisation to 
the periphery of seminiferous tubules was seen in LPS-treated rat testes where testosterone production 
was attenuated, resulting in a pro-inflammatory response (Gerdprasert et al. 2002, Hedger et al. 2005, 
O’Bryan et al. 2005). This inflammatory response was reversed following the exogenous application 
of testosterone (Gerdprasert et al. 2002, Hedger et al. 2005, O’Bryan et al. 2005). The very 
preliminary result for macrophage induction obtained for the GnRH antagonist-treated rat, suggests 
that there might have been an immune response, similar to LPS treatment, following gonadotrophin 
suppression and subsequent TJ disruption. Much more work is needed to identify which, if any, 
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macrophage elements and/or immuno-modulatory factors were elevated in response to the impaired 
Sertoli cell TJ. However, it is already known that several of these factors, including TNFα and TGFβ3, 
can negatively regulate blood-testis barrier dynamics (Lui et al. 2001, Lui et al. 2003a, Siu et al. 2003, 
Cheng and Mruk, 2004, Lui and Lee, 2006), and that their expression levels in the seminiferous 
epithelium are lowest as TJs form (Lui et al. 2001, Lui et al. 2003a, Siu et al. 2003, Cheng and Mruk, 
2004, Lui and Lee, 2006). In addition, intratesticular administration of TNFα to rats resulted in germ 
cell loss, and the opening of testicular TJs as monitored with a fluorescent dye (FITC) in vivo (Li et al. 
2006). Similarly, TGFβ3 dose-dependently disrupted the function of cultured rat Sertoli cell TJs as 
shown by decreases in TER in vitro (Lui et al. 2001). Given the regulatory role these local paracrine 
factors appear to have with respect to TJ function, it is hypothesised that an interplay between these 
factors and gonadotrophins can regulate Sertoli cell TJ function in the rat in vivo.  
The infiltration of biotin into the seminiferous epithelium in low levels of gonadotrophins in 
this thesis, points to an alteration in the size-selective nature of the Sertoli cell TJ. Two other tracers of 
differing size ([14C]mannitol, 182Da, and [3H]methoxy-inulin, 5kDa) were also employed in this 
thesis, but without success primarily due to technical difficulties. However, other tracers such as 
fluorescently labelled FITC-dextran (4kDa, 10kDa or 40kDa) (Sonoda et al. 1999, Nitta et al. 2003) 
are available and might be easier alternatives which could provide a more detailed qualitative analysis 
of changes in Sertoli cell TJ size-selectivity following hormone suppression and/or 
replacement/administration. If the TJ was permeable to each of these tracers in the acyline-treated rat 
or hpg mouse, one might be able to analyse changes in the size-selectivity of the TJ as hormones are 
replaced/administered, and in particular, determine at which specific point with respect to size-
selectivity that germ cells normally found in the adluminal compartment, reappear. Evidently, 
spermatogenesis can re-initiate while TJs are still permeable to small molecules less than or equal to 
600Da as shown with biotin. Such data suggests a link between TJ function/size-selectivity and germ 
cell survival/progression in animal models, which could potentially be useful in predicting the extent 
to which TJ function has to be suppressed for spermatogenic arrest in the human. 
In the low levels of circulating gonadotrophins in the GnRH antagonist-treated rat or hpg mouse 
models, testicular TJ proteins were either undetectable (as for occludin in the rat model), or localised 
in the Sertoli cell cytoplasm (as for claudin-11 in the rat and mouse models) toward the centre of the 
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seminiferous tubules. This cytoplasmic localisation of claudin-11 was very similar to that observed in 
the short-day hamster testis, where occludin was also seen to be cytoplasmic (Tarulli et al. 2006, 
Tarulli et al. 2008) (Figure 8.2), suggesting species differences and similarities with respect to 
hormonal regulation of TJ protein localisation. Unlike the rodent models, claudin-11 in 
gonadotrophin-suppressed men became more punctate at the Sertoli cell TJ and did not redistribute to 
the cytoplasm, suggesting differences in the regulatory pathways for TJ proteins between humans and 
rodents. The human and rodent models did, however, give unexpected results for gonadotrophin 
regulation of TJ mRNA expression. Given that testosterone has been shown elsewhere to regulate rat 
Sertoli cell claudin-11 mRNA expression in vitro (Kaitu’u et al. 2007), and that treatment with the 
androgen receptor antagonist, flutamide, inhibited claudin-11 mRNA expression in vivo (Florin et al. 
2005), it was expected that gonadotrophin suppression would lead to reduced TJ mRNA expression in 
the rat, mouse and human models. This was not the case, with mRNA expression for occludin and 
claudin-11 remaining unchanged in the human following gonadotrophin suppression, but significantly 
elevated or tending to be increased in the rodent models. Elevated mRNA expression levels of 
occludin and claudin-11 have also been reported in the rodent short-day hamster model, which has low 
serum gonadotrophins (Tarulli et al. 2008). 
These mRNA results are difficult to explain, but suggest a differential response between TJ 
mRNA expression and TJ protein localisation, with the potential for a block after mRNA transcription. 
The nature of such a inhibitory function is unknown, but could include the action of local cytokines 
such as TNFα and TGFβ3, which are known to prevent the localisation of TJ proteins to the TJ in vitro 
(Lui et al. 2001, Lui and Lee, 2006). This reinforces the notion made earlier for an interplay between 
hormonal and paracrine regulation of the Sertoli cell TJ, and also demonstrates that regulation of TJ 
mRNA expression across rodent species is conserved, but differs to the human. 
In the absence of detectable circulating gonadotrophins in the hpg mouse, TJ proteins were 
localised to the Sertoli cell cytoplasm, in a similar manner to that observed in the GnRH-antagonist 
treated rat, and short day hamster (Tarulli et al. 2006, Tarulli et al. 2008). The application of 
exogenous hormones to each of these models stimulated the re-localisation of TJ protein back to the 
TJ at the basal aspect of the seminiferous epithelium. This observation strengthens the conclusion that 
TJ protein localisation is hormonally regulated, but does not show the extent to which newly
  
 
 
 
 
 
 
Figure 8.2 Cytoplasmic localisation of TJ proteins in gonadotrophin suppressed rodent testes. 
The Sertoli cell TJ protein claudin-11 was stained in a Bouin’s fixed GnRH-antagonist treated 
rat testis (panel A, green) and a hpg mouse testis (panel B, red) to display the cytoplasmic localisation 
that occurs in low circulating gonadotrophin levels in rodents. This has been compared to a result 
obtained for occludin (green –open circles) in a short-day hamster testis (panel C) obtained from 
Tarulli et al. (2008). Bar = 50μm and inset = the negative control in panels A and B. In panel C, the 
bar = 50μm and the inset = an enlarged version of the micrograph. 
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synthesised protein is added to this apparent cytoplasmic pool as part of the relocalisation process. 
This cytoplasmic pool of TJ protein may exist in readiness for rapid TJ formation. It could 
also be important in the mechanism of TJ remodelling needed to allow germ cells to migrate into the 
adluminal compartment, where a rapid breakdown and reassembly of TJ proteins to maintain blood-
testis barrier integrity is required (Setchell, 1967, Zhou et al. 2002). 
Intracellular pools of claudins and occludin have been observed in Ca2+ depleted MDCK cells, 
in wound healing, and following treatment with proinflammatory cytokines (Ando-Akatsuka et al. 
1999, Lu et al. 2001, Bruewer et al. 2003, Ivanov et al. 2004, Bruewer et al. 2005, Morimoto et al. 
2005).  In fibroblastic baby hamster kidney cells and epithelial MTD-1A cells, it was found that the G-
protein Rab13, a member of a family of proteins which regulate the localisation of proteins to the cell 
surface and control cell polarity (Morimoto et al. 2005), regulated the localisation of occludin to the 
TJ in vitro and was co-localised with internalised occludin in the protein pool (Morimoto et al. 2005). 
The existence of a TJ protein pool was further demonstrated by the treatment of cultured polarised T84 
intestinal cells with the Escherichia coli-derived toxin cytotoxic necrotising factor-1 (Hopkins et al. 
2003). Upon exposure to the toxin, occludin was internalised and pooled into caveolae, early 
endosomes and recycling endosomes, and the authors suggested that this could enable occludin to 
avoid degradation and be recycled back into the TJ (Hopkins et al. 2003). Therefore, the existence of a 
TJ protein pool is not unusual, and hence may also be expected in the Sertoli cell. As mentioned in 
Chapter 5, images presented herein were not of sufficient resolution to allow visualisation of TJ 
proteins within defined cytoplasmic vesicles, although the data is strong enough to hypothesise that 
similar recycling of TJ proteins from the cytoplasm to the Sertoli cell TJ occurs like in other cell types. 
Recent studies have suggested that this is the case, where the cytokine IL-1α induced the relocalisation 
of claudin-11 and occludin to the Sertoli cell cytoplasm in rats (Sarkar et al. 2008). Furthermore, 
testosterone was also seen to induce internalisation of these proteins and their subsequent recycling 
back to the Sertoli cell membrane (Kaitu’u et al. 2007, Yan et al. 2008). It would be of interest to see 
whether Rab13 is localised at the Sertoli cell TJ, and is involved in the gonadotrophin-regulated 
recycling and redistribution of occludin and/or claudin-11 to the TJ. 
Claudin-11 and occludin were the key TJ proteins studied in this thesis, but in the mouse and 
hamster testes, claudin-3 is also present at the TJ, although only when germ cells migrate across the 
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blood-testis barrier (Meng et al. 2005, Tarulli et al. 2008). Previous evidence has shown that the 
mRNA expression of claudin-3 in mice is androgen regulated (Meng et al. 2005), whereas the 
localisation of claudin-3 protein to the TJ in the hamster is FSH regulated (Tarulli et al. 2008, Tarulli 
et al. 2006). This thesis confirmed these findings, with androgens seemingly playing a larger role than 
FSH with respect to claudin-3 localisation to the TJ in mice. Interestingly however, claudin-3 was not 
localised at the Sertoli cell TJ in rats or humans (recall Figure 7.8), suggesting that a different claudin 
could be expressed at the Sertoli cell TJ in rats and humans alongside claudin-11. The presence of 
more than one claudin in any given epithelial TJ is not unusual. Both claudin-5 and claudin-12 are at 
the blood-brain barrier (Nitta et al. 2003), claudin-1 and claudin-2 are present at TJs in the liver 
(Furuse et al. 1998), and claudin-3 and claudin-4 are often co-localised in numerous epithelia 
including the endometrium and ovary, pancreas, esophagus, breast and lung (Rangel et al. 2003, 
Nichols et al. 2004, Gyorffy et al. 2005, Tokes et al. 2005, Moldvay et al. 2007). It may be possible 
that claudin-4 is also present at the Sertoli cell TJ with claudin-3 (and claudin-11) in the mouse and 
hamster testis, or instead of claudin-3 in the human and rat testis. The presence of testicular claudin-4 
has only been demonstrated using northern blot analyses (Morita et al. 1999, Michl et al. 2001), hence 
the particular cells to which it is localised remain unknown. Further analyses are needed to find if 
other claudins are involved in the restructuring of Sertoli cell TJs as germ cells migrate, with claudin-4 
a suitable starting candidate along with other more ubiquitous claudins such as claudin-1 and claudin-5 
(Sidhu et al. 2003). 
In addition to claudin-11 and occludin, this thesis also investigated the regulation and 
localisation of JAM-A and ZO-1 in response to gonadotrophin suppression. The amount of literature 
covering JAM-A is limited, but is increasing. It appears that JAM-A is mainly important during TJ 
formation such as in the trophectoderm, where JAM-A has been shown to recruit adherens junction 
and TJ components (Thomas et al. 2004). Most recently, Tarulli et al. (2008) localised JAM-A to 
Sertoli-germ cell contacts surrounding the most basal spermatogonia in hamster testes, and also at 
Sertoli-Sertoli cell contact points. Its localisation around human spermatogonia has also been recently 
observed (Tarulli, personal communication). Following gonadotrophin suppression in the GnRH-
antagonist treated rat, JAM-A was predominantly localised to Sertoli cell cytoplasm in a similar 
manner to claudin-11 and occludin, but staining was also extensive at the basement membrane, which 
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may reflect spermatogonial staining as seen in the hamster (Tarulli et al. 2008) and human (Tarulli, 
personal communication). Like claudin-11 and occludin, JAM-A mRNA expression increased 
following gonadotrophin suppression, but in contrast to claudin-11 and occludin, JAM-A mRNA 
expression levels in the rat did not return back toward control levels upon short-term hormone 
replacement, which could again be due to a spermatogonial contribution. This early germ cell 
localisation of JAM-A, which appears conserved between hamsters, rats and men, is very interesting 
as TJs do not exist between Sertoli and germ cells (Cheng and Mruk, 2004, Sluka et al. 2006). JAM-A 
is known to regulate the passage of leukocytes across microvasculature epithelial cells (Martin-Padura 
et al. 1998, Tsukita and Furuse, 1999, Chavakis et al. 2004, Morris et al. 2006, Bradfield et al. 2007), 
believed to be conducted by interactions between JAM-A and proteins important for cytoskeletal 
restructuring. The passage of germ cells across the Sertoli cell TJ requires similar cytoskeletal 
restructuring, and JAM-A mRNA has been detected in Sertoli cells and germ cells (Chalmel et al. 
2007), and protein has been detected in spermatozoa from the caudal epididymis (Shao et al. 2008). 
Taking the results from these studies into account, it has been hypothesised that JAM-A in the hamster 
may play an important role in spermatogenesis by mediating the passage of germ cells across the 
blood-testis barrier (Tarulli et al. 2008). Unfortunately, JAM-A was undetectable in the human in 
Chapter 7 or hpg mouse studies by immunohistochemistry, where its localisation in the hpg mouse 
would have provided a unique opportunity to study the role of this protein in the initiation of 
spermatogenesis and TJ formation. 
The localisation and mRNA expression of the adapter cytoplasmic plaque protein ZO-1 was 
predominantly unchanged in the Sertoli cells as a result of gonadotrophin suppression across each 
chapter in this thesis, although it had moved slightly adluminally from the basement membrane in the 
GnRH-antagonist treated rat. The redistribution of claudin-11 and occludin in the absence of ZO-1 
redistribution suggests that both of these proteins had somehow disengaged from ZO-1. A similar 
disengagement event between ZO-1 and occludin has been observed in the lung following TJ 
restructuring (Kawkitinarong et al. 2004). In the testis, disengagement of Sertoli cell TJ proteins, as 
well as adherens junction proteins from the cytoplasmic plaque has been shown to be a requirement 
for blood-testis barrier restructuring as germ cells migrate (Yan and Cheng, 2005). Interestingly, the 
cytokine TGFβe has been shown to modulate ZO-1 redistribution and disengagement at the time of 
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germ cell migration (Ahdieh et al. 2001, Xia et al. 2005, Xia and Cheng, 2005), and other cytokines 
such as IL-4 and IL-13 have been shown to modulate ZO-1 mRNA and protein expression (Ahdieh et 
al. 2001, Xia et al. 2005, Xia and Cheng, 2005). Results obtained from this thesis suggest that 
occludin/claudin-11 disengagement and engagement from/to ZO-1 could also be hormonally 
regulated. The results obtained in this thesis also show that the changes in TJ function are directly due 
to changes in claudin-11 and occludin redistribution and this is further shown by the continued 
presence of ZO-1 at the outer edge of seminiferous tubules in the claudin-11 knockout mouse (Gow et 
al. 1999). Furthermore, two MDCK cell-lines which record either high or low TERs in vitro displayed 
similar amounts of ZO-1 protein at TJs, suggesting that the amount of ZO-1 in any given tissue does 
not correlate with the tightness and therefore function of TJs (Stevenson et al. 1986). 
In the hpg mouse and human studies, this thesis also analysed the effect of gonadotrophin 
suppression on other testicular junctional types in association with the TJ. No changes were seen in β-
catenin localisation at the adherens junction, and the fact that this junction is also associated with ZO-
1 (Yan and Cheng, 2005), may be another reason as to why there was no ZO-1 protein redistribution. 
Vinculin as a marker of the ectoplasmic specialisation was localised in the Sertoli cell cytoplasm of 
the hpg mouse, and gonadotrophin administration stimulated vinculin redistribution to the blood-testis 
barrier. Hormonal regulation of vinculin localisation in the gonadotrophin-suppressed human however 
was not observed, with any apparent changes in vinculin localisation more likely due to tubular 
shrinkage as a result of hormone suppression. However, the hpg mouse and gonadotrophin-suppressed 
human are two different models, with the results actually demonstrating that gonadotrophins stimulate 
the formation of the ectoplasmic specialisation (ES) in mice, but do not regulate its maintenance in 
humans at least in the time frame (8 weeks) that these men were suppressed. It is arguable however, 
that a longer suppression phase could produce a greater spermatogenic regression as evidenced by 
increased germ cell loss, particularly of pachytene spermatocytes and round spermatids, and under 
these circumstances, ES regulation could well be altered. The results obtained in the hpg mice, suggest 
that in some species, there is a global regulation of the blood-testis barrier (at least in terms of 
formation) with the regulation of the most important component, the Sertoli cell TJ, being conserved 
across many species.  
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In barely-detectable levels of circulating gonadotrophins in the hpg mouse, gap junction 
protein connexin-43 was localised to the Sertoli cell cytoplasm at the centre of the seminiferous 
tubules in the 20 day old pubertal animals, but had re-localised to the basement membrane by 
adulthood as per the wt adult mouse, indicating a hormone-independent mechanism with respect to its 
localisation. The presence of connexin-43 at the basement membrane indicated that gap junctions had 
possibly formed between adjacent Sertoli cells (Drummond et al. 2000, Sridharan et al. 2008). 
Handelsman et al. (1999), reported that despite hpg mice having no circulating gonadotrophins and 
infantile gonads, that the reproductive system was functionally competent as shown by the initiation of 
spermatogenesis following testosterone treatment (Singh et al. 1995). The continued presence of 
connexin-43 at gap junctions may also contribute to this functional competency, and thereby have a 
role in the initiation of spermatogenesis following gonadotrophin treatment. In the gonadotrophin-
suppressed human, connexin-43 had moved adluminally toward the centre of the seminiferous tubules 
and away from the basement membrane. This adluminal movement was marginal however and a 
greater effect on connexin-43 re-localisation, may have been observed had gonadotrophins been 
suppressed in the human for longer than 8 weeks. 
Overall, it is concluded that gonadotrophin suppression and replacement in the adult animal 
selectively regulates the Sertoli cell TJ via its effects on claudin-11 and occludin expression and 
localisation. However, it does not appear that the associated junction types (ectoplasmic specialisation, 
adherens, and gap junctions) are regulated in the same manner, highlighting the TJ as a potential site 
of gonadotrophin action. It is known that gonadotrophins regulate different points of spermatogenesis 
(McLachlan et al. 2002a, McLachlan et al. 2002b, Allan et al. 2001, Allan et al. 2004, Matthiesson et 
al. 2006), and while FSH alone is sufficient to drive spermatogenesis through to the start of 
spermiation in the mouse (Allan et al. 2001, Allan et al. 2004), testosterone alone is sufficient to drive 
qualitatively normal spermatogenesis producing fertile sperm (Singh et al. 1995, Handelsman et al. 
1999). In the human, it is generally agreed that both FSH and LH/testosterone can maintain 
spermatogenesis independently of each other, albeit at a quantitatively reduced capacity (Matthiesson 
et al. 2006). Studies have shown that FSH has key roles in the progression of types A and B 
spermatogonia (McLachlan et al. 2002b), and provides better maintenance of pachytene spermatocytes 
than LH/testosterone (Matthiesson et al. 2006). In contrast, hCG stimulated a better conversion of 
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pachytene spermatocytes to round spermatids than FSH (Matthiesson et al. 2006). Steroid-based 
contraceptives result in spermiogenic failure (McLachlan et al. 2002b), with principle lesions at 
spermiation and spermatogonial progression (Matthiesson et al. 2006). Future male hormonal 
contraceptive regimens however must ensure to suppress both LH/testosterone and FSH for maximal 
spermatogenic suppression (Matthiesson et al. 2006). 
One of the key findings in this thesis is that both gonadotrophins can regulate the Sertoli cell 
TJ, suggesting a common regulatory pathway which is involved in both the formation and 
maintenance of Sertoli cell TJs. In men who underwent gonadotrophin suppression, spermatogenesis 
was arrested at spermiation (Zhengwei et al. 1998, McLachlan et al. 2002a, McLachlan et al. 2002b, 
Matthiesson et al. 2005b). This led to the conclusion that the reduction in numbers of all of the other 
types of germ cells was due to a back-flow effect of significant spermiogenic failure. The results 
obtained in this thesis which showed a reduced claudin-11 localisation at the human Sertoli cell TJ in 
the presence of markedly reduced pachytene spermatocyte numbers, suggests that the reduction in 
germ cell numbers is a combined effect of a loss of TJ function and spermiogenic failure.  
As mentioned in Chapter 7, functional testing on the Sertoli cell TJ in the gonadotrophin-
suppressed man is required to show that the reduced claudin-11 localisation at the TJ is coincident 
with reduced TJ function. It would also be beneficial to combine this approach with a hormonal 
suppression regime designed to achieve greater spermatogenic suppression than the model used by 
Matthiesson et al (2005a). However, considering results obtained from the rat and mouse studies 
where i) claudin-11, as well as occludin contributed significantly to TJ function in vitro, ii) the 
localisation of both proteins was disorganised in the low levels of circulating gonadotrophins in vivo in 
association with dysfunctional TJs and suppressed spermatogenic activity, and iii) that gonadotrophin 
suppression in men also disrupts TJ protein localisation, then the Sertoli cell TJ appears to be another 
potential target of hormonal-based contraception in men.  
In conclusion, the formation and maintenance of a structurally and functionally competent 
Sertoli cell TJ is regulated by the gonadotrophins testosterone and FSH, either separately to, or in 
combination with each other, in vivo. This is achieved through the hormonal regulation of claudin-11 
and occludin relocalisation to the Sertoli cell TJ in vivo. It is further concluded that the Sertoli cell TJ 
does not need to be fully functional for spermatogenesis to proceed, as indicated by the continuing 
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presence of biotin tracer on the adluminal side of the Sertoli cell TJ during active spermatogenesis 
shortly after gonadotrophin treatment. Thus, it is also concluded that Sertoli cell TJs are size-selective 
and that there is a dynamic threshold required for spermatogenesis to proceed into the meiotic stages 
of germ cell development. It is further hypothesised that this threshold is controlled by the amount of 
the TJ proteins claudin-11 and occludin which are actually present at the Sertoli cell TJ, such that TJ 
function can be progressively upregulated to a point sufficient to support full spermatogenesis. In 
presenting this hypothesis, it is recognised that additional features, such as phosphorylation of 
occludin, or the presence of local cytokines and so on, can also regulate TJ function in vitro and in 
vivo (Sakakibara et al. 1997, Farshori and Kachar, 1999, Li et al. 2001, Lui et al. 2001, Lui et al. 
2003a, Siu et al. 2003, Cheng and Mruk, 2004, Lui and Lee, 2006), which have not been investigated 
in this thesis. 
The nature of the Sertoli cell TJ which requires it to continually ‘open’ and ‘close’ during 
active spermatogenesis, to allow the germ cells to cross the blood-testis barrier to proceed with 
spermatogenesis, sets this junction apart from other epithelial TJs. Surprisingly though, this thesis 
concludes that the Sertoli cell TJ also has several characteristics in common with other epithelial TJs. 
These features include the presence of protein pools in the Sertoli cell cytoplasm for rapid TJ 
formation, and a potential paracrine regulation of TJ mRNA and protein expression which could 
operate in conjunction with hormonal regulation. While claudin-3 appears to be important for the 
process of TJ assembly or disassembly in mice and hamsters to allow germ cell migration into the 
adluminal compartment of the seminiferous epithelium, it is concluded that its absence at the Sertoli 
cell TJ in rats and humans means that it is not required in these species. It may be possible that an 
alternative claudin or other TJ protein is localised at the Sertoli cell TJ in rats and humans with a 
similar role to claudin-3 in mice and hamsters. An example of another protein could be JAM-A which 
has been localised to spermatogonia as well as TJs (Tarulli et al. 2006) and may play a role in their 
migration across the blood-testis barrier. Alternatively, it may also be possible that such a mechanism 
regulated by claudin-3 in mice and hamsters, is not required in rats or humans. 
Overall, it is concluded that the Sertoli cell TJ is actively regulated by gonadotrophins and is 
essential for spermatogenesis, with the TJ proteins claudin-11 and occludin both important in 
 182
maintaining TJ integrity in several rodent species, as well as in men. The significance of this work is 
that the Sertoli cell TJ has been identified as a site of action of hormonal-based contraception in men. 
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Appendices 
 
Appendix 1.1: Immature Sertoli cell culture 
 
IMMATURE SERTOLI CELL CULTURE 
Method for a 12 rat culture 
SOLUTIONS 
 
1. DMEM / F12 (2 litres) Make the day before            
• For DMEM/F12/ 1% bSA  work out the amount required from the DMEM/F12 stock and 
only make amount required then 
• NB. FCS is only used for the plating step. Do not use for hypotonic shock treatments 
 
Wash a 2L measuring cylinder with MilliQ. Using this cylinder (and a mixer/flea) put 1600ml MilliQ 
To the MilliQ add: 
 1 bottle of DMEM (stored at -80°C in freezer in centrifuge room) 
 1 bottle F12 powder(stored at -80°C in freezer in centrifuge room) 
 40ml pen strep (stored at -80°C in freezer in centrifuge room) 
 10ml glutamate (aliquots in freezer) 
 20ml non-essential amino acids (NEAA:aliquots in freezer) 
 32ml Sodium bicarbonate (in fridge) 
 
Adjust this solution's pH to between 7.2 - 7.4 (use 7.3) then make up with to 2L with MilliQ and use 
flea to mix. 
Filter into 2 × 1L sterile bottles and store in fridge (lasts ≈ 1 month) 
 
NB Medium must be replaced every 2 days (48hours)  
• If the medium is more than 2 days old, add 1ml of pen strep (left over is kept in freezer 
door) per 50ml medium 
 
Also must add this every day using old medium: Prior to use DMEM/F12/ 1%bSA/1%ITS OR 
DMEM/F12/ 10%FCS/1%ITS must be made up adding 
- either 1% bSA (w/v) or 10% FCS 
- 1:100 HEPES 
- 1:50 PenStrep 
- 1:100 ITS 
 
2. Stock DNAse (10mg/ml) 
 
Add 300mg DNAse to 30ml PBS, filter (0.2μm), and then aliquot into sterile eppendorph tubes (3ml) 
Store frozen.  Aliquots can be re-used if snap frozen each time 
 
 
3. PBS / Trypsin /DNAse 
 
• The day before measure out 0.19g of trypsin (stored at -80°C in freezer in centrifuge room) 
into a 25ml camalac and store in freezer 
• On the day dissolve this in 75ml PBS  
• Put in orbital shaker (37°C) until dissolved 
• Filter the dissolved trypsin into a sterile camalac and add 400μl of DNAse stock (when step 
in protocol says so) 
 
4. (PBS / FCS / DNAse) × 2 
• Measure out 40ml PBS, to this filter in 4ml foetal calf serum using 0.2μm filter.  
• To this add 40μl DNAse (when protocol says to) 
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5. PBS / DNAse 
• Measure out 120ml PBS 
• To this add 240μl DNAse (DNAse should be sterile)  
 
6. PBS / 1% bSA / DNAse 
• The day before weigh out 0.4g bSA (white tub with red lid kept in cold room) in a 25ml 
camalac 
• On the day measure out 40ml PBS 
• Dissolve the bSA in 20ml and then filter into the remaining solution 
• To this add 40μl DNAse (when protocol says to) 
 
7. DMEM / F12 / 1%bSA / 1% HEPES (for 600μl pellet) 
(Isolation - Day 0) 
- See table page 7 
 
 
8. 10% DMEM / F12 (enough for 63 wells + some extra) FOR HYPOTONIC SHOCK 
(no. of wells x 0.5ml) 
• Combine: 
- 5ml DMEM / F12 
- 45ml sterile MilliQ 
 
9. DMEM / 1% bSA / 1% HEPES – FOLLOWING  HYPOTONIC SHOCK- day 4 
(enough for 130 wells + some extra ( total 80ml))  (no. of wells x 1.5ml) 
 
• For washing use 60ml of medium alone made up as on page 8 
 
________________________________________________________________ 
 
PROTOCOL 
 
Prior to day 1: 
• Book fume hood 
• Rats (12) 19 – 21 day old Sprague Dawley (out bred) rats  
NB. Place order down stairs well before 
• CHECK 
- There is enough mesh, coverslips, homogeniser, razorblades and a sterile bottle of MQ 
and also PCF filters 
- AUTOCLAVE homogeniser, razors and mesh (80μm) if required.   
- Take out 1 aliquot of Matrigel from freezer, and place in fridge to thaw overnight 
 
 
Day 1 - Sertoli cell isolation 
 
Prior to culture (before killing the rats) 
 
• Matrigel: aliquots of neat Matrigel are stored in the fridge.  
- Everything, including plates should be kept cool on ice 
 
• Make a 1:8 dilution of Matrigel.  (must be done prior to warming medium bottle) 
 
- Add 1ml DMEM/F12 to 239μL Matrigel and label bottle. (NB. Matrigel can only be 
frozen/thawed twice) 
 
- Label a 24 well plate with ISCC# , name, and plate number if more then one plate 
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- Place coverslips in wells to be used and add 20μL Matrigel (1:8) to each well using a pipette.  
Spread well using a sterile 1ml syringe plunger (NB. If coating a bicameral chamber, wet 
membrane by adding 2-3 drops of medium into the well and then putting chamber in.  
Add 50μL Matrigel and ensure entire surface of membrane is covered, dab gently and 
then remove excess medium using pipette as above.) 
- By tilting plate slightly in ice box, use a pipette to remove excess Matrigel and transfer back 
into vial for reuse. Don't snap freeze, but place back into freezer.  
- Place in 37°C incubator and allow at least 1 hour to set.  
 
Testis removal, decapsulation and trypsin digestion 
 
• Measure out trypsin (0.19g) and bSA (0.4g) into 25ml camalacs. Can be weighed the day before 
(weigh on day if after weekend) and put in freezer/fridge. NB. They are not sterile. 
• Turn on the 37°C water bat and warm DMEM/F12, PBS, FCS and PenStrep. 
 
1. Need three 50ml camalacs, and two 100ml camalacs. Label, and measure out required PBS (see 
solutions page) 
- Trypsin - 75ml PBS 
- FCS - 40ml PBS  (X2) 
- DNAse (add just before use) - 120ml PBS 
- bSA - 40ml PBS -  
 
2. For dry materials, approximately 20ml PBS can be added to camalacs to allow material to dissolve 
(37°C orbital shaker), and the rest of the required volume put in the sterile camalac. (NB. This 
20ml is not sterile and must be filtered into the remaining PBS. Trypsin should be added to 
entire 75ml to prevent clumping and then filtered later) Remember to keep warm (air 37°C) 
 
Take DNAse from freezer and allow to thaw on bench 
 
In the laminar flow set up: 
• Petri dish (1 dish/12 animals and 1 waste dish) 
• Sterile blade 
• Milk dilution bottle and parafilm (1 bottle / 12 animals) 
 
3. Take dissection tools, 70% ethanol and a 60ml camalac of warm DMEM/F12 to the animal house.  
Kill rats using CO2 and collect testes (Squirt ethanol on groin area of rats and on tools.  Lift penis 
and make an incision using scissors. Locate and gently remove each testis and place in camalac 
containing DMEM) 
 
4. Place a small amount of warm DMEM/F12 into shallow half (lid) of waste petri dish and 
decapsulate testes using curved forceps and tweezers.  Do so by holding testis with tweezers and 
gently piercing capsule with forceps. Proceed to push tubules from the tunica ensuring all tubules 
are removed.  Place waste into other half of petri dish.  
 
5. Using medium in the dish, was off any blood from the testis, and then remove any excess 
(medium).  
 
6. Transfer testis to a clean petri dish and using a sterile razor blade held at 45° angle (90° will 
moosh them) chop longitudinally and then horizontally into 1mm blocks.  DO NOT OVER 
CHOP! 
 
7. Add DNAse (400μl) to the trypsin 
 
8. Add 10ml of PBS / Trypsin / DNAse to the petri dish using the automated pipette and aspirate up 
and down until the solution is uniform (approximately 4 ×). Try not to aspirate air or it will go 
clumpy. If there are large clumps mash with pipette until it can be sucked up.  
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Place the tissue in a sterile round milk bottle and wash the remaining tissue from the petri dish 
with the rest of the PBS / Trypsin / DNAse. 
 
9. Place horizontally in the 37°C orbital shaker (round bottle @ 120rpm) and bath for 25 minutes.  
Hypochloride the waste testes tissue.  N.B The trypsin is used to strip all the peritubular cells 
off the interstitial tissue 
 
Tubule purification and preparation of single-cell suspension 
 
10. Add DNAse (40μl) to FCS (×1) 
 
11. Add 40ml  PBS / FCS / DNAse to milk bottle. Mix up and down and allow to settle - collect waste 
bottle 
 
12. Aspirate supernatant. Put in other 40ml PBS / FCS / DNAse (add DNAse) 
 
13.  Swirl bottle vigorously and allow to settle for 5 minutes 
 
14. Add DNAse (240μl) to PBS 
 
15. Remove most of the supernatant. 
 
16. Replace removed supernatant with ≈ 40ml PBS / DNAse (roughly divide bottle into 40ml sections 
using pen).  Swirl bottle vigorously and allow to settle (If tilting bottle, tape down and gently tap 
tubules down) 
 
17. Repeat step 16 
 
18. Repeat step 16 
 
19.  Add DNAse (40μl) to bSA 
 
20. Remove the supernatant and add the PBS / 0.25% bSA / DNAse NOTE, If the solution is gluggy 
at this point add some more DNAse (1μl per ml of suspension) 
21. Place some of the suspension into a sterile teflon/glass tissue homogeniser and SLOWLY depress 
pistle eight times.  AVOID getting bubbles on the surface.  Pour into sterile 50ml Falcon tubes 
(will need 2), and repeat with the rest of the suspension 
 
22.  Centrifuge at 1000rpm for 5 minutes 
Set up in the flow hood:  
- ISC mesh,  
- PBS  
- DMEM / F12 
- Haematocytometer and Trypan Blue 
 
CELL WASHING 
 
23. Remove supernatant and resuspend pellet by flicking the side of the tube. Resuspend in PBS (i.e. 
combine pellets and wash tubes to total around ≈ 10ml PBS ) NOTE: If the cells don't spin down, 
i.e it is really gluggy, add some more DNAse and dilute out further with PBS. Usually will add 
~60-100ul DNAse at this stage before filtering. 
 
24. Filter the suspension through the sterile nylon mesh (80μm) into a 15ml centrifuge tube and 
centrifuge at 1000rpm for 5 minutes 
 
PELLET VOLUME: 
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25. Wash the pellet twice (by removing the supernatant and filling the tube with PBS, then centrifuge 
as above) PELLET VOLUME: 
 
26. After the spin take note of the volume of the pellet (≈800-1200) and make up enough plating 
medium, DMEM / F12 / 1%bSA / 1% ITS / 1% HEPES  for the pellet - 20ml per 100μl of pellet 
 
FINAL PELLET VOLUME 
 
27. Sterilise area with ethanol 
 
CELL COUNTS 
 
28. Make the cell suspension up to 10ml with DMEM / F12 / 1% / 1% ITS / 1% HEPES.  Add 20μl 
of the suspension to 20μl of trypan blue (i.e 1:2 dilution) 
 
29. Fill both sides of haematocytometer. Count stained (dead) and unstained (alive) cells in the 4 outer 
squares and middle square for both chambers, ignoring large cells, small cells, and clumps of cells.  
Count top and left line of each square. (expected cell no ≈ 50-70 million cells / 100μl pellet) 
 
30.  Calculate volume of cells to remove from the 10ml and amount of medium to add to dilute to total 
required volume  
 
 
Haemocytometer 
 
Count 5 squares in both chambers 
 
 
Preparation of cells in medium for plating 
 
1. Once cells have been counted, calculate the % viability, ie the total number of cells isolated, and 
the cell concentration (cells/ml) 
2. Knowing the cell concentration and wanted concentration to be added to each well, calculate the 
required dilution 
3. Prepare cell dilution and add cells to plates in a RANDOM ORDER but plate the last plate last. 
 
- For a 24 well plate, add 0.5ml of cells (2.5 × 106 cells/ml or 1.25 × 106 cells/cm2) 
- Add 300μl for a 16 well chamberslide (0.75 × 106 cells/cm2) 
- For 12mm bicameral chambers, add 600μl of cells (NB must also add 600μl medium w/o cells 
to outside of bicameral chamber) 
NB. Keep the suspension uniform by aspiring the suspension with pipette for every 6 wells 
plated 
 
4. Incubate cells at 37°C / 5%CO2 in incubator for 2 days (until day 3) 
 
 
 
Viable Viable Unviable Unviable 
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CALCULATING % VIABILITY 
% viability = Total # cells unstained  
     Total # cells      
 
To CALCULATE THE No. OF CELLS IN 10ml: 
 No. of cells in 10ml (millions) = Average no. counted 
 
Average # total cells × 50 000 × dilution × volume 
Eg 308 × 50 000 × 2 × 10 = 308 million / 10ml 
 
So if we want :   2.5 million /ml 
And we have:     30.8 million /ml 
 
We need to make a 1: 12.32 dilution 
So that is 1ml of solution which has our 30.8 million cells + 12.32ml 
Or 10ml + 123.2ml 
 
Day 2/3 
(Usually missed over the weekend) 
If the colour of the medium changes then replace it with 500μl of fresh medium 
NB Medium should be changed every 2 days 
 
DAY 4 - Hypotonic shock 
 The use of a low salt medium to alter the osmolarity of the cells and attempt to kill off the germ cells. 
Used to obtain greater then 95% purity in SCC 
 
ON ARRIVAL 
• Warm DMEM / F12 in water bath 
• Thaw PenStrep 
• Prepare the following solutions- 
- 10% DMEM / F12 (total volume of wells / 2).  10% DMEM / F12 in sterile MQ water 
 
- DMEM / F12 + bSA + HEPES + PenStrep (total volume of wells × 1.5) 
 
Dissolve 1% bSA in about 50ml DMEM / F12 (sit on top) 
Filter dissolved bSA directly into remaining DMEM / F12 
To DMEM / F12 add 
 - 1% bSA (pre dissolved) 
 - 1:100 HEPES 
  - 1:50 PenStrep 
1. Add PenStrep to DMEM / F12 / 1% bSA / 1% HEPES / 1% ITS 
2. Add sterile water to DMEM / F12 
3. Check for contamination - cloudy medium or string fungus 
4. Prepare suction apparatus (side tube-vacuum, top tube-pasteur pipette without cotton bud) 
5. Put culture plate on foam-warmer than hood bench, with plate to tilt it 
6. Set timer, remove medium from wells and replace it with 500μl 10% DMEM / F12 for 45sec 
(500μl for 24 well plate, 150μl for 16 well chamber slides) 
7. Remove 10% DMEM / F12 in wells and replace with 500μl DMEM / F12 / 1% bSA / 1% ITS / 
1% HEPES 
8. Remove DMEM / F12 / 1% bSA / 1% ITS / 1% HEPES in wells and replace it with 1ml DMEM 
/ F12 / 1% bSA / 1% ITS / 1% HEPES (1ml for 24 well plate, 300μl for 16 well chamber slides) 
9. Put back into incubator (37°C/ 5% CO2) 
10. 10. Rinse suction tube with EtOH and bottle with hypochloride 
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Appendix 1.2: siRNA protocol 
 
                 
    siRNA preparation and calculations   
STOCKS    
BUFFER
S     
SiRNA Amount Nmol MW  Solution Amount Purpose  
Claudin-11-
A 
295.89μ
g 20 14794.54  RNAiFect 1 x 1.0ml 
Transfection 
of  
Claudin-11-
B 
297.61μ
g 20 14880.26    1 x 0.5ml 
siRNA into 
cells 
Lamin A/C 74.40μg 5 14880.00  
Suspensio
n 2 x 9.0ml 
Dissolve 
siRNA for  
    Buffer   first time use 
      
Buffer 
ECR 
2 x 
15.0ml 
To replace 
medium if 
          
transfection 
is poor 
          
Aim: 1) To observe the ability of the Sertoli cells from ISCC#8 to take up siRNA (fluorescence) 
        2) To determine if the siRNA is toxic to the Sertoli cells (Lamin A/C)   
        3) To determine which of the claudin-11 siRNA fragments is most effective at silencing claudin-
11 
           and at which optimal siRNA dilution/amount        
          
Method         
          
Upon receipt of siRNA strands        
          
1) To Claudin-11-A and Claudin-11-B siRNA fragments, add 1ml of the sterile suspension buffer 
provided 
    (have 20nmol of both fragments)       
2) To the Lamin A/C siRNA fragments, add 250μl of the same sterile buffer (have 5nmol  
    of both fragments)        
NB: This gives a final concentration of 20μM for each of the four siRNA fragments  
3) Heat tubes for 1min at 90°C       
4) Incubate tubes for 60mins at 37°C      
5) Either begin experiment or freeze solutions     
NB: Steps 1-5 only need to be conducted on the first occasion of using the siRNA. The 
solutions  
can be freezed and thawed repeatedly      
ISCC#8 aims to determine the appropriate dilution of siRNA to use for future cultures. The following 
table 
has been constructed to show what siRNA to transfection reagent ratios will be used, when adding a 
final volume of 400μl to each well       
NB: All weight measurements in the table below, refers to the siRNA   
          
siRNA 
1:3 
(1.0μg) 
1:6 
(0.5μg) 
1:6 
(1.0μg) 
1:6 
(1.5μg) 
1:9 
(1.0μg)    
Lamin A/C - - + - -    
Claudin-11-
A + + + + +    
Claudin-11-
B + + + + +    
          
However, TER wells receive a total of 1,200μl per well so the amount of siRNA is trebled, as is the 
amount 
of transfection reagent it is diluted in.      
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Lamin A/C                
          
74.40μg has been dissolved in 250μl. Want 1μg of Lamin A/C siRNA, at a 1:6 ratio   
250/74.4 = 3.36. This is for final volume of 400μl, but ISCC#8 has final volume of 1,200μl.  
So, 3.36 x 3 = 10.08μl        
This is enough for one well. Have triplicate wells, so in total, will take 30.24μl of the 250μl stock 
solution 
For a final volume of 400μl, would make up the 3.36μl of siRNA to 100μl, so would add 96.64μl. 
However, 
since the final volume is 1,200μl and this is in triplicate, we want 9(96.64)μl medium to dilute the 
siRNA 
= 869.76μl of medium        
To achieve the 1:6 ratio for a 400μl final volume, would add 6μl transfection reagent, but in this case  
would need to add 54μl for the reasons described above.      
1) Remove 30.24μl of siRNA dissolved in suspension buffer, and add 869.76μl of prepared medium 
2) Mix by vortexing. Add 54μl of transfection reagent to the solution and mix by pipetting up and 
   down 5 times, or by vortexing for 10s      
3) Incubate solution for 10-15mins at room temperature to allow transfection complexes to form 
4) While this incubation is underway, remove all media from the wells, inside and out, and replace 
    with 450μl of freshly prepared medium to the inside and outside of the well   
5) Add the 150μl of transfection complexes dropwise to the inside and outside of each well.  
6) Swirl plate to evenly distribute the transfection complexes    
7) Incubate cells under normal growth conditions, taking TER analysis over 3 days before fixing cells 
NB: If cytotoxicity is evident, change the medium 6-24 hours after transfection. Would change 
medium as per normal over days anyway      
          
Claudin-11-A        
295.89μg of siRNA has been dissolved in 1ml of suspension buffer. Want 1μg of siRNA is using a 
final 
volume of 400μl, but we're using 1,200μl so we want 3μg     
For 1μg: would need 3.38μl suspension. So for 3μg, would need 10.139μl of suspension. Since each 
well 
is done in triplicate, need a final volume of 30.417μl from the 1ml stock.    
This is to be diluted to 900μl final, by adding 869.583μl of freshly prepared medium   
For the 1:3, 1:6 (1μg siRNA/400μl) and 1:9 ratios, add 27μl, 54μl and 81μl of the transfection 
reagents, to  
the respective solution        
Mix as normal, and follow protocol as per Lamin A/C, steps 3-7    
          
1:6 siRNA:Transfection reagent ratios, with 0.5μg/400μl and 1.5μg/400μl    
          
0.5μg/400μ
l 
Need 30.417μl for 3μg/1.2ml across 3 wells. So for 1.5μg/1.2ml, would need 15.209μl 
of stock 
  
Add this to 884.791μl of freshly prepared medium and to this solution, add 27μl 
transfection 
  reagent        
                 
1.5μg/400μ
l Need 30.417μl for 3μg/1.2 and 15.209μl for 1.5μ/1.2. So for 4.5μg/1.2ml, need:  
  30.417μl + 15.209μl = 45.626μl of stock     
  
Add this to 854.374μl of freshly prepared medium and to this solution, add 81μl of 
transfection 
  reagent        
          
  Mix solutions as per normal, and follow Lamin A/C protocol steps 3-7   
          
Claudin-11-B (following same calculation rationale as those used for Claudin-11-A siRNA) 
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  Have 297.61μl siRNA dissolved in 1ml of buffer.    
  For the 1:3, 1:6 (1μg/400μl), 1:9 ratios, add 30.241μl of stock, to 869.759μl of freshly 
  prepared medium       
  For the respective ratios mentioned above, add 27μl, 54μl and 81μl   
          
1:6 siRNA:Transfection reagent ratios, with 0.5μg/400μl and 1.5μg/400μl    
          
0.5μg/400μ
l Add 15.121μl of stock to 884.879μl of freshly prepared medium. To this add 27μl of  
  transfection reagent and mix as per normal     
          
1.5μg/400μ
l Add 45.362μl of stock to 854.638μl of freshly prepared medium. To this add 81μl of  
  transfection reagent and mix as per normal     
          
  Follow Lamin A/C protocol steps 3-7     
          
Since the claudin-11-A and claudin-11-B siRNA will be added to cells which have been treated with 
ethanol 
or testosterone, each in triplicate, the final volumes for each calculation in regards to claudin-11-A 
and 
claudin-11-B need to be doubled. The following table presents the volume of each component of the 
experiment and how much will be used in total      
          
Sample Amount Amount Amount Amount Amount Amount Amount  
  
susp. 
buff 
Availabl
e required 
remainin
g medium 
RNAiFec
t 
remainin
g  
Lamin A/C 250μl 250μl 30.24μl 219.76μl 869.76μl 54μl 1.446ml  
siRNA                
Claudin-11-
A 1ml 1ml 
182.504μ
l 817.496μl 
5,217.376
μl 540μl 0.744ml  
siRNA                
Claudin-11-
B 1ml 1ml 
181.448μ
l 818.552μl 
5,218.552
μl 540μl 0.204ml  
siRNA                
Suspension - 18ml 485μl 17.515ml - - -  
Buffer                
Transfectio
n - 1.5ml 1.296ml 204μl - - -  
Reagent               
                 
          
Results         
                 
          
Conclusio
n         
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Appendix 1.3: Serum hormone assays 
*Data also presented on CD inside back cover 
 
a. LH 
 
Mark 
McCab
e PhD 
Study -      ep4-07  
        
        
Treatmen
t Id LH pg/100ul rLH ng/ml 
Treatmen
t id 
LH 
pg/100u
l 
rLH 
ng/m
l 
Control 19 black 180.8 1.81 Acyline + 
11 
black 12 0.012*
  19 blue 179.2 1.79 hCG 11 blue 73.2 0.732 
  19 none na Na   
11 
none na Na 
  20 black 287.2 2.87   
12 
black na Na 
  20 blue 528 5.28   12 blue 27.4 0.274 
  20 none 106.8 1.07   
12 
none na Na 
  21 black 151.2 1.51   
13 
black na Na 
  21 blue na Na   13 blue na Na 
  21 none 227.2 2.27   
13 
none 19.28 
0.192
8 
  22 none na Na   
18 
black 21.8 0.218 
Average   237.2 2.37 Average   30.7 0.354 
St Dev   140.3 1.40 St Dev   24.374 0.254 
        
Acyline 4 black 37.88 0.038 Acyline + 8 black na Na 
  4 blue 12 0.012* 
hCG + 
FSH Ab 8 blue 12 0.012*
  4 none 16.64 0.017   8 none 15.2 
0.015
2 
  5 black 46 0.046   9 black 24.8 
0.024
8 
  5 blue 36.72 0.037   9 blue 12 0.012*
  5 none 26 0.026   9 none 12 0.012*
  6 black  75.6 0.076   
10 
black 12 0.012*
  6 blue na Na   10 blue na Na 
  6 none 53.6 0.054   
10 
none na Na 
  7 none na Na   
14 
none na Na 
Average   38.1 0.381 Average   14.7 0.020 
St Dev   20.7 0.207 St Dev   5.1 0.007 
        
Acyline + 1 black na Na Glycerol 23 572 0.572 
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black 
 FSH Ab 1 blue na Na   23 blue 480 0.480 
  1 none na Na   
23 
none na Na 
  2 black 12 0.012*   
24 
black 318.4 0.318 
  2 blue 12 0.012*   24 blue 532 0.532 
  2 none na Na   
24 
none na Na 
  3 black 12 0.012*   
25 
black 275.6 0.276 
  3 blue na Na   25 blue 244.8 0.245 
  3 none 12 0.012*   
25 
none 524 0.524 
  7 black 14 0.140   
26 
none 239.6 0.240 
Average   12.4 0.124 Average   398.3 3.98 
St Dev   0.9 0.009 St Dev   141.8 1.42 
        
Acyline + 15 black 40.4 0.404 Glycerol 
27 
none 186.8 
0.186
8 
FSH 15 blue 20.4 0.204 Control 
28 
black 248.4 
0.248
4 
  15 none na Na   28 blue 140.8 
0.140
8 
  16 black na Na   
28 
none 222.4 
0.222
4 
  16 blue 16.4 0.164   
29 
black 168.4 
0.168
4 
  16 none na Na   29 blue 144.8 
0.144
8 
  17 black 61.2 0.612   
29 
none 180.8 
0.180
8 
  17 blue na Na   
30 
black na Na 
  17 none 42.8 0.428   30 blue 110.4 
0.110
4 
  18 none 12 0.012*   30none 381.2 
0.381
2 
Average   32.2 0.322 Average   198.2 1.982 
St Dev   19.1 0.191 St Dev   80.4 0.804 
        
        
Rat LH 
IFMA QC data       
        
Assay no 
rLH 
ng/ml   
* assay 
sensitivity 
= 
0.012ng/ml 
(ie below 
sensitivity)    
ep4-07pl 1 2.256       
ep4-07pl 1 2.0       
ep4-07pl 2 1.752       
ep4-07pl 2 1.8       
Average 1.976       
Stdev 0.2       
CV 11.3       
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b. Androgens 
 
Acyline 
+ FSH 
Ab Acyline 
Acyline + 
hCG + 
FSH Ab 
Acyline 
+ hCG 
+ C Ab FSH Control Glycerol 
Glycerol 
Control 
 0.523 0.545  0.742 0.277 2.303 4.479  
 0.545 0.274 0.883 0.682 0.255 1.758 5.892 10.63 
 0.281 0.227 0.247 0.85 0.323 1.12 3.505 7.34 
 0.264 0.191 0.765 0.551 0.322 1.2 3.632 2.104 
 0.2 0.368 0.66 0.93 0.277 1.677 2.253 7.605 
 0.188 0.276 1.71 1.082  1.233 4.383 5.652 
 0.272 0.265 0.74 0.795 0.271 2.194 5.345 6.307 
 0.197 0.255 0.759 0.388 0.279 4.734 2.905 5.627 
 0.566 0.223 0.526 0.31 0.29 4.064 7.953 3.795 
 0.241 0.21 0.769 0.356 0.507 1.946 6.889 7.106 
Avg 0.328 0.283 0.784 0.669 0.311 2.223 4.724 6.241 
SD 0.153 0.104 0.394 0.261 0.077 1.226 1.799 2.421 
 
c. FSH 
 
Mark 
McCab
e PhD 
Study -   
Rat 
FSH 
IFMA 
results  
ep2-07 
and   3-07  Apr-07  
         
Treatmen
t id 
rFSH 
pg/100u
l 
rFSH 
ng/ml  
Treatmen
t id 
rFSH 
pg/100u
l 
rFSH 
ng/ml 
Control 19 black 464 4.64  Acyline + 
11 
black 169 1.69 
  19 blue 673 6.73  hCG 11 blue 166 1.66 
  19 none na na    11 none Na Na 
  20 black 677 6.77    
12 
black Na Na 
  20 blue 523 5.23    12 blue 138 1.38 
  20 none 413 4.13    12 none Na Na 
  21 black 529 5.29    
13 
black na Na 
  21 blue na na    13 blue 105 1.05 
  21 none 604 6.04    13 none 130 1.3 
  22 none na na    
18 
black 109 1.09 
Average   554.71 5.547  Average   136.2 1.362 
St Dev   101.12 1.011  St Dev   27.3 0.27 
             
Acyline 4 black 67.1 0.671  Acyline + 8 black na Na 
  4 blue 40 0.4  
hCG + 
FSH Ab 8 blue 15 
0.015
* 
  4 none 34 0.34    8 none 15 
0.015
* 
  5 black 55.3 0.553    9 black 21.3 0.213 
  5 blue 86.9 0.869    9 blue 15 
0.015
* 
  5 none 92.2 0.922    9 none 15 
0.015
* 
  6 black  86.6 0.866    
10 
black 15 
0.015
* 
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  6 blue na na    10 blue na Na 
  6 none 80.2 0.802    10 none na Na 
  7 none na na    14 none na Na 
Average   67.8 0.678  Average   16.1 0.161 
St Dev   22.5 0.225  St Dev   2.6 0.0 
         
Acyline + 1 black 15 0.015*  Glycerol 
23 
black 1013 10.13 
 FSH Ab 1 blue na na    23 blue 1176 11.76 
  1 none na na    23 none na Na 
  2 black 15 0.015*    
24 
black 499 4.99 
  2 blue 15 0.015*    24 blue 1232 12.32 
  2 none na na    24 none na Na 
  3 black 19.2 0.192    
25 
black 978 9.78 
  3 blue 15 0.015*    25 blue 621 6.21 
  3 none na na    25 none 764 7.64 
  7 black 452 4.52    26 none 708 7.08 
Average   88.5 0.890  Average   873.9 8.739 
St Dev   178.1 0.178  St Dev   265.6 2.656 
         
Acyline + 15 black 32.9 0.329  Glycerol 27 none 675 6.75 
FSH 15 blue 37.3 0.373  Control 
28 
black 612 6.12 
  15 none na na    28 blue 422 4.22 
  16 black na na    28 none 545 5.45 
  16 blue 68.5 0.685    
29 
black 419 4.19 
  16 none na na    29 blue 420 4.2 
  17 black 23.2 0.232    29 none 395 3.95 
  17 blue na na    
30 
black na Na 
  17 none 34.1 0.341    30 blue 380 3.8 
  18 none 45.4 0.454    30none 916 9.16 
Average   40.2 0.402  Average   531.6 5.316 
St Dev   15.6 0.156  St Dev   178.1 1.781 
         
         
QC data         
         
Assay no QC        
Ep2-07 676        
  574   
* assay 
sensitivity 
= 
0.015ng/m
l (ie below 
sensitivity)     
  729        
Ep3-07 632        
  630        
  634        
Average 646        
St Dev 52.1        
CV 8.07        
 251
Appendix 1.4: Data for the stereological assessment of germ cell types and numbers 
* Data also presented on CD inside back cover 
Mark McCabe. PhD Study 2. GnRH-antagonist treated rat study. Stereology germ cell counts 
(Georgia Balourdos and Sarah Meachem) 
TW vol is testis weight converted into volume (μl) by multiplying by 10E12. Number of cells is the total 
number of cells of a specific type counted 
in each of the three sections from the same testis. Cells are counted in a volume of 10μm3 and number 
of fields reflects that as does the frame 
area. Nuclear volume is the number of nuclei (or cells) counted in the given section. This calculated by 
dividing the number of cells by the frame 
  
Note: The testis weights refer to the left testis of the applicable animal (see number in tables) 
which was prepared for stereology 
         
    CONTROLS     
 Cell type   
Type A+intermediate 
spermatogonia   
 Group Control Control Control Control  Control   
 rat no. 20 None 21 Black 21 Blue 21 None 22 None   
 TW(vol) 1.86E+12 1.818E+12 1.678E+12 1.784E+12 1.666E+12   
 no.cells 122 101 116 130 108   
 no.fields 463 463 463 463 463   
 
Frame 
um2 3228.9 3228.9 3228.9 3228.9 3228.9   
 Nv 8.16064E-06 6.75594E-06 7.75930E-06 8.69576E-06 7.22417E-06   
 Cells/TW 1.51788E+07 1.22823E+07 1.30201E+07 1.55132E+07 1.20355E+07   
         
 Cell type   
Type B+preleptotene 
spermatocytes   
 Group Control Control Control Control  Control   
 rat no. 20 None 21 Black 21 Blue 21 None 22 None   
 TW(vol) 1.86E+12 1.818E+12 1.678E+12 1.784E+12 1.666E+12   
 no.cells 78 70 90 90 69   
 no.fields 463 463 463 463 463   
 
Frame 
um2 968.7 968.7 968.7 968.7 968.7   
 Nv 1.73910E-05 1.56073E-05 2.00665E-05 2.00665E-05 1.53843E-05   
 Cells/TW 3.23472E+07 2.83741E+07 3.36716E+07 3.57987E+07 2.56303E+07   
         
 Cell type   
Leptotene/zygotene 
spermatocytes   
 Group Control Control Control Control  Control   
 rat no. 20 None 21 Black 21 Blue 21 None 22 None   
 TW(vol) 1.86E+12 1.818E+12 1.678E+12 1.784E+12 1.666E+12   
 no.cells 112 97 103 100 96   
 no.fields 463 463 463 463 463   
 
Frame 
um2 968.7 968.7 968.7 968.7 968.7   
 Nv 2.49717E-05 2.16273E-05 2.29650E-05 2.22961E-05 2.14043E-05   
 Cells/TW 4.64473E+07 3.93184E+07 3.85353E+07 3.97763E+07 3.56596E+07   
         
 Cell type    Sertoli cells     
 Group Control Control Control Control  Control   
 rat no. 20 None 21 Black 21 Blue 21 None 22 None   
 TW(vol) 1.86E+12 1.818E+12 1.678E+12 1.784E+12 1.666E+12   
 no.cells 108 93 104 110 109   
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 no.fields 463 463 463 463 463   
 
Frame 
um2 968.7 968.7 968.7 968.7 968.7   
 Nv 2.40798E-05 2.07354E-05 2.31880E-05 2.45258E-05 2.43028E-05   
 Cells/TW 4.47885E+07 3.76970E+07 3.89094E+07 4.37539E+07 4.04885E+07   
         
 Cell type   
              Round spermatids 
I - VIII   
 Group Control Control Control Control  Control   
 rat no. 20 None 21 Black 21 Blue 21 None 22 None   
 TW(vol) 1.86E+12 1.818E+12 1.678E+12 1.784E+12 1.666E+12   
 no.cells 109 133 124 234 134   
 no.fields 250 247 254 247 246   
 
Frame 
um2 242.17 242.17 242.17 645.78 242.17   
 Nv 1.80039E-04 2.22349E-04 2.01589E-04 1.46701E-04 2.24931E-04   
 Cells/TW 3.34872E+08 4.04230E+08 3.38267E+08 2.61715E+08 3.74735E+08   
         
 Cell type   
           Elongated 
spermatids I - VIII   
 Group Control Control Control Control  Control   
 rat no. 20 None 21 Black 21 Blue 21 None 22 None   
 TW(vol) 1.86E+12 1.818E+12 1.678E+12 1.784E+12 1.666E+12   
 no.cells 103 147 114 117 144   
 no.fields 250 247 254 249 246   
 
Frame 
um2 242.17 242.17 242.17 242.17 242.17   
 Nv 1.70128E-04 2.45754E-04 1.85332E-04 1.94029E-04 2.41717E-04   
 Cells/TW 3.16439E+08 4.46780E+08 3.10987E+08 3.46147E+08 4.02700E+08   
         
 Cell type   
           Elongating 
spermatids IX - XIV   
 Group Control Control Control Control  Control   
 rat no. 20 None 21 Black 21 Blue 21 None 22 None   
 TW(vol) 1.86E+12 1.818E+12 1.678E+12 1.784E+12 1.666E+12   
 no.cells 194 221 239 230 77   
 no.fields 250 247 254 249 241   
 
Frame 
um2 1614.46 1614.46 1614.46 1614.46 645.78   
 Nv 4.80656E-05 5.54202E-05 5.82823E-05 5.72139E-05 4.94754E-05   
 Cells/TW 8.94020E+07 1.00754E+08 9.77977E+07 1.02070E+08 8.24260E+07   
         
 Cell type   
           Pachytene 
spermatocytes I - VIII   
 Group Control Control Control Control  Control   
 rat no. 20 None 21 Black 21 Blue 21 None 22 None   
 TW(vol) 1.86E+12 1.818E+12 1.678E+12 1.784E+12 1.666E+12   
 no.cells 148 161 177 87 78   
 no.fields 250 247 254 247 241   
 
Frame 
um2 1614.46 1614.46 1614.46 645.78 645.78   
 Nv 3.66686E-05 4.03740E-05 4.31631E-05 5.45428E-05 5.01179E-05   
 Cells/TW 6.82036E+07 7.33999E+07 7.24276E+07 9.73044E+07 8.34964E+07   
         
 Cell type   
           Pachytene 
spermatocytes IX - XIV   
 Group Control Control Control Control  Control   
 rat no. 20 None 21 Black 21 Blue 21 None 22 None   
 253
 TW(vol) 1.86E+12 1.818E+12 1.678E+12 1.784E+12 1.666E+12   
 no.cells 99 79 77 92 114   
 no.fields 250 247 254 249 246   
 
frame 
um2 1614.46 1614.46 1614.46 1614.46 1614.46   
 Nv 2.45283E-05 1.98108E-05 1.87772E-05 2.28855E-05 2.87040E-05   
 Cells/TW 4.56227E+07 3.60161E+07 3.15081E+07 4.08278E+07 4.78209E+07   
   Acyline   
Cell type   
Type A+intermediate 
spermatogonia  
Group Acyline Acyline Acyline Acyline Acyline 
rat no. 5 None 6 Black 6 Blue 6 None 7 None 
TW(vol) 2.96E+11 3.53E+11 2.81E+11 3.62E+11 2.5E+11 
no.cells 67 42 81 54 44 
no.fields 443 436 457 470 465 
frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 3.51300E-05 2.23753E-05 4.11695E-05 2.66872E-05 2.19789E-05 
Cells/TW 1.03985E+07 7.89849E+06 1.15686E+07 9.66076E+06 5.49473E+06 
      
Cell type   
Type B+preleptotene 
spermatocytes  
group Acyline Acyline Acyline Acyline Acyline 
rat no. 5 None 6 Black 6 Blue 6 None 7 None 
TW(vol) 2.96E+11 3.53E+11 2.81E+11 3.62E+11 2.5E+11 
no.cells 163 135 136 199 186 
no.fields 443 436 450 470 465 
frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 8.54654E-05 7.19207E-05 7.01993E-05 9.83472E-05 9.29109E-05 
Cells/TW 2.52978E+07 2.53880E+07 1.97260E+07 3.56017E+07 2.32277E+07 
      
Cell type   Leptotene/zygotene spermatocytes  
group Acyline Acyline Acyline Acyline Acyline 
rat no. 5 None 6 Black 6 Blue 6 None 7 None 
TW(vol) 2.96E+11 3.53E+11 2.81E+11 3.62E+11 2.5E+11 
no.cells 110 121 125 139 113 
no.fields 450 460 450 450 400 
frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 5.67789E-05 6.10990E-05 6.45215E-05 7.17479E-05 6.56183E-05 
Cells/TW 1.68065E+07 2.15680E+07 1.81305E+07 2.59727E+07 1.64046E+07 
      
Cell type    Sertoli cells   
group Acyline Acyline Acyline Acyline Acyline 
rat no. 5 None 6 Black 6 Blue 6 None 7 None 
TW(vol) 2.96E+11 3.53E+11 2.81E+11 3.62E+11 2.5E+11 
no.cells 173 84 169 94 167 
no.fields 450 450 450 384 400 
frame um2 215.26 215.26 215.26 215.26 215.26 
Nv 1.78595E-04 8.67168E-05 1.74466E-04 1.13719E-04 1.93952E-04 
Cells/TW 5.28642E+07 3.06110E+07 4.90250E+07 4.11663E+07 4.84879E+07 
      
Cell type                 Round spermatids I - VIII  
group Acyline Acyline Acyline Acyline Acyline 
rat no. 5 None 6 Black 6 Blue 6 None 7 None 
TW(vol) 2.96E+11 3.53E+11 2.81E+11 3.62E+11 2.5E+11 
no.cells 68 31 56 53 12 
no.fields 256 255 246 253 247 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
 254
Nv 7.71226E-06 3.52967E-06 6.60946E-06 6.08231E-06 1.41058E-06 
Cells/TW 2.28283E+06 1.24597E+06 1.85726E+06 2.20179E+06 3.52645E+05 
      
Cell type              Elongated spermatids I - VIII  
group Acyline Acyline Acyline Acyline Acyline 
rat no. 5 None 6 Black 6 Blue 6 None 7 None 
TW(vol) 2.96E+11 3.53E+11 2.81E+11 3.62E+11 2.5E+11 
no.cells 0 0 0 0 0 
no.fields 2456 255 246 253 247 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
Nv 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00 
Cells/TW 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00 
      
Cell type   
           Elongated spermatids IX - 
XIV  
group Acyline Acyline Acyline Acyline Acyline 
rat no. 5 None 6 Black 6 Blue 6 None 7 None 
TW(vol) 2.96E+11 3.53E+11 2.81E+11 3.62E+11 2.5E+11 
no.cells 0 2 14 4 0 
no.fields 256 255 246 253 247 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
Nv 0.00000E+00 2.27721E-07 1.65236E-06 4.59042E-07 0.00000E+00 
Cells/TW 0.00000E+00 8.03854E+04 4.64314E+05 1.66173E+05 0.00000E+00 
      
Cell type   
           Pachytene spermatocytes I - 
VIII  
group Acyline Acyline Acyline Acyline Acyline 
rat no. 5 None 6 Black 6 Blue 6 None 7 None 
TW(vol) 2.96E+11 3.53E+11 2.81E+11 3.62E+11 2.5E+11 
no.cells 101 94 103 130 76 
no.fields 256 255 246 253 247 
frame um2 1033.26 1033.26 1033.26 1033.26 1033.26 
Nv 3.81832E-05 3.56762E-05 4.05222E-05 4.97294E-05 2.97788E-05 
Cells/TW 1.13022E+07 1.25937E+07 1.13867E+07 1.80020E+07 7.44470E+06 
      
Cell type   
           Pachytene spermatocytes IX 
- XIV  
group Acyline Acyline Acyline Acyline Acyline 
rat no. 5 None 6 Black 6 Blue 6 None 7 None 
TW(vol) 2.96E+11 3.53E+11 2.81E+11 3.62E+11 2.5E+11 
no.cells 45 28 40 37 36 
no.fields 256 255 246 253 247 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
Nv 5.10370E-06 3.18809E-06 4.72104E-06 4.24614E-06 4.23173E-06 
Cells/TW 1.51070E+06 1.12540E+06 1.32661E+06 1.53710E+06 1.05793E+06 
   Acyline + FSH Ab  
Cell type   
Type A+intermediate 
spermatogonia  
group A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab 
rat no. 2 None 3 Black 3 Blue 3 None 7 Black 
TW(vol) 2.22E+11 2.73E+11 2.76E+11 3.66E+11 3.77E+11 
no.cells 33 53 21 34 49 
no.fields 454 453 322 437 466 
frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 1.68836E-05 2.71759E-05 1.51485E-05 1.80719E-05 2.44240E-05 
Cells/TW 3.74816E+06 7.41903E+06 4.18099E+06 6.61432E+06 9.20785E+06
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Cell type   
Type B+preleptotene 
spermatocytes  
group A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab 
rat no. 2 None 3 Black 3 Blue 3 None 7 Black 
TW(vol) 2.22E+11 2.73E+11 2.76E+11 3.66E+11 3.77E+11 
no.cells 100 94 99 128 171 
no.fields 454 453 322 437 466 
frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 5.11624E-05 4.81988E-05 7.14144E-05 6.80354E-05 8.52348E-05 
Cells/TW 1.13581E+07 1.31583E+07 1.97104E+07 2.49010E+07 3.21335E+07
      
Cell type   
Leptotene/zygotene 
spermatocytes  
group A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab 
rat no. 2 None 3 Black 3 Blue 3 None 7 Black 
TW(vol) 2.22E+11 2.73E+11 2.76E+11 3.66E+11 3.77E+11 
no.cells 129 72 95 60 81 
no.fields 454 453 450 450 400 
frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 6.59995E-05 3.69182E-05 4.90363E-05 3.09703E-05 4.70361E-05 
Cells/TW 1.46519E+07 1.00787E+07 1.35340E+07 1.13351E+07 1.77326E+07
      
Cell type    Sertoli cells   
group A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab 
rat no. 2 None 3 Black 3 Blue 3 None 7 Black 
TW(vol) 2.22E+11 2.73E+11 2.76E+11 3.66E+11 3.77E+11 
no.cells 209 118 116 139 158 
no.fields 450 453 450 450 400 
frame um2 215.26 215.26 215.26 215.26 215.26 
Nv 2.15760E-04 1.21010E-04 1.19752E-04 1.43496E-04 1.83499E-04 
Cells/TW 4.78987E+07 3.30357E+07 3.30515E+07 5.25194E+07 6.91791E+07
      
Cell type                 Round spermatids I - VIII  
group A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab 
rat no. 2 None 3 Black 3 Blue 3 None 7 Black 
TW(vol) 2.22E+11 2.73E+11 2.76E+11 3.66E+11 3.77E+11 
no.cells 55 33 27 53 71 
no.fields 252 170 211 251 253 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
Nv 6.33687E-06 5.63609E-06 3.71530E-06 6.13077E-06 8.14799E-06 
Cells/TW 1.40679E+06 1.53865E+06 1.02542E+06 2.24386E+06 3.07179E+06
      
Cell type              Elongated spermatids I - VIII  
group A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab 
rat no. 2 None 3 Black 3 Blue 3 None 7 Black 
TW(vol) 2.22E+11 2.73E+11 2.76E+11 3.66E+11 3.77E+11 
no.cells 0 0 0 0 0 
no.fields 252 170 211 251 253 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
Nv 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00
Cells/TW 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00
      
Cell type   
           Elongated spermatids IX - 
XIV  
group A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab 
rat no. 2 None 3 Black 3 Blue 3 None 7 Black 
TW(vol) 2.22E+11 2.73E+11 2.76E+11 3.66E+11 3.77E+11 
 256
no.cells 3 0 0 1 0 
no.fields 252 170 211 251 253 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
Nv 3.45648E-07 0.00000E+00 0.00000E+00 1.15675E-07 0.00000E+00
Cells/TW 7.67338E+04 0.00000E+00 0.00000E+00 4.23370E+04 0.00000E+00
      
Cell type   
           Pachytene 
spermatocytes I - VIII 
group A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab 
rat no. 2 None 3 Black 3 Blue 3 None 7 Black 
TW(vol) 2.22E+11 2.73E+11 2.76E+11 3.66E+11 3.77E+11 
no.cells 58 46 105 165 180 
no.fields 252 170 211 251 253 
frame um2 1033.26 1033.26 3444.19 3444.19 3444.19 
Nv 2.22750E-05 2.61878E-05 1.44484E-05 1.90864E-05 2.06569E-05 
Cells/TW 4.94505E+06 7.14927E+06 3.98776E+06 6.98561E+06 7.78765E+06
      
Cell type   
           Pachytene 
spermatocytes IX – XIV 
group A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab A + FSH Ab 
rat no. 2 None 3 Black 3 Blue 3 None 7 Black 
TW(vol) 2.22E+11 2.73E+11 2.76E+11 3.66E+11 3.77E+11 
no.cells 26 7 23 23 19 
no.fields 252 170 211 251 253 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
Nv 2.99561E-06 1.19553E-06 3.16489E-06 2.66052E-06 2.18045E-06 
Cells/TW 6.65026E+05 3.26381E+05 8.73509E+05 9.73751E+05 8.22029E+05
   
Acyline + 
FSH   
Cell type   
Type A+intermediate 
spermatogonia  
group A + FSH A + FSH A + FSH A + FSH A + FSH 
rat no. 16 None 17 Black 17 Blue 17 None 18 None 
TW(vol) 4.92E+11 4.02E+11 4.43E+11 4.02E+11 4.82E+11 
no.cells 25 31 21 28 25 
no.fields 439 458 423 457 456 
frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 1.32276E-05 1.57218E-05 1.15315E-05 1.42314E-05 1.27345E-05 
Cells/TW 6.50800E+06 6.32017E+06 5.10845E+06 5.72103E+06 6.13803E+06
      
Cell type   
Type B+preleptotene 
spermatocytes  
group A + FSH A + FSH A + FSH A + FSH A + FSH 
rat no. 16 None 17 Black 17 Blue 17 None 18 None 
TW(vol) 4.92E+11 4.02E+11 4.43E+11 4.02E+11 4.82E+11 
no.cells 133 185 134 178 166 
no.fields 439 458 423 457 456 
frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 7.03710E-05 9.38238E-05 7.35819E-05 9.04712E-05 8.45571E-05 
Cells/TW 3.46225E+07 3.77172E+07 3.25968E+07 3.63694E+07 4.07565E+07
      
Cell type   
Leptotene/zygotene 
spermatocytes  
group A + FSH A + FSH A + FSH A + FSH A + FSH 
rat no. 16 None 17 Black 17 Blue 17 None 18 None 
TW(vol) 4.92E+11 4.02E+11 4.43E+11 4.02E+11 4.82E+11 
no.cells 93 106 108 109 97 
no.fields 450 373 450 450 457 
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frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 4.80040E-05 6.60091E-05 5.57465E-05 5.62627E-05 4.93017E-05 
Cells/TW 2.36180E+07 2.65357E+07 2.46957E+07 2.26176E+07 2.37634E+07
      
Cell type    Sertoli cells   
group A + FSH A + FSH A + FSH A + FSH A + FSH 
rat no. 16 None 17 Black 17 Blue 17 None 18 None 
TW(vol) 4.92E+11 4.02E+11 4.43E+11 4.02E+11 4.82E+11 
no.cells 70 136 112 116 136 
no.fields 450 450 450 450 450 
frame um2 215.26 215.26 215.26 215.26 215.26 
Nv 7.22640E-05 1.40399E-04 1.15622E-04 1.19752E-04 1.40399E-04 
Cells/TW 3.55539E+07 5.64403E+07 5.12207E+07 4.81402E+07 6.76722E+07
      
Cell type                 Round spermatids I - VIII  
group A + FSH A + FSH A + FSH A + FSH A + FSH 
rat no. 16 None 17 Black 17 Blue 17 None 18 None 
TW(vol) 4.92E+11 4.02E+11 4.43E+11 4.02E+11 4.82E+11 
no.cells 155 86 115 139 143 
no.fields 245 220 249 250 256 
frame um2 1033.26 1033.26 1033.26 1033.26 1033.26 
Nv 6.12288E-05 3.78326E-05 4.46981E-05 5.38103E-05 5.40613E-05 
Cells/TW 3.01246E+07 1.52087E+07 1.98012E+07 2.16317E+07 2.60575E+07
      
Cell type              Elongated spermatids I - VIII  
group A + FSH A + FSH A + FSH A + FSH A + FSH 
rat no. 16 None 17 Black 17 Blue 17 None 18 None 
TW(vol) 4.92E+11 4.02E+11 4.43E+11 4.02E+11 4.82E+11 
no.cells 0 0 0 0 0 
no.fields 245 220 249 250 256 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
Nv 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00
Cells/TW 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00
      
Cell type   
           Elongated spermatids IX - 
XIV  
group A + FSH A + FSH A + FSH A + FSH A + FSH 
rat no. 16 None 17 Black 17 Blue 17 None 18 None 
TW(vol) 4.92E+11 4.02E+11 4.43E+11 4.02E+11 4.82E+11 
no.cells 4 0 20 10 2 
no.fields 245 220 249 250 256 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
Nv 4.74031E-07 0.00000E+00 2.33208E-06 1.16138E-06 2.26831E-07 
Cells/TW 2.33223E+05 0.00000E+00 1.03311E+06 4.66873E+05 1.09333E+05
      
Cell type   
           Pachytene spermatocytes I 
- VIII  
group A + FSH A + FSH A + FSH A + FSH A + FSH 
rat no. 16 None 17 Black 17 Blue 17 None 18 None 
TW(vol) 4.92E+11 4.02E+11 4.43E+11 4.02E+11 4.82E+11 
no.cells 289 289 266 303 290 
no.fields 245 220 249 250 256 
frame um2 1033.26 1033.26 1033.26 1033.26 1033.26 
Nv 1.14162E-04 1.27135E-04 1.03389E-04 1.17299E-04 1.09635E-04 
Cells/TW 5.61678E+07 5.11083E+07 4.58012E+07 4.71541E+07 5.28440E+07
      
Cell type              Pachytene spermatocytes  
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IX - XIV 
group A + FSH A + FSH A + FSH A + FSH A + FSH 
rat no. 16 None 17 Black 17 Blue 17 None 18 None 
TW(vol) 4.92E+11 4.02E+11 4.43E+11 4.02E+11 4.82E+11 
no.cells 174 99 135 145 133 
no.fields 245 220 249 250 256 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
Nv 2.06204E-05 1.30655E-05 1.57415E-05 1.68400E-05 1.50843E-05 
Cells/TW 1.01452E+07 5.25232E+06 6.97350E+06 6.76966E+06 7.27062E+06
   
Acyline + hCG + 
FSH Ab  
Cell type   
Type A+intermediate 
spermatogonia  
group 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
rat no. 9 None 10 Black 10 Blue 10 None 14 None 
TW(vol) 4.6E+11 3.6E+11 5.13E+11 3.7E+11 3.72E+11 
no.cells 22 32 26 28 24 
no.fields 443 462 454 458 369 
frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 1.15352E-05 1.60885E-05 1.33022E-05 1.42004E-05 1.51075E-05 
Cells/TW 5.30620E+06 5.79185E+06 6.82404E+06 5.25413E+06 5.61998E+06
      
Cell type   
Type B+preleptotene 
spermatocytes  
group 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
rat no. 9 None 10 Black 10 Blue 10 None 14 None 
TW(vol) 4.6E+11 3.6E+11 5.13E+11 3.7E+11 3.72E+11 
no.cells 92 101 88 118 108 
no.fields 443 464 454 458 369 
frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 4.82382E-05 5.05603E-05 4.50229E-05 5.98444E-05 6.79836E-05 
Cells/TW 2.21896E+07 1.82017E+07 2.30967E+07 2.21424E+07 2.52899E+07
      
Cell type   
Leptotene/zygotene 
spermatocytes  
group 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
rat no. 9 None 10 Black 10 Blue 10 None 14 None 
TW(vol) 4.6E+11 3.6E+11 5.13E+11 3.7E+11 3.72E+11 
no.cells 87 116 62 89 99 
no.fields 400 450 450 450 369 
frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 5.05203E-05 5.98759E-05 3.20026E-05 4.59393E-05 6.23183E-05 
Cells/TW 2.32393E+07 2.15553E+07 1.64174E+07 1.69975E+07 2.31824E+07
      
Cell type    Sertoli cells   
group 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
rat no. 9 None 10 Black 10 Blue 10 None 14 None 
TW(vol) 4.6E+11 3.6E+11 5.13E+11 3.7E+11 3.72E+11 
no.cells 116 141 58 198 120 
no.fields 400 450 450 450 369 
frame um2 215.26 215.26 215.26 215.26 215.26 
Nv 1.34721E-04 1.45560E-04 5.98759E-05 2.04404E-04 1.51075E-04 
Cells/TW 6.19716E+07 5.24017E+07 3.07163E+07 7.56295E+07 5.61998E+07
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Cell type                 Round spermatids I - VIII  
group 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
rat no. 9 None 10 Black 10 Blue 10 None 14 None 
TW(vol) 4.6E+11 3.6E+11 5.13E+11 3.7E+11 3.72E+11 
no.cells 27 102 120 51 197 
no.fields 219 242 258 194 242 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
Nv 3.57958E-06 1.22376E-05 1.35044E-05 7.63276E-06 2.36354E-05 
Cells/TW 1.64661E+06 4.40555E+06 6.92774E+06 2.82412E+06 8.79239E+06
      
Cell type              Elongated spermatids I - VIII  
group 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
rat no. 9 None 10 Black 10 Blue 10 None 14 None 
TW(vol) 4.6E+11 3.6E+11 5.13E+11 3.7E+11 3.72E+11 
no.cells 0 0 0 0 0 
no.fields 219 242 258 194 242 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
Nv 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00
Cells/TW 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00
      
Cell type   
           Elongated spermatids IX - 
XIV  
group 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
rat no. 9 None 10 Black 10 Blue 10 None 14 None 
TW(vol) 4.6E+11 3.6E+11 5.13E+11 3.7E+11 3.72E+11 
no.cells 0 0 1 10 0 
no.fields 219 242 258 194 242 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
Nv 0.00000E+00 0.00000E+00 1.12536E-07 1.49662E-06 0.00000E+00
Cells/TW 0.00000E+00 0.00000E+00 5.77312E+04 5.53749E+05 0.00000E+00
      
Cell type   
           Pachytene spermatocytes I 
- VIII  
group 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
rat no. 9 None 10 Black 10 Blue 10 None 14 None 
TW(vol) 4.6E+11 3.6E+11 5.13E+11 3.7E+11 3.72E+11 
no.cells 125 187 129 84 155 
no.fields 219 242 258 194 242 
frame um2 1033.26 1033.26 1033.26 1033.26 1033.26 
Nv 5.52403E-05 7.47854E-05 4.83905E-05 4.19052E-05 6.19879E-05 
Cells/TW 2.54106E+07 2.69227E+07 2.48243E+07 1.55049E+07 2.30595E+07
      
Cell type   
           Pachytene spermatocytes 
IX - XIV  
group 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
A + hCG + F 
Ab 
rat no. 9 None 10 Black 10 Blue 10 None 14 None 
TW(vol) 4.6E+11 3.6E+11 5.13E+11 3.7E+11 3.72E+11 
no.cells 53 90 90 56 51 
no.fields 219 242 258 194 242 
frame um2 3444.19 3444.19 3444.19 3444.19 3444.19 
Nv 7.02659E-06 1.07979E-05 1.01283E-05 8.38106E-06 6.11882E-06 
Cells/TW 3.23223E+06 3.88725E+06 5.19581E+06 3.10099E+06 2.27620E+06
   Acyline +   
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hCG 
Cell type   
Type A+intermediate 
spermatogonia  
group A + hCG A + hCG A + hCG A + hCG A + hCG 
rat no. 12 None 13 Black 13 Blue 13 None 18 Black 
TW(vol) 5.05E+11 5.71E+11 3.75E+11 3.61E+11 5.76E+11 
no.cells 17 19 37 35 28 
no.fields 455 428 447 363 454 
frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 8.67849E-06 1.03114E-05 1.92265E-05 2.23959E-05 1.43255E-05 
Cells/TW 4.38264E+06 5.88779E+06 7.20995E+06 8.08491E+06 8.25147E+06
      
Cell type   
Type B+preleptotene 
spermatocytes  
group A + hCG A + hCG A + hCG A + hCG A + hCG 
rat no. 12 None 13 Black 13 Blue 13 None 18 Black 
TW(vol) 5.05E+11 5.71E+11 3.75E+11 3.61E+11 5.76E+11 
no.cells 116 83 124 120 113 
no.fields 455 428 447 363 454 
frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 5.92179E-05 4.50444E-05 6.44349E-05 7.67859E-05 5.78135E-05 
Cells/TW 2.99051E+07 2.57204E+07 2.41631E+07 2.77197E+07 3.33006E+07
      
Cell type   
Leptotene/zygotene 
spermatocytes  
group A + hCG A + hCG A + hCG A + hCG A + hCG 
rat no. 12 None 13 Black 13 Blue 13 None 18 Black 
TW(vol) 5.05E+11 5.71E+11 3.75E+11 3.61E+11 5.76E+11 
no.cells 92 68 129 95 103 
no.fields 450 450 450 400 446 
frame um2 430.52 430.52 430.52 430.52 430.52 
Nv 4.74878E-05 3.50997E-05 6.65861E-05 5.51658E-05 5.36425E-05 
Cells/TW 2.39813E+07 2.00419E+07 2.49698E+07 1.99149E+07 3.08981E+07
      
Cell type    Sertoli cells   
group A + hCG A + hCG A + hCG A + hCG A + hCG 
rat no. 12 None 13 Black 13 Blue 13 None 18 Black 
TW(vol) 5.05E+11 5.71E+11 3.75E+11 3.61E+11 5.76E+11 
no.cells 109 107 117 83 98 
no.fields 450 450 450 400 446 
frame um2 215.26 215.26 215.26 215.26 215.26 
Nv 1.12525E-04 1.10461E-04 1.20784E-04 9.63951E-05 1.02077E-04 
Cells/TW 5.68253E+07 6.30731E+07 4.52941E+07 3.47986E+07 5.87963E+07
      
Cell type                 Round spermatids I - VIII  
group A + hCG A + hCG A + hCG A + hCG A + hCG 
rat no. 12 None 13 Black 13 Blue 13 None 18 Black 
TW(vol) 5.05E+11 5.71E+11 3.75E+11 3.61E+11 5.76E+11 
no.cells 191 176 98 83 83 
no.fields 252 248 304 219 252 
frame um2 3444.19 3444.56 1033.26 1033.26 3444.19 
Nv 2.20062E-05 2.06028E-05 3.11992E-05 3.66796E-05 9.56292E-06 
Cells/TW 1.11131E+07 1.17642E+07 1.16997E+07 1.32413E+07 5.50824E+06
      
Cell type              Elongated spermatids I - VIII  
group A + hCG A + hCG A + hCG A + hCG A + hCG 
rat no. 12 None 13 Black 13 Blue 13 None 18 Black 
 261
TW(vol) 5.05E+11 5.71E+11 3.75E+11 3.61E+11 5.76E+11 
no.cells 0 0 0 0 0 
no.fields 252 248 304 219 252 
frame um2 3444.19 3444.56 3444.19 3444.19 3444.19 
Nv 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00
Cells/TW 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00 0.00000E+00
      
Cell type   
           Elongated spermatids IX - 
XIV  
group A + hCG A + hCG A + hCG A + hCG A + hCG 
rat no. 12 None 13 Black 13 Blue 13 None 18 Black 
TW(vol) 5.05E+11 5.71E+11 3.75E+11 3.61E+11 5.76E+11 
no.cells 17 5 0 7 0 
no.fields 252 248 304 219 252 
frame um2 3444.19 3444.56 3444.19 3444.19 3444.19 
Nv 1.95867E-06 5.85308E-07 0.00000E+00 9.28040E-07 0.00000E+00
Cells/TW 9.89128E+05 3.34211E+05 0.00000E+00 3.35023E+05 0.00000E+00
      
Cell type   
           Pachytene spermatocytes I 
- VIII  
group A + hCG A + hCG A + hCG A + hCG A + hCG 
rat no. 12 None 13 Black 13 Blue 13 None 18 Black 
TW(vol) 5.05E+11 5.71E+11 3.75E+11 3.61E+11 5.76E+11 
no.cells 179 182 297 260 214 
no.fields 252 248 304 219 252 
frame um2 1033.26 1033.26 1033.26 1033.26 1033.26 
Nv 6.87453E-05 7.10248E-05 9.45526E-05 1.14900E-04 8.21871E-05 
Cells/TW 3.47164E+07 4.05552E+07 3.54572E+07 4.14789E+07 4.73398E+07
      
Cell type   
           Pachytene spermatocytes 
IX - XIV  
group A + hCG A + hCG A + hCG A + hCG A + hCG 
rat no. 12 None 13 Black 13 Blue 13 None 18 Black 
TW(vol) 5.05E+11 5.71E+11 3.75E+11 3.61E+11 5.76E+11 
no.cells 61 68 122 71 86 
no.fields 252 248 304 219 252 
frame um2 3444.19 3444.56 3444.19 3444.19 3444.19 
Nv 7.02817E-06 7.96019E-06 1.16520E-05 9.41298E-06 9.90857E-06 
Cells/TW 3.54923E+06 4.54527E+06 4.36949E+06 3.39809E+06 5.70733E+06
 
 
 
 
 
 
 
 
 
 262
Appendix 1.5: Individual human immunos.  
*Full size pictures presented on CD inside back cover 
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